data_6e3c_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6e3c _Structure_validation_residue.Date_analyzed 2019-04-12 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.471 HD21 ' HA ' ' C' ' 22' ' ' SER . 8.1 mt . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.7 ' CB ' ' HA ' ' C' ' 87' ' ' THR . 52.5 m-85 -117.71 -161.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -166.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -122.63 127.98 50.06 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 -157.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.568 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -74.84 -165.92 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.184 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.481 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.73 -44.69 96.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.93 -9.7 14.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.235 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.89 23.62 1.43 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.445 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.568 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 77.6 t -83.57 150.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' C' ' 70' ' ' GLN . 0.2 OUTLIER -83.54 148.02 27.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.131 0.967 . . . . 0.0 111.084 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.0 144.9 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.395 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.471 ' HA ' HD21 ' C' ' 12' ' ' LEU . 22.8 t -94.93 142.93 26.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.57 39.88 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.405 0.621 . . . . 0.0 110.313 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.423 HD13 ' N ' ' C' ' 24' ' ' LEU . 5.1 mp -108.09 97.95 24.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.764 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.7 101.64 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.431 2.087 . . . . 0.0 112.233 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.4 mt -66.36 110.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.426 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -81.01 -74.02 0.34 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.473 0.654 . . . . 0.0 109.496 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.94 169.97 16.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.212 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.423 0.63 . . . . 0.0 110.847 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.491 ' HD3' ' C ' ' C' ' 30' ' ' LYS . 1.4 tmtp? -103.04 101.4 11.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.413 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -87.87 104.78 16.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.763 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 143.84 29.57 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.546 0.688 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -66.38 -13.13 60.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.174 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -76.22 -20.89 57.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.58 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.03 -37.63 2.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.496 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 69.7 p -74.85 157.77 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.893 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.12 139.77 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 2.5 p-10 -110.02 129.23 55.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.39 125.58 38.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.263 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -89.39 118.21 28.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.25 152.03 33.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.95 32.68 5.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' C' ' 45' ' ' TYR . . . -115.38 -137.49 6.28 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.846 172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.85 30.07 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.553 2.169 . . . . 0.0 111.539 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' C' ' 43' ' ' GLY . 88.3 m-85 -142.45 139.81 31.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.778 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.36 -160.78 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.191 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.08 133.78 53.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 51.2 mm-40 -127.13 108.74 11.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -80.07 128.52 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.381 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.8 mmm -117.39 144.95 44.43 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' SER . . . . . 0.549 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 0.0 OUTLIER -65.25 156.76 30.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -57.34 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . 0.549 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 0.8 OUTLIER -61.72 -26.36 68.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.108 0.48 . . . . 0.0 110.395 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -75.76 -41.75 52.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.347 0.594 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.5 t -70.14 -17.2 20.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.382 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.2 -27.7 47.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.0 -32.2 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.364 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.96 16.19 26.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 49.4 pttt -59.53 107.09 0.86 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 111.399 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.452 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 87.7 Cg_endo -102.24 -150.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.649 2.899 . . . . 0.0 112.011 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.452 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 43.1 mt-10 -127.05 142.86 51.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.417 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.18 121.74 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 122.126 0.965 . . . . 0.0 109.683 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.63 28.8 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.472 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.27 -165.07 33.72 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.992 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -132.7 131.25 41.06 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' C' ' 75' ' ' LEU . 8.8 tt -114.13 154.52 27.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 53.4 p90 -134.14 159.57 40.46 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.173 -0.329 . . . . 0.0 110.272 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -133.36 116.0 15.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 71.7 p -100.01 162.69 12.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.833 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 13.8 mm100 -63.25 -15.73 58.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.775 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -81.08 -10.7 59.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.79 8.98 61.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.63 114.62 26.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.9 pt? -126.86 128.71 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 72.8 mt -150.48 159.9 44.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.894 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 139.95 34.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 1.7 mmt -137.43 163.16 31.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.381 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -81.04 143.33 32.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -52.36 -36.45 53.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -167.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.2 p -58.7 -49.35 77.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 111.356 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.79 -42.08 58.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.272 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -54.04 -52.31 61.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.93 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.65 -37.3 84.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.068 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.36 -19.6 31.19 Favored 'General case' 0 C--N 1.315 -0.929 0 O-C-N 121.869 -0.519 . . . . 0.0 111.291 -168.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.467 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.7 m-80 -113.74 -25.84 8.48 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.762 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.2 m-85 -128.66 25.57 5.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.7 ' HA ' ' CB ' ' C' ' 13' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.93 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.631 ' HB2' ' CZ ' ' C' ' 20' ' ' TYR . 2.2 mm? . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.447 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 29.7 m-85 -95.59 -179.54 4.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -166.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 93.3 mttt -140.03 131.64 27.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -170.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.557 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -77.33 -168.41 1.13 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.736 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.63 -38.29 86.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -105.85 -0.34 25.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.269 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.48 13.27 6.92 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.292 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 51.7 t -70.23 119.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' C' ' 12' ' ' LEU . 33.5 t80 -77.78 137.72 38.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 109.736 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.6 131.75 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.54 -171.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.403 ' HA ' ' HG ' ' C' ' 12' ' ' LEU . 12.1 m -89.21 141.48 28.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.61 117.48 34.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.625 0.726 . . . . 0.0 110.647 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.45 ' N ' HD21 ' C' ' 24' ' ' LEU . 2.3 mm? -113.51 101.32 53.52 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.518 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.669 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 23.0 Cg_exo -63.46 143.01 87.19 Favored 'Trans proline' 0 C--O 1.221 -0.368 0 C-N-CA 121.678 1.585 . . . . 0.0 110.775 -174.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' C' ' 60' ' ' PRO . 72.1 mt -78.55 106.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.669 ' HG3' ' O ' ' C' ' 25' ' ' PRO . 0.0 OUTLIER -90.83 -73.69 0.52 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.67 -162.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.11 144.27 19.83 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.184 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -142.83 153.94 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.567 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -146.67 144.06 29.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -93.27 126.11 38.22 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.61 176.92 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.41 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -60.7 -52.92 63.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.438 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.44 -28.79 68.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.665 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.84 -25.19 3.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.328 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 40.2 m -57.18 144.9 33.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.572 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.44 131.81 52.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -91.28 94.85 9.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.83 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.55 156.89 22.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.118 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 7.3 pt-20 -162.34 115.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . 0.654 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 30.3 m-85 -60.4 154.18 21.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.539 0.685 . . . . 0.0 112.691 165.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.58 -27.83 17.11 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.219 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.34 170.15 52.06 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.416 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.27 67.22 2.69 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.795 2.33 . . . . 0.0 112.371 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.427 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 90.2 m-85 -133.28 -174.96 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.29 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.719 ' O ' ' HB2' ' C' ' 47' ' ' ASP . . . -66.02 -160.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.255 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' C' ' 46' ' ' ALA . 3.6 m-20 99.95 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.594 1.158 . . . . 0.0 111.625 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.08 -152.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.193 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 121.39 18.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.125 0.488 . . . . 0.0 110.158 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.06 146.56 44.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.93 136.48 51.7 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.741 0.651 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.04 92.34 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.22 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -62.64 -32.75 73.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.518 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -73.41 -42.63 61.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.662 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -68.06 -26.22 33.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.747 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.39 74.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.089 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.8 -30.07 4.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.242 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.96 7.4 45.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.408 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 23.2 tptm -58.19 108.6 1.35 Allowed Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.581 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' C' ' 26' ' ' ILE . 54.9 Cg_endo -104.76 -148.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 124.072 3.181 . . . . 0.0 111.872 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 42.8 mt-10 -132.71 124.05 27.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.758 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.18 121.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 122.388 1.09 . . . . 0.0 110.476 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.98 30.78 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.247 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.53 -172.12 42.74 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.953 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 95.2 m-85 -124.67 112.1 16.38 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.961 0.41 . . . . 0.0 110.778 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 22.1 tp -85.76 147.45 26.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.507 ' HB2' ' CG2' ' C' ' 21' ' ' VAL . 39.3 p90 -147.09 153.18 39.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.52 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 3.9 ptp85 -146.8 145.0 29.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.24 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 88.6 p -115.07 -177.36 3.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.014 0.435 . . . . 0.0 111.513 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -56.83 -42.11 79.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.814 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.76 3.98 15.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.049 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.93 27.98 59.54 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.902 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 42.7 mt-10 -75.52 105.93 6.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' C' ' 75' ' ' LEU . 2.9 tm? -107.85 130.18 55.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.363 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' C' ' 74' ' ' LEU . 57.7 mt -168.06 162.73 13.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.638 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -129.3 148.16 51.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.417 ' HE1' ' HB2' ' C' ' 77' ' ' MET . 33.2 ttm -152.79 149.51 28.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.653 0.263 . . . . 0.0 111.225 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 15.7 p -68.82 146.91 52.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.144 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 21.5 pttp -56.52 -29.54 61.98 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -166.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -60.4 -55.24 35.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.076 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.91 45.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.482 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 55.8 t80 -59.16 -49.31 78.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.069 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -73.18 -32.56 64.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.658 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.64 -26.03 61.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.175 -172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 45.9 m-80 -99.87 -37.37 9.07 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.615 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.589 ' O ' HG21 ' C' ' 87' ' ' THR . 0.1 OUTLIER -135.21 72.23 1.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.589 HG21 ' O ' ' C' ' 86' ' ' TYR . 51.0 p . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 166.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.724 ' CB ' ' HA ' ' C' ' 86' ' ' TYR . 76.0 m-85 -140.0 -161.61 1.22 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.635 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -129.09 132.82 47.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.355 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' C' ' 84' ' ' ALA . 3.7 p-10 -86.65 -153.0 0.19 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.734 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.68 67.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -167.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.88 4.21 23.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.591 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.52 24.77 6.01 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.66 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.562 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.1 t -86.84 133.03 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 140.42 36.88 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.881 0.848 . . . . 0.0 109.91 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.3 145.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.242 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 6.3 m -105.82 131.53 53.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.0 117.06 33.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.614 0.721 . . . . 0.0 110.935 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.401 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.6 mp -96.33 111.77 57.77 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.31 114.34 4.01 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.543 2.162 . . . . 0.0 112.42 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 42.0 mt -79.0 107.2 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -75.57 -57.7 3.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.172 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.33 163.29 39.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.735 0.302 . . . . 0.0 111.078 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 62.7 mt -142.01 146.67 22.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.848 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.504 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 21.1 ptmt -133.25 144.53 49.81 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.29 123.89 50.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.822 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 167.91 12.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.441 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.19 -11.28 60.25 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.034 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -93.31 -5.87 48.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.953 0.406 . . . . 0.0 110.573 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.05 -16.83 42.2 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.793 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -71.46 140.99 50.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -112.85 120.24 40.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.134 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.504 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 5.7 t30 -83.3 119.26 24.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.008 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -114.22 124.94 53.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.98 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.55 131.49 54.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.021 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.84 154.68 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.612 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -87.12 74.13 9.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.128 0.966 . . . . 0.0 110.017 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.74 -171.6 43.84 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.246 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.69 50.9 3.58 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.079 2.52 . . . . 0.0 111.869 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.36 -176.55 3.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.31 166.41 18.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.854 0.835 . . . . 0.0 112.926 -174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.694 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 6.6 p-10 -149.63 85.66 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.105 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 77.7 mt-30 -149.12 154.68 39.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.791 -163.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 8.3 p90 -89.26 112.41 23.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.571 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.6 mtp -85.18 147.07 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.121 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.06 141.09 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.996 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.87 -22.84 65.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.18 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -68.6 -38.51 80.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.9 m -77.78 -38.51 46.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.786 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.33 -18.58 19.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.288 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.53 80.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.022 0.439 . . . . 0.0 110.502 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.8 -33.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.307 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -109.54 22.65 15.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -48.79 106.07 0.57 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.4 0.437 . . . . 0.0 111.433 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.83 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.851 2.368 . . . . 0.0 112.112 -172.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -136.0 138.85 42.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.9 105.02 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 11.17 60.11 Favored Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.089 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.2 -160.15 35.78 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.56 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.67 134.46 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.12 0.486 . . . . 0.0 111.163 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 48.1 tp -115.87 111.58 20.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.076 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -108.9 144.47 36.77 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.543 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' C' ' 74' ' ' LEU . 28.5 ptt180 -123.06 142.53 50.77 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.251 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 59.3 p -94.33 -174.87 3.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -54.46 -43.37 71.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.548 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -79.33 2.32 21.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.287 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.7 22.94 71.13 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.249 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.78 118.4 20.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' C' ' 68' ' ' ARG . 6.8 mt -99.97 126.92 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.259 0.552 . . . . 0.0 112.103 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.41 HD22 ' C ' ' C' ' 74' ' ' LEU . 3.2 mm? -132.41 140.84 48.62 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.636 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' C' ' 77' ' ' MET . 27.1 p90 -112.98 157.41 21.54 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.489 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -178.23 166.29 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.23 0.331 . . . . 0.0 110.524 172.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' SER . . . . . 0.489 ' H ' ' HG3' ' C' ' 77' ' ' MET . 6.3 p -74.52 -156.76 0.05 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -67.93 -41.89 81.88 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -168.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 16.8 p -44.76 -63.58 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.75 0.656 . . . . 0.0 112.358 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.2 -37.18 80.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.758 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.698 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 28.9 t80 -59.72 -42.2 92.57 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . 0.807 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 40.9 tt0 -62.97 -24.88 68.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.851 0.834 . . . . 0.0 110.669 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' C' ' 15' ' ' ASP . . . -89.63 2.14 55.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' C' ' 15' ' ' ASP . 16.7 m-80 -119.94 -19.69 7.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.978 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.807 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 5.9 p90 -115.11 7.24 15.35 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.21 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.224 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.606 ' HB3' ' O ' ' C' ' 86' ' ' TYR . 26.5 m-85 -106.83 162.85 13.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.373 -169.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.522 ' H ' ' HA ' ' C' ' 87' ' ' THR . 98.8 mttt -150.09 152.82 35.39 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -164.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.585 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -90.65 -156.99 0.46 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.735 175.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.91 -51.85 55.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.27 -8.36 23.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.564 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.77 16.63 2.7 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.763 -1.208 . . . . 0.0 113.206 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.585 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 76.3 t -76.9 101.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 173.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' C' ' 14' ' ' LYS . 2.8 p90 -81.19 168.58 18.37 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.627 0.727 . . . . 0.0 110.511 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -146.89 140.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.179 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -86.44 141.65 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -108.28 117.4 34.04 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.453 0.644 . . . . 0.0 110.598 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -104.25 100.52 22.01 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.354 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.431 ' HB2' ' OD1' ' C' ' 42' ' ' ASP . 16.3 Cg_exo -68.42 121.1 8.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.316 2.011 . . . . 0.0 112.358 -172.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' C' ' 60' ' ' PRO . 40.0 mt -79.87 101.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.194 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 22.8 ttmm -67.92 -69.31 0.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.443 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.86 148.21 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 41.3 mt -132.16 151.81 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.131 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -135.68 116.45 14.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.268 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.98 119.3 31.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.084 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.4 161.84 13.91 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.994 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.59 -11.64 61.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.011 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.81 -13.86 38.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 -31.22 6.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.741 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -68.44 141.58 55.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.95 55.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 8.1 t30 -88.95 116.37 27.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.57 162.37 14.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.451 ' CA ' ' HB3' ' C' ' 47' ' ' ASP . 38.4 mt-10 -154.07 127.25 8.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.4 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.02 155.88 17.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' C' ' 25' ' ' PRO . 6.0 p-10 -110.41 171.45 7.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -155.9 23.54 Favored Glycine 0 C--N 1.307 -1.05 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -169.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.37 39.8 0.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.671 2.247 . . . . 0.0 112.021 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.96 159.53 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 111.724 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.48 179.93 3.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.077 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.451 ' HB3' ' CA ' ' C' ' 40' ' ' GLU . 3.8 t0 -167.62 169.5 11.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 165.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -149.49 179.75 7.72 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.475 -158.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.6 p90 -85.57 125.38 33.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 95.3 mmm -122.25 156.58 33.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.945 0.403 . . . . 0.0 111.487 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.75 151.9 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.355 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.13 77.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.36 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.09 -38.87 84.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.465 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.4 m -73.32 -41.23 63.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.965 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.447 ' O ' HG13 ' C' ' 55' ' ' VAL . 98.7 t -77.55 -12.07 13.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.87 61.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.984 0.421 . . . . 0.0 110.253 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.38 -33.9 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.035 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -105.11 22.63 15.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.941 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 53.6 pttt -53.86 107.53 0.88 Allowed Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.518 0.512 . . . . 0.0 111.011 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.46 ' HB2' HD12 ' C' ' 26' ' ' ILE . 6.9 Cg_endo -93.61 -156.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.159 2.572 . . . . 0.0 112.367 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -143.4 130.44 20.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.992 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.42 100.66 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.133 0.492 . . . . 0.0 110.227 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.49 -25.39 5.1 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.312 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.27 -165.28 37.66 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.194 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.26 126.39 48.07 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.655 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.37 140.07 29.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 45.4 p90 -137.37 159.66 41.3 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.675 -173.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 48.0 ttt180 -139.19 135.65 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.784 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 87.0 p -107.33 -178.63 3.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.98 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.42 -28.63 69.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -75.62 -14.46 60.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.581 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 20.86 34.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 7.1 tp10 -69.44 101.03 1.48 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt -103.36 108.45 19.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.644 0.735 . . . . 0.0 110.972 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 98.6 mt -146.46 177.39 9.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.149 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -130.18 143.68 50.92 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -148.62 136.16 20.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.994 0.426 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -69.4 150.57 47.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.166 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.25 -38.87 59.36 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.31 -59.02 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 111.824 -176.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.17 -33.3 61.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.494 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 56.4 t80 -58.99 -47.53 84.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.171 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . 0.565 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 4.7 tp10 -62.64 -40.95 98.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.94 -18.43 40.08 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.819 -0.55 . . . . 0.0 111.613 -166.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.434 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.1 m-80 -121.09 -31.53 4.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 2.3 m-85 -117.91 13.84 14.09 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -171.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' C' ' 83' ' ' GLU . 13.7 p . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 118.647 0.658 . . . . 0.0 109.586 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.665 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 22.1 m-85 -92.92 156.05 17.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.834 -0.166 . . . . 0.0 110.762 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.7 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 23.8 ttpp -124.74 136.41 53.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.371 0.605 . . . . 0.0 110.38 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.556 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -81.5 -164.95 0.85 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.174 176.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.85 -56.43 10.41 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -98.94 -1.37 40.12 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.791 -168.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.66 13.92 2.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.289 -1.434 . . . . 0.0 114.037 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.556 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 61.2 t -80.6 125.34 39.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -96.73 174.38 6.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.331 -0.547 . . . . 0.0 109.828 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.66 139.81 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -175.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 46.1 m -77.8 142.08 38.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.6 117.7 34.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.352 0.596 . . . . 0.0 109.8 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 1.2 mm? -112.44 98.15 42.63 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.872 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.16 104.23 0.71 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.537 2.158 . . . . 0.0 111.806 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' C' ' 66' ' ' LEU . 8.4 mt -72.13 94.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -75.43 -59.23 2.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.154 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' C' ' 62' ' ' VAL . . . -155.61 148.18 24.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.943 0.401 . . . . 0.0 111.573 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 32.9 mt -137.68 131.63 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.969 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -124.52 110.45 14.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.89 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.18 115.42 6.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.167 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.4 -174.89 5.44 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.039 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.23 -26.27 52.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.182 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.73 -20.64 30.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.122 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.25 -32.55 4.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.916 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -65.09 157.99 27.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.98 131.37 49.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.939 0.399 . . . . 0.0 111.623 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 71.7 m-20 -77.42 126.95 31.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.766 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -105.19 153.9 20.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -136.25 122.1 19.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.871 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -122.32 -179.3 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.17 -39.9 73.06 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.83 -73.24 0.06 OUTLIER Glycine 0 C--N 1.316 -0.582 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.713 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.89 14.88 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.862 2.374 . . . . 0.0 113.913 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -128.8 -175.77 3.64 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.92 119.77 2.1 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 0.5 OUTLIER -133.8 61.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.261 168.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -167.64 175.04 7.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.299 -169.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 26.2 p90 -73.27 133.56 43.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 82.5 mtp -108.74 144.08 37.02 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.08 136.7 47.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.394 0.616 . . . . 0.0 111.312 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.88 76.4 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.316 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.504 0.668 . . . . 0.0 109.552 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -72.33 -40.99 67.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.719 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 72.4 t -74.67 -16.83 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.32 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.58 -35.5 67.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.82 -33.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.123 0.487 . . . . 0.0 110.092 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . 0.45 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 83.1 m-85 -102.83 18.0 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.445 -172.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 0.1 OUTLIER -71.0 110.12 6.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.088 170.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 56.7 Cg_endo -96.83 -100.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.708 2.272 . . . . 0.0 112.149 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -153.48 143.4 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' C' ' 28' ' ' ALA . 69.0 t -82.49 110.31 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.049 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.52 11.12 36.55 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.824 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.58 -163.41 29.25 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.164 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -132.16 123.73 27.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 15.2 tp -100.43 156.41 17.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.1 p90 -142.13 147.35 36.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.346 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -128.83 115.46 17.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 16.0 p -96.97 163.96 12.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.398 0.618 . . . . 0.0 110.125 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -73.5 -0.41 14.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.677 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.35 -4.55 58.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.04 24.11 46.1 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.527 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.417 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 7.0 tp10 -99.9 121.32 41.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.407 ' C ' HD21 ' C' ' 75' ' ' LEU . 6.5 mp -125.76 112.34 15.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 2.8 mm? -135.11 169.68 17.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.502 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -124.25 154.56 40.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 20.4 ptp -178.12 -178.79 0.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.36 0.413 . . . . 0.0 109.992 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 9.1 p -67.48 125.83 27.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -65.92 -23.54 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -59.54 -40.62 87.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.027 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.83 51.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.409 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 11.7 t80 -68.43 -42.05 79.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.74 -27.72 68.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.19 0.519 . . . . 0.0 111.085 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.39 -34.45 63.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.193 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.466 ' N ' HD21 ' C' ' 85' ' ' ASN . 0.9 OUTLIER -97.44 -33.47 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.318 -177.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.7 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 25.6 m-85 -90.79 -57.33 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -169.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.665 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 43.5 p . . . . . 0 C--N 1.317 -0.836 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.592 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.95 163.2 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -166.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 12.8 mptt -118.69 -173.7 2.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.51 0.672 . . . . 0.0 111.742 -167.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.54 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.6 OUTLIER -127.84 -148.57 0.38 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.515 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.454 ' H ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.91 -40.98 71.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.73 -12.69 13.33 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.491 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.79 26.16 1.3 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.522 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.54 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 68.5 t -83.88 124.44 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -91.15 175.27 7.0 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.447 0.641 . . . . 0.0 110.817 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.28 134.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 37.3 m -78.19 141.04 38.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . 0.446 ' C ' HD21 ' C' ' 24' ' ' LEU . . . -127.9 137.46 52.31 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 0.4 OUTLIER -116.16 97.57 49.78 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.95 122.34 10.82 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.34 2.027 . . . . 0.0 111.3 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.0 mt -83.58 107.69 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -69.95 -64.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.09 159.4 36.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -139.02 141.9 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.473 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -120.74 109.09 14.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.448 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.01 108.42 15.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.088 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.83 145.95 26.97 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -61.36 -18.88 60.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.887 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.83 -20.74 57.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.15 -38.17 2.07 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.204 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -73.64 152.94 40.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.407 . . . . 0.0 111.027 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.7 128.71 25.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.4 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 24.9 p30 -80.57 149.01 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.348 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -135.37 133.39 38.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.663 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.24 138.8 54.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.192 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' C' ' 45' ' ' TYR . 53.0 m-85 -112.38 -177.48 3.17 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -52.68 -51.61 59.51 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.64 -144.0 7.59 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.239 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.78 62.38 5.65 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.54 2.827 . . . . 0.0 111.671 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' C' ' 41' ' ' PHE . 93.7 m-85 -115.43 -173.94 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.242 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 144.34 10.89 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.755 0.788 . . . . 0.0 112.523 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 28.1 t70 -148.02 80.84 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.656 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 9.2 pt20 -152.84 158.28 41.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -166.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 78.9 m-85 -79.33 114.25 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.883 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.7 mmt -84.01 145.01 28.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.08 171.0 4.96 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.92 -48.82 67.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.226 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . 0.452 ' O ' HG21 ' C' ' 57' ' ' VAL . 29.0 mt-30 -63.44 -31.53 72.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.262 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -73.87 -51.82 14.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.604 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 24.1 t -64.53 -31.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.414 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.02 70.97 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.198 -0.314 . . . . 0.0 111.712 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . 0.452 HG21 ' O ' ' C' ' 53' ' ' GLN . 2.9 t -97.09 -30.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . 0.417 ' CD1' HD23 ' C' ' 75' ' ' LEU . 34.9 m-85 -109.26 14.54 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.091 -171.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 18.9 ptpt -53.88 117.73 13.38 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-O 121.177 0.513 . . . . 0.0 112.383 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 91.4 Cg_endo -105.14 -152.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 124.153 3.235 . . . . 0.0 111.291 172.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 22.3 mt-10 -141.67 154.49 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.63 130.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.822 0.82 . . . . 0.0 109.86 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 -10.37 39.77 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.378 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' C' ' 76' ' ' TYR . . . -98.91 -158.55 29.42 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.098 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -129.29 138.34 51.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 57.9 mt -91.34 169.55 10.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' C' ' 22' ' ' SER . 13.9 p90 -170.28 167.06 8.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.991 0.359 . . . . 0.0 110.22 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 73.8 ttt180 -151.78 129.18 11.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.573 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -110.87 159.39 17.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -70.83 -10.51 59.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.405 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -86.63 -12.32 48.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.518 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.96 7.95 28.4 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.89 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 5.6 mp0 -75.04 121.11 21.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.599 0.699 . . . . 0.0 109.572 174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' C' ' 75' ' ' LEU . 5.5 mt -131.94 167.51 19.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.363 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' C' ' 66' ' ' LEU . 91.2 mt 84.33 -139.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.304 1.003 . . . . 0.0 112.522 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' C' ' 64' ' ' GLY . 50.9 t80 -91.59 135.51 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.468 0.652 . . . . 0.0 111.355 -165.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.6 ptm -118.49 130.18 55.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.869 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -95.77 162.57 13.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.253 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 0.0 OUTLIER -56.97 -34.77 68.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.9 p -56.13 -48.17 76.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 0.0 111.176 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . 0.493 ' HA ' HD21 ' C' ' 85' ' ' ASN . . . -73.22 -50.08 24.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.0 t80 -37.75 -62.25 0.56 Allowed 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.964 1.415 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.18 -54.44 29.55 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.96 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.11 -34.86 14.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -161.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.493 HD21 ' HA ' ' C' ' 81' ' ' ALA . 33.7 m-80 -82.46 -28.55 31.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.177 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 34.6 m-85 -99.9 -71.12 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.415 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 51.3 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.683 -173.516 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.498 HD11 ' OH ' ' C' ' 20' ' ' TYR . 47.9 mt . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.607 ' CD2' ' HA ' ' C' ' 87' ' ' THR . 66.6 m-85 -111.82 -169.97 1.56 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -157.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 19.9 pttm -156.09 159.95 39.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 120.956 0.408 . . . . 0.0 110.2 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.74 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 21.0 p-10 -84.52 -140.56 0.07 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.858 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' C' ' 15' ' ' ASP . . . -80.04 -44.65 19.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.784 -169.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.78 -14.13 18.15 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.938 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.17 26.66 1.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.077 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.519 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 47.9 t -77.29 125.56 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . 0.498 ' OH ' HD11 ' C' ' 12' ' ' LEU . 76.9 t80 -73.69 142.67 46.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.93 0.871 . . . . 0.0 110.779 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.08 138.99 40.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.802 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 7.5 m -88.86 134.91 33.79 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.203 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.67 121.53 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.275 0.56 . . . . 0.0 110.324 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.8 mp -107.5 97.35 19.25 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.437 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 19.4 Cg_exo -68.98 118.77 5.88 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.57 2.18 . . . . 0.0 111.817 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mt -82.08 100.89 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 0.1 OUTLIER -68.86 -53.07 23.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.217 179.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.88 166.49 19.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.732 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.49 146.51 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.947 0.403 . . . . 0.0 110.178 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.7 tmtp? -130.28 115.67 17.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.292 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -85.24 117.44 24.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.49 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.38 146.76 26.84 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.215 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -60.53 -17.65 47.09 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.874 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.83 -13.55 55.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.525 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 -35.23 4.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.76 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 68.5 p -62.54 140.86 58.64 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.094 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.41 123.9 48.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -91.42 114.85 27.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -99.3 111.36 23.75 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 38.4 mt-10 -73.71 102.52 3.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.531 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.06 153.98 17.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 110.161 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -119.44 127.35 53.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.04 -128.2 7.12 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.161 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.37 9.35 3.45 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.748 2.299 . . . . 0.0 112.562 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.44 ' CE2' ' HG ' ' C' ' 24' ' ' LEU . 86.0 m-85 -135.06 145.35 47.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.381 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.82 -164.37 1.13 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.508 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 5.9 p-10 -84.86 144.6 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.154 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -149.03 141.16 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.527 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -88.35 139.24 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.6 tpt -122.62 146.66 47.25 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.0 135.36 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.684 0.615 . . . . 0.0 111.576 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.39 -38.25 90.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.363 -172.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -61.76 -34.97 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.545 0.688 . . . . 0.0 109.639 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 7.2 m -73.06 -42.04 63.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.4 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 54.1 t -68.25 -22.94 27.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.429 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.27 82.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.792 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.06 -33.2 4.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.451 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.94 20.09 18.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.799 -170.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 40.0 tttm -50.98 124.28 20.54 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.474 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 50.0 Cg_endo -99.89 -153.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.527 2.818 . . . . 0.0 111.429 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.418 ' HB2' ' HH ' ' C' ' 76' ' ' TYR . 7.2 mm-40 -149.85 164.63 34.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.664 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.16 128.53 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.96 0.886 . . . . 0.0 109.609 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.08 49.65 Favored Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.18 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -166.08 37.4 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.123 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -124.32 126.83 46.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.329 0.585 . . . . 0.0 111.476 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 34.7 tp -97.28 155.05 17.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.9 p90 -147.65 160.97 42.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.234 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -139.17 130.53 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.705 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 96.7 p -99.78 170.0 8.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.268 0.556 . . . . 0.0 110.241 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 11.2 mm100 -69.94 -9.1 53.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.069 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -90.38 -0.8 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.151 0.5 . . . . 0.0 109.985 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 17.62 64.5 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.765 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.427 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 21.0 mm-40 -92.09 122.16 34.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.947 0.403 . . . . 0.0 110.574 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.427 HD22 ' N ' ' C' ' 74' ' ' LEU . 1.6 pt? -131.38 130.88 43.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.941 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 73.3 mt -151.43 157.85 42.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.994 -174.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . 0.418 ' HH ' ' HB2' ' C' ' 61' ' ' GLU . 36.5 t80 -96.25 131.07 43.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.221 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.445 ' HA ' ' CE ' ' C' ' 77' ' ' MET . 0.9 OUTLIER -143.04 140.23 30.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 110.693 178.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -69.33 158.4 35.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.744 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' C' ' 80' ' ' THR . 1.5 ptmt -55.42 -32.43 62.68 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -168.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.428 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 5.7 p -55.33 -58.94 5.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.437 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.66 74.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.805 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.16 -44.07 92.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.54 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . 0.506 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 24.3 tt0 -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.94 -27.85 63.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.848 -167.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.74 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 11.8 m120 -105.58 -30.7 9.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.466 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -142.79 70.66 1.33 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.607 ' HA ' ' CD2' ' C' ' 13' ' ' TYR . 80.5 p . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 123.825 0.85 . . . . 0.0 109.067 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.439 HD12 ' OH ' ' C' ' 20' ' ' TYR . 93.1 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' C' ' 86' ' ' TYR . 82.0 m-85 -111.13 -167.63 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -164.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 0.0 OUTLIER -158.7 164.37 35.98 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.998 0.428 . . . . 0.0 110.03 -167.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.585 ' OD2' ' HB ' ' C' ' 19' ' ' VAL . 2.4 p30 -103.07 -139.21 0.35 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.079 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -60.39 3.48 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -161.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.25 -4.98 50.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.283 0.563 . . . . 0.0 109.808 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.87 27.92 4.41 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.767 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.585 ' HB ' ' OD2' ' C' ' 15' ' ' ASP . 62.8 t -64.73 127.57 25.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . 0.439 ' OH ' HD12 ' C' ' 12' ' ' LEU . 50.8 t80 -81.93 134.99 35.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.032 0.92 . . . . 0.0 111.091 -172.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.75 131.87 4.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.65 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -90.71 152.05 20.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.654 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.04 116.28 31.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.356 0.598 . . . . 0.0 109.696 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.663 ' O ' ' HB3' ' C' ' 66' ' ' LEU . 16.8 mt -118.2 98.92 51.74 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.213 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -66.25 152.05 82.0 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 121.655 1.57 . . . . 0.0 111.267 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . 0.444 HG21 ' O ' ' C' ' 61' ' ' GLU . 46.2 mt -82.7 98.04 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -86.12 -60.79 1.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.514 -163.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' C' ' 39' ' ' ALA . . . -154.56 154.53 33.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.366 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 73.7 mt -140.79 143.05 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.472 0.653 . . . . 0.0 110.558 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -135.84 124.76 24.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.263 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -85.37 118.72 25.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 110.009 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.81 -163.62 0.94 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.558 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.297 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -97.8 17.24 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.09 87.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.705 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 18.2 p -72.92 138.59 46.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.863 0.363 . . . . 0.0 110.371 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.491 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -100.28 113.97 27.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 15.5 m-80 -90.07 108.26 19.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.722 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' C' ' 28' ' ' ALA . . . -87.73 89.11 7.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.149 0.499 . . . . 0.0 111.233 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 38.1 mt-10 -76.55 106.47 8.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.747 -174.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . 0.582 ' CG ' ' HB2' ' C' ' 45' ' ' TYR . 1.6 m-85 -59.33 138.61 57.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.549 0.69 . . . . 0.0 112.164 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.22 -33.52 16.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.619 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.12 179.48 35.48 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.775 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 56.85 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.007 2.472 . . . . 0.0 113.103 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.582 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 89.9 m-85 -131.6 -177.95 4.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.046 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.7 -179.0 6.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.224 0.535 . . . . 0.0 111.533 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -111.48 127.38 55.68 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.84 124.77 40.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.584 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -87.21 112.11 21.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' MET . . . . . 0.408 ' CG ' ' HB2' ' C' ' 37' ' ' ALA . 22.4 ptp -110.37 129.52 55.74 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.759 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' SER . . . . . 0.452 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.6 OUTLIER -62.35 159.42 15.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.057 -176.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.46 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . 0.404 ' H ' ' CD ' ' C' ' 53' ' ' GLN . 0.2 OUTLIER -58.26 -40.14 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 109.144 173.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -72.96 -40.12 65.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 79.4 t -67.56 -22.45 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.283 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.7 74.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.08 -31.44 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.487 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -113.17 19.8 16.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 52.1 tttm -48.7 107.45 0.76 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.495 0.497 . . . . 0.0 111.526 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 85.9 Cg_endo -106.03 -154.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 123.809 3.006 . . . . 0.0 111.83 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.444 ' O ' HG21 ' C' ' 26' ' ' ILE . 25.3 mt-10 -141.51 153.81 45.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.687 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.47 125.0 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.926 0.87 . . . . 0.0 109.753 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.31 -10.35 28.73 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.434 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.45 -158.24 27.95 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.042 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.35 156.95 34.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.915 0.388 . . . . 0.0 111.133 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.663 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 23.5 tp -147.08 154.03 40.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.12 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -151.5 163.6 38.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -143.33 132.9 23.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 31.2 p -102.55 178.28 4.62 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.442 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -55.28 -33.71 63.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.896 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . 0.425 ' HB2' ' HG2' ' C' ' 73' ' ' GLU . 44.7 m-85 -72.52 -5.77 39.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.3 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.38 1.93 83.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.378 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' C' ' 71' ' ' TYR . 9.4 pt-20 -91.11 140.33 29.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.269 0.557 . . . . 0.0 110.478 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.488 HD23 ' N ' ' C' ' 74' ' ' LEU . 0.6 OUTLIER -131.13 155.34 47.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.895 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.543 ' O ' HD13 ' C' ' 66' ' ' LEU . 71.6 mt -148.44 157.27 43.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -91.7 138.06 31.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.019 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.473 ' HB2' ' HB1' ' C' ' 81' ' ' ALA . 0.4 OUTLIER -162.24 -179.81 7.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.196 0.522 . . . . 0.0 111.619 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.5 p -122.49 -174.91 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.068 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -57.04 -28.5 62.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 8.6 p -54.27 -54.96 33.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' C' ' 77' ' ' MET . . . -74.21 -33.23 63.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.9 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.609 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 2.6 t80 -50.13 -49.59 51.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.309 0.576 . . . . 0.0 109.504 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . 0.769 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 10.8 tp10 -60.85 -45.15 95.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.187 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.6 -26.02 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.479 ' O ' ' HB3' ' C' ' 15' ' ' ASP . 0.9 OUTLIER -91.77 -27.39 18.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.623 ' O ' HG22 ' C' ' 87' ' ' THR . 0.2 OUTLIER -167.88 78.54 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.769 ' OG1' ' HA ' ' C' ' 83' ' ' GLU . 6.6 p . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 124.142 0.977 . . . . 0.0 109.52 162.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' C' ' 22' ' ' SER . 23.1 mt . . . . . 0 CA--C 1.523 -0.07 0 CA-C-O 120.653 0.264 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' C' ' 82' ' ' PHE . 2.8 m-85 -91.7 136.96 32.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.236 -174.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.461 ' H ' ' HB3' ' C' ' 86' ' ' TYR . 93.2 mttt -116.02 105.89 13.14 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.005 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.549 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -72.44 -166.26 0.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.505 -171.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.7 -50.64 72.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -170.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.36 -6.53 14.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.16 14.07 3.42 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.602 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.549 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 97.8 t -74.23 103.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . 0.451 ' OH ' ' HE2' ' C' ' 14' ' ' LYS . 1.2 m-85 -76.7 151.68 36.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.496 1.141 . . . . 0.0 112.261 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -148.8 120.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.81 -1.995 . . . . 0.0 108.952 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.417 ' HA ' HD21 ' C' ' 12' ' ' LEU . 23.0 t -78.04 148.86 34.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.114 -177.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.57 117.87 35.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.828 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -99.78 114.43 65.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.666 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.32 125.97 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 55.8 mt -80.35 96.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -67.22 -45.99 75.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.137 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' C' ' 62' ' ' VAL . . . -157.25 159.49 37.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 0.0 111.988 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.5 mt -145.71 145.58 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.982 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -131.42 132.03 44.04 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -94.3 136.0 35.09 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.916 -172.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.2 131.38 56.48 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.993 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -60.34 -19.85 57.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.329 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.81 -21.74 61.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.803 0.335 . . . . 0.0 110.78 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.98 -26.35 4.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.246 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 10.1 m -72.67 161.51 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.989 0.423 . . . . 0.0 110.883 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -141.07 122.53 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 9.0 t-20 -77.26 128.92 35.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -115.17 147.95 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.211 0.529 . . . . 0.0 112.179 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.03 110.35 11.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.859 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -102.3 156.47 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.33 132.49 33.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.72 -178.93 19.54 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.252 -174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.77 58.31 6.91 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.883 2.389 . . . . 0.0 111.857 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.487 ' HH ' ' NH2' ' C' ' 68' ' ' ARG . 18.7 m-85 -122.19 -176.51 3.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -176.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.6 50.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.734 0.778 . . . . 0.0 112.908 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.0 p-10 -132.78 79.91 1.87 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -152.62 169.16 23.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.205 -164.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 50.3 p90 -92.55 138.28 31.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.054 0.454 . . . . 0.0 110.747 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.3 mmt -103.64 140.75 37.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.234 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' SER . . . . . 0.425 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 1.3 p -61.08 154.61 22.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.422 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -30.19 71.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 23.4 mp0 -58.45 -44.77 89.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.756 0.789 . . . . 0.0 109.057 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -67.89 -43.6 78.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.949 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.2 t -65.63 -27.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.585 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -29.91 69.34 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.298 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.72 -34.11 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.51 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.14 24.53 11.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 0.0 OUTLIER -46.08 117.86 4.19 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 121.299 0.571 . . . . 0.0 111.36 175.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 83.6 Cg_endo -106.37 -156.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 123.403 2.735 . . . . 0.0 111.876 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.437 ' HB2' ' CZ ' ' C' ' 76' ' ' TYR . 48.1 mt-10 -149.18 142.65 25.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.05 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' C' ' 28' ' ' ALA . 5.2 p -78.27 111.63 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.834 0.826 . . . . 0.0 109.977 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.96 -18.68 7.47 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.74 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.8 -155.11 31.47 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.402 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -131.8 142.55 49.77 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.408 HD23 ' C ' ' C' ' 66' ' ' LEU . 0.0 OUTLIER -118.84 134.88 54.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 44.0 p90 -109.56 158.04 18.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.758 -172.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' HH ' ' C' ' 45' ' ' TYR . 60.4 ttp180 -134.32 129.51 35.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' SER . . . . . 0.451 ' HA ' ' HB ' ' C' ' 21' ' ' VAL . 40.5 p -95.35 178.0 5.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.002 0.43 . . . . 0.0 111.001 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.34 -9.49 58.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.991 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -85.04 -6.34 59.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.09 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.52 12.07 78.85 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.53 127.15 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.07 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.3 pt? -130.53 140.27 50.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.074 0.464 . . . . 0.0 110.843 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.505 HD21 ' C ' ' C' ' 74' ' ' LEU . 2.1 mm? -148.22 160.81 42.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.405 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 61' ' ' GLU . 71.7 t80 -92.52 141.57 28.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.464 ' SD ' ' HB1' ' C' ' 81' ' ' ALA . 40.6 tpp -155.86 147.38 22.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 111.134 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 77' ' ' MET . 20.3 p -89.71 158.34 17.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 13.6 ptmm? -66.91 -13.01 61.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 11.3 p -60.38 -61.83 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.511 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . 0.464 ' HB1' ' SD ' ' C' ' 77' ' ' MET . . . -69.83 -38.01 76.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.694 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -50.8 -52.92 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.265 177.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.98 -36.52 64.54 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.16 25.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.786 -169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.09 -29.15 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.303 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.461 ' HB3' ' H ' ' C' ' 14' ' ' LYS . 23.0 m-85 -103.08 -73.01 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.748 -173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 C--N 1.317 -0.822 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -167.453 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 mt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' C' ' 86' ' ' TYR . 79.8 m-85 -145.63 -161.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.144 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' C' ' 13' ' ' TYR . 2.0 mptp? -146.34 145.59 30.37 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.258 0.552 . . . . 0.0 109.916 -168.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.619 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -87.67 -165.08 1.21 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.536 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.36 -52.25 54.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.31 -6.96 22.5 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -170.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.37 26.18 1.22 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.385 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.619 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.3 t -83.54 117.56 29.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.038 0.446 . . . . 0.0 110.173 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -87.69 132.84 33.97 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 109.574 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.4 OUTLIER -150.74 139.36 14.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.876 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -105.23 163.89 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.596 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . 0.421 ' HB1' ' CD2' ' C' ' 65' ' ' TYR . . . -108.66 117.29 33.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.125 0.488 . . . . 0.0 110.335 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.474 HD11 ' N ' ' C' ' 24' ' ' LEU . 4.4 mp -107.37 115.26 59.89 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.922 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' C' ' 24' ' ' LEU . 3.0 Cg_exo -72.22 138.4 30.42 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.744 1.63 . . . . 0.0 112.206 -173.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.56 117.42 37.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.935 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -79.03 -60.79 2.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.996 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 151.27 9.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.816 0.341 . . . . 0.0 111.131 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 54.9 mt -132.11 140.87 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.912 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.3 114.48 16.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -65.56 104.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.584 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.84 170.99 15.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.606 0.717 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -69.75 -14.08 62.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.06 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.18 -18.4 21.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.475 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.93 -37.25 2.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.103 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -60.08 146.49 42.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.434 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.73 120.51 41.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 37.2 m-80 -71.77 117.43 13.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.836 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.692 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -106.47 107.86 19.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 0.0 112.104 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.45 114.37 25.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.054 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -99.43 148.1 24.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.871 0.367 . . . . 0.0 110.302 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.22 125.85 32.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 0.0 109.929 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.63 17.65 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.201 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.95 59.37 6.89 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.551 2.168 . . . . 0.0 112.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.56 -175.76 3.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.432 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.536 ' HB2' HE21 ' C' ' 48' ' ' GLN . . . -66.01 152.9 43.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.562 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 8.3 p-10 -149.7 92.01 1.87 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 168.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 40.9 mt-30 -149.44 174.7 12.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 -164.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.93 112.65 9.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.9 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 51.6 tpp -91.2 129.78 37.15 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.03 135.35 31.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.337 0.589 . . . . 0.0 111.554 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.47 95.65 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.547 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -63.75 -31.49 72.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.405 0.622 . . . . 0.0 109.903 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 19.3 m -74.11 -40.93 62.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.679 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 77.7 t -70.53 -20.78 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.423 0.63 . . . . 0.0 110.308 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.46 73.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.87 -28.0 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.677 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -106.16 15.03 26.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.209 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 55.1 pttt -51.44 114.97 5.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.5 Cg_endo -102.99 -151.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.85 3.034 . . . . 0.0 111.123 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -138.23 143.03 39.93 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.409 ' O ' HG21 ' C' ' 62' ' ' VAL . 27.8 m -80.1 119.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.279 1.038 . . . . 0.0 109.827 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.19 20.27 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.811 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 -155.09 30.06 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.577 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . 0.421 ' CD2' ' HB1' ' C' ' 23' ' ' ALA . 50.7 m-85 -122.23 146.82 46.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.291 0.567 . . . . 0.0 112.017 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.23 136.33 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 54.5 p90 -121.77 159.53 26.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.574 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -134.85 128.09 32.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.46 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 94.6 p -103.39 -170.19 1.75 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.221 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' C' ' 19' ' ' VAL . 36.4 mt-30 -65.17 -45.99 82.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.434 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.09 18.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.22 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.97 34.05 70.63 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.322 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.48 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 32.3 mt-10 -89.7 123.88 34.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.4 pt? -130.71 132.38 45.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.046 0.451 . . . . 0.0 110.169 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.621 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.5 mt -153.44 -171.14 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.721 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.77 135.54 33.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 4.9 ttp -103.76 118.04 35.78 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 111.545 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 19.1 p -106.31 -169.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -76.87 -30.87 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.491 1.041 . . . . 0.0 111.026 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.0 p -60.73 -31.58 70.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.741 0.782 . . . . 0.0 109.885 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.67 33.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.129 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' C' ' 86' ' ' TYR . 62.8 t80 -56.56 -40.61 75.48 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.356 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.53 -49.51 66.24 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.895 -0.503 . . . . 0.0 111.655 174.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.28 77.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.861 0.362 . . . . 0.0 110.952 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.474 HD21 ' HB2' ' C' ' 15' ' ' ASP . 15.1 m120 -105.12 -24.68 12.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.833 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.561 ' HA ' ' HB2' ' C' ' 13' ' ' TYR . 6.7 m-85 -120.92 33.39 5.58 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 47.4 p . . . . . 0 C--N 1.314 -0.939 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.066 178.239 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' C' ' 23' ' ' ALA . 48.4 m-85 -93.19 141.65 28.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -133.85 123.34 24.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.591 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -90.64 -164.64 1.2 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.511 -177.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.472 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -63.07 -49.72 73.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -172.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.5 -4.2 17.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.589 -0.445 . . . . 0.0 112.107 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.01 18.25 2.38 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.771 -1.204 . . . . 0.0 113.575 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.591 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.7 t -73.74 133.88 30.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.09 160.86 30.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.684 0.754 . . . . 0.0 110.995 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.79 137.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.185 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 31.4 m -78.88 151.22 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.54 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . . . -119.42 128.44 54.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.758 0.314 . . . . 0.0 110.497 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 1.5 mt -105.35 105.68 53.11 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.474 ' HB2' ' HB2' ' C' ' 42' ' ' ASP . 13.9 Cg_exo -67.65 115.25 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.101 1.867 . . . . 0.0 111.395 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 27.9 mt -78.8 111.97 16.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.237 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.404 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 53.1 tttm -85.94 -63.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.04 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.32 158.39 32.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 70.0 mt -115.51 132.78 63.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.865 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.491 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 6.0 mmpt? -91.98 94.61 9.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.029 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -84.06 112.78 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.114 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.79 135.63 33.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -58.29 -19.89 38.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.491 -172.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.8 -20.25 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.714 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.11 -45.12 1.16 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.761 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' C' ' 50' ' ' MET . 2.3 m -60.71 158.48 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.034 0.445 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -145.47 179.09 7.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.601 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 0.2 OUTLIER -162.06 127.73 3.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 173.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -92.05 129.52 37.99 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.508 -172.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -90.9 130.2 36.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.44 146.7 35.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' C' ' 25' ' ' PRO . 44.6 m-20 -78.37 88.83 4.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.132 0.492 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.3 -148.42 17.65 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.063 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.75 26.09 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.41 2.74 . . . . 0.0 112.454 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -129.59 120.09 24.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.2 -161.02 0.6 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.668 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 7.6 p-10 -76.08 126.74 31.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.11 171.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.79 104.93 3.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 9.4 m-85 -154.91 -166.45 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' C' ' 36' ' ' SER . 44.3 tpp -159.21 -67.11 0.08 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.624 0.647 . . . . 0.0 112.427 -171.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' SER . . . . . 0.405 ' O ' HG22 ' C' ' 55' ' ' VAL . 0.3 OUTLIER -104.09 134.13 47.87 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.29 0.567 . . . . 0.0 111.455 -175.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.53 92.31 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.584 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -65.98 -31.05 71.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.562 0.696 . . . . 0.0 109.823 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.6 m -75.24 -38.01 60.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.577 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 74.8 t -70.21 -22.15 24.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.178 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.72 80.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.21 -29.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.861 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.53 9.63 31.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.96 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 87.1 tttt -70.95 113.43 18.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.764 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 83.3 Cg_endo -101.06 -146.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.876 3.051 . . . . 0.0 111.828 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.464 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 35.5 mt-10 -130.0 131.61 45.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.068 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.13 121.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 122.232 1.015 . . . . 0.0 109.915 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.26 -23.02 9.35 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.484 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.34 36.37 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.227 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -125.51 130.76 52.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.764 0.316 . . . . 0.0 111.436 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 8.6 tp -87.42 172.54 9.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' C' ' 22' ' ' SER . 27.4 p90 -158.43 158.14 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.462 0.573 . . . . 0.0 110.902 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 60.9 ttt180 -148.9 114.83 5.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 77.3 p -95.37 175.88 6.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.459 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.19 -8.48 56.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.813 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -90.12 -7.11 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.076 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.84 14.31 56.69 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.848 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.648 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 31.5 mt-10 -78.09 121.58 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 33.3 tp -131.36 87.0 2.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 96.5 mt -134.5 -173.98 3.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.206 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.82 153.74 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.517 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.432 ' HE3' ' HA ' ' C' ' 81' ' ' ALA . 54.6 mtm -145.15 160.9 40.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 0.0 110.675 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 18.4 p -110.75 -87.32 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.242 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -77.94 -31.38 50.93 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.287 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 3.9 p -65.67 -18.3 65.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.219 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . 0.432 ' HA ' ' HE3' ' C' ' 77' ' ' MET . . . -70.4 -50.1 42.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.787 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.28 -47.93 80.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.315 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . 0.554 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 34.3 tt0 -60.2 -20.2 57.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.702 0.286 . . . . 0.0 111.67 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' C' ' 13' ' ' TYR . . . -93.39 -19.66 21.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' C' ' 13' ' ' TYR . 1.1 m-80 -68.85 -17.41 63.99 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.774 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.554 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 4.3 p90 -132.01 -12.01 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.479 HG22 ' CD2' ' C' ' 86' ' ' TYR . 39.5 p . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 118.563 -1.255 . . . . 0.0 113.718 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.539 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 63.2 m-85 -92.98 143.26 26.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 67.0 mttm -117.06 139.71 50.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -170.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p-10 -46.98 136.18 8.68 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.14 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.88 -55.85 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.32 167.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.72 -7.04 47.81 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.65 26.81 1.24 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.767 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 54.3 t -116.24 119.86 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -97.87 138.66 34.88 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -148.15 124.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.646 -172.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -83.17 147.77 27.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.091 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.02 128.19 53.67 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.191 0.519 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 5.2 mp -98.74 98.7 6.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.242 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.8 Cg_exo -64.77 114.8 2.91 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.159 2.573 . . . . 0.0 113.116 -174.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . 0.451 HD11 ' HG ' ' C' ' 66' ' ' LEU . 12.0 mt -84.54 99.05 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.438 ' C ' ' HD3' ' C' ' 27' ' ' LYS . 5.7 tmtm? -63.24 -69.57 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.65 162.15 41.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.374 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.82 132.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 0.0 109.932 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.437 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 11.5 mmpt? -105.87 100.29 9.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.427 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -73.98 112.4 10.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.161 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 153.26 28.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.709 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.28 -15.62 62.92 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.046 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.26 -21.63 31.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.348 . . . . 0.0 110.669 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.66 -26.19 5.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.109 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -70.09 165.73 21.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -140.58 122.31 15.33 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.955 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 5.1 t30 -83.83 114.86 21.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -94.69 155.78 16.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.452 -172.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -130.17 119.15 22.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.071 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 14.6 m-85 -126.13 179.49 5.22 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -175.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -36.27 -55.0 0.82 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.079 0.952 . . . . 0.0 113.405 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.8 -81.82 0.06 OUTLIER Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.185 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.63 45.17 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.094 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' C' ' 41' ' ' PHE . 97.4 m-85 -138.38 -173.48 3.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.082 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.33 116.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 0.0 112.078 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 9.8 p-10 -137.83 42.71 2.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.49 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.423 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 2.0 pp0? -165.32 173.92 10.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.841 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 29.3 p90 -97.11 132.51 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -109.43 166.8 10.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.05 144.41 12.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 112.368 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.38 90.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.057 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.539 0.685 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -74.13 -39.17 63.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.67 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.98 -32.31 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.8 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.7 68.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.787 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.68 -23.25 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.351 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.64 6.78 28.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.065 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -54.9 113.33 5.21 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 56.5 Cg_endo -92.76 -99.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.231 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 21.0 mm-40 -156.95 140.6 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.633 0.373 . . . . 0.0 110.011 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.84 107.85 17.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.712 0.767 . . . . 0.0 109.806 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.04 -5.53 39.35 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.727 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.87 -158.85 34.56 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.147 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.27 123.64 28.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.918 0.389 . . . . 0.0 111.067 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 20.7 mt -79.28 163.53 24.86 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 43.8 p90 -148.21 147.9 29.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -134.92 120.55 19.39 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -94.67 164.44 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -79.72 19.11 0.69 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.624 -173.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.2 -6.41 18.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.444 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.29 -5.52 55.46 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.505 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.22 123.93 33.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.178 0.513 . . . . 0.0 111.111 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.452 ' N ' HD21 ' C' ' 74' ' ' LEU . 1.5 pt? -131.43 138.69 49.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.889 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 83.3 mt -150.1 179.62 7.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -107.72 141.38 39.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 34.4 mmm -150.12 144.07 25.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.855 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 33.0 p -65.38 126.55 28.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 167.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -61.01 -27.74 68.54 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.221 -171.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 17.3 p -52.91 -47.64 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.44 -38.46 55.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.157 0.503 . . . . 0.0 111.414 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.441 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 0.8 OUTLIER -74.16 -39.94 62.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.0 110.261 -175.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.13 -26.25 68.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.185 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.27 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.966 -172.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.22 -31.55 12.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 5.1 m-85 -97.1 -69.25 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 50.2 p . . . . . 0 C--N 1.319 -0.742 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -171.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.627 ' HB3' ' HA ' ' C' ' 86' ' ' TYR . 95.4 m-85 -125.84 155.86 40.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.401 -166.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -156.51 158.38 37.09 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -165.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.599 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 9.6 p-10 -96.17 -144.82 0.28 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.616 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.402 ' H ' ' CG ' ' C' ' 15' ' ' ASP . . . -78.24 -40.85 36.01 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -170.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.29 -18.28 17.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.625 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.67 22.29 1.84 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.475 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.9 t -66.73 107.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -84.15 143.16 29.83 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.187 0.994 . . . . 0.0 111.803 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.49 137.27 18.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.482 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 25.9 t -81.79 144.26 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . 0.518 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -105.96 122.72 46.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.591 0.71 . . . . 0.0 110.983 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.9 mm? -101.52 96.74 6.62 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.476 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 2.6 Cg_exo -76.37 104.26 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.778 2.319 . . . . 0.0 111.527 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 44.5 mt -71.29 90.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.718 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.789 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 27.9 tptp -66.65 -51.61 54.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.814 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' C' ' 62' ' ' VAL . . . -166.05 166.66 17.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.821 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' C' ' 37' ' ' ALA . 73.1 mt -135.62 141.62 41.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -104.06 99.78 9.54 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.092 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -79.94 106.68 12.15 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.53 168.4 19.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.778 0.799 . . . . 0.0 110.316 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.15 -10.36 59.2 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.414 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.37 -15.47 37.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.182 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.06 -28.71 6.51 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.977 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -72.09 158.64 35.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.762 0.315 . . . . 0.0 110.411 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' C' ' 29' ' ' ILE . . . -134.12 162.21 32.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.697 0.284 . . . . 0.0 111.15 -177.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 23.8 m-80 -125.92 124.04 39.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.85 106.61 18.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.238 0.542 . . . . 0.0 111.198 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.789 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 23.6 mt-10 -77.77 89.73 4.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.382 -177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -91.18 141.64 28.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.28 -8.13 9.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.59 -124.63 0.72 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.409 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.09 11.25 2.87 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.822 2.348 . . . . 0.0 113.028 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.68 161.55 36.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.879 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.73 -165.0 1.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.31 133.21 36.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 46.8 mm-40 -132.92 139.19 47.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.949 -0.114 . . . . 0.0 110.867 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -75.66 154.47 36.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.876 0.369 . . . . 0.0 110.27 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.8 ptp -150.29 128.08 11.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.575 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 151.19 44.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.665 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.99 77.35 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.91 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.32 -35.2 80.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.401 0.62 . . . . 0.0 109.788 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -71.18 -36.62 72.02 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.282 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 55.5 t -70.18 -23.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.438 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.36 -31.48 67.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.779 0.323 . . . . 0.0 111.026 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.03 -29.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.639 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -116.1 21.96 13.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 20.2 ptmt -52.71 110.82 2.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.309 0.381 . . . . 0.0 111.034 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.2 Cg_endo -100.14 -151.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.411 2.741 . . . . 0.0 111.742 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 43.0 mt-10 -138.36 131.13 29.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.358 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' C' ' 28' ' ' ALA . 95.6 t -72.99 105.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 0.0 109.781 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.85 -23.12 4.47 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.457 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.0 -165.22 38.05 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.878 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -116.44 135.27 53.99 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.894 0.378 . . . . 0.0 110.991 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.515 HD13 ' O ' ' C' ' 75' ' ' LEU . 36.4 tp -106.32 149.93 26.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -148.29 154.92 40.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.221 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -121.9 121.96 38.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 5.2 p -106.56 -175.45 2.8 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.019 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.08 -46.91 88.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -69.9 -8.73 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.677 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.27 41.92 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.09 136.67 48.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 110.243 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.486 ' O ' HD23 ' C' ' 75' ' ' LEU . 1.6 pt? -130.7 128.43 40.85 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.515 ' O ' HD13 ' C' ' 66' ' ' LEU . 1.6 mm? -138.97 169.51 17.65 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.792 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' C' ' 77' ' ' MET . 24.2 p90 -122.35 156.87 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' C' ' 76' ' ' TYR . 35.7 tpp -177.21 166.12 2.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.411 0.444 . . . . 0.0 110.408 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 24.9 p -77.03 -147.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.703 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -75.09 -24.75 58.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.3 p -47.92 -45.6 30.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.654 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.16 -33.43 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.704 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.711 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 70.5 t80 -53.96 -40.44 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 110.947 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -74.12 -45.07 51.24 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.824 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.39 -30.85 27.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.79 -13.89 11.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.711 ' CD1' ' HA ' ' C' ' 82' ' ' PHE . 0.8 OUTLIER -104.75 -11.61 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.412 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 111.682 -175.182 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 58.1 m-85 -132.95 -169.76 2.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -168.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 9.8 mtmp? -141.25 135.31 30.54 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -170.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.703 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -77.94 -169.83 1.69 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.555 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -58.28 -45.72 87.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -102.23 -9.46 20.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.193 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.66 16.58 2.74 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.222 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.588 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 44.7 t -67.88 116.38 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.14 134.8 36.19 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.775 0.798 . . . . 0.0 110.185 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.547 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.75 136.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.57 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.3 m -86.48 144.09 27.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.265 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.68 117.34 33.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.566 0.698 . . . . 0.0 109.971 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.21 104.79 54.94 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.688 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.02 122.59 9.19 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.363 2.042 . . . . 0.0 112.275 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . 0.426 HG12 ' CZ ' ' C' ' 41' ' ' PHE . 38.1 mt -78.29 110.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -77.47 -46.94 20.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -157.18 160.55 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.984 0.421 . . . . 0.0 111.817 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 64.1 mt -146.56 143.47 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.659 175.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -130.48 111.99 12.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.413 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -82.61 104.56 12.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.27 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.44 165.12 25.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.745 0.783 . . . . 0.0 110.363 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.21 -19.33 65.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.193 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -84.8 -22.05 29.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.318 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.62 -25.96 6.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.559 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 60.0 p -66.47 148.66 51.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.423 . . . . 0.0 110.772 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.23 123.89 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 5.3 t30 -87.0 120.91 28.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.56 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.699 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -96.65 160.53 14.34 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.924 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -141.66 118.5 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.798 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . 0.426 ' CZ ' HG12 ' C' ' 26' ' ' ILE . 50.5 m-85 -117.31 171.85 7.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.75 -57.8 4.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.097 0.475 . . . . 0.0 111.474 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.7 -168.04 33.42 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.888 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.05 41.01 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.336 2.69 . . . . 0.0 112.493 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.33 -173.32 2.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.068 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -36.06 114.77 0.3 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 124.059 0.849 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.699 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 33.4 t70 -149.02 66.12 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.244 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.673 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 2.2 pp0? -168.81 163.26 11.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.036 -168.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -80.07 111.76 16.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tpt -86.53 145.85 26.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.35 132.09 16.61 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.777 0.673 . . . . 0.0 111.722 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.55 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.13 -35.64 79.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.627 0.727 . . . . 0.0 109.63 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.6 m -74.83 -40.16 61.22 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.577 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 44.2 t -69.04 -25.71 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.88 91.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.837 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.7 -24.7 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.101 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -116.15 14.74 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -170.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 8.9 ptpp? -52.74 116.79 9.6 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.786 0.326 . . . . 0.0 111.447 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 5.5 Cg_endo -88.2 -149.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.179 2.586 . . . . 0.0 111.477 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.402 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 41.9 mt-10 -128.2 132.06 48.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.276 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.23 106.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.96 0.886 . . . . 0.0 109.967 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.86 33.42 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.067 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.17 -159.31 25.24 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.265 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.6 121.36 40.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 tp -96.43 157.66 15.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 46.9 p90 -148.84 153.95 38.8 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.745 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -149.38 142.88 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.276 0.36 . . . . 0.0 110.254 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' SER . . . . . 0.464 ' HG ' ' HB2' ' C' ' 73' ' ' GLU . 20.4 p -115.08 -175.81 2.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.269 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -69.37 -35.75 76.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.889 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.69 -4.7 28.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.156 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.95 19.53 57.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.85 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' HG ' ' C' ' 69' ' ' SER . 28.2 mm-40 -86.05 109.09 18.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 109.895 177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.3 pt? -130.32 139.62 50.69 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.838 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.644 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 67.8 mt -157.94 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.208 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -118.99 144.17 46.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.453 ' HE3' ' HA ' ' C' ' 77' ' ' MET . 1.8 mmt -147.11 145.94 29.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.738 0.304 . . . . 0.0 110.75 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 29.5 p -73.33 145.5 45.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 17.6 ptpt -51.12 -31.87 20.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -167.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -59.74 -57.32 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.25 -38.77 68.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.323 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 70.7 t80 -54.62 -44.37 73.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . 0.48 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 27.8 tt0 -56.66 -51.25 69.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.901 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.44 41.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.893 0.378 . . . . 0.0 110.688 -167.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.703 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 13.6 m120 -93.25 -33.42 13.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.026 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -148.82 66.64 1.05 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.497 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 31.1 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.6 ' HB3' ' O ' ' C' ' 85' ' ' ASN . 15.4 m-30 -93.25 160.13 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.873 -168.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.579 ' H ' ' HA ' ' C' ' 86' ' ' TYR . 55.9 mttp -138.58 120.07 14.98 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -174.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.525 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -82.25 -165.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.659 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.467 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.81 -41.69 71.24 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.42 -8.71 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.56 9.02 5.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.398 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.525 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 78.7 t -77.6 100.04 2.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -84.15 163.12 19.97 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' C' ' 13' ' ' TYR . 3.7 m -147.98 139.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.388 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.42 153.22 24.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.872 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 127.73 55.16 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.379 0.609 . . . . 0.0 110.569 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.456 ' N ' HD23 ' C' ' 24' ' ' LEU . 2.4 mm? -112.2 98.0 41.22 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.993 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' C' ' 42' ' ' ASP . 20.8 Cg_exo -66.02 118.98 5.95 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.932 2.422 . . . . 0.0 112.94 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mt -85.4 96.0 4.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.069 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 60.3 tptt -66.72 -54.44 22.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.698 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.23 164.77 22.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.894 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.6 144.08 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.0 110.996 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -120.28 108.2 13.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.657 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.25 106.45 15.03 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.754 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 162.77 20.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.794 0.806 . . . . 0.0 110.789 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -77.14 -11.72 59.85 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.042 -171.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.23 -12.41 43.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.93 -37.1 3.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.22 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -67.02 131.75 46.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.325 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.69 121.31 41.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.625 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.542 ' N ' HD21 ' C' ' 38' ' ' ASN . 0.8 OUTLIER -86.76 113.07 22.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.27 126.37 52.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.45 0.643 . . . . 0.0 112.359 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 39.9 mt-10 -86.26 108.25 18.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.318 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -107.66 160.81 15.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . 0.505 ' O ' ' HD2' ' C' ' 25' ' ' PRO . 1.9 m-20 -113.61 147.88 37.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.362 172.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.5 13.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.69 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 -31.12 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.808 2.339 . . . . 0.0 112.18 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -86.97 140.52 29.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.219 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.47 -162.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' C' ' 40' ' ' GLU . 2.1 m-20 -64.99 119.24 10.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -154.66 146.18 23.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.056 0.455 . . . . 0.0 111.627 -175.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.2 p90 -93.49 131.34 38.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.499 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.24 137.74 37.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.54 139.52 37.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.712 0.633 . . . . 0.0 111.298 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.56 75.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.473 -173.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -66.41 -34.92 79.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.53 0.681 . . . . 0.0 109.401 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m -71.98 -40.21 68.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.7 t -70.13 -26.66 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.447 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.17 79.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.87 -31.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.586 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.24 20.17 17.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' C' ' 59' ' ' LYS . 0.0 OUTLIER -49.27 110.12 1.44 Allowed Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.253 0.345 . . . . 0.0 110.413 172.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 9.7 Cg_endo -91.33 -155.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.86 2.373 . . . . 0.0 112.772 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.25 137.34 49.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.024 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.49 100.51 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.52 7.38 54.01 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.332 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.55 -166.38 40.0 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.563 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.61 130.41 56.72 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.93 0.395 . . . . 0.0 111.256 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 56.8 tp -119.07 139.53 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 29.5 p90 -146.03 156.29 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.956 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -147.44 139.27 24.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 89.7 p -110.57 179.7 4.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.89 -38.38 90.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.444 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -68.31 -18.8 64.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.093 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.29 12.78 32.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.1 119.78 25.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.0 pt? -130.91 130.62 43.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.415 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.2 mt -145.26 158.51 43.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -113.9 151.17 32.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' C' ' 81' ' ' ALA . 9.4 ttm -175.54 175.31 2.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.726 0.298 . . . . 0.0 110.455 170.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 23.6 p -81.89 -149.78 0.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.496 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.5 ptmt -66.78 -20.52 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -58.18 -64.82 0.78 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.131 0.491 . . . . 0.0 111.308 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . 0.603 ' HB2' ' SD ' ' C' ' 77' ' ' MET . . . -62.53 -37.58 86.63 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.593 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 20.5 t80 -48.47 -55.87 9.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.532 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . 0.817 ' HA ' ' CE2' ' C' ' 86' ' ' TYR . 35.2 tt0 -64.69 -22.21 66.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.373 0.606 . . . . 0.0 111.384 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.23 -6.53 56.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 9.9 m-80 -107.32 -39.3 5.71 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.048 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.817 ' CE2' ' HA ' ' C' ' 83' ' ' GLU . 13.2 p90 -94.75 -7.34 40.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.356 -1.338 . . . . 0.0 112.318 -173.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.586 HG23 ' CD1' ' C' ' 86' ' ' TYR . 35.0 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.388 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' C' ' 22' ' ' SER . 52.5 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.499 ' HA ' HG23 ' C' ' 87' ' ' THR . 7.6 m-85 -92.31 166.03 12.8 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.92 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -115.38 154.46 29.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.558 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -93.55 -167.44 1.7 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.77 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -71.64 -42.07 68.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -170.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.75 -8.52 24.15 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.131 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.61 10.08 5.09 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.907 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.558 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.0 t -71.23 141.96 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.86 136.08 33.43 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.865 0.841 . . . . 0.0 109.447 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 20.0 m -134.26 135.31 54.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.356 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.52 ' HA ' HD13 ' C' ' 12' ' ' LEU . 14.3 m -73.94 147.27 43.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.631 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.77 115.15 29.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.102 0.477 . . . . 0.0 110.67 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.92 96.91 50.54 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.326 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.653 ' O ' ' HE3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -69.59 177.01 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.488 2.126 . . . . 0.0 111.655 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . 0.614 HG23 ' O ' ' C' ' 61' ' ' GLU . 0.1 OUTLIER -120.29 86.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.448 0.642 . . . . 0.0 109.753 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.653 ' HE3' ' O ' ' C' ' 25' ' ' PRO . 0.0 OUTLIER -87.36 -54.44 4.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.268 -163.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.536 ' HB1' ' HB3' ' C' ' 40' ' ' GLU . . . -158.89 151.4 21.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.994 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.81 143.8 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.2 0.524 . . . . 0.0 110.724 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.602 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -128.82 109.07 10.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.571 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -88.72 111.43 21.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.599 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.97 171.52 14.89 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.822 0.82 . . . . 0.0 110.49 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -78.52 -8.47 58.6 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.892 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -99.46 -7.52 25.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.915 0.388 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -19.69 29.3 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.599 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.53 155.02 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 110.442 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -141.35 143.57 34.08 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.989 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.602 ' ND2' ' HB2' ' C' ' 30' ' ' LYS . 11.5 p30 -116.4 147.73 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.97 91.46 3.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.692 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 6.1 tp10 -64.16 101.34 0.4 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.859 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . 0.628 ' CD2' ' HE2' ' C' ' 27' ' ' LYS . 0.5 OUTLIER -62.36 161.9 10.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 113.396 169.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.84 -19.06 4.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.755 167.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.82 -150.67 9.35 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.872 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.39 35.87 0.56 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.323 2.682 . . . . 0.0 114.317 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' C' ' 41' ' ' PHE . 96.0 m-85 -140.96 -177.46 5.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' C' ' 41' ' ' PHE . . . -100.22 -164.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.634 -177.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.73 118.55 31.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -95.93 120.96 37.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 44.2 p90 -104.7 139.45 39.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.079 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.55 147.75 46.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.5 154.26 29.16 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.517 0.511 . . . . 0.0 111.704 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.01 -57.46 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -59.68 -27.72 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.415 0.626 . . . . 0.0 110.259 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.8 m -75.64 -37.26 59.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.055 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.432 ' O ' HG12 ' C' ' 55' ' ' VAL . 71.4 t -73.08 -14.17 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.382 0.61 . . . . 0.0 110.061 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.44 68.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.41 -37.93 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.549 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.12 20.14 17.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.138 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.16 114.77 4.12 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 123.515 0.509 . . . . 0.0 111.742 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' C' ' 65' ' ' TYR . 19.4 Cg_endo -98.14 -161.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 123.209 2.606 . . . . 0.0 112.289 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.614 ' O ' HG23 ' C' ' 26' ' ' ILE . 40.2 mt-10 -155.44 143.72 20.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.564 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -69.08 109.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . 0.566 ' H ' ' HB ' ' C' ' 26' ' ' ILE . . . 93.24 15.21 52.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.011 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' C' ' 76' ' ' TYR . . . -136.79 63.79 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.947 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . 0.596 ' N ' HG12 ' C' ' 26' ' ' ILE . 0.1 OUTLIER -151.9 -171.44 3.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' C' ' 82' ' ' PHE . 0.5 OUTLIER -168.25 -79.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.24 -171.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -150.38 169.56 21.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.432 -165.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 55.8 ttt180 -151.81 131.09 12.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.153 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 97.0 p -97.02 175.38 6.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.845 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.93 -1.49 22.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.186 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -104.62 2.14 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.568 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.89 20.05 60.23 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.42 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 33.6 mt-10 -89.01 110.44 21.14 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.11 133.54 46.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.037 0.446 . . . . 0.0 110.297 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.77 167.96 18.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.676 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' C' ' 64' ' ' GLY . 0.8 OUTLIER -118.71 150.6 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 19.4 ttm -179.58 -175.76 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -78.8 103.99 9.12 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 160.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.82 -26.9 62.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.612 -170.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 18.1 p -58.78 -33.91 70.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.119 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.85 -49.16 63.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 110.2 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.653 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 48.5 t80 -64.22 -53.53 47.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.819 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.07 -23.61 63.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.731 -174.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.05 -12.96 27.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.451 . . . . 0.0 110.849 -171.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -98.36 -32.1 11.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.217 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.653 ' HD1' ' O ' ' C' ' 82' ' ' PHE . 15.3 m-85 -97.84 -58.34 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.511 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.499 HG23 ' HA ' ' C' ' 13' ' ' TYR . 64.9 p . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.204 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' C' ' 86' ' ' TYR . 50.9 m-85 -92.25 123.92 35.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.601 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -86.93 170.06 11.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.38 1.086 . . . . 0.0 111.157 -171.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -49.63 151.93 1.55 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.52 -2.127 . . . . 0.0 115.31 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.16 -54.7 2.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.113 -2.312 . . . . 0.0 108.614 163.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.43 -7.84 19.57 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.241 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.86 35.97 0.53 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.731 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.48 160.04 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.65 155.69 29.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' C' ' 69' ' ' SER . 5.7 m -149.66 136.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.808 -170.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -74.33 154.41 38.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.57 130.88 52.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.464 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.62 98.48 49.54 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.598 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' C' ' 42' ' ' ASP . 7.4 Cg_exo -76.76 105.99 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.621 2.214 . . . . 0.0 111.202 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.59 117.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.229 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -93.71 -55.0 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.729 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.6 158.13 37.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.536 0.208 . . . . 0.0 111.062 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.56 145.23 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 30' ' ' LYS . 27.2 mtpp -133.71 133.24 41.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.866 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -101.48 117.87 35.82 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.28 -172.62 3.88 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.144 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -74.71 -42.91 57.47 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.965 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.36 -20.23 62.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.74 -25.83 6.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.809 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 30.1 p -63.26 143.94 57.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.86 144.68 48.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 111.748 -176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 8.2 t30 -106.54 127.65 53.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.749 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.66 116.58 31.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.35 121.58 25.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -110.95 147.08 35.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.959 0.409 . . . . 0.0 110.629 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' C' ' 25' ' ' PRO . 21.3 t70 -101.77 150.39 23.2 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.81 -139.66 15.29 Favored Glycine 0 C--N 1.313 -0.704 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.979 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.53 28.35 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.794 2.329 . . . . 0.0 112.467 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.93 165.68 25.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.29 -162.99 0.85 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.675 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -93.91 150.41 20.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 153.36 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 46.9 p90 -109.34 143.17 39.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtt -127.69 148.18 50.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.901 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 152.92 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.71 98.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.49 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -56.61 -38.66 72.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.515 0.674 . . . . 0.0 110.165 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -69.04 -44.55 72.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.565 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 49.5 t -69.62 -27.37 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.821 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.86 76.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.357 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.57 -31.66 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.504 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.8 9.98 36.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 41.6 ttmt -55.58 114.19 6.91 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.465 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 98.9 Cg_endo -98.19 -145.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 123.525 2.817 . . . . 0.0 110.68 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.512 ' HB2' ' CE2' ' C' ' 76' ' ' TYR . 42.9 mm-40 -135.86 142.77 44.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.931 0.396 . . . . 0.0 110.701 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.1 127.19 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.781 0.8 . . . . 0.0 109.543 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.59 -8.74 56.79 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 -172.9 36.96 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.955 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' C' ' 79' ' ' LYS . 58.5 m-85 -146.51 149.33 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -173.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -175.24 -144.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' C' ' 66' ' ' LEU . 6.9 p90 -153.62 -179.3 7.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -140.09 126.37 20.0 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' SER . . . . . 0.405 ' HA ' HG12 ' C' ' 21' ' ' VAL . 42.0 p -98.59 177.21 5.39 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.863 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.56 16.12 1.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.86 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -107.99 3.07 23.7 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.24 89.57 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.222 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -78.21 114.52 17.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.118 0.485 . . . . 0.0 110.899 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.504 HD11 ' N ' ' C' ' 75' ' ' LEU . 3.4 tm? -100.08 137.8 38.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.504 ' N ' HD11 ' C' ' 74' ' ' LEU . 98.3 mt -142.24 158.62 43.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' C' ' 61' ' ' GLU . 17.8 t80 -126.73 147.81 49.94 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.765 0.665 . . . . 0.0 110.461 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.528 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -166.78 175.95 7.46 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' SER . . . . . 0.528 ' H ' ' HG3' ' C' ' 77' ' ' MET . 12.4 p -82.85 122.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.482 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 61.0 pttt -52.44 -46.68 66.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 30.9 p -51.9 -38.95 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.449 0.468 . . . . 0.0 112.164 -173.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.23 -57.08 4.27 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.294 0.569 . . . . 0.0 111.205 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.565 ' CE1' ' HE1' ' C' ' 67' ' ' PHE . 0.5 OUTLIER -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.344 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . 0.609 ' HG3' ' OG1' ' C' ' 87' ' ' THR . 12.9 tt0 -56.02 -39.89 72.62 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.851 0.46 . . . . 0.0 111.824 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.46 84.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.482 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.502 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 43.2 m-80 -98.22 -36.95 9.87 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.974 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.55 ' O ' HG21 ' C' ' 87' ' ' THR . 3.4 m-85 -120.99 59.77 0.93 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -171.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.609 ' OG1' ' HG3' ' C' ' 83' ' ' GLU . 71.9 p . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' C' ' 22' ' ' SER . 10.9 mp . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -132.83 170.16 15.7 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.678 -172.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.45 125.23 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -75.36 -167.76 0.7 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.313 0.383 . . . . 0.0 111.771 -171.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.82 -47.45 75.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.6 -13.56 31.72 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.399 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.72 17.55 2.56 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.031 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 41.7 t -67.28 110.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 109.903 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -90.76 140.15 30.06 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.451 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -139.72 136.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.365 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' C' ' 12' ' ' LEU . 22.9 m -92.26 139.68 30.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.256 175.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.07 117.24 33.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.43 0.633 . . . . 0.0 110.899 -174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.12 106.81 59.3 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.699 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.35 128.05 15.83 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.277 1.985 . . . . 0.0 112.644 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.51 107.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.108 0.48 . . . . 0.0 109.921 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 76.0 tttt -76.45 -59.93 2.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.925 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.08 166.14 17.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.0 mt -144.8 141.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 110.063 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.459 ' HB3' ' ND2' ' C' ' 38' ' ' ASN . 19.3 tptm -96.33 100.0 11.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.935 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -90.95 120.87 32.3 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.03 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.93 158.11 18.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.494 0.664 . . . . 0.0 109.56 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -71.24 -10.72 60.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.714 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.07 -26.22 20.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.016 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.22 -35.36 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -63.7 152.55 38.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 0.0 110.27 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -150.3 173.8 13.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.749 -177.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 1.3 p30 -145.71 140.08 26.98 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.43 157.58 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -167.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 42.4 mt-10 -126.42 107.28 10.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.51 171.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' C' ' 46' ' ' ALA . 84.2 m-85 -100.47 151.29 21.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.17 129.98 35.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 109.77 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.55 -179.67 26.75 Favored Glycine 0 C--N 1.31 -0.917 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.755 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.92 61.35 7.6 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.771 2.314 . . . . 0.0 111.852 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -124.76 -174.05 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.59 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.448 ' O ' ' HD1' ' C' ' 41' ' ' PHE . . . -43.49 121.68 2.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.612 0.72 . . . . 0.0 112.59 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.31 59.22 1.1 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.704 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 174.51 165.14 0.23 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.278 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER -155.49 -165.7 2.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.381 161.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -160.04 -129.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.455 0.57 . . . . 0.0 111.63 -167.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.29 136.58 3.95 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.655 0.782 . . . . 0.0 112.931 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.22 67.46 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.843 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -61.15 -39.65 90.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.401 0.619 . . . . 0.0 109.337 173.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.2 m -71.19 -40.55 71.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.675 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.715 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 67.5 t -78.46 -7.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.818 -176.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.56 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.41 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.25 -33.62 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.183 0.516 . . . . 0.0 109.655 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.85 21.56 16.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -174.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 20.6 ttmm -68.21 113.99 18.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.923 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.417 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 74.3 Cg_endo -100.98 -150.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.514 2.809 . . . . 0.0 111.356 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.417 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 40.6 mt-10 -146.06 128.61 16.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.31 123.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.166 0.984 . . . . 0.0 110.108 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.41 -28.14 5.85 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.139 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.9 37.72 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.371 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 43.6 m-85 -112.48 135.99 52.52 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.809 0.338 . . . . 0.0 110.685 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.37 125.46 37.99 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 47.7 p90 -124.3 147.19 48.31 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.453 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.404 ' CB ' ' HG ' ' C' ' 74' ' ' LEU . 7.3 ptm180 -124.31 148.41 47.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.665 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' SER . . . . . 0.413 ' HG ' ' HB2' ' C' ' 73' ' ' GLU . 58.8 p -121.31 173.94 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.604 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . 0.451 ' CD ' ' H ' ' C' ' 70' ' ' GLN . 20.2 mp0 -59.58 -42.13 91.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.465 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -72.47 0.97 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.649 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.42 28.44 55.53 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.964 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.413 ' HB2' ' HG ' ' C' ' 69' ' ' SER . 40.5 mt-10 -91.37 104.61 17.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 5.7 mp -109.74 108.72 19.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.0 mm? -129.52 175.55 8.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.449 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' C' ' 60' ' ' PRO . 35.6 p90 -122.76 146.45 47.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 46.0 tpp -153.25 139.74 18.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.911 0.386 . . . . 0.0 110.413 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -60.75 138.91 58.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.427 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 61.5 pttt -64.07 -25.27 68.03 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.3 p -61.04 -52.22 65.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 110.283 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.53 63.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.7 t80 -57.27 -42.83 82.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.639 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.32 -34.83 79.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.362 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.65 -30.43 14.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.985 -167.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.28 -30.07 67.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.475 ' CD2' ' N ' ' C' ' 86' ' ' TYR . 6.3 m-85 -100.19 -75.51 0.57 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.381 -175.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.718 -176.353 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.467 ' HB2' HG13 ' C' ' 21' ' ' VAL . 3.6 m-85 -93.04 143.25 26.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.171 0.51 . . . . 0.0 111.892 -166.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 53.1 mtmt -129.45 112.47 13.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.634 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -70.18 -169.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.029 0.443 . . . . 0.0 111.873 -169.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -55.53 -53.98 49.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.438 -170.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.48 -14.26 26.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.174 0.512 . . . . 0.0 110.415 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.93 30.91 1.06 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.289 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.634 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.3 t -76.36 113.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -78.01 137.41 38.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.797 0.808 . . . . 0.0 110.528 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.44 125.82 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.355 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -88.74 162.02 16.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.74 119.86 40.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.93 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.85 97.79 42.83 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.809 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.18 134.52 59.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.417 2.078 . . . . 0.0 111.569 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mt -76.2 93.67 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 21.9 tptm -70.57 -74.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.978 -172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.85 143.75 24.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.865 0.364 . . . . 0.0 111.527 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.93 143.9 33.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.013 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.522 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 11.7 ptmm? -131.59 147.48 52.53 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -110.53 133.93 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.519 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.82 141.36 35.75 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.236 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -64.77 -15.09 61.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.167 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.44 -10.21 59.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.697 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.25 -34.03 4.75 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.417 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -64.45 164.38 11.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.784 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -142.12 146.15 35.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.522 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 6.3 t30 -106.42 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.485 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.536 ' HB1' ' OD1' ' C' ' 47' ' ' ASP . . . -119.35 175.91 5.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -173.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 10.3 pt-20 -160.28 144.55 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 165.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . 0.672 ' O ' ' HB2' ' C' ' 45' ' ' TYR . 88.4 m-85 -117.07 155.04 29.93 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.915 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . 0.456 ' OD1' ' HD2' ' C' ' 44' ' ' PRO . 19.9 t70 69.07 -64.06 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.121 0.968 . . . . 0.0 111.877 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.35 -73.15 0.2 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.532 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.456 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 71.6 Cg_endo -79.45 -3.96 13.33 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.798 2.332 . . . . 0.0 112.36 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . 0.672 ' HB2' ' O ' ' C' ' 41' ' ' PHE . 17.4 m-85 -85.34 155.29 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.131 0.491 . . . . 0.0 110.426 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . 0.469 ' HB2' HE22 ' C' ' 48' ' ' GLN . . . -99.74 -174.18 2.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.023 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.536 ' OD1' ' HB1' ' C' ' 39' ' ' ALA . 14.9 t70 -174.45 -63.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.297 170.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.514 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 2.9 mp0 75.37 -159.3 0.05 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.027 0.931 . . . . 0.0 111.686 175.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 76.2 m-85 -75.02 140.67 43.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.377 0.608 . . . . 0.0 112.396 -172.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 44.8 ttp -129.79 148.49 51.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.401 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.67 137.26 25.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.522 0.677 . . . . 0.0 111.837 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.87 -41.27 91.16 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.956 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.79 -33.94 75.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 0.0 109.467 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -74.91 -40.65 60.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.471 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.38 -28.02 38.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.471 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.78 72.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.635 0.255 . . . . 0.0 111.041 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.374 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . 0.589 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 63.7 m-85 -95.41 14.84 21.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.596 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -81.65 99.91 0.65 Allowed Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 73.5 Cg_endo -101.07 -102.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.052 2.501 . . . . 0.0 112.917 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -143.61 123.45 13.45 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.8 t -72.18 101.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.15 -21.53 3.89 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.598 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.69 -159.6 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.163 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -124.04 120.26 31.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.059 0.456 . . . . 0.0 111.172 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 tp -93.96 154.95 17.4 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 50.9 p90 -139.47 146.99 40.71 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.563 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.99 123.76 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -172.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 25.8 p -91.81 167.29 12.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 109.957 175.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.12 11.18 0.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.38 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -109.72 -4.37 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 0.0 110.086 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.22 23.01 33.21 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.749 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.484 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 43.2 tt0 -99.22 120.44 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -125.63 116.26 21.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.1 mm? -128.06 169.2 14.33 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -132.27 155.93 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.8 ptp -175.89 -175.77 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.316 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -70.58 121.05 17.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' C' ' 79' ' ' LYS . 11.7 ptmt -64.96 -24.65 67.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.75 -173.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 13.6 p -61.24 -32.13 71.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.963 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.52 -50.18 19.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.1 0.476 . . . . 0.0 111.011 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.519 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 8.0 t80 -72.89 -41.37 64.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.18 -31.71 71.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.422 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.59 -35.06 67.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.772 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.21 -25.8 60.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.519 ' HD2' ' O ' ' C' ' 82' ' ' PHE . 14.7 m-85 -120.54 -85.94 0.65 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.374 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -164.734 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.618 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 30.0 m-85 -105.42 164.0 12.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.637 -170.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.44 -176.88 3.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ASP . . . . . 0.595 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -120.92 -164.35 1.1 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -61.54 -35.87 78.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.21 -11.87 12.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.3 20.04 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.935 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . 0.595 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 55.4 t -70.05 131.35 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -82.31 141.5 32.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.779 0.799 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.81 140.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.368 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -98.59 143.35 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' C' ' 67' ' ' PHE . . . -106.5 132.75 52.16 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.712 0.768 . . . . 0.0 111.248 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . 0.505 ' N ' HD12 ' C' ' 24' ' ' LEU . 3.3 mp -101.39 99.4 11.12 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.834 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.2 Cg_exo -64.99 105.64 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.699 2.266 . . . . 0.0 112.371 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' C' ' 66' ' ' LEU . 16.9 mt -73.25 110.88 7.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -98.1 -43.63 6.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.31 162.33 30.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -139.52 134.3 39.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 7.4 mmpt? -91.55 90.07 7.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.222 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -76.5 101.18 5.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.02 140.07 29.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.617 0.723 . . . . 0.0 110.329 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -63.63 -17.99 63.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.93 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -71.98 -18.48 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 110.805 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.5 -47.93 0.99 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.066 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 77.2 p -70.41 176.71 3.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.328 0.585 . . . . 0.0 110.969 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -155.14 -164.47 1.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.061 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.547 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 2.6 p30 -166.83 145.33 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 168.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -103.61 135.39 45.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.45 119.58 39.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.476 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -111.75 144.31 41.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 110.742 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.72 -25.91 44.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.706 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.07 -178.92 48.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.502 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.52 67.47 3.67 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.686 2.257 . . . . 0.0 111.524 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.25 -174.42 3.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.752 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.87 168.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.354 1.073 . . . . 0.0 113.83 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.68 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 16.2 p-10 -148.22 51.33 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.018 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' GLN . . . . . 0.521 ' HA ' ' HB2' ' C' ' 38' ' ' ASN . 28.0 mt-30 -163.99 144.35 8.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -157.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' C' ' 37' ' ' ALA . 9.2 m-85 -148.06 -166.76 2.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 160.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -179.02 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.439 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -86.66 105.76 17.13 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.295 0.569 . . . . 0.0 111.477 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.78 82.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.732 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.14 -35.33 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.392 0.615 . . . . 0.0 110.183 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 41.8 m -77.48 -41.0 41.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.286 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.568 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 85.9 t -74.83 -14.75 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.936 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -36.52 58.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.7 -30.18 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.268 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -103.38 14.57 31.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.843 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' LYS . . . . . 0.568 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 24.8 pttm -60.09 119.89 45.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 59.8 Cg_endo -97.54 -150.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.362 2.708 . . . . 0.0 110.579 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -135.42 157.57 46.55 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 95.0 t -87.67 105.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.197 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 -19.63 5.44 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.135 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.5 -171.76 47.35 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.315 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.49 107.78 15.18 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.991 0.424 . . . . 0.0 110.723 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 37.1 tp -78.67 152.28 31.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 50.1 p90 -146.0 151.3 37.56 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.538 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 38.3 ttm180 -143.69 140.09 29.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.303 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p -103.27 170.78 7.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.191 0.519 . . . . 0.0 110.576 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.9 -21.41 66.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.398 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -81.36 -6.87 59.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.549 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.2 56.49 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.646 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 34.5 tt0 -87.5 121.48 29.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.55 139.41 49.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 0.0 111.249 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.438 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 93.4 mt -153.1 169.27 23.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.31 145.57 46.96 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.399 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -157.85 144.94 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.403 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -64.05 129.58 40.57 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -62.51 -27.59 69.25 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.734 -167.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -56.11 -39.59 72.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.823 0.344 . . . . 0.0 111.876 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -44.07 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.989 0.423 . . . . 0.0 111.189 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' C' ' 86' ' ' TYR . 0.7 OUTLIER -80.8 -27.19 36.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -172.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.42 -32.32 62.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.982 0.42 . . . . 0.0 110.191 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.61 -62.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.528 -171.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -75.12 -25.31 58.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' C' ' 82' ' ' PHE . 33.2 m-85 -96.2 -57.69 2.27 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' THR . . . . . 0.618 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 20.4 p . . . . . 0 C--N 1.324 -0.505 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.648 0.261 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.13 71.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.735 0.778 . . . . 0.0 109.767 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.08 130.97 23.88 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.532 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.08 13.84 1.44 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.428 2.085 . . . . 0.0 113.15 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.5 m120 52.48 43.31 31.14 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.169 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . 0.421 ' CE1' HG22 ' C' ' 7' ' ' THR . 38.7 p90 -70.05 -33.92 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.401 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.421 HG22 ' CE1' ' C' ' 6' ' ' PHE . 1.2 p -78.27 123.19 85.92 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.296 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.42 45.31 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.761 2.308 . . . . 0.0 112.639 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 8.7 m -77.23 -56.48 4.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.294 0.569 . . . . 0.0 109.633 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -80.56 127.53 75.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.335 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.91 102.17 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.92 1.747 . . . . 0.0 112.333 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.471 HD21 ' HA ' ' C' ' 22' ' ' SER . 8.1 mt -97.41 148.39 23.23 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.7 ' CB ' ' HA ' ' C' ' 87' ' ' THR . 52.5 m-85 -117.71 -161.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -166.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -122.63 127.98 50.06 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 -157.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.568 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -74.84 -165.92 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.184 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.481 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.73 -44.69 96.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.93 -9.7 14.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.235 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.89 23.62 1.43 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.445 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.568 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 77.6 t -83.57 150.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' C' ' 70' ' ' GLN . 0.2 OUTLIER -83.54 148.02 27.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.131 0.967 . . . . 0.0 111.084 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.0 144.9 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.395 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.471 ' HA ' HD21 ' C' ' 12' ' ' LEU . 22.8 t -94.93 142.93 26.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.57 39.88 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.405 0.621 . . . . 0.0 110.313 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.423 HD13 ' N ' ' C' ' 24' ' ' LEU . 5.1 mp -108.09 97.95 24.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.764 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.7 101.64 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.431 2.087 . . . . 0.0 112.233 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.4 mt -66.36 110.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.426 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -81.01 -74.02 0.34 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.473 0.654 . . . . 0.0 109.496 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.94 169.97 16.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.212 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.423 0.63 . . . . 0.0 110.847 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.491 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.4 tmtp? -103.04 101.4 11.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.413 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -87.87 104.78 16.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.763 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 143.84 29.57 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.546 0.688 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -66.38 -13.13 60.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.174 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -76.22 -20.89 57.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.58 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.03 -37.63 2.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.496 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 69.7 p -74.85 157.77 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.893 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.12 139.77 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 2.5 p-10 -110.02 129.23 55.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.39 125.58 38.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.263 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -89.39 118.21 28.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.25 152.03 33.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.95 32.68 5.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' C' ' 45' ' ' TYR . . . -115.38 -137.49 6.28 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.846 172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.85 30.07 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.553 2.169 . . . . 0.0 111.539 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' C' ' 43' ' ' GLY . 88.3 m-85 -142.45 139.81 31.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.778 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.36 -160.78 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.191 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.08 133.78 53.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 51.2 mm-40 -127.13 108.74 11.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -80.07 128.52 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.381 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.8 mmm -117.39 144.95 44.43 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' SER . . . . . 0.549 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 0.0 OUTLIER -65.25 156.76 30.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -57.34 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . 0.549 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 0.8 OUTLIER -61.72 -26.36 68.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.108 0.48 . . . . 0.0 110.395 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -75.76 -41.75 52.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.347 0.594 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.5 t -70.14 -17.2 20.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.382 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.2 -27.7 47.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.0 -32.2 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.364 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.96 16.19 26.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 49.4 pttt -59.53 107.09 0.86 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 111.399 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.452 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 87.7 Cg_endo -102.24 -150.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.649 2.899 . . . . 0.0 112.011 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.452 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 43.1 mt-10 -127.05 142.86 51.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.417 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.18 121.74 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 122.126 0.965 . . . . 0.0 109.683 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.63 28.8 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.472 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.27 -165.07 33.72 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.992 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -132.7 131.25 41.06 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' C' ' 75' ' ' LEU . 8.8 tt -114.13 154.52 27.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 53.4 p90 -134.14 159.57 40.46 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.173 -0.329 . . . . 0.0 110.272 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -133.36 116.0 15.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 71.7 p -100.01 162.69 12.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.833 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 13.8 mm100 -63.25 -15.73 58.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.775 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -81.08 -10.7 59.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.79 8.98 61.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.63 114.62 26.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.9 pt? -126.86 128.71 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.476 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 72.8 mt -150.48 159.9 44.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.894 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 139.95 34.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 1.7 mmt -137.43 163.16 31.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.381 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -81.04 143.33 32.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -52.36 -36.45 53.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -167.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.2 p -58.7 -49.35 77.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 111.356 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.79 -42.08 58.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.272 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -54.04 -52.31 61.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.93 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.65 -37.3 84.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.068 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.36 -19.6 31.19 Favored 'General case' 0 C--N 1.315 -0.929 0 O-C-N 121.869 -0.519 . . . . 0.0 111.291 -168.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.467 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.7 m-80 -113.74 -25.84 8.48 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.762 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.2 m-85 -128.66 25.57 5.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.7 ' HA ' ' CB ' ' C' ' 13' ' ' TYR . 16.7 p -150.84 -34.17 0.15 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.93 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 58.5 m -95.61 -70.35 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -170.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' C' ' 90' ' ' SER . . . 59.46 66.92 0.95 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -170.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' C' ' 89' ' ' ALA . 49.7 m 76.38 148.86 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.245 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.0 57.94 2.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.648 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 16.4 m -150.6 -43.61 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 60.9 t 69.15 -78.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.5 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.23 -7.6 24.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.24 0.543 . . . . 0.0 110.799 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 60.45 39.49 18.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.41 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.25 3.58 12.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.403 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -78.78 -36.41 42.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 0.0 OUTLIER -79.0 -18.99 52.7 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.166 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.53 -150.2 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.187 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.2 -23.23 28.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.314 . . . . 0.0 110.98 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -72.45 -27.16 62.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.671 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt 57.93 22.23 8.51 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.289 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' C' ' 106' ' ' ARG . 3.0 p -142.23 44.52 1.66 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.421 0.629 . . . . 0.0 111.054 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' C' ' 98' ' ' THR . 21.0 p -83.39 -80.45 0.18 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.418 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -119.61 6.05 11.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.86 0.838 . . . . 0.0 109.181 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' C' ' 103' ' ' SER . 66.6 mtt180 -132.01 151.09 51.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.241 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p -121.23 98.78 6.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.122 0.487 . . . . 0.0 110.06 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.31 74.52 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.071 -174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 23.9 p 49.01 50.83 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.496 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.28 130.24 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 13.0 p -92.0 33.05 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.953 0.406 . . . . 0.0 111.521 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.36 -93.44 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.168 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.39 63.51 7.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.126 0.489 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.35 129.25 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.326 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.3 p -58.43 -32.76 68.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.426 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.3 9.4 58.07 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.861 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -134.45 -43.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.48 87.55 2.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.817 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 19.4 m -68.28 135.22 51.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 68.59 -75.92 0.06 Allowed 'General case' 0 C--N 1.346 0.413 0 C-N-CA 123.337 0.655 . . . . 0.0 111.658 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -164.24 172.78 13.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.46 72.47 1.26 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.755 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -68.39 149.3 49.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.959 0.409 . . . . 0.0 111.154 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.56 157.41 24.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.718 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 74.68 145.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.275 0.985 . . . . 0.0 110.24 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . 0.494 ' C ' ' HG1' ' C' ' 127' ' ' THR . 39.9 t 59.52 74.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.54 . . . . 0.0 109.701 -174.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' THR . . . . . 0.494 ' HG1' ' C ' ' C' ' 126' ' ' VAL . 24.2 p 51.16 -100.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.893 -175.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 75.2 mt -136.02 -40.68 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.526 0.679 . . . . 0.0 109.996 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -146.51 136.97 23.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.146 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 39.9 p -66.23 -28.88 69.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.894 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -107.6 97.66 7.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 46.6 m -141.24 33.35 1.7 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 0.0 109.961 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.18 44.07 0.46 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.054 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.248 1.012 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.81 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.91 -25.69 32.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 111.314 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' C' ' 6' ' ' PHE . 7.8 t-20 -126.94 78.43 73.97 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.189 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.93 -32.58 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.383 2.056 . . . . 0.0 113.672 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -123.78 25.82 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -172.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . 0.404 ' HA ' ' OD1' ' C' ' 3' ' ' ASN . 96.6 m-85 69.08 -72.07 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.949 0.5 . . . . 0.0 111.467 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 92.0 m 65.26 117.69 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.784 0.433 . . . . 0.0 111.469 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.48 103.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.92 2.414 . . . . 0.0 112.417 -176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -132.94 44.05 2.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.434 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.18 11.68 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.691 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.38 179.99 2.65 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.906 1.737 . . . . 0.0 110.594 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.631 ' HB2' ' CZ ' ' C' ' 20' ' ' TYR . 2.2 mm? -83.49 177.36 8.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.203 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.447 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 29.7 m-85 -95.59 -179.54 4.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -166.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 93.3 mttt -140.03 131.64 27.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -170.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.557 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -77.33 -168.41 1.13 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.736 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.63 -38.29 86.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -105.85 -0.34 25.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.269 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.48 13.27 6.92 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.292 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 51.7 t -70.23 119.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' C' ' 12' ' ' LEU . 33.5 t80 -77.78 137.72 38.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 109.736 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.6 131.75 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.54 -171.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.403 ' HA ' ' HG ' ' C' ' 12' ' ' LEU . 12.1 m -89.21 141.48 28.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.61 117.48 34.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.625 0.726 . . . . 0.0 110.647 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.45 ' N ' HD21 ' C' ' 24' ' ' LEU . 2.3 mm? -113.51 101.32 53.52 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.518 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.669 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 23.0 Cg_exo -63.46 143.01 87.19 Favored 'Trans proline' 0 C--O 1.221 -0.368 0 C-N-CA 121.678 1.585 . . . . 0.0 110.775 -174.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' C' ' 60' ' ' PRO . 72.1 mt -78.55 106.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.669 ' HG3' ' O ' ' C' ' 25' ' ' PRO . 0.0 OUTLIER -90.83 -73.69 0.52 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.67 -162.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.11 144.27 19.83 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.184 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -142.83 153.94 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.567 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -146.67 144.06 29.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -93.27 126.11 38.22 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.61 176.92 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.41 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -60.7 -52.92 63.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.438 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.44 -28.79 68.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.665 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.84 -25.19 3.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.328 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 40.2 m -57.18 144.9 33.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.572 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -105.44 131.81 52.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -91.28 94.85 9.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.83 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.55 156.89 22.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.118 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 7.3 pt-20 -162.34 115.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . 0.654 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 30.3 m-85 -60.4 154.18 21.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.539 0.685 . . . . 0.0 112.691 165.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.58 -27.83 17.11 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.219 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.34 170.15 52.06 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.416 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.27 67.22 2.69 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.795 2.33 . . . . 0.0 112.371 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.427 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 90.2 m-85 -133.28 -174.96 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.29 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.719 ' O ' ' HB2' ' C' ' 47' ' ' ASP . . . -66.02 -160.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.255 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' C' ' 46' ' ' ALA . 3.6 m-20 99.95 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.594 1.158 . . . . 0.0 111.625 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.08 -152.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.193 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 121.39 18.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.125 0.488 . . . . 0.0 110.158 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.06 146.56 44.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.93 136.48 51.7 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.741 0.651 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.04 92.34 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.22 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -62.64 -32.75 73.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.518 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -73.41 -42.63 61.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.662 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -68.06 -26.22 33.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.747 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.39 74.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.089 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.8 -30.07 4.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.242 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.96 7.4 45.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.408 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 23.2 tptm -58.19 108.6 1.35 Allowed Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.581 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' C' ' 26' ' ' ILE . 54.9 Cg_endo -104.76 -148.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 124.072 3.181 . . . . 0.0 111.872 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 42.8 mt-10 -132.71 124.05 27.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.758 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.18 121.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 122.388 1.09 . . . . 0.0 110.476 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.98 30.78 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.247 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.53 -172.12 42.74 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.953 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 95.2 m-85 -124.67 112.1 16.38 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.961 0.41 . . . . 0.0 110.778 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 22.1 tp -85.76 147.45 26.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.507 ' HB2' ' CG2' ' C' ' 21' ' ' VAL . 39.3 p90 -147.09 153.18 39.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.52 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 3.9 ptp85 -146.8 145.0 29.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.24 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 88.6 p -115.07 -177.36 3.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.014 0.435 . . . . 0.0 111.513 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -56.83 -42.11 79.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.814 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.76 3.98 15.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.049 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.93 27.98 59.54 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.902 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 42.7 mt-10 -75.52 105.93 6.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' C' ' 75' ' ' LEU . 2.9 tm? -107.85 130.18 55.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.363 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' C' ' 74' ' ' LEU . 57.7 mt -168.06 162.73 13.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.638 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -129.3 148.16 51.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.417 ' HE1' ' HB2' ' C' ' 77' ' ' MET . 33.2 ttm -152.79 149.51 28.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.653 0.263 . . . . 0.0 111.225 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 15.7 p -68.82 146.91 52.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.144 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 21.5 pttp -56.52 -29.54 61.98 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -166.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -60.4 -55.24 35.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.076 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.91 45.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.482 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 55.8 t80 -59.16 -49.31 78.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.069 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -73.18 -32.56 64.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.658 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.64 -26.03 61.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.175 -172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 45.9 m-80 -99.87 -37.37 9.07 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.615 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.589 ' O ' HG21 ' C' ' 87' ' ' THR . 0.1 OUTLIER -135.21 72.23 1.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.589 HG21 ' O ' ' C' ' 86' ' ' TYR . 51.0 p -165.11 -54.4 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 166.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -60.67 -77.5 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.702 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.18 55.5 6.27 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 50.7 m -147.48 175.42 10.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.255 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.55 94.0 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.384 -0.436 . . . . 0.0 113.676 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -66.52 -27.5 67.82 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.6 -0.353 . . . . 0.0 111.641 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t 65.23 -81.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 123.578 0.549 . . . . 0.0 111.122 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.21 6.59 28.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.24 0.543 . . . . 0.0 109.688 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' C' ' 99' ' ' ALA . 8.1 m120 66.6 45.98 1.92 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.823 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.83 25.78 2.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.081 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -136.97 -63.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.6 t -88.29 63.69 7.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.279 1.037 . . . . 0.0 108.316 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' C' ' 95' ' ' ASN . . . -64.17 92.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.947 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.84 -36.64 56.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.963 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -91.01 -31.53 16.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.05 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 6.6 mp 64.9 163.78 0.14 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.259 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' SER . . . . . 0.428 ' HB3' ' HB ' ' C' ' 108' ' ' ILE . 49.8 m 63.63 22.55 13.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.066 174.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 8.4 t -99.2 -2.49 36.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -173.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.73 29.33 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -136.55 14.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.557 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p 41.87 39.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' C' ' 103' ' ' SER . 79.6 mt -77.43 97.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 77.1 p 58.62 28.82 17.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.693 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -89.63 140.62 29.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.8 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 3.0 p -74.74 76.01 2.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.195 0.521 . . . . 0.0 110.987 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.96 -75.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.321 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . 0.482 ' H ' ' HB1' ' C' ' 118' ' ' ALA . . . -156.71 122.6 4.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . 0.445 HG13 ' H ' ' C' ' 115' ' ' THR . 16.0 t 65.92 171.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.444 0.465 . . . . 0.0 109.768 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.445 ' H ' HG13 ' C' ' 114' ' ' VAL . 12.8 p -66.52 -23.1 66.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 111.581 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.81 63.64 0.15 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.378 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 16.2 t -150.23 18.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.083 0.468 . . . . 0.0 110.464 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . 0.482 ' HB1' ' H ' ' C' ' 113' ' ' ALA . . . -74.46 -56.19 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.3 p 43.02 65.15 1.0 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.25 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.21 154.47 40.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.401 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -157.23 169.26 25.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.57 -65.7 3.91 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.182 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 46.7 m 59.54 40.41 20.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.999 0.428 . . . . 0.0 111.22 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' C' ' 128' ' ' ILE . . . -92.45 121.04 33.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.8 -26.67 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.033 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -71.84 -74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.722 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 14.0 p -92.52 3.16 56.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' C' ' 124' ' ' ALA . 65.3 mt 72.98 -49.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.904 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -119.67 152.03 37.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 41.1 p 50.36 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.843 0.857 . . . . 0.0 113.279 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 7.3 p -64.25 -40.72 96.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.44 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 27.4 t 179.28 -45.42 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.716 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -171.51 -138.2 2.49 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.361 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.282 179.092 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' C' ' 4' ' ' PRO . . . -91.53 -6.56 52.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.919 0.39 . . . . 0.0 110.803 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -102.49 100.06 14.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.585 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' C' ' 2' ' ' ALA . 98.3 Cg_endo -82.09 57.35 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.8 2.333 . . . . 0.0 112.072 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -91.83 -2.96 56.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.65 22.53 0.9 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.969 0.414 . . . . 0.0 110.85 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.442 ' H ' ' HD2' ' C' ' 8' ' ' PRO . 19.8 m -118.55 -54.21 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' C' ' 7' ' ' THR . 72.9 Cg_endo -75.41 90.96 1.08 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 121.793 1.662 . . . . 0.0 113.49 -171.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 9.6 t -84.25 -60.91 1.94 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.97 88.9 35.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.03 105.37 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.226 2.617 . . . . 0.0 112.75 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.09 108.33 18.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.299 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.724 ' CB ' ' HA ' ' C' ' 86' ' ' TYR . 76.0 m-85 -140.0 -161.61 1.22 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.635 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -129.09 132.82 47.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.355 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' C' ' 84' ' ' ALA . 3.7 p-10 -86.65 -153.0 0.19 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.734 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.68 67.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -167.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.88 4.21 23.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.591 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.52 24.77 6.01 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.66 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.562 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.1 t -86.84 133.03 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 140.42 36.88 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.881 0.848 . . . . 0.0 109.91 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.3 145.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.242 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 6.3 m -105.82 131.53 53.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.0 117.06 33.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.614 0.721 . . . . 0.0 110.935 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.401 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.6 mp -96.33 111.77 57.77 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.31 114.34 4.01 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.543 2.162 . . . . 0.0 112.42 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 42.0 mt -79.0 107.2 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -75.57 -57.7 3.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.172 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.33 163.29 39.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.735 0.302 . . . . 0.0 111.078 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 62.7 mt -142.01 146.67 22.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.848 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.504 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 21.1 ptmt -133.25 144.53 49.81 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.29 123.89 50.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.822 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 167.91 12.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.441 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.19 -11.28 60.25 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.034 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -93.31 -5.87 48.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.953 0.406 . . . . 0.0 110.573 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.05 -16.83 42.2 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.793 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -71.46 140.99 50.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -112.85 120.24 40.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.134 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.504 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 5.7 t30 -83.3 119.26 24.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.008 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -114.22 124.94 53.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.98 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.55 131.49 54.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.021 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.84 154.68 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.612 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -87.12 74.13 9.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.128 0.966 . . . . 0.0 110.017 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.74 -171.6 43.84 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.246 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.69 50.9 3.58 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.079 2.52 . . . . 0.0 111.869 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.36 -176.55 3.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.31 166.41 18.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.854 0.835 . . . . 0.0 112.926 -174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.694 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 6.6 p-10 -149.63 85.66 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.105 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 77.7 mt-30 -149.12 154.68 39.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.791 -163.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 8.3 p90 -89.26 112.41 23.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.571 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.6 mtp -85.18 147.07 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.121 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.06 141.09 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.996 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.87 -22.84 65.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.18 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -68.6 -38.51 80.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.9 m -77.78 -38.51 46.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.786 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.33 -18.58 19.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.288 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.53 80.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.022 0.439 . . . . 0.0 110.502 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.8 -33.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.307 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -109.54 22.65 15.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -48.79 106.07 0.57 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.4 0.437 . . . . 0.0 111.433 174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.83 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.851 2.368 . . . . 0.0 112.112 -172.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -136.0 138.85 42.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.9 105.02 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 11.17 60.11 Favored Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.089 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.2 -160.15 35.78 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.56 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.67 134.46 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.12 0.486 . . . . 0.0 111.163 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 48.1 tp -115.87 111.58 20.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.076 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -108.9 144.47 36.77 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.543 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.453 ' HB3' ' CD2' ' C' ' 74' ' ' LEU . 28.5 ptt180 -123.06 142.53 50.77 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.251 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 59.3 p -94.33 -174.87 3.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -54.46 -43.37 71.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.548 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -79.33 2.32 21.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.287 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.7 22.94 71.13 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.249 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.78 118.4 20.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' C' ' 68' ' ' ARG . 6.8 mt -99.97 126.92 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.259 0.552 . . . . 0.0 112.103 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.41 HD22 ' C ' ' C' ' 74' ' ' LEU . 3.2 mm? -132.41 140.84 48.62 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.636 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' C' ' 77' ' ' MET . 27.1 p90 -112.98 157.41 21.54 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.489 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -178.23 166.29 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.23 0.331 . . . . 0.0 110.524 172.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' SER . . . . . 0.489 ' H ' ' HG3' ' C' ' 77' ' ' MET . 6.3 p -74.52 -156.76 0.05 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -67.93 -41.89 81.88 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -168.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 16.8 p -44.76 -63.58 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.75 0.656 . . . . 0.0 112.358 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.2 -37.18 80.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.758 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.698 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 28.9 t80 -59.72 -42.2 92.57 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . 0.807 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 40.9 tt0 -62.97 -24.88 68.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.851 0.834 . . . . 0.0 110.669 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' C' ' 15' ' ' ASP . . . -89.63 2.14 55.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' C' ' 15' ' ' ASP . 16.7 m-80 -119.94 -19.69 7.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.978 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.807 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 5.9 p90 -115.11 7.24 15.35 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.21 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -155.34 -63.14 0.12 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' SER . . . . . 0.543 ' C ' ' H ' ' C' ' 90' ' ' SER . 20.0 t 68.72 -60.78 0.43 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.858 172.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' C' ' 90' ' ' SER . . . 72.95 -27.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.777 0.831 . . . . 0.0 110.91 -172.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.543 ' H ' ' C ' ' C' ' 88' ' ' SER . 9.2 t 163.15 -41.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.138 0.975 . . . . 0.0 108.488 -174.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.98 -118.51 0.94 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 12.9 m -89.54 80.5 6.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.45 -43.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.424 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.64 47.86 1.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.748 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.583 ' O ' HG23 ' C' ' 98' ' ' THR . 23.5 p30 -164.63 143.82 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.44 1.93 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' C' ' 101' ' ' LYS . 32.4 mt-10 -72.38 -29.32 63.65 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.593 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' THR . . . . . 0.583 HG23 ' O ' ' C' ' 95' ' ' ASN . 5.1 t -76.14 -15.56 60.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.254 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.76 -94.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -108.12 2.61 23.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -170.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' C' ' 97' ' ' GLU . 59.9 tttp -73.25 -52.42 14.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.719 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 mt 72.95 -45.54 0.63 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.476 0.71 . . . . 0.0 111.541 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' SER . . . . . 0.405 ' H ' ' C ' ' C' ' 101' ' ' LYS . 19.6 m -88.39 54.23 2.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.385 0.612 . . . . 0.0 111.127 -173.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' C' ' 97' ' ' GLU . 0.9 OUTLIER -101.17 -2.58 31.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.98 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -133.09 26.66 4.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.648 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? 61.71 21.82 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.729 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 5.2 p -91.64 -21.74 20.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.896 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 54.1 mt 66.82 -81.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 23.3 p -92.27 2.01 56.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.86 148.85 48.04 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.636 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 6.8 p -82.51 70.8 9.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.192 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 46.99 92.72 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.191 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -131.68 152.17 51.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.91 0.386 . . . . 0.0 110.854 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.02 158.45 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.778 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 11.3 p -50.3 -42.35 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.27 8.79 79.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.404 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t 56.9 25.25 10.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.32 0.648 . . . . 0.0 111.333 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 60.81 20.21 10.38 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -110.64 163.56 13.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.312 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.54 41.32 1.14 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.45 0.643 . . . . 0.0 109.818 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -145.83 151.6 38.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.677 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.63 0.92 88.3 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.158 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 14.1 m -64.12 -53.68 45.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.09 0.156 . . . . 0.0 110.603 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 53.11 65.08 1.62 Allowed 'General case' 0 C--O 1.234 0.244 0 O-C-N 123.561 0.538 . . . . 0.0 111.742 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -112.99 148.15 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 29.8 t -113.39 82.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.88 -57.53 2.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.148 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 21.2 mt 52.39 62.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.398 0.618 . . . . 0.0 110.269 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.95 78.92 9.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p 46.94 64.04 1.7 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.646 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 16.0 p -72.68 -55.96 6.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.482 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 24.2 p -135.05 -40.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.878 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.2 16.38 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.722 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.46 178.526 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.51 33.57 20.51 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.63 0.581 . . . . 0.0 112.114 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -124.31 138.69 31.35 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.86 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.62 -63.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.155 1.903 . . . . 0.0 112.111 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 47.49 53.55 10.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.309 0.644 . . . . 0.0 111.221 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -75.06 153.4 38.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.074 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' C' ' 8' ' ' PRO . 3.6 m -53.86 -52.91 63.53 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . 0.405 ' HD3' ' HB ' ' C' ' 7' ' ' THR . 96.6 Cg_endo -76.22 50.13 2.79 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.305 2.003 . . . . 0.0 113.207 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 56.47 0.82 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 110.144 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -63.07 154.8 76.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.06 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.29 102.49 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.17 1.914 . . . . 0.0 110.657 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.61 -178.94 5.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.264 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.606 ' HB3' ' O ' ' C' ' 86' ' ' TYR . 26.5 m-85 -106.83 162.85 13.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.373 -169.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.522 ' H ' ' HA ' ' C' ' 87' ' ' THR . 98.8 mttt -150.09 152.82 35.39 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -164.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.585 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -90.65 -156.99 0.46 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.735 175.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.91 -51.85 55.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.27 -8.36 23.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.564 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.77 16.63 2.7 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.763 -1.208 . . . . 0.0 113.206 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.585 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 76.3 t -76.9 101.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 173.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' C' ' 14' ' ' LYS . 2.8 p90 -81.19 168.58 18.37 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.627 0.727 . . . . 0.0 110.511 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -146.89 140.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.179 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -86.44 141.65 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -108.28 117.4 34.04 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.453 0.644 . . . . 0.0 110.598 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -104.25 100.52 22.01 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.354 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.431 ' HB2' ' OD1' ' C' ' 42' ' ' ASP . 16.3 Cg_exo -68.42 121.1 8.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.316 2.011 . . . . 0.0 112.358 -172.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' C' ' 60' ' ' PRO . 40.0 mt -79.87 101.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.194 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 22.8 ttmm -67.92 -69.31 0.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.443 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.86 148.21 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 41.3 mt -132.16 151.81 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.131 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -135.68 116.45 14.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.268 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.98 119.3 31.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.084 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.4 161.84 13.91 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.994 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.59 -11.64 61.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.011 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.81 -13.86 38.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 -31.22 6.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.741 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -68.44 141.58 55.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.95 55.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 8.1 t30 -88.95 116.37 27.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.57 162.37 14.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.451 ' CA ' ' HB3' ' C' ' 47' ' ' ASP . 38.4 mt-10 -154.07 127.25 8.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.4 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.02 155.88 17.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' C' ' 25' ' ' PRO . 6.0 p-10 -110.41 171.45 7.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -155.9 23.54 Favored Glycine 0 C--N 1.307 -1.05 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -169.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.37 39.8 0.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.671 2.247 . . . . 0.0 112.021 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.96 159.53 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 111.724 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.48 179.93 3.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.077 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.451 ' HB3' ' CA ' ' C' ' 40' ' ' GLU . 3.8 t0 -167.62 169.5 11.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 165.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -149.49 179.75 7.72 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.475 -158.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.6 p90 -85.57 125.38 33.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 95.3 mmm -122.25 156.58 33.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.945 0.403 . . . . 0.0 111.487 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.75 151.9 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.355 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.13 77.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.36 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.09 -38.87 84.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.465 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.4 m -73.32 -41.23 63.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.965 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.447 ' O ' HG13 ' C' ' 55' ' ' VAL . 98.7 t -77.55 -12.07 13.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.87 61.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.984 0.421 . . . . 0.0 110.253 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.38 -33.9 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.035 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -105.11 22.63 15.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.941 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 53.6 pttt -53.86 107.53 0.88 Allowed Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.518 0.512 . . . . 0.0 111.011 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.46 ' HB2' HD12 ' C' ' 26' ' ' ILE . 6.9 Cg_endo -93.61 -156.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.159 2.572 . . . . 0.0 112.367 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -143.4 130.44 20.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.992 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.42 100.66 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.133 0.492 . . . . 0.0 110.227 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.49 -25.39 5.1 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.312 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.27 -165.28 37.66 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.194 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.26 126.39 48.07 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.655 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.37 140.07 29.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 45.4 p90 -137.37 159.66 41.3 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.675 -173.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 48.0 ttt180 -139.19 135.65 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.784 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 87.0 p -107.33 -178.63 3.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.98 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.42 -28.63 69.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -75.62 -14.46 60.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.581 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 20.86 34.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 7.1 tp10 -69.44 101.03 1.48 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt -103.36 108.45 19.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.644 0.735 . . . . 0.0 110.972 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 98.6 mt -146.46 177.39 9.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.149 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -130.18 143.68 50.92 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -148.62 136.16 20.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.994 0.426 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -69.4 150.57 47.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.166 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.25 -38.87 59.36 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.31 -59.02 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 111.824 -176.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.17 -33.3 61.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.494 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 56.4 t80 -58.99 -47.53 84.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.171 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . 0.565 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 4.7 tp10 -62.64 -40.95 98.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.94 -18.43 40.08 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.819 -0.55 . . . . 0.0 111.613 -166.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.434 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.1 m-80 -121.09 -31.53 4.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 2.3 m-85 -117.91 13.84 14.09 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -171.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' C' ' 83' ' ' GLU . 13.7 p -143.13 -53.11 0.38 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.647 0.658 . . . . 0.0 109.586 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -86.57 159.4 19.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 174.71 -50.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t 73.2 -52.91 0.7 Allowed 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.873 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.74 -38.76 3.17 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.463 ' HB3' ' OE1' ' C' ' 97' ' ' GLU . 16.0 m -77.22 8.07 4.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 111.4 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.79 -55.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -114.83 16.02 17.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -166.01 -53.32 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' C' ' 92' ' ' SER . . . -74.2 5.3 4.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' C' ' 92' ' ' SER . 32.2 mt-10 -144.81 58.71 1.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 30.7 p 69.75 -35.6 0.32 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.177 1.391 . . . . 0.0 113.974 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.02 27.62 14.26 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.796 0.439 . . . . 0.0 110.879 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.58 -69.09 0.22 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.787 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' C' ' 103' ' ' SER . 0.1 OUTLIER -111.45 -17.83 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.259 -0.276 . . . . 0.0 110.956 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.79 -11.49 0.33 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 111.849 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' SER . . . . . 0.53 ' H ' ' C ' ' C' ' 101' ' ' LYS . 53.9 p 53.4 37.87 26.56 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.283 1.033 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 25.8 p -69.29 -13.31 62.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.97 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -49.57 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.001 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -118.35 0.42 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.662 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 37.9 p 47.72 53.01 11.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.168 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.61 67.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 5.0 p -16.05 74.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 O-C-N 125.316 1.635 . . . . 0.0 115.317 -172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -126.47 122.47 35.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.505 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 11.4 p -110.15 -35.15 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.094 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' C' ' 114' ' ' VAL . . . -118.8 147.18 18.48 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.64 -37.42 0.39 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 112.399 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' C' ' 112' ' ' GLY . 23.5 t 72.84 2.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.333 0.587 . . . . 0.0 110.876 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.2 p 48.99 33.54 4.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.204 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.73 -100.7 0.2 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.514 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 16.5 t -118.38 21.69 12.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.059 0.456 . . . . 0.0 109.903 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 55.9 41.2 30.26 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.564 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 8.9 m -78.31 73.63 4.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.732 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -74.39 -41.01 61.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 110.177 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 -68.37 0.19 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.111 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.62 -175.7 17.99 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.581 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 23.5 p -119.35 129.95 55.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.48 15.35 8.72 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -102.76 -7.08 21.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 55.2 t 66.3 -80.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.775 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 2.7 p -139.82 -72.64 0.37 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.284 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 18.3 mm 57.1 35.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 122.007 0.908 . . . . 0.0 109.298 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -98.11 -31.3 12.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.344 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.7 p -88.65 58.31 4.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.552 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' C' ' 132' ' ' SER . 22.2 p -81.73 -64.72 1.12 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' C' ' 131' ' ' THR . 15.3 t 174.68 -34.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.032 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.12 -151.56 22.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.623 178.196 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.38 -61.22 1.9 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.874 0.845 . . . . 0.0 110.398 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -128.06 88.85 51.88 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.869 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.8 -61.45 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.839 2.36 . . . . 0.0 112.876 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' C' ' 7' ' ' THR . 40.2 m-80 -148.92 -59.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.525 0.202 . . . . 0.0 111.297 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' C' ' 5' ' ' ASN . 59.4 m-85 71.92 -36.27 0.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.746 0.818 . . . . 0.0 111.7 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.448 ' H ' ' C ' ' C' ' 5' ' ' ASN . 8.0 t -148.56 134.69 9.88 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 110.17 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.47 -10.81 25.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.541 2.161 . . . . 0.0 111.931 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -96.99 74.62 2.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.661 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -64.8 123.65 84.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.49 142.09 10.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.611 2.207 . . . . 0.0 112.613 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 mp -104.34 166.85 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.665 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 22.1 m-85 -92.92 156.05 17.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.834 -0.166 . . . . 0.0 110.762 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.7 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 23.8 ttpp -124.74 136.41 53.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.371 0.605 . . . . 0.0 110.38 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.556 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -81.5 -164.95 0.85 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.174 176.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.85 -56.43 10.41 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' C' ' 96' ' ' ALA . 1.6 p-10 -98.94 -1.37 40.12 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.791 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.66 13.92 2.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.289 -1.434 . . . . 0.0 114.037 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.556 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 61.2 t -80.6 125.34 39.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -96.73 174.38 6.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.331 -0.547 . . . . 0.0 109.828 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.66 139.81 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -175.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 46.1 m -77.8 142.08 38.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.6 117.7 34.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.352 0.596 . . . . 0.0 109.8 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 1.2 mm? -112.44 98.15 42.63 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.872 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.16 104.23 0.71 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.537 2.158 . . . . 0.0 111.806 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' C' ' 66' ' ' LEU . 8.4 mt -72.13 94.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -75.43 -59.23 2.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.154 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' C' ' 62' ' ' VAL . . . -155.61 148.18 24.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.943 0.401 . . . . 0.0 111.573 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 32.9 mt -137.68 131.63 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.969 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -124.52 110.45 14.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.89 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.18 115.42 6.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.167 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.4 -174.89 5.44 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.039 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.23 -26.27 52.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.182 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.73 -20.64 30.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.122 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.25 -32.55 4.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.916 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -65.09 157.99 27.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.98 131.37 49.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.939 0.399 . . . . 0.0 111.623 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 71.7 m-20 -77.42 126.95 31.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.766 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -105.19 153.9 20.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -136.25 122.1 19.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.871 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -122.32 -179.3 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.17 -39.9 73.06 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.83 -73.24 0.06 OUTLIER Glycine 0 C--N 1.316 -0.582 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.713 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.89 14.88 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.862 2.374 . . . . 0.0 113.913 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -128.8 -175.77 3.64 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.92 119.77 2.1 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 0.5 OUTLIER -133.8 61.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.261 168.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -167.64 175.04 7.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.299 -169.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 26.2 p90 -73.27 133.56 43.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 82.5 mtp -108.74 144.08 37.02 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.08 136.7 47.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.394 0.616 . . . . 0.0 111.312 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.88 76.4 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.316 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.504 0.668 . . . . 0.0 109.552 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -72.33 -40.99 67.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.719 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 72.4 t -74.67 -16.83 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.32 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.58 -35.5 67.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.82 -33.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.123 0.487 . . . . 0.0 110.092 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . 0.45 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 83.1 m-85 -102.83 18.0 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.445 -172.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 0.1 OUTLIER -71.0 110.12 6.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.088 170.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 56.7 Cg_endo -96.83 -100.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.708 2.272 . . . . 0.0 112.149 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -153.48 143.4 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' C' ' 28' ' ' ALA . 69.0 t -82.49 110.31 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.049 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.52 11.12 36.55 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.824 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.58 -163.41 29.25 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.164 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -132.16 123.73 27.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 15.2 tp -100.43 156.41 17.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.1 p90 -142.13 147.35 36.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.346 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -128.83 115.46 17.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 16.0 p -96.97 163.96 12.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.398 0.618 . . . . 0.0 110.125 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -73.5 -0.41 14.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.677 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.35 -4.55 58.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.04 24.11 46.1 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.527 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.417 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 7.0 tp10 -99.9 121.32 41.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.407 ' C ' HD21 ' C' ' 75' ' ' LEU . 6.5 mp -125.76 112.34 15.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 2.8 mm? -135.11 169.68 17.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.502 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -124.25 154.56 40.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 20.4 ptp -178.12 -178.79 0.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.36 0.413 . . . . 0.0 109.992 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 9.1 p -67.48 125.83 27.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -65.92 -23.54 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -59.54 -40.62 87.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.027 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.83 51.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.409 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 11.7 t80 -68.43 -42.05 79.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.74 -27.72 68.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.19 0.519 . . . . 0.0 111.085 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.39 -34.45 63.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.193 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.466 ' N ' HD21 ' C' ' 85' ' ' ASN . 0.9 OUTLIER -97.44 -33.47 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.318 -177.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.7 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 25.6 m-85 -90.79 -57.33 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -169.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.665 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 43.5 p -84.29 -38.0 20.99 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.592 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 4.9 t -82.11 170.21 15.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.023 0.439 . . . . 0.0 110.894 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 58.4 29.66 18.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.012 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -113.25 0.22 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.803 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.32 96.88 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.588 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.419 ' H ' ' HG3' ' C' ' 97' ' ' GLU . 37.9 m 70.69 -6.05 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.419 0.688 . . . . 0.0 112.147 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.74 -18.3 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.51 0.671 . . . . 0.0 109.706 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.84 -12.32 59.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.781 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' C' ' 97' ' ' GLU . 0.9 OUTLIER 72.93 -41.85 0.52 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.485 174.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' C' ' 17' ' ' ASP . . . -72.1 10.25 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.05 0.453 . . . . 0.0 111.18 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' C' ' 95' ' ' ASN . 77.4 mm-40 -79.51 -11.86 59.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m 65.49 26.6 11.79 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.346 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.7 -164.57 0.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.423 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.66 -37.52 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.955 0.407 . . . . 0.0 110.848 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -76.19 -15.34 60.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.99 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 84.8 mt 60.81 -97.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.003 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 7.5 p -151.78 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 112.08 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -88.9 -81.74 0.26 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.724 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.69 12.53 1.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.586 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -99.0 -63.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.498 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' C' ' 110' ' ' LEU . 34.5 p -72.31 -78.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.372 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm 72.54 -47.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.181 0.592 . . . . 0.0 111.659 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -81.24 -6.12 58.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 0.0 111.767 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.4 ' HB2' ' HB ' ' C' ' 107' ' ' THR . 4.6 mm? -94.24 34.59 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.433 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 22.9 p -88.82 123.55 33.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.325 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.63 -92.39 1.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.222 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.31 51.73 1.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.553 0.216 . . . . 0.0 110.674 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 60.2 t 66.03 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.454 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 p -80.56 48.83 1.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.73 -86.68 0.11 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.223 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 8.6 t -149.35 77.59 1.35 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 70.72 -64.64 0.37 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.595 0.758 . . . . 0.0 112.125 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 62.9 p -120.51 -170.7 2.03 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -56.83 -54.37 47.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.519 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -129.54 -70.09 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.998 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.23 -166.76 31.33 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.4 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 6.0 t 60.08 41.15 17.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.671 . . . . 0.0 110.474 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.37 0.38 55.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.197 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -86.44 36.73 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.24 95.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.285 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 15.5 p -87.08 -50.89 6.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.208 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 55.1 mt 59.71 75.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.528 0.68 . . . . 0.0 109.868 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.78 -22.71 59.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.562 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -77.33 111.51 13.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 5.2 p -73.88 -26.56 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.16 0.505 . . . . 0.0 110.373 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -155.98 -42.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.877 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.72 -100.41 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.066 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.805 -178.462 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.772 0.32 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 -57.88 2.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.027 0.441 . . . . 0.0 111.387 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . 0.441 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 57.9 m-80 -63.0 -52.55 62.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.267 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' C' ' 3' ' ' ASN . 38.1 Cg_endo -66.42 -20.65 54.51 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.882 1.722 . . . . 0.0 112.788 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -111.59 47.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.158 0.504 . . . . 0.0 110.174 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -66.62 148.01 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.75 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -114.35 89.41 17.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.62 3.07 7.35 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.946 2.431 . . . . 0.0 113.833 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -57.27 -46.0 83.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -103.19 128.79 26.84 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.456 ' C ' HD13 ' C' ' 12' ' ' LEU . 72.1 Cg_endo -82.43 99.27 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.795 1.664 . . . . 0.0 112.58 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.456 HD13 ' C ' ' C' ' 11' ' ' PRO . 8.4 mp -133.17 153.93 51.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.95 163.2 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -166.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 12.8 mptt -118.69 -173.7 2.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.51 0.672 . . . . 0.0 111.742 -167.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.54 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.6 OUTLIER -127.84 -148.57 0.38 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.515 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.454 ' H ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.91 -40.98 71.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.73 -12.69 13.33 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.491 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.79 26.16 1.3 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.522 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.54 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 68.5 t -83.88 124.44 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -91.15 175.27 7.0 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.447 0.641 . . . . 0.0 110.817 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.28 134.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 37.3 m -78.19 141.04 38.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . 0.446 ' C ' HD21 ' C' ' 24' ' ' LEU . . . -127.9 137.46 52.31 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 0.4 OUTLIER -116.16 97.57 49.78 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.95 122.34 10.82 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.34 2.027 . . . . 0.0 111.3 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.0 mt -83.58 107.69 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -69.95 -64.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.09 159.4 36.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -139.02 141.9 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.473 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -120.74 109.09 14.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.448 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.01 108.42 15.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.088 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.83 145.95 26.97 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -61.36 -18.88 60.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.887 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.83 -20.74 57.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.15 -38.17 2.07 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.204 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -73.64 152.94 40.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.407 . . . . 0.0 111.027 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.7 128.71 25.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.4 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 24.9 p30 -80.57 149.01 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.348 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -135.37 133.39 38.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.663 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.24 138.8 54.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.192 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' C' ' 45' ' ' TYR . 53.0 m-85 -112.38 -177.48 3.17 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -52.68 -51.61 59.51 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.64 -144.0 7.59 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.239 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.78 62.38 5.65 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.54 2.827 . . . . 0.0 111.671 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' C' ' 41' ' ' PHE . 93.7 m-85 -115.43 -173.94 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.242 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 144.34 10.89 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.755 0.788 . . . . 0.0 112.523 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 28.1 t70 -148.02 80.84 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.656 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 9.2 pt20 -152.84 158.28 41.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -166.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 78.9 m-85 -79.33 114.25 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.883 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.7 mmt -84.01 145.01 28.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.08 171.0 4.96 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.92 -48.82 67.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.226 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . 0.452 ' O ' HG21 ' C' ' 57' ' ' VAL . 29.0 mt-30 -63.44 -31.53 72.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.262 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -73.87 -51.82 14.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.604 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 24.1 t -64.53 -31.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.414 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.02 70.97 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.198 -0.314 . . . . 0.0 111.712 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . 0.452 HG21 ' O ' ' C' ' 53' ' ' GLN . 2.9 t -97.09 -30.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . 0.417 ' CD1' HD23 ' C' ' 75' ' ' LEU . 34.9 m-85 -109.26 14.54 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.091 -171.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 18.9 ptpt -53.88 117.73 13.38 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-O 121.177 0.513 . . . . 0.0 112.383 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 91.4 Cg_endo -105.14 -152.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 124.153 3.235 . . . . 0.0 111.291 172.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 22.3 mt-10 -141.67 154.49 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.63 130.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.822 0.82 . . . . 0.0 109.86 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 -10.37 39.77 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.378 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' C' ' 76' ' ' TYR . . . -98.91 -158.55 29.42 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.098 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -129.29 138.34 51.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 57.9 mt -91.34 169.55 10.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' C' ' 22' ' ' SER . 13.9 p90 -170.28 167.06 8.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.991 0.359 . . . . 0.0 110.22 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 73.8 ttt180 -151.78 129.18 11.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.573 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -110.87 159.39 17.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -70.83 -10.51 59.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.405 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -86.63 -12.32 48.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.518 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.96 7.95 28.4 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.89 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 5.6 mp0 -75.04 121.11 21.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.599 0.699 . . . . 0.0 109.572 174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' C' ' 75' ' ' LEU . 5.5 mt -131.94 167.51 19.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.363 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' C' ' 66' ' ' LEU . 91.2 mt 84.33 -139.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.304 1.003 . . . . 0.0 112.522 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' C' ' 64' ' ' GLY . 50.9 t80 -91.59 135.51 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.468 0.652 . . . . 0.0 111.355 -165.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.6 ptm -118.49 130.18 55.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.869 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -95.77 162.57 13.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.253 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 0.0 OUTLIER -56.97 -34.77 68.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.9 p -56.13 -48.17 76.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 0.0 111.176 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . 0.493 ' HA ' HD21 ' C' ' 85' ' ' ASN . . . -73.22 -50.08 24.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.0 t80 -37.75 -62.25 0.56 Allowed 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.964 1.415 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.18 -54.44 29.55 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.96 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.11 -34.86 14.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -161.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.493 HD21 ' HA ' ' C' ' 81' ' ' ALA . 33.7 m-80 -82.46 -28.55 31.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.177 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 34.6 m-85 -99.9 -71.12 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.415 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 51.3 p -83.89 -46.7 11.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.683 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t 60.81 -165.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.239 0.542 . . . . 0.0 111.426 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 177.0 -48.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.113 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -141.96 43.6 1.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.862 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.39 -79.67 0.54 Allowed Glycine 0 C--N 1.32 -0.347 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.433 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.444 ' HB2' ' ND2' ' C' ' 95' ' ' ASN . 4.4 m -79.63 -17.02 54.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 109.722 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' C' ' 92' ' ' SER . 90.1 t 78.53 -62.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.542 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.09 -25.6 13.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.493 0.663 . . . . 0.0 110.31 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' C' ' 92' ' ' SER . 9.1 m120 59.16 30.42 20.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.529 171.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -110.68 9.84 22.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.68 7.77 12.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.324 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.0 m 57.41 55.04 6.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.276 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.98 44.66 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.855 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . 0.416 ' HA ' ' OG ' ' C' ' 92' ' ' SER . 4.7 p-10 -75.45 -11.33 60.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.946 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -88.03 -25.67 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 7.8 mp 61.64 -80.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.703 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 47.7 m -128.84 -3.0 5.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.723 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' THR . . . . . 0.426 ' C ' ' H ' ' C' ' 106' ' ' ARG . 20.3 p -86.29 123.5 31.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.722 0.296 . . . . 0.0 110.785 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 73.41 -37.01 0.37 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.735 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' C' ' 104' ' ' THR . 57.2 mtp180 -138.35 124.01 19.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 37.5 p -84.14 66.81 9.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.321 0.582 . . . . 0.0 110.589 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.74 -28.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.181 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 31.3 p -83.99 -0.03 49.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.12 39.12 23.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.7 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 7.6 p -79.28 34.89 0.26 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.543 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.36 -83.49 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -136.94 -92.79 0.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.526 0.203 . . . . 0.0 110.56 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' C' ' 117' ' ' SER . 6.7 t -140.6 155.48 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -48.76 77.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 111.495 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.95 71.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.485 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' SER . . . . . 0.422 ' HB3' HG11 ' C' ' 114' ' ' VAL . 33.1 t -148.76 -66.96 0.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.837 -0.214 . . . . 0.0 110.988 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.25 -57.01 14.05 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.837 0.351 . . . . 0.0 111.587 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 14.4 m -115.95 30.52 7.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.258 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 59.0 -152.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.933 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.15 -34.14 24.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.75 -71.98 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.905 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 7.9 p -128.12 139.93 52.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.01 -45.61 11.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -100.88 -17.8 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.238 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.7 76.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.054 0.454 . . . . 0.0 110.768 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 31.8 p -105.37 112.04 24.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.2 -45.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.763 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -105.21 -40.18 5.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' C' ' 133' ' ' GLY . 21.0 p -83.08 43.79 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.417 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 1.9 p -78.72 68.63 4.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 29.6 t 174.0 -33.58 0.0 OUTLIER 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' C' ' 130' ' ' THR . . . 176.21 -113.56 0.44 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.429 174.762 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.79 38.54 27.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.567 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -138.24 97.19 9.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.006 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.6 -29.58 43.72 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.057 2.505 . . . . 0.0 112.579 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.17 -36.48 13.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -103.61 60.59 0.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.356 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.524 ' N ' ' HD2' ' C' ' 8' ' ' PRO . 15.8 m -62.01 -47.04 91.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.737 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' C' ' 7' ' ' THR . 31.2 Cg_endo -64.6 89.01 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.036 1.824 . . . . 0.0 112.487 175.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -64.28 -33.08 75.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.186 0.517 . . . . 0.0 110.65 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -75.17 125.07 89.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.432 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.72 115.02 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.286 1.99 . . . . 0.0 110.11 171.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.498 HD11 ' OH ' ' C' ' 20' ' ' TYR . 47.9 mt -65.11 157.32 28.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.017 0.437 . . . . 0.0 110.519 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.607 ' CD2' ' HA ' ' C' ' 87' ' ' THR . 66.6 m-85 -111.82 -169.97 1.56 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -157.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 19.9 pttm -156.09 159.95 39.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 120.956 0.408 . . . . 0.0 110.2 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.74 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 21.0 p-10 -84.52 -140.56 0.07 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.858 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' C' ' 15' ' ' ASP . . . -80.04 -44.65 19.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.784 -169.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.78 -14.13 18.15 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.938 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.17 26.66 1.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.077 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.519 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 47.9 t -77.29 125.56 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . 0.498 ' OH ' HD11 ' C' ' 12' ' ' LEU . 76.9 t80 -73.69 142.67 46.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.93 0.871 . . . . 0.0 110.779 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.08 138.99 40.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.802 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 7.5 m -88.86 134.91 33.79 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.203 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.67 121.53 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.275 0.56 . . . . 0.0 110.324 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.8 mp -107.5 97.35 19.25 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.437 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 19.4 Cg_exo -68.98 118.77 5.88 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.57 2.18 . . . . 0.0 111.817 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mt -82.08 100.89 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 0.1 OUTLIER -68.86 -53.07 23.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.217 179.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.88 166.49 19.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.732 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.49 146.51 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.947 0.403 . . . . 0.0 110.178 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.7 tmtp? -130.28 115.67 17.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.292 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -85.24 117.44 24.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.49 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.38 146.76 26.84 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.215 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -60.53 -17.65 47.09 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.874 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.83 -13.55 55.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.525 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 -35.23 4.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.76 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 68.5 p -62.54 140.86 58.64 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.094 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.41 123.9 48.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -91.42 114.85 27.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -99.3 111.36 23.75 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.551 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 38.4 mt-10 -73.71 102.52 3.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.531 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.06 153.98 17.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 110.161 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -119.44 127.35 53.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.04 -128.2 7.12 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.161 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.37 9.35 3.45 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.748 2.299 . . . . 0.0 112.562 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.44 ' CE2' ' HG ' ' C' ' 24' ' ' LEU . 86.0 m-85 -135.06 145.35 47.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.381 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.82 -164.37 1.13 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.508 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 5.9 p-10 -84.86 144.6 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.154 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -149.03 141.16 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.527 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -88.35 139.24 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.6 tpt -122.62 146.66 47.25 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.0 135.36 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.684 0.615 . . . . 0.0 111.576 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.39 -38.25 90.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.363 -172.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -61.76 -34.97 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.545 0.688 . . . . 0.0 109.639 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 7.2 m -73.06 -42.04 63.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.4 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 54.1 t -68.25 -22.94 27.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.429 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.27 82.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.792 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.06 -33.2 4.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.451 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.94 20.09 18.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.799 -170.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 40.0 tttm -50.98 124.28 20.54 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.474 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 50.0 Cg_endo -99.89 -153.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.527 2.818 . . . . 0.0 111.429 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.418 ' HB2' ' HH ' ' C' ' 76' ' ' TYR . 7.2 mm-40 -149.85 164.63 34.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.664 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.16 128.53 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.96 0.886 . . . . 0.0 109.609 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.08 49.65 Favored Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.18 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -166.08 37.4 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.123 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -124.32 126.83 46.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.329 0.585 . . . . 0.0 111.476 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 34.7 tp -97.28 155.05 17.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.9 p90 -147.65 160.97 42.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.234 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -139.17 130.53 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.705 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 96.7 p -99.78 170.0 8.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.268 0.556 . . . . 0.0 110.241 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 11.2 mm100 -69.94 -9.1 53.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.069 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -90.38 -0.8 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.151 0.5 . . . . 0.0 109.985 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 17.62 64.5 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.765 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.427 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 21.0 mm-40 -92.09 122.16 34.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.947 0.403 . . . . 0.0 110.574 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.427 HD22 ' N ' ' C' ' 74' ' ' LEU . 1.6 pt? -131.38 130.88 43.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.941 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 73.3 mt -151.43 157.85 42.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.994 -174.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . 0.418 ' HH ' ' HB2' ' C' ' 61' ' ' GLU . 36.5 t80 -96.25 131.07 43.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.221 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.445 ' HA ' ' CE ' ' C' ' 77' ' ' MET . 0.9 OUTLIER -143.04 140.23 30.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 110.693 178.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -69.33 158.4 35.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.744 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' C' ' 80' ' ' THR . 1.5 ptmt -55.42 -32.43 62.68 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -168.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.428 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 5.7 p -55.33 -58.94 5.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.437 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.66 74.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.805 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.16 -44.07 92.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.54 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . 0.506 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 24.3 tt0 -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.94 -27.85 63.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.848 -167.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.74 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 11.8 m120 -105.58 -30.7 9.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.466 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -142.79 70.66 1.33 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.607 ' HA ' ' CD2' ' C' ' 13' ' ' TYR . 80.5 p -166.54 -35.43 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.825 0.85 . . . . 0.0 109.067 169.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -64.33 171.07 3.32 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.678 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.34 42.62 5.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.232 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.0 p -69.78 -18.13 63.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.113 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.33 26.64 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.408 ' C ' ' H ' ' C' ' 94' ' ' ALA . 11.9 t -114.37 -9.35 12.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.075 0.464 . . . . 0.0 110.541 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.757 ' HB ' ' ND2' ' C' ' 95' ' ' ASN . 18.4 t 63.99 3.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.52 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' C' ' 97' ' ' GLU . . . 62.06 31.41 17.89 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.757 ' ND2' ' HB ' ' C' ' 93' ' ' VAL . 41.9 m-80 -62.19 -58.11 8.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.412 -177.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.52 9.59 40.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.375 0.607 . . . . 0.0 109.963 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' C' ' 94' ' ' ALA . 8.9 mp0 -97.4 -56.55 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.541 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 48.1 p -97.86 -15.98 19.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.268 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.31 -168.83 0.21 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.414 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -83.02 -28.9 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 110.962 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . 0.542 ' HZ3' ' HB3' ' C' ' 101' ' ' LYS . 1.1 ptpm? -80.88 -11.88 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.213 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 72.3 mt 58.01 25.89 12.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.926 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 49.1 m -151.77 79.53 1.27 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.784 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -160.19 140.95 12.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.771 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 58.83 -99.31 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.887 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' C' ' 106' ' ' ARG . 14.3 mmt85 -104.34 21.63 16.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -172.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 7.4 p -69.78 -68.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.35 0.595 . . . . 0.0 111.009 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . 0.508 ' C ' ' H ' ' C' ' 110' ' ' LEU . 5.5 mt -107.34 5.93 9.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 65.2 p 61.52 -28.05 0.06 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.295 1.438 . . . . 0.0 113.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' C' ' 108' ' ' ILE . 4.2 mm? -121.41 77.76 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.06 34.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.233 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.72 19.61 67.71 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.42 165.03 37.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.021 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 67.3 t -93.59 127.6 45.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.3 p -64.32 -26.7 68.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.19 -81.66 0.18 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.983 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 15.6 p -84.2 2.89 37.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 67.85 4.79 4.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.214 0.605 . . . . 0.0 111.107 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.8 p 47.42 38.33 7.42 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.081 0.952 . . . . 0.0 112.968 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.86 -4.64 36.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.335 0.588 . . . . 0.0 110.215 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -98.69 54.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.668 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' C' ' 124' ' ' ALA . . . -57.32 126.79 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.179 -175.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 18.6 t 72.74 -32.88 0.25 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.732 0.813 . . . . 0.0 112.039 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' C' ' 122' ' ' GLY . . . -74.67 -28.01 60.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 111.059 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -132.68 133.95 44.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.815 0.341 . . . . 0.0 110.813 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.27 119.54 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.666 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 24.7 p -86.49 -94.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.363 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.06 -56.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 110.481 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' C' ' 129' ' ' GLU . 0.3 OUTLIER -100.03 40.83 1.21 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.795 -172.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 3.0 p -68.07 -73.77 0.14 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.47 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -122.28 16.81 10.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.399 0.618 . . . . 0.0 110.451 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 28.8 m -128.62 23.3 5.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -154.19 43.86 0.59 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.567 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.708 -179.032 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.571 0.224 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.12 -51.59 2.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.468 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -136.11 76.35 51.65 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.546 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.26 -24.97 26.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 113.312 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.91 -51.26 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.55 143.24 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -91.57 112.59 55.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.804 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.96 110.28 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.4 m -68.82 -35.63 77.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.317 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -81.68 130.47 61.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.839 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.87 105.38 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.192 1.928 . . . . 0.0 111.479 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.439 HD12 ' OH ' ' C' ' 20' ' ' TYR . 93.1 mt -70.13 147.11 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' C' ' 86' ' ' TYR . 82.0 m-85 -111.13 -167.63 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -164.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 0.0 OUTLIER -158.7 164.37 35.98 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.998 0.428 . . . . 0.0 110.03 -167.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.585 ' OD2' ' HB ' ' C' ' 19' ' ' VAL . 2.4 p30 -103.07 -139.21 0.35 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.079 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -60.39 3.48 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -161.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.25 -4.98 50.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.283 0.563 . . . . 0.0 109.808 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.87 27.92 4.41 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.767 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.585 ' HB ' ' OD2' ' C' ' 15' ' ' ASP . 62.8 t -64.73 127.57 25.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . 0.439 ' OH ' HD12 ' C' ' 12' ' ' LEU . 50.8 t80 -81.93 134.99 35.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.032 0.92 . . . . 0.0 111.091 -172.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.75 131.87 4.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.65 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -90.71 152.05 20.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.654 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.04 116.28 31.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.356 0.598 . . . . 0.0 109.696 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.663 ' O ' ' HB3' ' C' ' 66' ' ' LEU . 16.8 mt -118.2 98.92 51.74 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.213 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -66.25 152.05 82.0 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 121.655 1.57 . . . . 0.0 111.267 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . 0.444 HG21 ' O ' ' C' ' 61' ' ' GLU . 46.2 mt -82.7 98.04 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -86.12 -60.79 1.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.514 -163.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' C' ' 39' ' ' ALA . . . -154.56 154.53 33.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.366 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 73.7 mt -140.79 143.05 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.472 0.653 . . . . 0.0 110.558 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -135.84 124.76 24.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.263 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -85.37 118.72 25.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 110.009 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.81 -163.62 0.94 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.558 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.297 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -97.8 17.24 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.09 87.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.705 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 18.2 p -72.92 138.59 46.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.863 0.363 . . . . 0.0 110.371 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.491 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -100.28 113.97 27.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 15.5 m-80 -90.07 108.26 19.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.722 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' C' ' 28' ' ' ALA . . . -87.73 89.11 7.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.149 0.499 . . . . 0.0 111.233 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 38.1 mt-10 -76.55 106.47 8.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.747 -174.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . 0.582 ' CG ' ' HB2' ' C' ' 45' ' ' TYR . 1.6 m-85 -59.33 138.61 57.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.549 0.69 . . . . 0.0 112.164 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.22 -33.52 16.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.619 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.12 179.48 35.48 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.775 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 56.85 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.007 2.472 . . . . 0.0 113.103 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.582 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 89.9 m-85 -131.6 -177.95 4.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.046 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.7 -179.0 6.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.224 0.535 . . . . 0.0 111.533 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -111.48 127.38 55.68 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.84 124.77 40.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.584 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -87.21 112.11 21.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' MET . . . . . 0.408 ' CG ' ' HB2' ' C' ' 37' ' ' ALA . 22.4 ptp -110.37 129.52 55.74 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.759 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' SER . . . . . 0.452 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.6 OUTLIER -62.35 159.42 15.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.057 -176.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.46 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . 0.404 ' H ' ' CD ' ' C' ' 53' ' ' GLN . 0.2 OUTLIER -58.26 -40.14 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 109.144 173.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -72.96 -40.12 65.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 79.4 t -67.56 -22.45 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.283 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.7 74.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.08 -31.44 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.487 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -113.17 19.8 16.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 52.1 tttm -48.7 107.45 0.76 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.495 0.497 . . . . 0.0 111.526 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 85.9 Cg_endo -106.03 -154.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 123.809 3.006 . . . . 0.0 111.83 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.444 ' O ' HG21 ' C' ' 26' ' ' ILE . 25.3 mt-10 -141.51 153.81 45.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.687 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.47 125.0 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.926 0.87 . . . . 0.0 109.753 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.31 -10.35 28.73 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.434 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.45 -158.24 27.95 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.042 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.35 156.95 34.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.915 0.388 . . . . 0.0 111.133 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.663 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 23.5 tp -147.08 154.03 40.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.12 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -151.5 163.6 38.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -143.33 132.9 23.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 31.2 p -102.55 178.28 4.62 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.442 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -55.28 -33.71 63.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.896 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . 0.425 ' HB2' ' HG2' ' C' ' 73' ' ' GLU . 44.7 m-85 -72.52 -5.77 39.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.3 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.38 1.93 83.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.378 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' C' ' 71' ' ' TYR . 9.4 pt-20 -91.11 140.33 29.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.269 0.557 . . . . 0.0 110.478 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.488 HD23 ' N ' ' C' ' 74' ' ' LEU . 0.6 OUTLIER -131.13 155.34 47.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.895 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.543 ' O ' HD13 ' C' ' 66' ' ' LEU . 71.6 mt -148.44 157.27 43.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -91.7 138.06 31.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.019 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.473 ' HB2' ' HB1' ' C' ' 81' ' ' ALA . 0.4 OUTLIER -162.24 -179.81 7.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.196 0.522 . . . . 0.0 111.619 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.5 p -122.49 -174.91 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.068 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -57.04 -28.5 62.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 8.6 p -54.27 -54.96 33.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' C' ' 77' ' ' MET . . . -74.21 -33.23 63.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.9 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.609 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 2.6 t80 -50.13 -49.59 51.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.309 0.576 . . . . 0.0 109.504 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . 0.769 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 10.8 tp10 -60.85 -45.15 95.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.187 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.6 -26.02 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.479 ' O ' ' HB3' ' C' ' 15' ' ' ASP . 0.9 OUTLIER -91.77 -27.39 18.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.623 ' O ' HG22 ' C' ' 87' ' ' THR . 0.2 OUTLIER -167.88 78.54 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.769 ' OG1' ' HA ' ' C' ' 83' ' ' GLU . 6.6 p -164.85 -28.55 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.142 0.977 . . . . 0.0 109.52 162.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 8.6 t -67.19 -179.32 0.96 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.867 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.12 1.76 3.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.788 0.835 . . . . 0.0 112.454 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.418 ' HB2' ' CG2' ' C' ' 93' ' ' VAL . 15.1 m 65.07 167.78 0.18 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.873 0.844 . . . . 0.0 113.154 172.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.3 -65.21 1.89 Allowed Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.251 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -104.86 87.66 2.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.552 0.692 . . . . 0.0 112.084 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' C' ' 90' ' ' SER . 87.3 t -126.65 -54.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.131 171.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.99 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.039 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.407 ' OD1' ' HG3' ' C' ' 14' ' ' LYS . 8.7 p30 -61.09 -12.95 13.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.05 9.39 7.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.692 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.43 -35.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.138 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 79.3 p -88.76 -64.59 1.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 46.91 45.94 15.43 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.964 0.79 . . . . 0.0 112.431 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -107.54 -67.13 0.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.933 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -113.28 -69.45 0.86 Allowed 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.835 -0.54 . . . . 0.0 109.914 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' C' ' 110' ' ' LEU . 7.0 mp 54.59 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.198 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 1.6 p -136.9 16.61 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 60.3 p -79.6 39.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.82 -89.24 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.61 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -140.98 -2.78 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.529 0.681 . . . . 0.0 109.412 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 12.5 p -86.62 159.21 19.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.507 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 35.8 mm -132.16 -51.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.637 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 19.1 p -82.37 26.42 0.55 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' C' ' 102' ' ' LEU . 60.9 mt -102.76 18.21 21.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.185 0.517 . . . . 0.0 110.433 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 11.6 p -85.12 36.8 0.64 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.377 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.62 -56.45 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.334 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.64 155.32 41.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.608 0.242 . . . . 0.0 110.477 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.74 94.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.868 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.9 p -56.96 -40.67 76.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.149 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.69 -17.13 62.2 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.891 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 41.2 t -103.84 -42.62 5.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.131 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.28 -23.14 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.614 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -57.39 -33.22 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.701 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.09 -55.49 3.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.178 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -152.97 -51.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.04 -172.63 27.03 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.445 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 22.3 t -157.02 138.91 14.33 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.3 77.85 9.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.149 0.499 . . . . 0.0 110.26 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.92 137.78 36.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.679 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 25.4 t -94.03 94.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.81 49.88 1.7 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.091 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 59.5 mt 64.76 -78.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.586 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.439 ' C ' ' HG1' ' C' ' 130' ' ' THR . 44.2 mt-10 38.04 52.25 1.53 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.654 0.597 . . . . 0.0 112.058 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' C' ' 129' ' ' GLU . 48.6 p 50.16 27.48 2.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -126.99 133.54 50.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.824 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 48.4 m -149.75 31.37 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.286 0.565 . . . . 0.0 109.776 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.8 -63.67 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.458 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.486 179.374 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.59 -48.03 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' C' ' 5' ' ' ASN . 53.2 m-80 -62.2 -54.13 52.41 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.37 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.48 26.74 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.749 1.633 . . . . 0.0 112.439 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' C' ' 3' ' ' ASN . 17.9 m120 -134.87 -60.0 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.127 0.489 . . . . 0.0 110.042 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -97.64 178.85 5.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.504 ' OG1' ' HD3' ' C' ' 8' ' ' PRO . 0.0 OUTLIER -81.24 -54.02 0.73 Allowed Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 177.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . 0.504 ' HD3' ' OG1' ' C' ' 7' ' ' THR . 6.0 Cg_exo -75.29 156.22 41.68 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 111.635 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -65.74 -35.4 80.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.486 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -96.22 121.06 61.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.528 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.604 ' HB2' ' CZ ' ' C' ' 82' ' ' PHE . 68.6 Cg_endo -76.87 101.89 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.152 1.902 . . . . 0.0 111.406 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' C' ' 22' ' ' SER . 23.1 mt -86.81 155.15 20.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -172.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' C' ' 82' ' ' PHE . 2.8 m-85 -91.7 136.96 32.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.236 -174.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.461 ' H ' ' HB3' ' C' ' 86' ' ' TYR . 93.2 mttt -116.02 105.89 13.14 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.005 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.549 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -72.44 -166.26 0.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.505 -171.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.7 -50.64 72.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -170.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.36 -6.53 14.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.16 14.07 3.42 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.602 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.549 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 97.8 t -74.23 103.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . 0.451 ' OH ' ' HE2' ' C' ' 14' ' ' LYS . 1.2 m-85 -76.7 151.68 36.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.496 1.141 . . . . 0.0 112.261 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -148.8 120.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.81 -1.995 . . . . 0.0 108.952 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.417 ' HA ' HD21 ' C' ' 12' ' ' LEU . 23.0 t -78.04 148.86 34.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.114 -177.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.57 117.87 35.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.828 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -99.78 114.43 65.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.666 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.32 125.97 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 55.8 mt -80.35 96.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -67.22 -45.99 75.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.137 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' C' ' 62' ' ' VAL . . . -157.25 159.49 37.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 0.0 111.988 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.5 mt -145.71 145.58 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.982 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -131.42 132.03 44.04 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -94.3 136.0 35.09 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.916 -172.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.2 131.38 56.48 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.993 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -60.34 -19.85 57.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.329 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.81 -21.74 61.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.803 0.335 . . . . 0.0 110.78 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.98 -26.35 4.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.246 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 10.1 m -72.67 161.51 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.989 0.423 . . . . 0.0 110.883 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -141.07 122.53 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 9.0 t-20 -77.26 128.92 35.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -115.17 147.95 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.211 0.529 . . . . 0.0 112.179 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.03 110.35 11.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.859 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -102.3 156.47 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.33 132.49 33.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.72 -178.93 19.54 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.252 -174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.77 58.31 6.91 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.883 2.389 . . . . 0.0 111.857 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.487 ' HH ' ' NH2' ' C' ' 68' ' ' ARG . 18.7 m-85 -122.19 -176.51 3.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -176.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.6 50.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.734 0.778 . . . . 0.0 112.908 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.0 p-10 -132.78 79.91 1.87 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -152.62 169.16 23.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.205 -164.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 50.3 p90 -92.55 138.28 31.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.054 0.454 . . . . 0.0 110.747 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.3 mmt -103.64 140.75 37.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.234 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' SER . . . . . 0.425 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 1.3 p -61.08 154.61 22.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.422 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -30.19 71.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 23.4 mp0 -58.45 -44.77 89.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.756 0.789 . . . . 0.0 109.057 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -67.89 -43.6 78.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.949 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.2 t -65.63 -27.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.585 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -29.91 69.34 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.298 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.72 -34.11 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.51 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.14 24.53 11.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 0.0 OUTLIER -46.08 117.86 4.19 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 121.299 0.571 . . . . 0.0 111.36 175.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 83.6 Cg_endo -106.37 -156.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 123.403 2.735 . . . . 0.0 111.876 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.437 ' HB2' ' CZ ' ' C' ' 76' ' ' TYR . 48.1 mt-10 -149.18 142.65 25.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.05 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' C' ' 28' ' ' ALA . 5.2 p -78.27 111.63 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.834 0.826 . . . . 0.0 109.977 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.96 -18.68 7.47 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.74 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.8 -155.11 31.47 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.402 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -131.8 142.55 49.77 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.408 HD23 ' C ' ' C' ' 66' ' ' LEU . 0.0 OUTLIER -118.84 134.88 54.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 44.0 p90 -109.56 158.04 18.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.758 -172.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' HH ' ' C' ' 45' ' ' TYR . 60.4 ttp180 -134.32 129.51 35.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' SER . . . . . 0.451 ' HA ' ' HB ' ' C' ' 21' ' ' VAL . 40.5 p -95.35 178.0 5.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.002 0.43 . . . . 0.0 111.001 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.34 -9.49 58.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.991 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -85.04 -6.34 59.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.09 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.52 12.07 78.85 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.53 127.15 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.07 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.3 pt? -130.53 140.27 50.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.074 0.464 . . . . 0.0 110.843 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.505 HD21 ' C ' ' C' ' 74' ' ' LEU . 2.1 mm? -148.22 160.81 42.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.405 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 61' ' ' GLU . 71.7 t80 -92.52 141.57 28.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.464 ' SD ' ' HB1' ' C' ' 81' ' ' ALA . 40.6 tpp -155.86 147.38 22.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 111.134 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 77' ' ' MET . 20.3 p -89.71 158.34 17.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 13.6 ptmm? -66.91 -13.01 61.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 11.3 p -60.38 -61.83 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.511 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . 0.464 ' HB1' ' SD ' ' C' ' 77' ' ' MET . . . -69.83 -38.01 76.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.694 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' C' ' 11' ' ' PRO . 0.2 OUTLIER -50.8 -52.92 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.265 177.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.98 -36.52 64.54 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.16 25.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.786 -169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.09 -29.15 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.303 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.461 ' HB3' ' H ' ' C' ' 14' ' ' LYS . 23.0 m-85 -103.08 -73.01 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.748 -173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 68.8 p -84.22 -9.36 58.59 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -167.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -63.91 -48.53 76.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.643 0.259 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.26 -76.65 0.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.454 -176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.4 t 57.28 35.43 26.1 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.905 0.859 . . . . 0.0 109.508 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.84 -81.12 0.43 Allowed Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.428 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' C' ' 95' ' ' ASN . 58.6 m -148.69 6.66 0.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.354 0.262 . . . . 0.0 110.562 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 50.4 t 63.21 -79.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 123.734 0.646 . . . . 0.0 111.376 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' C' ' 95' ' ' ASN . . . -93.36 -14.05 27.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.21 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' C' ' 97' ' ' GLU . 48.8 m-80 74.95 -43.57 0.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.948 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.02 33.87 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.835 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' C' ' 95' ' ' ASN . 29.7 mm-40 -100.28 -49.55 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 10.9 t -74.65 -17.64 60.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.678 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.72 48.67 2.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.674 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.84 -24.18 48.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.121 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . 0.633 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 83.2 tttt -73.04 -13.52 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 110.851 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.95 -31.04 72.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -92.33 -28.35 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.545 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' C' ' 101' ' ' LYS . 42.2 p -85.32 -28.26 25.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.14 -31.75 11.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -98.94 -63.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.644 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 33.9 p -84.61 -54.79 4.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 70.0 mt 75.79 -31.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 12.8 p -76.94 2.0 16.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.456 ' C ' ' HG1' ' C' ' 111' ' ' THR . 95.6 mt -135.63 -57.24 0.78 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.676 0.274 . . . . 0.0 110.522 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' THR . . . . . 0.456 ' HG1' ' C ' ' C' ' 110' ' ' LEU . 23.7 p 50.46 -101.0 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.891 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.9 34.39 1.23 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.8 -73.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 40.1 t -136.72 133.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -78.28 56.15 1.65 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 111.97 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.59 -62.05 0.33 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.772 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -81.27 4.4 20.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.637 0.256 . . . . 0.0 111.502 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.92 -8.37 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.086 0.469 . . . . 0.0 110.08 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.9 t -67.83 103.69 1.51 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.628 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 67.94 -74.89 0.07 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-O 121.098 0.475 . . . . 0.0 110.609 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -163.66 -25.34 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.664 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.51 -165.84 29.12 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 10.7 t -164.65 -29.27 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.102 0.477 . . . . 0.0 110.211 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.44 -6.46 46.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.298 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -85.64 -17.64 35.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . 0.499 HG13 ' H ' ' C' ' 128' ' ' ILE . 16.2 t -80.96 138.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 2.2 p -75.18 -2.13 26.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . 0.499 ' H ' HG13 ' C' ' 126' ' ' VAL . 10.3 mt 55.45 33.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.703 0.763 . . . . 0.0 110.95 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -97.31 159.2 15.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.825 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 7.3 p -71.41 108.09 4.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.635 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -78.26 56.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.435 0.636 . . . . 0.0 111.301 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 18.0 p -146.17 -56.62 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.459 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 152.23 -19.29 0.83 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.519 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.381 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.806 0.336 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.91 43.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.333 0.587 . . . . 0.0 110.164 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -143.86 115.37 5.59 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.749 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.89 4.07 2.46 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.913 2.409 . . . . 0.0 113.029 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 56.7 32.9 21.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.401 0.68 . . . . 0.0 111.549 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -70.28 -25.34 63.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.472 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -155.1 78.96 4.67 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.596 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.43 -16.12 38.77 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.59 2.194 . . . . 0.0 112.448 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -105.99 68.81 0.79 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -62.46 130.02 93.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.441 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.41 101.47 1.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.073 1.849 . . . . 0.0 111.296 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 mt -121.96 143.06 49.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.83 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' C' ' 86' ' ' TYR . 79.8 m-85 -145.63 -161.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.144 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.473 ' HB2' ' HA ' ' C' ' 89' ' ' ALA . 2.0 mptp? -146.34 145.59 30.37 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.258 0.552 . . . . 0.0 109.916 -168.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.619 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -87.67 -165.08 1.21 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.536 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' C' ' 90' ' ' SER . . . -65.36 -52.25 54.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.31 -6.96 22.5 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -170.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.42 ' HA2' ' OG ' ' C' ' 90' ' ' SER . . . 126.37 26.18 1.22 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.385 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.619 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.3 t -83.54 117.56 29.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.038 0.446 . . . . 0.0 110.173 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -87.69 132.84 33.97 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 109.574 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.4 OUTLIER -150.74 139.36 14.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.876 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -105.23 163.89 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.596 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . 0.421 ' HB1' ' CD2' ' C' ' 65' ' ' TYR . . . -108.66 117.29 33.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.125 0.488 . . . . 0.0 110.335 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.474 HD11 ' N ' ' C' ' 24' ' ' LEU . 4.4 mp -107.37 115.26 59.89 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.922 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' C' ' 24' ' ' LEU . 3.0 Cg_exo -72.22 138.4 30.42 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.744 1.63 . . . . 0.0 112.206 -173.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.56 117.42 37.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.935 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -79.03 -60.79 2.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.996 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 151.27 9.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.816 0.341 . . . . 0.0 111.131 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 54.9 mt -132.11 140.87 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.912 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.3 114.48 16.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -65.56 104.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.584 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.84 170.99 15.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.606 0.717 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -69.75 -14.08 62.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.06 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.18 -18.4 21.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.475 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.93 -37.25 2.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.103 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -60.08 146.49 42.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.434 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.73 120.51 41.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 37.2 m-80 -71.77 117.43 13.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.836 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.692 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -106.47 107.86 19.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 0.0 112.104 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.45 114.37 25.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.054 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -99.43 148.1 24.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.871 0.367 . . . . 0.0 110.302 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.22 125.85 32.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 0.0 109.929 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.63 17.65 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.201 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.95 59.37 6.89 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.551 2.168 . . . . 0.0 112.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.56 -175.76 3.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.432 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.536 ' HB2' HE21 ' C' ' 48' ' ' GLN . . . -66.01 152.9 43.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.562 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.692 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 8.3 p-10 -149.7 92.01 1.87 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 168.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 40.9 mt-30 -149.44 174.7 12.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 -164.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.93 112.65 9.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.9 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 51.6 tpp -91.2 129.78 37.15 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.03 135.35 31.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.337 0.589 . . . . 0.0 111.554 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.47 95.65 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.547 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -63.75 -31.49 72.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.405 0.622 . . . . 0.0 109.903 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 19.3 m -74.11 -40.93 62.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.679 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 77.7 t -70.53 -20.78 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.423 0.63 . . . . 0.0 110.308 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.46 73.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.87 -28.0 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.677 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -106.16 15.03 26.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.209 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 55.1 pttt -51.44 114.97 5.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.5 Cg_endo -102.99 -151.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.85 3.034 . . . . 0.0 111.123 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -138.23 143.03 39.93 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.409 ' O ' HG21 ' C' ' 62' ' ' VAL . 27.8 m -80.1 119.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.279 1.038 . . . . 0.0 109.827 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.19 20.27 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.811 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 -155.09 30.06 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.577 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . 0.421 ' CD2' ' HB1' ' C' ' 23' ' ' ALA . 50.7 m-85 -122.23 146.82 46.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.291 0.567 . . . . 0.0 112.017 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.23 136.33 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 54.5 p90 -121.77 159.53 26.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.574 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -134.85 128.09 32.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.46 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 94.6 p -103.39 -170.19 1.75 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.221 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' C' ' 19' ' ' VAL . 36.4 mt-30 -65.17 -45.99 82.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.434 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.09 18.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.22 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.97 34.05 70.63 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.322 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.48 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 32.3 mt-10 -89.7 123.88 34.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.4 pt? -130.71 132.38 45.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.046 0.451 . . . . 0.0 110.169 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.621 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.5 mt -153.44 -171.14 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.721 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.77 135.54 33.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 4.9 ttp -103.76 118.04 35.78 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 111.545 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 19.1 p -106.31 -169.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -76.87 -30.87 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.491 1.041 . . . . 0.0 111.026 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.0 p -60.73 -31.58 70.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.741 0.782 . . . . 0.0 109.885 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.67 33.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.129 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' C' ' 86' ' ' TYR . 62.8 t80 -56.56 -40.61 75.48 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.356 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.53 -49.51 66.24 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.895 -0.503 . . . . 0.0 111.655 174.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.28 77.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.861 0.362 . . . . 0.0 110.952 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.474 HD21 ' HB2' ' C' ' 15' ' ' ASP . 15.1 m120 -105.12 -24.68 12.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.833 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.561 ' HA ' ' HB2' ' C' ' 13' ' ' TYR . 6.7 m-85 -120.92 33.39 5.58 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 47.4 p -154.87 -40.5 0.09 Allowed 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.066 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' SER . . . . . 0.408 ' OG ' ' HA ' ' C' ' 16' ' ' ALA . 7.9 t -46.62 -38.51 9.73 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.901 0.751 . . . . 0.0 112.32 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' C' ' 14' ' ' LYS . . . 63.63 22.09 12.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.062 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' C' ' 16' ' ' ALA . 44.5 m 70.32 122.16 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 O-C-N 124.023 0.827 . . . . 0.0 112.07 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.87 -9.33 74.52 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' C' ' 95' ' ' ASN . 12.6 m -92.67 51.39 1.72 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.401 0.62 . . . . 0.0 110.701 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.88 -63.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.926 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.94 2.4 16.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.935 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' C' ' 92' ' ' SER . 9.2 p30 -154.22 160.28 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 67.02 17.02 10.45 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.021 0.825 . . . . 0.0 111.186 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.98 -25.39 27.79 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -68.05 -22.81 64.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.016 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' C' ' 102' ' ' LEU . . . 69.6 124.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.931 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.96 -12.44 60.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.268 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -79.8 0.61 30.12 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.376 0.608 . . . . 0.0 110.721 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' C' ' 127' ' ' THR . 3.7 mm? -72.25 114.53 10.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' C' ' 124' ' ' ALA . 22.1 m 78.94 23.91 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.294 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 82.6 p -88.09 -15.3 36.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.318 0.58 . . . . 0.0 110.247 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.56 -157.44 0.27 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.295 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' C' ' 110' ' ' LEU . 99.7 mtt180 -71.28 75.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.535 0.683 . . . . 0.0 110.143 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -106.41 -58.96 1.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.726 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 60.7 mt -148.81 -58.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.189 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 7.0 p -64.89 -60.39 3.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.004 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' C' ' 106' ' ' ARG . 82.3 mt -85.26 118.89 25.08 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -101.24 -31.29 11.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.75 -79.19 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.292 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.54 144.8 26.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . 0.641 ' HB ' ' O ' ' C' ' 117' ' ' SER . 41.0 t -65.49 144.75 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -70.35 62.27 0.23 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.72 -56.41 0.21 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' SER . . . . . 0.641 ' O ' ' HB ' ' C' ' 114' ' ' VAL . 27.6 t -144.97 137.73 26.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -85.29 43.89 1.05 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 110.168 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 24.3 t -92.11 -27.43 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.181 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 59.76 52.16 5.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.494 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.91 -14.03 58.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.711 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.03 -46.52 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.191 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 32.1 t 66.41 13.8 9.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.071 0.548 . . . . 0.0 111.451 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' C' ' 103' ' ' SER . . . -113.67 87.78 2.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.887 0.375 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -101.97 129.63 48.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.803 0.335 . . . . 0.0 110.596 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . 0.444 ' C ' ' HG1' ' C' ' 127' ' ' THR . 98.0 t 70.61 -64.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.824 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' C' ' 102' ' ' LEU . 40.9 p 48.36 -105.13 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.097 0.559 . . . . 0.0 111.284 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 46.8 mt -139.15 -52.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.456 ' C ' ' HG1' ' C' ' 130' ' ' THR . 22.8 mm-40 -90.87 11.83 21.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.569 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.456 ' HG1' ' C ' ' C' ' 129' ' ' GLU . 33.6 p 53.37 -89.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.134 0.974 . . . . 0.0 112.004 -174.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -85.66 -73.44 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.998 0.428 . . . . 0.0 110.319 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 60.7 m -161.82 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.96 34.31 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.112 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.457 -179.501 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.64 0.257 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.01 38.38 17.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -126.37 118.8 23.23 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.28 -19.07 62.34 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.102 2.534 . . . . 0.0 112.713 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.405 ' ND2' ' HE2' ' C' ' 14' ' ' LYS . 5.8 m-20 -77.67 -26.59 50.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.992 0.425 . . . . 0.0 110.706 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . 0.424 ' C ' ' HD3' ' C' ' 8' ' ' PRO . 60.9 m-85 -94.97 -15.81 23.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.146 0.498 . . . . 0.0 110.041 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -122.22 71.55 34.54 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.845 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' C' ' 6' ' ' PHE . 11.8 Cg_endo -90.23 107.99 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.134 2.556 . . . . 0.0 112.57 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -64.34 -41.15 96.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.2 0.524 . . . . 0.0 109.899 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.69 133.27 42.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.529 ' O ' HD22 ' C' ' 12' ' ' LEU . 74.0 Cg_endo -76.76 99.75 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.511 1.474 . . . . 0.0 111.885 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.529 HD22 ' O ' ' C' ' 11' ' ' PRO . 3.4 mm? -137.23 132.85 34.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.271 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' C' ' 23' ' ' ALA . 48.4 m-85 -93.19 141.65 28.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.405 ' HE2' ' ND2' ' C' ' 5' ' ' ASN . 28.3 mtpp -133.85 123.34 24.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.591 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -90.64 -164.64 1.2 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.511 -177.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.472 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -63.07 -49.72 73.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -172.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.5 -4.2 17.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.589 -0.445 . . . . 0.0 112.107 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.01 18.25 2.38 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.771 -1.204 . . . . 0.0 113.575 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.591 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.7 t -73.74 133.88 30.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.09 160.86 30.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.684 0.754 . . . . 0.0 110.995 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.79 137.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.185 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 31.4 m -78.88 151.22 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.54 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . . . -119.42 128.44 54.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.758 0.314 . . . . 0.0 110.497 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 1.5 mt -105.35 105.68 53.11 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.474 ' HB2' ' HB2' ' C' ' 42' ' ' ASP . 13.9 Cg_exo -67.65 115.25 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.101 1.867 . . . . 0.0 111.395 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 27.9 mt -78.8 111.97 16.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.237 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.404 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 53.1 tttm -85.94 -63.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.04 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.32 158.39 32.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 70.0 mt -115.51 132.78 63.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.865 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.491 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 6.0 mmpt? -91.98 94.61 9.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.029 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -84.06 112.78 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.114 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.79 135.63 33.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -58.29 -19.89 38.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.491 -172.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.8 -20.25 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.714 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.11 -45.12 1.16 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.761 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' C' ' 50' ' ' MET . 2.3 m -60.71 158.48 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.034 0.445 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -145.47 179.09 7.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.601 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 0.2 OUTLIER -162.06 127.73 3.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 173.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -92.05 129.52 37.99 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.508 -172.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -90.9 130.2 36.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.44 146.7 35.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' C' ' 25' ' ' PRO . 44.6 m-20 -78.37 88.83 4.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.132 0.492 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.3 -148.42 17.65 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.063 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.75 26.09 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.41 2.74 . . . . 0.0 112.454 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -129.59 120.09 24.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.2 -161.02 0.6 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.668 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 7.6 p-10 -76.08 126.74 31.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.11 171.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.79 104.93 3.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 9.4 m-85 -154.91 -166.45 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' C' ' 36' ' ' SER . 44.3 tpp -159.21 -67.11 0.08 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.624 0.647 . . . . 0.0 112.427 -171.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' SER . . . . . 0.405 ' O ' HG22 ' C' ' 55' ' ' VAL . 0.3 OUTLIER -104.09 134.13 47.87 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.29 0.567 . . . . 0.0 111.455 -175.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.53 92.31 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.584 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -65.98 -31.05 71.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.562 0.696 . . . . 0.0 109.823 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.6 m -75.24 -38.01 60.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.577 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 74.8 t -70.21 -22.15 24.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.178 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.72 80.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.21 -29.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.861 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.53 9.63 31.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.96 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 87.1 tttt -70.95 113.43 18.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.764 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.464 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 83.3 Cg_endo -101.06 -146.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.876 3.051 . . . . 0.0 111.828 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.464 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 35.5 mt-10 -130.0 131.61 45.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.068 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.13 121.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 122.232 1.015 . . . . 0.0 109.915 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.26 -23.02 9.35 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.484 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.34 36.37 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.227 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -125.51 130.76 52.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.764 0.316 . . . . 0.0 111.436 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 8.6 tp -87.42 172.54 9.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' C' ' 22' ' ' SER . 27.4 p90 -158.43 158.14 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.462 0.573 . . . . 0.0 110.902 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 60.9 ttt180 -148.9 114.83 5.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 77.3 p -95.37 175.88 6.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.459 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.19 -8.48 56.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.813 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -90.12 -7.11 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.076 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.84 14.31 56.69 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.848 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.648 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 31.5 mt-10 -78.09 121.58 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 33.3 tp -131.36 87.0 2.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 96.5 mt -134.5 -173.98 3.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.206 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.82 153.74 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.517 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.432 ' HE3' ' HA ' ' C' ' 81' ' ' ALA . 54.6 mtm -145.15 160.9 40.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 0.0 110.675 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 18.4 p -110.75 -87.32 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.242 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -77.94 -31.38 50.93 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.287 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 3.9 p -65.67 -18.3 65.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.219 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . 0.432 ' HA ' ' HE3' ' C' ' 77' ' ' MET . . . -70.4 -50.1 42.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.787 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.28 -47.93 80.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.315 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . 0.554 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 34.3 tt0 -60.2 -20.2 57.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.702 0.286 . . . . 0.0 111.67 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' C' ' 13' ' ' TYR . . . -93.39 -19.66 21.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' C' ' 13' ' ' TYR . 1.1 m-80 -68.85 -17.41 63.99 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.774 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.554 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 4.3 p90 -132.01 -12.01 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.479 HG22 ' CD2' ' C' ' 86' ' ' TYR . 39.5 p -147.08 -51.7 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 118.563 -1.255 . . . . 0.0 113.718 -172.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' SER . . . . . 0.432 ' N ' ' HA ' ' C' ' 84' ' ' ALA . 28.2 m 72.78 -35.51 0.33 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.213 1.005 . . . . 0.0 111.581 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' C' ' 87' ' ' THR . . . -126.07 -67.12 0.89 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -164.16 -179.98 6.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -77.59 1.23 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.763 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.534 ' HB3' ' ND2' ' C' ' 95' ' ' ASN . 49.2 m -71.28 -37.43 71.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 0.0 110.621 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.551 ' H ' ' HG3' ' C' ' 97' ' ' GLU . 46.4 t 78.15 -77.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.495 172.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.35 5.15 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.844 -173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' C' ' 92' ' ' SER . 7.4 p30 -150.37 135.45 17.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 69.25 -26.27 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.686 0.794 . . . . 0.0 113.141 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.551 ' HG3' ' H ' ' C' ' 93' ' ' VAL . 6.2 mm-40 -94.84 -47.06 6.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -76.67 -29.91 56.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.28 73.11 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.254 0.55 . . . . 0.0 110.499 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.24 -4.11 30.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.661 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -77.01 -17.29 58.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 85.6 mt 63.34 14.43 7.87 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.45 169.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m 56.54 73.13 0.46 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.432 0.634 . . . . 0.0 109.69 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 4.7 t -93.51 -171.88 2.75 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.867 -170.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.4 -41.81 63.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -171.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.474 ' HA ' HD21 ' C' ' 110' ' ' LEU . 96.7 mtt180 -126.11 77.47 1.68 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.76 -81.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.38 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 59.0 mt -86.79 -28.71 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.529 0.681 . . . . 0.0 109.8 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -63.6 -27.93 69.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.664 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.474 HD21 ' HA ' ' C' ' 106' ' ' ARG . 4.1 mm? -111.89 86.67 2.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.396 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 13.8 p -80.58 -55.46 4.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.344 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.98 35.4 1.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.44 155.67 24.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 80.2 t -90.94 127.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.001 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' C' ' 120' ' ' PHE . 25.5 p -60.39 -40.58 91.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.376 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.37 38.49 2.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.211 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 11.4 t -154.9 -45.48 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.74 27.25 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.2 m 61.1 61.29 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.097 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . 0.402 ' HB2' ' HA ' ' C' ' 115' ' ' THR . 72.6 m-85 -132.82 102.6 5.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -121.52 133.88 55.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.75 -107.6 3.19 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.189 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 36.2 m 54.97 46.63 23.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.339 0.59 . . . . 0.0 110.264 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.46 31.64 4.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.69 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 71.41 150.46 0.1 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.021 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 46.8 t -80.79 93.96 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 5.9 p -82.53 83.66 7.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.311 0.577 . . . . 0.0 111.453 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.32 -36.31 77.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.144 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -115.15 147.95 39.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.267 175.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.5 p -132.01 117.71 18.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.687 0.279 . . . . 0.0 110.809 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 23.0 p -66.26 100.86 0.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.064 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -149.3 13.06 0.84 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.367 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.57 -1.0 10.09 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.889 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.421 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.959 0.409 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.57 56.59 0.64 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -97.98 123.92 49.57 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.258 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.96 32.1 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.933 2.422 . . . . 0.0 111.864 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -129.24 28.66 5.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -80.55 149.01 30.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.336 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -144.05 101.62 4.88 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.511 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.55 39.52 0.56 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.132 2.554 . . . . 0.0 112.661 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 33.7 t -70.79 -53.92 13.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -83.73 122.32 76.46 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' C' ' 23' ' ' ALA . 72.7 Cg_endo -77.21 103.84 1.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.243 1.962 . . . . 0.0 112.293 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.2 128.26 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.539 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 63.2 m-85 -92.98 143.26 26.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 67.0 mttm -117.06 139.71 50.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -170.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p-10 -46.98 136.18 8.68 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.14 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.88 -55.85 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.32 167.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.72 -7.04 47.81 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.65 26.81 1.24 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.767 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 54.3 t -116.24 119.86 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -97.87 138.66 34.88 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -148.15 124.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.646 -172.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -83.17 147.77 27.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.091 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.02 128.19 53.67 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.191 0.519 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 5.2 mp -98.74 98.7 6.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.242 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.8 Cg_exo -64.77 114.8 2.91 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.159 2.573 . . . . 0.0 113.116 -174.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . 0.451 HD11 ' HG ' ' C' ' 66' ' ' LEU . 12.0 mt -84.54 99.05 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.438 ' C ' ' HD3' ' C' ' 27' ' ' LYS . 5.7 tmtm? -63.24 -69.57 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.65 162.15 41.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.374 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.82 132.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 0.0 109.932 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.437 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 11.5 mmpt? -105.87 100.29 9.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.427 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -73.98 112.4 10.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.161 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 153.26 28.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.709 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.28 -15.62 62.92 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.046 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.26 -21.63 31.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.348 . . . . 0.0 110.669 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.66 -26.19 5.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.109 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -70.09 165.73 21.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -140.58 122.31 15.33 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.955 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 5.1 t30 -83.83 114.86 21.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -94.69 155.78 16.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.452 -172.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -130.17 119.15 22.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.071 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 14.6 m-85 -126.13 179.49 5.22 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -175.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -36.27 -55.0 0.82 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.079 0.952 . . . . 0.0 113.405 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.8 -81.82 0.06 OUTLIER Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.185 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.63 45.17 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.094 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' C' ' 41' ' ' PHE . 97.4 m-85 -138.38 -173.48 3.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.082 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.33 116.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 0.0 112.078 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 9.8 p-10 -137.83 42.71 2.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.49 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.423 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 2.0 pp0? -165.32 173.92 10.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.841 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 29.3 p90 -97.11 132.51 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -109.43 166.8 10.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.05 144.41 12.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 112.368 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.38 90.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.057 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.539 0.685 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -74.13 -39.17 63.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.67 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.98 -32.31 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.8 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.7 68.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.787 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.68 -23.25 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.351 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.64 6.78 28.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.065 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -54.9 113.33 5.21 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.406 ' O ' ' HG2' ' C' ' 61' ' ' GLU . 56.5 Cg_endo -92.76 -99.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.231 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 21.0 mm-40 -156.95 140.6 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.633 0.373 . . . . 0.0 110.011 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.84 107.85 17.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.712 0.767 . . . . 0.0 109.806 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.04 -5.53 39.35 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.727 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.87 -158.85 34.56 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.147 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.27 123.64 28.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.918 0.389 . . . . 0.0 111.067 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 20.7 mt -79.28 163.53 24.86 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 43.8 p90 -148.21 147.9 29.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -134.92 120.55 19.39 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -94.67 164.44 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -79.72 19.11 0.69 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.624 -173.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.2 -6.41 18.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.444 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.29 -5.52 55.46 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.505 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.22 123.93 33.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.178 0.513 . . . . 0.0 111.111 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.452 ' N ' HD21 ' C' ' 74' ' ' LEU . 1.5 pt? -131.43 138.69 49.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.889 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 83.3 mt -150.1 179.62 7.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -107.72 141.38 39.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 34.4 mmm -150.12 144.07 25.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.855 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 33.0 p -65.38 126.55 28.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 167.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -61.01 -27.74 68.54 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.221 -171.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 17.3 p -52.91 -47.64 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.44 -38.46 55.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.157 0.503 . . . . 0.0 111.414 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.441 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 0.8 OUTLIER -74.16 -39.94 62.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.0 110.261 -175.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.13 -26.25 68.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.185 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.27 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.966 -172.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.22 -31.55 12.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 5.1 m-85 -97.1 -69.25 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 50.2 p -84.85 -20.98 30.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -171.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 13.1 t -58.6 -50.92 72.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 50.94 63.05 2.4 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.295 0.569 . . . . 0.0 110.861 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.3 m -133.14 147.76 52.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.123 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.53 68.92 Favored Glycine 0 CA--C 1.517 0.173 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.508 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 73.5 p -97.02 -9.38 28.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.474 0.654 . . . . 0.0 109.894 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t 69.96 -79.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.318 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.77 -13.93 43.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 61.67 31.51 18.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.143 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.95 5.35 3.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.146 0.498 . . . . 0.0 111.691 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.21 -28.13 32.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.572 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -111.48 11.59 21.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.956 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.04 -156.44 0.34 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.785 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.48 10.99 3.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 0.0 111.385 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -67.46 -12.98 61.6 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.938 -0.477 . . . . 0.0 111.044 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 32.0 mt -81.34 9.1 7.67 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.952 -0.468 . . . . 0.0 110.603 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -107.46 -30.71 8.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.172 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 52.5 p -64.43 109.02 1.8 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.72 0.295 . . . . 0.0 110.629 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 69.64 6.39 5.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.648 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -103.82 -44.88 4.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.033 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.416 ' O ' ' HB ' ' C' ' 108' ' ' ILE . 34.2 p -91.69 -36.93 13.33 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' C' ' 110' ' ' LEU . 50.1 mm 79.96 -37.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.041 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 2.4 p -75.87 43.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.468 0.652 . . . . 0.0 111.527 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' C' ' 108' ' ' ILE . 72.1 mt -81.64 161.46 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.341 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -101.9 18.11 21.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 110.733 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -154.86 169.06 32.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.29 112.43 24.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 0.0 110.941 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.87 137.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -69.49 61.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.062 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.9 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.665 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t -106.05 14.53 27.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 0.0 110.184 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 57.79 31.68 20.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.779 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 m 64.92 13.4 8.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.672 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 67.64 164.96 0.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.644 0.59 . . . . 0.0 111.314 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -166.28 157.5 13.18 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.42 23.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.218 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 15.3 m -82.65 104.11 12.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.65 73.49 6.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.145 0.498 . . . . 0.0 110.836 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.66 133.34 32.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.643 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.89 95.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.499 0.666 . . . . 0.0 111.525 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -126.45 6.81 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.329 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mm 62.12 36.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.225 1.012 . . . . 0.0 109.644 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' C' ' 131' ' ' THR . 9.2 tp10 -109.13 162.54 14.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.421 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.9 p -79.77 29.3 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' THR . . . . . 0.404 ' H ' ' C ' ' C' ' 129' ' ' GLU . 2.9 p -79.76 137.04 36.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -155.23 -45.48 0.08 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.239 0.542 . . . . 0.0 109.739 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.26 173.4 24.77 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.404 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.872 179.715 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mtp . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.97 -33.83 0.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.449 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -105.79 106.17 55.65 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.554 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.23 -21.07 48.66 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.555 2.17 . . . . 0.0 112.612 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.78 -75.23 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.668 0.27 . . . . 0.0 110.597 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -165.41 158.3 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.867 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.4 p -80.37 110.8 18.11 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.87 54.93 2.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.048 2.499 . . . . 0.0 113.064 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.2 m -74.07 -48.9 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -90.05 124.79 62.5 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.61 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.02 160.53 26.93 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.507 2.138 . . . . 0.0 112.008 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -96.17 161.24 14.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.627 ' HB3' ' HA ' ' C' ' 86' ' ' TYR . 95.4 m-85 -125.84 155.86 40.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.401 -166.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.481 ' HZ3' ' HB1' ' C' ' 89' ' ' ALA . 4.1 ptmm? -156.51 158.38 37.09 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -165.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.599 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 9.6 p-10 -96.17 -144.82 0.28 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.616 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.402 ' H ' ' CG ' ' C' ' 15' ' ' ASP . . . -78.24 -40.85 36.01 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -170.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.29 -18.28 17.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.625 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.67 22.29 1.84 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.475 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.9 t -66.73 107.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -84.15 143.16 29.83 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.187 0.994 . . . . 0.0 111.803 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.49 137.27 18.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.482 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 25.9 t -81.79 144.26 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . 0.518 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -105.96 122.72 46.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.591 0.71 . . . . 0.0 110.983 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.9 mm? -101.52 96.74 6.62 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.476 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 2.6 Cg_exo -76.37 104.26 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.778 2.319 . . . . 0.0 111.527 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 44.5 mt -71.29 90.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.718 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.789 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 27.9 tptp -66.65 -51.61 54.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.814 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' C' ' 62' ' ' VAL . . . -166.05 166.66 17.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.821 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' C' ' 37' ' ' ALA . 73.1 mt -135.62 141.62 41.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -104.06 99.78 9.54 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.092 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -79.94 106.68 12.15 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.53 168.4 19.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.778 0.799 . . . . 0.0 110.316 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.15 -10.36 59.2 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.414 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.37 -15.47 37.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.182 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.06 -28.71 6.51 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.977 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -72.09 158.64 35.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.762 0.315 . . . . 0.0 110.411 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' C' ' 29' ' ' ILE . . . -134.12 162.21 32.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.697 0.284 . . . . 0.0 111.15 -177.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 23.8 m-80 -125.92 124.04 39.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.85 106.61 18.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.238 0.542 . . . . 0.0 111.198 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.789 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 23.6 mt-10 -77.77 89.73 4.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.382 -177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -91.18 141.64 28.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.28 -8.13 9.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.59 -124.63 0.72 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.409 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.09 11.25 2.87 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.822 2.348 . . . . 0.0 113.028 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.68 161.55 36.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.879 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.73 -165.0 1.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.31 133.21 36.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 46.8 mm-40 -132.92 139.19 47.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.949 -0.114 . . . . 0.0 110.867 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -75.66 154.47 36.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.876 0.369 . . . . 0.0 110.27 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.8 ptp -150.29 128.08 11.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.575 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 151.19 44.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.665 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.99 77.35 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.91 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.32 -35.2 80.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.401 0.62 . . . . 0.0 109.788 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -71.18 -36.62 72.02 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.282 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 55.5 t -70.18 -23.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.438 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.36 -31.48 67.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.779 0.323 . . . . 0.0 111.026 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.03 -29.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.639 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -116.1 21.96 13.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 20.2 ptmt -52.71 110.82 2.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.309 0.381 . . . . 0.0 111.034 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.2 Cg_endo -100.14 -151.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.411 2.741 . . . . 0.0 111.742 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.411 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 43.0 mt-10 -138.36 131.13 29.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.358 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' C' ' 28' ' ' ALA . 95.6 t -72.99 105.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 0.0 109.781 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.85 -23.12 4.47 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.457 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.0 -165.22 38.05 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.878 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -116.44 135.27 53.99 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.894 0.378 . . . . 0.0 110.991 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.515 HD13 ' O ' ' C' ' 75' ' ' LEU . 36.4 tp -106.32 149.93 26.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -148.29 154.92 40.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.221 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -121.9 121.96 38.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 5.2 p -106.56 -175.45 2.8 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.019 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.08 -46.91 88.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -69.9 -8.73 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.677 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.27 41.92 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.09 136.67 48.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 110.243 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.486 ' O ' HD23 ' C' ' 75' ' ' LEU . 1.6 pt? -130.7 128.43 40.85 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.515 ' O ' HD13 ' C' ' 66' ' ' LEU . 1.6 mm? -138.97 169.51 17.65 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.792 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' C' ' 77' ' ' MET . 24.2 p90 -122.35 156.87 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' C' ' 76' ' ' TYR . 35.7 tpp -177.21 166.12 2.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.411 0.444 . . . . 0.0 110.408 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 24.9 p -77.03 -147.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.703 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -75.09 -24.75 58.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.3 p -47.92 -45.6 30.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.654 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.16 -33.43 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.704 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.711 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 70.5 t80 -53.96 -40.44 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 110.947 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -74.12 -45.07 51.24 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.824 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.39 -30.85 27.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.79 -13.89 11.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.711 ' CD1' ' HA ' ' C' ' 82' ' ' PHE . 0.8 OUTLIER -104.75 -11.61 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.412 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 40.9 p -140.25 -102.73 0.16 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 111.682 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t 49.65 -161.15 0.05 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.572 0.749 . . . . 0.0 111.391 175.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . 0.481 ' HB1' ' HZ3' ' C' ' 14' ' ' LYS . . . 52.67 55.59 8.83 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.319 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 39.6 m -70.98 105.96 3.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.703 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.08 -50.81 21.14 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.329 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 14.1 m -91.62 -26.76 18.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.587 0.232 . . . . 0.0 110.807 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 60.1 t 65.03 -82.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.319 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.25 -6.02 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.762 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 63.94 23.09 13.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.49 0.18 55.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.297 0.57 . . . . 0.0 110.85 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.96 -58.29 2.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.421 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -81.61 -16.94 49.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.14 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' C' ' 102' ' ' LEU . . . -136.94 73.99 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.567 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.43 -4.65 47.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.306 0.574 . . . . 0.0 110.174 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.55 13.4 28.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.438 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' C' ' 99' ' ' ALA . 89.1 mt -54.76 107.32 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 35.0 m 71.77 28.29 2.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.564 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 43.9 p -100.33 121.71 41.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.027 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.79 -91.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.191 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -139.18 44.92 1.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p -79.83 -105.28 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.9 -58.95 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 6.4 p -63.64 -43.33 97.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.066 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -118.65 126.48 52.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 48.1 p -87.83 -23.96 23.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.91 0.862 . . . . 0.0 108.893 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -129.52 131.13 6.58 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.058 173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.58 32.44 0.51 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.127 0.463 . . . . 0.0 111.904 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 61.3 t 65.96 110.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.471 0.653 . . . . 0.0 111.111 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.9 p -59.29 -31.69 69.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.926 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.4 24.0 19.05 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.475 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 33.3 t -139.39 -49.39 0.49 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.75 70.88 10.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.707 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -62.87 -44.74 95.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.248 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -100.13 -58.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -152.57 -25.06 0.17 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.109 0.481 . . . . 0.0 110.424 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.44 45.15 6.26 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 113.802 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 17.5 p -116.47 -81.76 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.055 0.427 . . . . 0.0 111.07 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.28 73.47 10.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -76.57 -50.25 14.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.056 0.455 . . . . 0.0 109.896 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 14.9 t -131.96 75.71 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.338 0.59 . . . . 0.0 110.114 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 4.3 p -100.89 -48.12 4.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 20.6 mt 45.13 62.25 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.218 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.59 -81.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.082 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.0 p -102.4 60.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.596 -173.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -79.53 -23.3 42.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.36 0.6 . . . . 0.0 110.319 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 31.9 t -144.01 33.16 1.24 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.83 -176.6 45.37 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.494 -173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.14 -179.422 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.933 0.397 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.51 58.49 1.13 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.883 0.373 . . . . 0.0 110.617 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -81.16 157.05 71.41 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.204 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.35 -43.66 10.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.46 2.773 . . . . 0.0 114.461 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -59.26 -30.29 68.18 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.288 0.566 . . . . 0.0 111.104 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.64 58.06 2.65 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 34.5 m -53.2 -50.82 80.26 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.971 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.09 55.61 2.93 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.119 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 40.9 t -71.24 -26.76 63.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.393 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -66.47 116.48 34.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.471 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.38 119.5 6.4 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.385 2.057 . . . . 0.0 110.809 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 14.8 mt -115.05 138.25 51.08 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 58.1 m-85 -132.95 -169.76 2.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -168.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 9.8 mtmp? -141.25 135.31 30.54 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -170.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.703 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -77.94 -169.83 1.69 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.555 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -58.28 -45.72 87.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -102.23 -9.46 20.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.193 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.66 16.58 2.74 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.222 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.588 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 44.7 t -67.88 116.38 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.14 134.8 36.19 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.775 0.798 . . . . 0.0 110.185 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.547 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.75 136.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.57 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.3 m -86.48 144.09 27.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.265 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.68 117.34 33.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.566 0.698 . . . . 0.0 109.971 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.21 104.79 54.94 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.688 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.02 122.59 9.19 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.363 2.042 . . . . 0.0 112.275 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . 0.426 HG12 ' CZ ' ' C' ' 41' ' ' PHE . 38.1 mt -78.29 110.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -77.47 -46.94 20.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -157.18 160.55 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.984 0.421 . . . . 0.0 111.817 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 64.1 mt -146.56 143.47 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.659 175.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -130.48 111.99 12.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.413 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -82.61 104.56 12.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.27 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.44 165.12 25.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.745 0.783 . . . . 0.0 110.363 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.21 -19.33 65.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.193 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -84.8 -22.05 29.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.318 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.62 -25.96 6.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.559 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 60.0 p -66.47 148.66 51.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.423 . . . . 0.0 110.772 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.23 123.89 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 5.3 t30 -87.0 120.91 28.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.56 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.699 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -96.65 160.53 14.34 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.924 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -141.66 118.5 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.798 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . 0.426 ' CZ ' HG12 ' C' ' 26' ' ' ILE . 50.5 m-85 -117.31 171.85 7.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.75 -57.8 4.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.097 0.475 . . . . 0.0 111.474 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.7 -168.04 33.42 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.888 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.05 41.01 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.336 2.69 . . . . 0.0 112.493 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.33 -173.32 2.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.068 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -36.06 114.77 0.3 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 124.059 0.849 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.699 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 33.4 t70 -149.02 66.12 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.244 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.673 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 2.2 pp0? -168.81 163.26 11.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.036 -168.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -80.07 111.76 16.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tpt -86.53 145.85 26.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.35 132.09 16.61 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.777 0.673 . . . . 0.0 111.722 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.55 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.13 -35.64 79.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.627 0.727 . . . . 0.0 109.63 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.6 m -74.83 -40.16 61.22 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.577 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 44.2 t -69.04 -25.71 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.88 91.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.837 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.7 -24.7 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.101 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -116.15 14.74 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -170.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 8.9 ptpp? -52.74 116.79 9.6 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.786 0.326 . . . . 0.0 111.447 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 5.5 Cg_endo -88.2 -149.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.179 2.586 . . . . 0.0 111.477 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.402 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 41.9 mt-10 -128.2 132.06 48.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.276 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.23 106.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.96 0.886 . . . . 0.0 109.967 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.86 33.42 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.067 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.17 -159.31 25.24 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.265 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.6 121.36 40.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 tp -96.43 157.66 15.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 46.9 p90 -148.84 153.95 38.8 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.745 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -149.38 142.88 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.276 0.36 . . . . 0.0 110.254 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' SER . . . . . 0.464 ' HG ' ' HB2' ' C' ' 73' ' ' GLU . 20.4 p -115.08 -175.81 2.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.269 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -69.37 -35.75 76.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.889 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.69 -4.7 28.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.156 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.95 19.53 57.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.85 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' HG ' ' C' ' 69' ' ' SER . 28.2 mm-40 -86.05 109.09 18.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 109.895 177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.3 pt? -130.32 139.62 50.69 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.838 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.644 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 67.8 mt -157.94 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.208 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -118.99 144.17 46.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.453 ' HE3' ' HA ' ' C' ' 77' ' ' MET . 1.8 mmt -147.11 145.94 29.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.738 0.304 . . . . 0.0 110.75 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 29.5 p -73.33 145.5 45.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 17.6 ptpt -51.12 -31.87 20.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -167.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -59.74 -57.32 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.25 -38.77 68.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.323 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 70.7 t80 -54.62 -44.37 73.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . 0.48 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 27.8 tt0 -56.66 -51.25 69.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.901 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.44 41.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.893 0.378 . . . . 0.0 110.688 -167.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.703 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 13.6 m120 -93.25 -33.42 13.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.026 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -148.82 66.64 1.05 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.497 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 31.1 p -169.03 -37.14 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -76.34 -161.2 0.17 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.466 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 81.43 -6.45 1.53 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.055 0.942 . . . . 0.0 111.123 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t 69.3 165.62 0.26 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.185 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.15 -32.57 65.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.425 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -72.8 -22.81 60.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 110.527 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.05 -52.39 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.196 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.49 101.32 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.9 -8.73 57.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.5 -177.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.25 -4.22 59.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.286 0.565 . . . . 0.0 110.82 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -112.9 -33.18 6.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.157 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.7 t -99.56 35.68 1.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.798 0.808 . . . . 0.0 108.878 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.99 139.11 58.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.31 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.77 10.14 36.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . 0.602 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 22.6 tptm -92.06 12.57 21.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.585 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.51 -57.77 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.357 -174.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 44.6 m -94.37 -14.24 25.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.332 . . . . 0.0 110.965 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' THR . . . . . 0.602 ' OG1' ' HA ' ' C' ' 101' ' ' LYS . 16.7 p -89.12 -2.25 58.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.991 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . 0.469 ' HB3' ' HG3' ' C' ' 101' ' ' LYS . . . -91.18 58.36 3.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.259 . . . . 0.0 110.457 175.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.4 ' C ' ' HG1' ' C' ' 107' ' ' THR . 0.0 OUTLIER 64.19 40.2 6.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.972 -178.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.4 ' HG1' ' C ' ' C' ' 106' ' ' ARG . 49.1 p 49.74 75.37 0.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.041 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.97 -31.31 52.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.586 0.708 . . . . 0.0 109.823 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 14.1 p -83.39 -3.91 57.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.193 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mp 61.92 -90.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.652 -175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 22.1 p -120.44 -64.63 1.23 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.7 42.72 0.39 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.82 -36.34 2.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 111.498 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t 57.22 27.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.401 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 69.4 p 53.05 -74.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 112.798 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' C' ' 120' ' ' PHE . . . -73.5 -41.29 44.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.716 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -60.55 -33.88 73.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.988 0.423 . . . . 0.0 110.545 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' C' ' 119' ' ' SER . . . -64.96 -55.39 19.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.546 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' C' ' 118' ' ' ALA . 23.9 t 173.1 -9.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.665 0.603 . . . . 0.0 111.433 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . 0.412 ' C ' ' HA2' ' C' ' 116' ' ' GLY . 62.5 m-85 -107.7 72.45 0.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.924 0.393 . . . . 0.0 111.479 -172.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.07 -50.22 9.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.18 21.39 0.19 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.051 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -138.45 84.57 2.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.891 0.377 . . . . 0.0 110.256 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.96 -5.18 12.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 63.44 -88.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.864 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . 0.443 ' C ' ' HG1' ' C' ' 127' ' ' THR . 6.0 t 47.71 49.1 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 110.273 -176.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' THR . . . . . 0.443 ' HG1' ' C ' ' C' ' 126' ' ' VAL . 50.1 p 56.32 -90.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 112.443 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . 0.542 ' HA ' ' OG1' ' C' ' 131' ' ' THR . 33.3 mm 57.94 47.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.938 0.875 . . . . 0.0 109.867 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -110.57 -75.67 0.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.659 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 2.3 p -92.44 7.25 43.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.629 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' C' ' 128' ' ' ILE . 23.3 p -64.2 -28.59 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.147 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -149.04 -31.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.164 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.27 41.65 7.36 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.785 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.339 -0.838 . . . . 0.0 109.769 -177.383 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.792 0.33 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.56 -24.46 60.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 110.307 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -115.91 98.48 51.18 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.759 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.4 53.37 4.73 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.783 2.322 . . . . 0.0 111.961 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -84.71 -55.02 4.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 52.52 46.92 25.79 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.245 0.545 . . . . 0.0 110.714 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.0 p -79.23 132.27 63.44 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.677 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 103.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.791 2.327 . . . . 0.0 111.666 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 8.1 m -65.58 -29.95 70.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -62.43 116.07 20.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.174 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.09 160.14 49.98 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.827 2.351 . . . . 0.0 111.237 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.79 165.17 25.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.261 0.553 . . . . 0.0 110.781 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.6 ' HB3' ' O ' ' C' ' 85' ' ' ASN . 15.4 m-30 -93.25 160.13 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.873 -168.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.579 ' H ' ' HA ' ' C' ' 86' ' ' TYR . 55.9 mttp -138.58 120.07 14.98 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -174.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.525 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -82.25 -165.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.659 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.467 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.81 -41.69 71.24 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.42 -8.71 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.56 9.02 5.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.398 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.525 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 78.7 t -77.6 100.04 2.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -84.15 163.12 19.97 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' C' ' 13' ' ' TYR . 3.7 m -147.98 139.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.388 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.42 153.22 24.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.872 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 127.73 55.16 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.379 0.609 . . . . 0.0 110.569 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.456 ' N ' HD23 ' C' ' 24' ' ' LEU . 2.4 mm? -112.2 98.0 41.22 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.993 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' C' ' 42' ' ' ASP . 20.8 Cg_exo -66.02 118.98 5.95 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.932 2.422 . . . . 0.0 112.94 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mt -85.4 96.0 4.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.069 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 60.3 tptt -66.72 -54.44 22.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.698 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.23 164.77 22.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.894 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.6 144.08 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.0 110.996 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -120.28 108.2 13.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.657 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.25 106.45 15.03 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.754 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 162.77 20.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.794 0.806 . . . . 0.0 110.789 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -77.14 -11.72 59.85 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.042 -171.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.23 -12.41 43.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.93 -37.1 3.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.22 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -67.02 131.75 46.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.325 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.69 121.31 41.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.625 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.542 ' N ' HD21 ' C' ' 38' ' ' ASN . 0.8 OUTLIER -86.76 113.07 22.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.27 126.37 52.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.45 0.643 . . . . 0.0 112.359 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 39.9 mt-10 -86.26 108.25 18.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.318 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -107.66 160.81 15.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . 0.505 ' O ' ' HD2' ' C' ' 25' ' ' PRO . 1.9 m-20 -113.61 147.88 37.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.362 172.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.5 13.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.69 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 -31.12 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.808 2.339 . . . . 0.0 112.18 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -86.97 140.52 29.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.219 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.47 -162.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' C' ' 40' ' ' GLU . 2.1 m-20 -64.99 119.24 10.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -154.66 146.18 23.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.056 0.455 . . . . 0.0 111.627 -175.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.2 p90 -93.49 131.34 38.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.499 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.24 137.74 37.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.54 139.52 37.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.712 0.633 . . . . 0.0 111.298 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.56 75.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.473 -173.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -66.41 -34.92 79.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.53 0.681 . . . . 0.0 109.401 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m -71.98 -40.21 68.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.7 t -70.13 -26.66 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.447 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.17 79.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.87 -31.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.586 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.24 20.17 17.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' C' ' 59' ' ' LYS . 0.0 OUTLIER -49.27 110.12 1.44 Allowed Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.253 0.345 . . . . 0.0 110.413 172.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 9.7 Cg_endo -91.33 -155.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.86 2.373 . . . . 0.0 112.772 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.25 137.34 49.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.024 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.49 100.51 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.52 7.38 54.01 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.332 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.55 -166.38 40.0 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.563 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.61 130.41 56.72 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.93 0.395 . . . . 0.0 111.256 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 56.8 tp -119.07 139.53 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 29.5 p90 -146.03 156.29 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.956 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -147.44 139.27 24.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 89.7 p -110.57 179.7 4.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.89 -38.38 90.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.444 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -68.31 -18.8 64.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.093 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.29 12.78 32.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.1 119.78 25.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.0 pt? -130.91 130.62 43.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.415 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.2 mt -145.26 158.51 43.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -113.9 151.17 32.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' C' ' 81' ' ' ALA . 9.4 ttm -175.54 175.31 2.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.726 0.298 . . . . 0.0 110.455 170.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 23.6 p -81.89 -149.78 0.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.496 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.5 ptmt -66.78 -20.52 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -58.18 -64.82 0.78 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.131 0.491 . . . . 0.0 111.308 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . 0.603 ' HB2' ' SD ' ' C' ' 77' ' ' MET . . . -62.53 -37.58 86.63 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.593 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 20.5 t80 -48.47 -55.87 9.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.532 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . 0.817 ' HA ' ' CE2' ' C' ' 86' ' ' TYR . 35.2 tt0 -64.69 -22.21 66.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.373 0.606 . . . . 0.0 111.384 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' C' ' 88' ' ' SER . . . -89.23 -6.53 56.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.6 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 9.9 m-80 -107.32 -39.3 5.71 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.048 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.817 ' CE2' ' HA ' ' C' ' 83' ' ' GLU . 13.2 p90 -94.75 -7.34 40.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.356 -1.338 . . . . 0.0 112.318 -173.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.586 HG23 ' CD1' ' C' ' 86' ' ' TYR . 35.0 p -147.77 -53.67 0.2 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.388 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' C' ' 84' ' ' ALA . 9.8 t 71.13 154.83 0.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.706 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 175.51 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.62 -1.627 . . . . 0.0 107.762 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -145.77 -173.95 4.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.019 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 143.29 -115.22 0.89 Allowed Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 55.8 m -95.88 27.3 3.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.37 -71.62 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.666 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.74 14.06 0.35 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.594 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.4 ' C ' HD21 ' C' ' 95' ' ' ASN . 0.3 OUTLIER -162.75 152.93 16.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.256 -177.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 75.61 -11.74 1.07 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.246 0.966 . . . . 0.0 112.883 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -139.19 -56.35 0.59 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.8 0.333 . . . . 0.0 111.013 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.4 m -53.53 -43.84 68.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.694 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.65 36.24 4.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.063 0.458 . . . . 0.0 110.322 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.75 -31.31 68.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.951 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -87.01 1.35 53.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.099 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.98 42.35 24.4 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.697 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -138.37 36.28 2.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.23 119.01 36.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.566 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 66.92 -77.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.802 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.567 ' C ' ' HG1' ' C' ' 107' ' ' THR . 99.1 mtt180 -124.99 -74.11 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.567 ' HG1' ' C ' ' C' ' 106' ' ' ARG . 2.9 p 46.92 -101.76 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.542 0.737 . . . . 0.0 112.647 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.0 -58.67 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 111.286 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 15.6 p -65.98 -40.55 91.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 0.0 111.814 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.4 34.7 0.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.827 0.346 . . . . 0.0 111.596 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 41.1 p -90.99 -36.17 14.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.31 0.576 . . . . 0.0 110.012 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -139.38 38.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.636 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . 56.05 43.34 27.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.898 0.41 . . . . 0.0 111.262 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t 68.33 143.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.227 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.2 p -75.87 51.63 0.65 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.077 0.465 . . . . 0.0 111.096 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.03 -105.6 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.731 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 5.0 m -104.63 -59.93 1.67 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 117.16 0.48 . . . . 0.0 110.863 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -179.27 63.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.408 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p 57.75 172.6 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.222 1.009 . . . . 0.0 111.671 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 61.38 28.12 17.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.776 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -97.32 55.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.674 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.03 48.36 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.673 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 40.0 m 61.34 44.5 9.56 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 72.68 -57.65 0.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.276 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . 0.412 ' OD1' HG22 ' C' ' 126' ' ' VAL . 22.6 t-20 -179.55 -71.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . 0.412 HG22 ' OD1' ' C' ' 125' ' ' ASN . 69.8 t -138.62 117.94 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 110.51 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 3.2 p -77.59 -77.16 0.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.473 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 69.6 mt -141.71 -49.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -103.7 122.02 44.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.316 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 38.3 p -69.52 -34.6 74.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.979 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -81.98 69.78 8.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.226 0.536 . . . . 0.0 111.024 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -131.79 -8.13 3.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.399 0.618 . . . . 0.0 109.932 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.67 51.73 2.97 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.487 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.778 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.772 0.32 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.65 56.7 4.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 110.578 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 136.95 73.12 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.933 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.61 -30.42 60.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.066 2.511 . . . . 0.0 112.544 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 m120 72.86 -19.7 0.3 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -86.83 108.7 18.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.484 0.659 . . . . 0.0 110.269 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 24.1 m -155.23 89.98 2.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.0 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' C' ' 10' ' ' TRP . 52.3 Cg_exo -55.56 138.47 80.74 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.953 2.435 . . . . 0.0 112.634 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 31.7 p -93.14 65.87 4.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.926 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . 0.599 ' O ' ' HG ' ' C' ' 12' ' ' LEU . 6.2 m-90 -60.27 155.87 43.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.37 102.86 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.346 2.031 . . . . 0.0 111.917 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' C' ' 10' ' ' TRP . 52.5 mt -110.21 -178.2 3.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.523 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.499 ' HA ' HG23 ' C' ' 87' ' ' THR . 7.6 m-85 -92.31 166.03 12.8 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.92 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -115.38 154.46 29.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.558 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -93.55 -167.44 1.7 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.77 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -71.64 -42.07 68.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -170.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.75 -8.52 24.15 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.131 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.61 10.08 5.09 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.907 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.558 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.0 t -71.23 141.96 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.86 136.08 33.43 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.865 0.841 . . . . 0.0 109.447 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 20.0 m -134.26 135.31 54.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.356 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.52 ' HA ' HD13 ' C' ' 12' ' ' LEU . 14.3 m -73.94 147.27 43.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.631 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.77 115.15 29.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.102 0.477 . . . . 0.0 110.67 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.92 96.91 50.54 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.326 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.653 ' O ' ' HE3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -69.59 177.01 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.488 2.126 . . . . 0.0 111.655 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . 0.614 HG23 ' O ' ' C' ' 61' ' ' GLU . 0.1 OUTLIER -120.29 86.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.448 0.642 . . . . 0.0 109.753 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.653 ' HE3' ' O ' ' C' ' 25' ' ' PRO . 0.0 OUTLIER -87.36 -54.44 4.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.268 -163.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.536 ' HB1' ' HB3' ' C' ' 40' ' ' GLU . . . -158.89 151.4 21.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.994 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.81 143.8 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.2 0.524 . . . . 0.0 110.724 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.602 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -128.82 109.07 10.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.571 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -88.72 111.43 21.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.599 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.97 171.52 14.89 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.822 0.82 . . . . 0.0 110.49 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -78.52 -8.47 58.6 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.892 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -99.46 -7.52 25.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.915 0.388 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -19.69 29.3 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.599 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.53 155.02 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 110.442 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -141.35 143.57 34.08 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.989 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.602 ' ND2' ' HB2' ' C' ' 30' ' ' LYS . 11.5 p30 -116.4 147.73 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.97 91.46 3.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.692 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 6.1 tp10 -64.16 101.34 0.4 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.859 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . 0.628 ' CD2' ' HE2' ' C' ' 27' ' ' LYS . 0.5 OUTLIER -62.36 161.9 10.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 113.396 169.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.84 -19.06 4.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.755 167.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.82 -150.67 9.35 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.872 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.39 35.87 0.56 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.323 2.682 . . . . 0.0 114.317 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' C' ' 41' ' ' PHE . 96.0 m-85 -140.96 -177.46 5.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' C' ' 41' ' ' PHE . . . -100.22 -164.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.634 -177.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.73 118.55 31.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -95.93 120.96 37.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 44.2 p90 -104.7 139.45 39.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.079 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.55 147.75 46.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.5 154.26 29.16 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.517 0.511 . . . . 0.0 111.704 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.01 -57.46 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -59.68 -27.72 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.415 0.626 . . . . 0.0 110.259 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.8 m -75.64 -37.26 59.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.055 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.432 ' O ' HG12 ' C' ' 55' ' ' VAL . 71.4 t -73.08 -14.17 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.382 0.61 . . . . 0.0 110.061 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.44 68.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.41 -37.93 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.549 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.12 20.14 17.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.138 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.16 114.77 4.12 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 123.515 0.509 . . . . 0.0 111.742 176.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' C' ' 65' ' ' TYR . 19.4 Cg_endo -98.14 -161.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 123.209 2.606 . . . . 0.0 112.289 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.614 ' O ' HG23 ' C' ' 26' ' ' ILE . 40.2 mt-10 -155.44 143.72 20.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.564 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -69.08 109.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . 0.566 ' H ' ' HB ' ' C' ' 26' ' ' ILE . . . 93.24 15.21 52.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.011 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' C' ' 76' ' ' TYR . . . -136.79 63.79 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.947 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . 0.596 ' N ' HG12 ' C' ' 26' ' ' ILE . 0.1 OUTLIER -151.9 -171.44 3.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' C' ' 82' ' ' PHE . 0.5 OUTLIER -168.25 -79.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.24 -171.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -150.38 169.56 21.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.432 -165.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 55.8 ttt180 -151.81 131.09 12.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.153 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 97.0 p -97.02 175.38 6.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.845 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.93 -1.49 22.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.186 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -104.62 2.14 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.568 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.89 20.05 60.23 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.42 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 33.6 mt-10 -89.01 110.44 21.14 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.11 133.54 46.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.037 0.446 . . . . 0.0 110.297 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.77 167.96 18.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.676 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' C' ' 64' ' ' GLY . 0.8 OUTLIER -118.71 150.6 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 19.4 ttm -179.58 -175.76 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -78.8 103.99 9.12 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 160.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.82 -26.9 62.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.612 -170.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 18.1 p -58.78 -33.91 70.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.119 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.85 -49.16 63.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 110.2 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.653 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 48.5 t80 -64.22 -53.53 47.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.819 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.07 -23.61 63.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.731 -174.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.05 -12.96 27.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.451 . . . . 0.0 110.849 -171.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -98.36 -32.1 11.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.217 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.653 ' HD1' ' O ' ' C' ' 82' ' ' PHE . 15.3 m-85 -97.84 -58.34 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.511 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.499 HG23 ' HA ' ' C' ' 13' ' ' TYR . 64.9 p -86.5 -65.39 1.02 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.204 174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 14.4 t 65.1 169.81 0.2 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.55 0.691 . . . . 0.0 110.841 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.46 28.73 3.65 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.431 ' HB2' HG21 ' C' ' 93' ' ' VAL . 7.7 m -96.55 -18.13 20.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.88 -67.94 3.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.767 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' C' ' 96' ' ' ALA . 12.4 p -97.65 80.86 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' C' ' 90' ' ' SER . 14.7 t -99.67 -78.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.24 -38.02 12.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.335 0.588 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -99.17 60.4 1.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . 0.426 ' HA ' ' HB2' ' C' ' 92' ' ' SER . . . -80.13 55.7 2.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.128 -173.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 64.16 8.5 4.11 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.074 0.55 . . . . 0.0 111.638 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 10.3 t -96.74 -16.1 21.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.353 0.597 . . . . 0.0 110.06 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.93 28.56 8.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.685 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.44 -27.45 66.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.22 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . 0.572 ' H ' ' HD3' ' C' ' 101' ' ' LYS . 0.0 OUTLIER -95.79 -10.92 27.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . 0.483 ' O ' HG23 ' C' ' 104' ' ' THR . 95.2 mt 59.02 11.42 1.95 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.379 0.672 . . . . 0.0 112.461 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' SER . . . . . 0.45 ' H ' ' HG2' ' C' ' 101' ' ' LYS . 22.5 m 65.25 22.24 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.129 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' THR . . . . . 0.483 HG23 ' O ' ' C' ' 102' ' ' LEU . 53.1 p -117.99 -53.91 2.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.08 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.64 99.0 2.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.516 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 72.63 125.8 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.945 0.778 . . . . 0.0 110.565 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -78.6 70.0 4.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.9 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 53.6 mt -68.38 -21.24 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 15.7 p -61.81 -28.11 69.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.384 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 94.4 mt 55.54 -91.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.177 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 17.4 p -132.45 23.7 4.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 0.0 110.814 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.2 56.63 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -174.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.0 175.48 13.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.463 -0.869 . . . . 0.0 108.673 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 43.3 t -78.05 69.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.175 0.512 . . . . 0.0 110.507 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 69.0 p 51.61 24.35 2.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.118 0.967 . . . . 0.0 112.508 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.97 70.75 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.316 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -112.16 -12.2 13.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.078 0.466 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 58.94 27.51 16.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.52 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 170.64 14.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.896 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 63.2 23.74 14.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.15 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -159.95 -168.22 2.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.75 -2.21 41.92 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.378 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 19.6 m 65.31 90.39 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.702 0.401 . . . . 0.0 110.881 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.96 95.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.835 0.35 . . . . 0.0 110.682 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -165.99 79.88 0.28 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.873 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . 0.476 ' C ' ' HG1' ' C' ' 127' ' ' THR . 60.5 t -115.33 -62.18 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.187 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' THR . . . . . 0.476 ' HG1' ' C ' ' C' ' 126' ' ' VAL . 37.1 p 49.52 -96.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.402 0.681 . . . . 0.0 112.004 -175.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.57 -57.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -147.72 94.46 2.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.702 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 26.9 p -79.71 -9.41 59.64 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 82.4 p -83.51 -3.64 57.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 110.591 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 70.8 m -158.42 50.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.34 166.77 12.17 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.322 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.754 -178.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.38 -15.66 20.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' C' ' 4' ' ' PRO . 7.5 t-20 -144.67 131.85 10.27 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.567 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' C' ' 3' ' ' ASN . 2.2 Cg_endo -80.17 44.62 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.232 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 54.62 37.15 27.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 48.11 44.92 19.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.484 0.659 . . . . 0.0 111.419 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 m -121.26 120.2 29.18 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.894 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.4 45.15 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.283 2.655 . . . . 0.0 112.989 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -125.49 57.76 1.32 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -64.02 134.17 95.84 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.07 103.41 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.431 2.088 . . . . 0.0 111.58 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.36 169.96 17.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.356 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' C' ' 86' ' ' TYR . 50.9 m-85 -92.25 123.92 35.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.601 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' C' ' 88' ' ' SER . 9.2 pttp -86.93 170.06 11.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.38 1.086 . . . . 0.0 111.157 -171.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -49.63 151.93 1.55 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.52 -2.127 . . . . 0.0 115.31 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.16 -54.7 2.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.113 -2.312 . . . . 0.0 108.614 163.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.43 -7.84 19.57 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.241 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.86 35.97 0.53 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.731 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.48 160.04 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.65 155.69 29.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' C' ' 69' ' ' SER . 5.7 m -149.66 136.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.808 -170.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -74.33 154.41 38.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.57 130.88 52.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.464 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.62 98.48 49.54 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.598 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' C' ' 42' ' ' ASP . 7.4 Cg_exo -76.76 105.99 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.621 2.214 . . . . 0.0 111.202 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.59 117.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.229 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -93.71 -55.0 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.729 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.6 158.13 37.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.536 0.208 . . . . 0.0 111.062 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.56 145.23 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 30' ' ' LYS . 27.2 mtpp -133.71 133.24 41.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.866 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -101.48 117.87 35.82 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.28 -172.62 3.88 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.144 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -74.71 -42.91 57.47 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.965 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.36 -20.23 62.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.74 -25.83 6.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.809 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 30.1 p -63.26 143.94 57.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.86 144.68 48.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 111.748 -176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 8.2 t30 -106.54 127.65 53.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.749 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.66 116.58 31.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.35 121.58 25.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -110.95 147.08 35.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.959 0.409 . . . . 0.0 110.629 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' C' ' 25' ' ' PRO . 21.3 t70 -101.77 150.39 23.2 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.81 -139.66 15.29 Favored Glycine 0 C--N 1.313 -0.704 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.979 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.53 28.35 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.794 2.329 . . . . 0.0 112.467 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.93 165.68 25.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.29 -162.99 0.85 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.675 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -93.91 150.41 20.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 153.36 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 46.9 p90 -109.34 143.17 39.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtt -127.69 148.18 50.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.901 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 152.92 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.71 98.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.49 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -56.61 -38.66 72.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.515 0.674 . . . . 0.0 110.165 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -69.04 -44.55 72.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.565 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 49.5 t -69.62 -27.37 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.821 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.86 76.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.357 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.57 -31.66 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.504 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.8 9.98 36.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 41.6 ttmt -55.58 114.19 6.91 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.465 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 98.9 Cg_endo -98.19 -145.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 123.525 2.817 . . . . 0.0 110.68 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.512 ' HB2' ' CE2' ' C' ' 76' ' ' TYR . 42.9 mm-40 -135.86 142.77 44.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.931 0.396 . . . . 0.0 110.701 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.1 127.19 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.781 0.8 . . . . 0.0 109.543 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.59 -8.74 56.79 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 -172.9 36.96 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.955 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' C' ' 79' ' ' LYS . 58.5 m-85 -146.51 149.33 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -173.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -175.24 -144.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' C' ' 66' ' ' LEU . 6.9 p90 -153.62 -179.3 7.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -140.09 126.37 20.0 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' SER . . . . . 0.405 ' HA ' HG12 ' C' ' 21' ' ' VAL . 42.0 p -98.59 177.21 5.39 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.863 -177.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.56 16.12 1.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.86 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -107.99 3.07 23.7 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.24 89.57 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.222 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -78.21 114.52 17.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.118 0.485 . . . . 0.0 110.899 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.504 HD11 ' N ' ' C' ' 75' ' ' LEU . 3.4 tm? -100.08 137.8 38.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.504 ' N ' HD11 ' C' ' 74' ' ' LEU . 98.3 mt -142.24 158.62 43.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' C' ' 61' ' ' GLU . 17.8 t80 -126.73 147.81 49.94 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.765 0.665 . . . . 0.0 110.461 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.528 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -166.78 175.95 7.46 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' SER . . . . . 0.528 ' H ' ' HG3' ' C' ' 77' ' ' MET . 12.4 p -82.85 122.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.482 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 61.0 pttt -52.44 -46.68 66.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 30.9 p -51.9 -38.95 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.449 0.468 . . . . 0.0 112.164 -173.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.23 -57.08 4.27 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.294 0.569 . . . . 0.0 111.205 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.565 ' CE1' ' HE1' ' C' ' 67' ' ' PHE . 0.5 OUTLIER -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.344 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . 0.609 ' HG3' ' OG1' ' C' ' 87' ' ' THR . 12.9 tt0 -56.02 -39.89 72.62 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.851 0.46 . . . . 0.0 111.824 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.46 84.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.482 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.502 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 43.2 m-80 -98.22 -36.95 9.87 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.974 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.55 ' O ' HG21 ' C' ' 87' ' ' THR . 3.4 m-85 -120.99 59.77 0.93 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -171.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.609 ' OG1' ' HG3' ' C' ' 83' ' ' GLU . 71.9 p -160.62 -49.19 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 165.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' C' ' 14' ' ' LYS . 5.4 t -61.32 162.51 7.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.613 -176.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 75.5 -44.55 0.52 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.321 1.048 . . . . 0.0 110.171 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.405 ' H ' ' C ' ' C' ' 88' ' ' SER . 22.5 m 50.63 17.74 0.41 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.572 -1.195 . . . . 0.0 114.034 171.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.96 27.7 69.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.149 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -146.26 -41.31 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.4 93.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.377 . . . . 0.0 111.373 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.64 18.89 10.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.458 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.15 152.78 32.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 65.03 -75.94 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.936 0.773 . . . . 0.0 112.521 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -71.9 -27.78 63.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.148 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 1.9 m -84.31 -8.42 59.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.49 144.37 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.719 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.39 -25.49 59.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -84.45 -29.36 26.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt 61.39 -98.72 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.058 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 74.5 m -155.85 90.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 6.9 p -86.24 -165.0 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.784 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 66.8 -84.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.888 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -154.5 30.93 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 40.2 p 48.85 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.066 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 4.1 mt -85.21 24.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.147 -170.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 44.7 p 50.02 37.46 14.16 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.993 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 59.75 80.29 0.2 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.074 0.464 . . . . 0.0 111.346 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 123.89 23.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.783 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.79 -86.77 0.82 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.451 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -165.68 -57.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.149 0.5 . . . . 0.0 110.871 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.55 133.7 54.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.411 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.7 p -77.52 54.76 1.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.261 0.553 . . . . 0.0 111.312 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -172.44 -105.81 0.19 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.673 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -153.48 102.75 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.053 0.427 . . . . 0.0 110.503 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 67.58 -75.01 0.06 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.437 0.695 . . . . 0.0 111.911 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 8.2 t -132.12 41.03 3.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 65.46 -86.18 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.981 -171.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -139.33 -57.35 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.636 0.732 . . . . 0.0 109.028 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.51 146.83 4.73 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 51.1 m -63.35 -29.38 70.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.598 0.699 . . . . 0.0 111.061 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.45 33.06 3.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.21 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.61 -24.32 62.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 110.073 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 t -86.0 123.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.475 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' THR . . . . . 0.478 ' C ' ' H ' ' C' ' 129' ' ' GLU . 7.8 p -73.96 -35.75 64.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.398 . . . . 0.0 111.299 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 21.3 mt 68.41 -8.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.633 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' C' ' 127' ' ' THR . 0.8 OUTLIER 58.25 33.36 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.429 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 2.2 p -77.08 86.07 3.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.101 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 31.2 p -81.26 9.06 7.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.723 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 15.5 t -145.69 23.68 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.55 -86.17 0.84 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.83 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.246 0.912 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.213 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.797 0.332 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.59 50.44 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.135 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.69 110.34 62.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.041 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.82 41.58 1.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 123.086 2.524 . . . . 0.0 112.935 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.21 43.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.436 0.636 . . . . 0.0 109.5 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -88.09 159.08 18.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.83 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' C' ' 8' ' ' PRO . 29.2 p -77.49 144.65 70.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.892 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' C' ' 7' ' ' THR . 7.7 Cg_exo -71.76 65.97 3.13 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.758 2.305 . . . . 0.0 112.514 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -79.14 -43.74 23.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.947 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -78.03 165.02 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.484 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.24 101.06 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.085 1.856 . . . . 0.0 111.806 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' C' ' 22' ' ' SER . 10.9 mp -119.77 161.57 20.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -132.83 170.16 15.7 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.678 -172.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.45 125.23 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -75.36 -167.76 0.7 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.313 0.383 . . . . 0.0 111.771 -171.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.82 -47.45 75.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.6 -13.56 31.72 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.399 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.72 17.55 2.56 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.031 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 41.7 t -67.28 110.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 109.903 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -90.76 140.15 30.06 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.451 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -139.72 136.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.365 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' C' ' 12' ' ' LEU . 22.9 m -92.26 139.68 30.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.256 175.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.07 117.24 33.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.43 0.633 . . . . 0.0 110.899 -174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.12 106.81 59.3 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.699 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.35 128.05 15.83 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.277 1.985 . . . . 0.0 112.644 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.51 107.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.108 0.48 . . . . 0.0 109.921 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 76.0 tttt -76.45 -59.93 2.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.925 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.08 166.14 17.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.0 mt -144.8 141.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 110.063 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.459 ' HB3' ' ND2' ' C' ' 38' ' ' ASN . 19.3 tptm -96.33 100.0 11.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.935 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -90.95 120.87 32.3 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.03 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.93 158.11 18.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.494 0.664 . . . . 0.0 109.56 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -71.24 -10.72 60.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.714 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.07 -26.22 20.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.016 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.22 -35.36 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -63.7 152.55 38.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 0.0 110.27 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -150.3 173.8 13.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.749 -177.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.634 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 1.3 p30 -145.71 140.08 26.98 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.43 157.58 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -167.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 42.4 mt-10 -126.42 107.28 10.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.51 171.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' C' ' 46' ' ' ALA . 84.2 m-85 -100.47 151.29 21.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.17 129.98 35.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 109.77 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.55 -179.67 26.75 Favored Glycine 0 C--N 1.31 -0.917 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.755 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.92 61.35 7.6 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.771 2.314 . . . . 0.0 111.852 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -124.76 -174.05 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.59 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.448 ' O ' ' HD1' ' C' ' 41' ' ' PHE . . . -43.49 121.68 2.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.612 0.72 . . . . 0.0 112.59 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.31 59.22 1.1 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.704 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 174.51 165.14 0.23 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.278 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER -155.49 -165.7 2.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.381 161.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -160.04 -129.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.455 0.57 . . . . 0.0 111.63 -167.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.29 136.58 3.95 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.655 0.782 . . . . 0.0 112.931 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.22 67.46 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.843 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -61.15 -39.65 90.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.401 0.619 . . . . 0.0 109.337 173.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.2 m -71.19 -40.55 71.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.675 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.715 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 67.5 t -78.46 -7.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.818 -176.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.56 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.41 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.25 -33.62 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.183 0.516 . . . . 0.0 109.655 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.85 21.56 16.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -174.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 20.6 ttmm -68.21 113.99 18.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.923 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.417 ' HB2' ' H ' ' C' ' 61' ' ' GLU . 74.3 Cg_endo -100.98 -150.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.514 2.809 . . . . 0.0 111.356 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.417 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 40.6 mt-10 -146.06 128.61 16.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.31 123.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.166 0.984 . . . . 0.0 110.108 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.41 -28.14 5.85 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.139 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.9 37.72 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.371 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 43.6 m-85 -112.48 135.99 52.52 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.809 0.338 . . . . 0.0 110.685 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.37 125.46 37.99 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 47.7 p90 -124.3 147.19 48.31 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.453 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.404 ' CB ' ' HG ' ' C' ' 74' ' ' LEU . 7.3 ptm180 -124.31 148.41 47.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.665 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' SER . . . . . 0.413 ' HG ' ' HB2' ' C' ' 73' ' ' GLU . 58.8 p -121.31 173.94 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.604 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . 0.451 ' CD ' ' H ' ' C' ' 70' ' ' GLN . 20.2 mp0 -59.58 -42.13 91.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.465 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -72.47 0.97 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.649 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.42 28.44 55.53 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.964 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.413 ' HB2' ' HG ' ' C' ' 69' ' ' SER . 40.5 mt-10 -91.37 104.61 17.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 5.7 mp -109.74 108.72 19.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.0 mm? -129.52 175.55 8.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.449 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' C' ' 60' ' ' PRO . 35.6 p90 -122.76 146.45 47.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 46.0 tpp -153.25 139.74 18.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.911 0.386 . . . . 0.0 110.413 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -60.75 138.91 58.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.427 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 61.5 pttt -64.07 -25.27 68.03 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.3 p -61.04 -52.22 65.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 110.283 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.53 63.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.7 t80 -57.27 -42.83 82.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.639 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.32 -34.83 79.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.362 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' C' ' 88' ' ' SER . . . -93.65 -30.43 14.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.985 -167.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.28 -30.07 67.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.475 ' CD2' ' N ' ' C' ' 86' ' ' TYR . 6.3 m-85 -100.19 -75.51 0.57 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.381 -175.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 33.7 p -86.23 -56.53 3.41 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.718 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' C' ' 84' ' ' ALA . 20.4 t 73.61 -48.74 0.68 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.328 1.051 . . . . 0.0 110.677 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.86 82.96 0.73 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.294 0.569 . . . . 0.0 109.912 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -63.93 -14.92 57.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.874 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.35 -57.5 4.74 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.493 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' SER . . . . . 0.484 ' HA ' ' ND2' ' C' ' 95' ' ' ASN . 32.3 t -80.85 18.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 0.0 111.328 -174.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.41 ' O ' ' HB ' ' C' ' 98' ' ' THR . 47.5 t -82.48 -32.32 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.04 13.81 32.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.868 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' C' ' 92' ' ' SER . 1.1 p-10 -160.96 136.15 7.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.737 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 75.81 -45.06 0.52 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.83 0.852 . . . . 0.0 112.86 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -92.3 -21.97 19.99 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.27 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' C' ' 93' ' ' VAL . 14.7 t -89.39 2.98 53.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.43 0.633 . . . . 0.0 109.405 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.74 97.73 3.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.707 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.14 -12.14 20.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . 0.447 ' O ' HG23 ' C' ' 104' ' ' THR . 39.5 ttpt -109.53 -29.45 8.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.0 110.3 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.62 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.023 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -150.41 27.46 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.014 0.435 . . . . 0.0 110.244 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' THR . . . . . 0.447 HG23 ' O ' ' C' ' 101' ' ' LYS . 11.0 t -88.25 10.51 19.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.245 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.62 100.17 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.405 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 66.24 98.43 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.904 0.752 . . . . 0.0 110.273 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 12.4 p -73.39 83.52 1.44 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.629 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.93 90.08 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.93 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p 58.44 12.76 2.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.987 0.915 . . . . 0.0 112.323 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt 60.01 172.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.479 0.657 . . . . 0.0 111.592 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -92.54 58.68 3.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.864 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.01 73.46 0.55 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.097 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . 55.39 43.94 27.98 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.023 0.439 . . . . 0.0 110.805 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t 53.24 69.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.603 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.8 p 48.6 37.96 10.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 112.168 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.46 12.84 83.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.541 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 33.0 t -80.2 -25.98 39.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.534 0.667 . . . . 0.0 110.074 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 64.32 1.07 1.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.819 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.2 t 55.88 51.14 12.67 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.715 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -60.23 -40.37 89.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.46 52.7 5.62 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.806 0.813 . . . . 0.0 109.183 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.84 -175.83 14.24 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.731 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 27.6 p -78.21 -24.13 47.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.576 0.227 . . . . 0.0 111.231 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 71.58 -51.63 0.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.758 0.823 . . . . 0.0 111.347 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 59.48 86.96 0.09 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.871 0.468 . . . . 0.0 111.239 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 62.5 t 65.75 90.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.91 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 7.2 p -78.14 109.6 12.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.111 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 45.3 mm -80.22 85.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.69 153.8 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.445 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -82.48 11.76 5.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.285 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 44.1 p 58.21 135.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.364 1.466 . . . . 0.0 113.885 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 29.3 m -127.11 7.51 6.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.918 0.866 . . . . 0.0 108.82 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.9 35.52 1.08 Allowed Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.967 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.436 -177.188 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.21 53.52 2.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 110.39 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . 0.469 ' HB3' ' HA ' ' C' ' 6' ' ' PHE . 11.8 m120 -117.76 101.54 52.06 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.775 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.05 -50.21 13.94 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.334 2.689 . . . . 0.0 113.136 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.87 26.86 4.63 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . 0.469 ' HA ' ' HB3' ' C' ' 3' ' ' ASN . 89.5 m-85 65.09 159.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 -173.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m 60.13 76.95 0.4 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.45 73.94 2.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.909 2.406 . . . . 0.0 113.027 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -73.86 -47.07 40.89 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.65 89.85 29.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.14 175.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.48 102.31 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.231 1.954 . . . . 0.0 110.721 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 59.9 mt -88.16 167.49 13.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.467 ' HB2' HG13 ' C' ' 21' ' ' VAL . 3.6 m-85 -93.04 143.25 26.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.171 0.51 . . . . 0.0 111.892 -166.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 53.1 mtmt -129.45 112.47 13.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.634 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -70.18 -169.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.029 0.443 . . . . 0.0 111.873 -169.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -55.53 -53.98 49.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.438 -170.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.48 -14.26 26.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.174 0.512 . . . . 0.0 110.415 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.93 30.91 1.06 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.289 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.634 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.3 t -76.36 113.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -78.01 137.41 38.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.797 0.808 . . . . 0.0 110.528 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.44 125.82 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.355 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -88.74 162.02 16.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.74 119.86 40.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.93 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.85 97.79 42.83 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.809 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.18 134.52 59.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.417 2.078 . . . . 0.0 111.569 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mt -76.2 93.67 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 21.9 tptm -70.57 -74.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.978 -172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.85 143.75 24.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.865 0.364 . . . . 0.0 111.527 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.93 143.9 33.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.013 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.522 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 11.7 ptmm? -131.59 147.48 52.53 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -110.53 133.93 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.519 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.82 141.36 35.75 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.236 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -64.77 -15.09 61.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.167 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.44 -10.21 59.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.697 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.25 -34.03 4.75 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.417 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -64.45 164.38 11.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.784 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -142.12 146.15 35.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.522 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 6.3 t30 -106.42 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.485 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.536 ' HB1' ' OD1' ' C' ' 47' ' ' ASP . . . -119.35 175.91 5.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -173.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 10.3 pt-20 -160.28 144.55 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 165.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . 0.672 ' O ' ' HB2' ' C' ' 45' ' ' TYR . 88.4 m-85 -117.07 155.04 29.93 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.915 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . 0.456 ' OD1' ' HD2' ' C' ' 44' ' ' PRO . 19.9 t70 69.07 -64.06 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.121 0.968 . . . . 0.0 111.877 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.35 -73.15 0.2 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.532 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.456 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 71.6 Cg_endo -79.45 -3.96 13.33 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.798 2.332 . . . . 0.0 112.36 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . 0.672 ' HB2' ' O ' ' C' ' 41' ' ' PHE . 17.4 m-85 -85.34 155.29 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.131 0.491 . . . . 0.0 110.426 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . 0.469 ' HB2' HE22 ' C' ' 48' ' ' GLN . . . -99.74 -174.18 2.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.023 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.536 ' OD1' ' HB1' ' C' ' 39' ' ' ALA . 14.9 t70 -174.45 -63.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.297 170.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.514 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 2.9 mp0 75.37 -159.3 0.05 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.027 0.931 . . . . 0.0 111.686 175.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 76.2 m-85 -75.02 140.67 43.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.377 0.608 . . . . 0.0 112.396 -172.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 44.8 ttp -129.79 148.49 51.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.401 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.67 137.26 25.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.522 0.677 . . . . 0.0 111.837 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.87 -41.27 91.16 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.956 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.79 -33.94 75.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 0.0 109.467 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -74.91 -40.65 60.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.471 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.38 -28.02 38.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.471 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.78 72.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.635 0.255 . . . . 0.0 111.041 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.374 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . 0.589 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 63.7 m-85 -95.41 14.84 21.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.596 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -81.65 99.91 0.65 Allowed Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 73.5 Cg_endo -101.07 -102.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.052 2.501 . . . . 0.0 112.917 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -143.61 123.45 13.45 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.8 t -72.18 101.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.15 -21.53 3.89 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.598 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.69 -159.6 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.163 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -124.04 120.26 31.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.059 0.456 . . . . 0.0 111.172 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 tp -93.96 154.95 17.4 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 50.9 p90 -139.47 146.99 40.71 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.563 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.99 123.76 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -172.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 25.8 p -91.81 167.29 12.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 109.957 175.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.12 11.18 0.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.38 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -109.72 -4.37 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 0.0 110.086 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.22 23.01 33.21 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.749 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.484 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 43.2 tt0 -99.22 120.44 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -125.63 116.26 21.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.1 mm? -128.06 169.2 14.33 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -132.27 155.93 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.8 ptp -175.89 -175.77 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.316 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -70.58 121.05 17.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' C' ' 79' ' ' LYS . 11.7 ptmt -64.96 -24.65 67.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.75 -173.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 13.6 p -61.24 -32.13 71.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.963 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.52 -50.18 19.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.1 0.476 . . . . 0.0 111.011 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.519 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 8.0 t80 -72.89 -41.37 64.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.18 -31.71 71.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.422 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.59 -35.06 67.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.772 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.21 -25.8 60.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.519 ' HD2' ' O ' ' C' ' 82' ' ' PHE . 14.7 m-85 -120.54 -85.94 0.65 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.374 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 69.5 p -87.55 2.82 49.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -164.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 1.2 t -76.31 -46.66 26.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 50.74 52.38 15.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.213 0.53 . . . . 0.0 111.293 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 10.8 m -87.97 -6.94 57.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.071 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.31 -51.08 3.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.625 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 7.8 p -72.12 -50.17 30.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 122.898 -0.178 . . . . 0.0 111.445 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.525 ' HB ' ' ND2' ' C' ' 95' ' ' ASN . 5.2 t 42.57 44.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 123.744 0.652 . . . . 0.0 111.172 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . 68.44 -42.37 0.47 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.892 0.877 . . . . 0.0 113.094 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . 0.525 ' ND2' ' HB ' ' C' ' 93' ' ' VAL . 8.9 p30 -65.05 -23.85 67.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.99 2.85 22.05 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -146.32 -57.69 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -83.7 48.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.572 0.701 . . . . 0.0 110.488 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.29 92.4 3.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.329 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.4 -3.87 19.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.361 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -66.26 -33.22 75.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.003 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt 48.31 64.9 1.48 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 171.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 70.6 m 57.69 38.43 27.57 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.349 0.595 . . . . 0.0 110.875 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 3.5 t -49.52 122.0 5.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.077 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.58 -95.75 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.431 173.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -127.74 19.09 6.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.58 0.229 . . . . 0.0 111.499 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' C' ' 110' ' ' LEU . 14.2 p -71.93 -56.45 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.192 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 23.1 mt 53.91 63.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.463 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 75.3 p 57.37 13.93 1.97 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.929 0.892 . . . . 0.0 113.116 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' C' ' 107' ' ' THR . 3.8 mm? -110.9 72.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.0 110.049 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 18.3 p -106.74 72.01 0.88 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.329 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.64 31.97 35.04 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.119 -175.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.93 -1.29 22.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.705 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 39.9 t 44.74 73.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 123.853 0.721 . . . . 0.0 111.998 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 58.5 p 53.32 13.47 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.45 -2.69 27.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.855 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 77.4 p -84.78 -9.89 57.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.902 0.851 . . . . 0.0 111.257 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 60.41 25.31 14.85 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.581 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.9 t 67.76 13.62 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.524 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -79.26 -9.81 59.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 110.185 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -86.27 -9.94 55.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.022 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.46 123.39 7.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.592 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 20.2 p -119.11 21.63 12.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.034 0.445 . . . . 0.0 110.409 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.54 94.66 0.19 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.424 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 62.08 26.78 16.15 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.556 0.343 . . . . 0.0 111.211 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.96 111.57 20.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 73.8 p 52.74 -85.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.43 1.081 . . . . 0.0 112.893 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 35.9 mt 60.97 61.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.884 0.85 . . . . 0.0 109.835 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -127.21 39.47 3.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.039 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 1.7 p -72.61 82.19 1.12 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.863 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 31.3 p -79.7 -8.64 59.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.495 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 20.0 m -141.33 44.9 1.75 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.12 127.38 27.21 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.982 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.274 -179.593 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.927 0.394 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.36 63.39 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.394 0.616 . . . . 0.0 109.919 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.91 108.68 19.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.203 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.16 0.82 7.95 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.479 2.119 . . . . 0.0 112.285 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.85 -29.83 63.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.299 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -148.45 146.17 28.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' C' ' 8' ' ' PRO . 10.5 t -151.73 135.98 9.95 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' C' ' 7' ' ' THR . 17.3 Cg_exo -66.76 97.6 0.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.432 2.088 . . . . 0.0 112.134 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -69.65 -19.86 63.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.479 0.657 . . . . 0.0 109.719 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -90.55 109.14 32.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.463 ' C ' HD23 ' C' ' 12' ' ' LEU . 72.8 Cg_endo -79.72 101.42 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.674 1.583 . . . . 0.0 112.017 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.463 HD23 ' C ' ' C' ' 11' ' ' PRO . 3.4 mm? -133.39 111.4 10.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.618 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 30.0 m-85 -105.42 164.0 12.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.637 -170.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.44 -176.88 3.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.595 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -120.92 -164.35 1.1 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -61.54 -35.87 78.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.21 -11.87 12.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.3 20.04 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.935 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . 0.595 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 55.4 t -70.05 131.35 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -82.31 141.5 32.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.779 0.799 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.81 140.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.368 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -98.59 143.35 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' C' ' 67' ' ' PHE . . . -106.5 132.75 52.16 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.712 0.768 . . . . 0.0 111.248 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.505 ' N ' HD12 ' C' ' 24' ' ' LEU . 3.3 mp -101.39 99.4 11.12 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.834 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.2 Cg_exo -64.99 105.64 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.699 2.266 . . . . 0.0 112.371 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' C' ' 66' ' ' LEU . 16.9 mt -73.25 110.88 7.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -98.1 -43.63 6.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.31 162.33 30.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -139.52 134.3 39.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 7.4 mmpt? -91.55 90.07 7.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.222 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -76.5 101.18 5.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.02 140.07 29.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.617 0.723 . . . . 0.0 110.329 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -63.63 -17.99 63.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.93 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -71.98 -18.48 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 110.805 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.5 -47.93 0.99 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.066 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 77.2 p -70.41 176.71 3.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.328 0.585 . . . . 0.0 110.969 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -155.14 -164.47 1.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.061 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.547 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 2.6 p30 -166.83 145.33 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 168.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -103.61 135.39 45.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.45 119.58 39.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.476 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -111.75 144.31 41.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 110.742 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.72 -25.91 44.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.706 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.07 -178.92 48.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.502 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.52 67.47 3.67 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.686 2.257 . . . . 0.0 111.524 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.25 -174.42 3.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.752 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.87 168.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.354 1.073 . . . . 0.0 113.83 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.68 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 16.2 p-10 -148.22 51.33 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.018 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' GLN . . . . . 0.521 ' HA ' ' HB2' ' C' ' 38' ' ' ASN . 28.0 mt-30 -163.99 144.35 8.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -157.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' TYR . . . . . 0.586 ' HB2' ' O ' ' C' ' 37' ' ' ALA . 9.2 m-85 -148.06 -166.76 2.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 160.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -179.02 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.439 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -86.66 105.76 17.13 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.295 0.569 . . . . 0.0 111.477 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.78 82.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.732 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.14 -35.33 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.392 0.615 . . . . 0.0 110.183 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 41.8 m -77.48 -41.0 41.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.286 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.568 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 85.9 t -74.83 -14.75 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.936 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -36.52 58.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.7 -30.18 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.268 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -103.38 14.57 31.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.843 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' LYS . . . . . 0.568 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 24.8 pttm -60.09 119.89 45.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 59.8 Cg_endo -97.54 -150.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.362 2.708 . . . . 0.0 110.579 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -135.42 157.57 46.55 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 95.0 t -87.67 105.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.197 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 -19.63 5.44 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.135 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.5 -171.76 47.35 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.315 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.49 107.78 15.18 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.991 0.424 . . . . 0.0 110.723 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 37.1 tp -78.67 152.28 31.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 50.1 p90 -146.0 151.3 37.56 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.538 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 38.3 ttm180 -143.69 140.09 29.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.303 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p -103.27 170.78 7.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.191 0.519 . . . . 0.0 110.576 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.9 -21.41 66.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.398 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -81.36 -6.87 59.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.549 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.2 56.49 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.646 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 34.5 tt0 -87.5 121.48 29.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.55 139.41 49.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 0.0 111.249 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.438 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 93.4 mt -153.1 169.27 23.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.31 145.57 46.96 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.399 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -157.85 144.94 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.403 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -64.05 129.58 40.57 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -62.51 -27.59 69.25 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.734 -167.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -56.11 -39.59 72.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.823 0.344 . . . . 0.0 111.876 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -44.07 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.989 0.423 . . . . 0.0 111.189 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' C' ' 86' ' ' TYR . 0.7 OUTLIER -80.8 -27.19 36.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -172.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.42 -32.32 62.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.982 0.42 . . . . 0.0 110.191 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' C' ' 88' ' ' SER . . . -74.61 -62.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.528 -171.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -75.12 -25.31 58.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' C' ' 82' ' ' PHE . 33.2 m-85 -96.2 -57.69 2.27 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' THR . . . . . 0.618 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 20.4 p -84.18 -43.87 14.52 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.797 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' C' ' 84' ' ' ALA . 56.0 m -75.83 -19.78 58.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.69 32.94 6.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.656 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 12.4 t 62.55 -160.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.576 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.02 -75.42 0.77 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.824 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 51.9 m -137.6 88.34 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 80.0 t -89.5 -61.9 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.216 0.531 . . . . 0.0 109.576 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.54 24.21 0.46 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.867 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -117.05 -56.62 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.757 -170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.55 -36.7 51.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.076 0.465 . . . . 0.0 112.253 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.7 40.03 3.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.606 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 15.0 t 41.33 42.15 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.246 1.018 . . . . 0.0 113.671 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.78 84.49 0.14 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 112.264 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.86 -24.35 66.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.098 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' LYS . . . . . 0.524 ' HZ1' ' HB3' ' C' ' 101' ' ' LYS . 0.4 OUTLIER -69.93 -17.83 63.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -177.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 96.8 mt 54.87 45.86 25.67 Favored 'General case' 0 C--N 1.335 -0.023 0 CA-C-O 121.088 0.471 . . . . 0.0 110.039 -175.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' SER . . . . . 0.653 ' HA ' ' OG1' ' C' ' 107' ' ' THR . 21.1 t -135.59 46.42 2.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.601 0.715 . . . . 0.0 109.594 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 4.5 p -69.63 -77.77 0.08 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.968 -1.014 . . . . 0.0 113.156 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.35 23.69 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -144.84 -48.27 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.297 0.57 . . . . 0.0 110.283 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.653 ' OG1' ' HA ' ' C' ' 103' ' ' SER . 2.8 p -82.98 169.2 16.25 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.396 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 34.1 mt -137.22 77.29 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p 49.15 76.76 0.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.168 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' LEU . . . . . 0.504 ' C ' ' HG1' ' C' ' 111' ' ' THR . 2.7 mm? -54.65 -42.66 71.55 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.697 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' THR . . . . . 0.504 ' HG1' ' C ' ' C' ' 110' ' ' LEU . 25.2 p 50.84 -93.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.898 . . . . 0.0 112.237 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -98.97 -64.98 0.84 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.925 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -154.55 147.74 24.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.03 124.53 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.036 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.5 p -79.09 52.21 1.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.968 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 -64.11 0.16 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' SER . . . . . 0.429 ' C ' ' H ' ' C' ' 119' ' ' SER . 13.4 t -135.06 18.64 3.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 71.29 -35.26 0.32 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 112.249 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.429 ' H ' ' C ' ' C' ' 117' ' ' SER . 13.8 m -62.06 153.42 29.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.67 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.97 171.69 8.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.104 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -163.27 153.43 15.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.03 -60.85 4.75 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.426 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 24.0 p 46.62 71.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.372 0.669 . . . . 0.0 111.402 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' C' ' 125' ' ' ASN . . . 70.39 -58.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.284 -176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' C' ' 124' ' ' ALA . 3.5 p-10 170.43 -18.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.605 0.762 . . . . 0.0 109.224 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.85 87.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.361 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.13 79.67 6.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.211 0.529 . . . . 0.0 111.364 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.88 -31.36 45.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -93.08 133.21 36.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 42.5 p -89.04 19.18 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.207 0.527 . . . . 0.0 110.43 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 10.7 p -80.84 15.58 1.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.317 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 11.3 p -114.64 0.11 13.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -102.33 110.83 3.87 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.823 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.527 -178.816 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.538 HD22 ' HA ' ' C' ' 22' ' ' SER . 8.1 mt . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.708 ' CB ' ' HA ' ' C' ' 87' ' ' THR . 52.5 m-85 -117.71 -161.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -166.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -122.63 127.98 50.06 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 -157.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.554 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -74.84 -165.92 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.184 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.481 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.73 -44.69 96.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.93 -9.7 14.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.235 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.89 23.62 1.43 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.445 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.554 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 77.6 t -83.57 150.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' C' ' 70' ' ' GLN . 0.2 OUTLIER -83.54 148.02 27.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.131 0.967 . . . . 0.0 111.084 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.0 144.9 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.395 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.538 ' HA ' HD22 ' C' ' 12' ' ' LEU . 22.8 t -94.93 142.93 26.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.57 39.88 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.405 0.621 . . . . 0.0 110.313 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.427 ' N ' HD12 ' C' ' 24' ' ' LEU . 5.1 mp -108.09 97.95 24.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.764 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.7 101.64 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.431 2.087 . . . . 0.0 112.233 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.4 mt -66.36 110.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.426 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -81.01 -74.02 0.34 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.473 0.654 . . . . 0.0 109.496 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.94 169.97 16.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.212 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.423 0.63 . . . . 0.0 110.847 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.495 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.4 tmtp? -103.04 101.4 11.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.413 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -87.87 104.78 16.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.763 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 143.84 29.57 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.546 0.688 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -66.38 -13.13 60.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.174 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -76.22 -20.89 57.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.58 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.03 -37.63 2.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.496 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 69.7 p -74.85 157.77 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.893 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.12 139.77 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 2.5 p-10 -110.02 129.23 55.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.39 125.58 38.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.263 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -89.39 118.21 28.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.25 152.03 33.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.95 32.68 5.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' C' ' 45' ' ' TYR . . . -115.38 -137.49 6.28 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.846 172.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.85 30.07 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.553 2.169 . . . . 0.0 111.539 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' C' ' 43' ' ' GLY . 88.3 m-85 -142.45 139.81 31.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.778 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.36 -160.78 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.191 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.08 133.78 53.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 51.2 mm-40 -127.13 108.74 11.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -80.07 128.52 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.381 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.8 mmm -117.39 144.95 44.43 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' SER . . . . . 0.569 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 0.0 OUTLIER -65.25 156.76 30.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.132 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -57.34 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.569 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 0.8 OUTLIER -61.72 -26.36 68.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.108 0.48 . . . . 0.0 110.395 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -75.76 -41.75 52.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.347 0.594 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.5 t -70.14 -17.2 20.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.382 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.2 -27.7 47.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.0 -32.2 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.364 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.96 16.19 26.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 49.4 pttt -59.53 107.09 0.86 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 111.399 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 87.7 Cg_endo -102.24 -150.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.649 2.899 . . . . 0.0 112.011 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.05 142.86 51.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.417 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.18 121.74 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 122.126 0.965 . . . . 0.0 109.683 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.63 28.8 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.472 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.27 -165.07 33.72 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.992 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -132.7 131.25 41.06 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' C' ' 75' ' ' LEU . 8.8 tt -114.13 154.52 27.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 53.4 p90 -134.14 159.57 40.46 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.173 -0.329 . . . . 0.0 110.272 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -133.36 116.0 15.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 71.7 p -100.01 162.69 12.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.833 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 78.9 mm-40 -63.25 -15.73 58.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.775 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -81.08 -10.7 59.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.79 8.98 61.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.63 114.62 26.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.9 pt? -126.86 128.71 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 72.8 mt -150.48 159.9 44.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.894 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 139.95 34.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 1.7 mmt -137.43 163.16 31.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.381 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -81.04 143.33 32.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.9 pttp -52.36 -36.45 53.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -167.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.2 p -58.7 -49.35 77.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 111.356 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.79 -42.08 58.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.272 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 78.0 t80 -54.04 -52.31 61.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.93 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.65 -37.3 84.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.068 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.36 -19.6 31.19 Favored 'General case' 0 C--N 1.315 -0.929 0 O-C-N 121.869 -0.519 . . . . 0.0 111.291 -168.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.7 m-80 -113.74 -25.84 8.48 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.762 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.2 m-85 -128.66 25.57 5.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.708 ' HA ' ' CB ' ' C' ' 13' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.93 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.639 ' HB2' ' CZ ' ' C' ' 20' ' ' TYR . 2.2 mm? . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.494 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 29.7 m-85 -95.59 -179.54 4.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -166.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 93.3 mttt -140.03 131.64 27.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -170.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -77.33 -168.41 1.13 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.736 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.63 -38.29 86.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -105.85 -0.34 25.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.269 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.48 13.27 6.92 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.292 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 51.7 t -70.23 119.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' TYR . . . . . 0.639 ' CZ ' ' HB2' ' C' ' 12' ' ' LEU . 33.5 t80 -77.78 137.72 38.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 109.736 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.6 131.75 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.54 -171.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.423 ' HA ' ' HG ' ' C' ' 12' ' ' LEU . 12.1 m -89.21 141.48 28.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.61 117.48 34.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.625 0.726 . . . . 0.0 110.647 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.464 HD22 ' N ' ' C' ' 24' ' ' LEU . 2.3 mm? -113.51 101.32 53.52 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.518 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.683 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 23.0 Cg_exo -63.46 143.01 87.19 Favored 'Trans proline' 0 C--O 1.221 -0.368 0 C-N-CA 121.678 1.585 . . . . 0.0 110.775 -174.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' C' ' 60' ' ' PRO . 72.1 mt -78.55 106.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' C' ' 25' ' ' PRO . 0.0 OUTLIER -90.83 -73.69 0.52 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.67 -162.161 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HB3' ' HG3' ' C' ' 40' ' ' GLU . . . -156.11 144.27 19.83 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -142.83 153.94 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.567 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -146.67 144.06 29.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -93.27 126.11 38.22 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.61 176.92 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.41 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -60.7 -52.92 63.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.438 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.44 -28.79 68.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.665 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.84 -25.19 3.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.328 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 40.2 m -57.18 144.9 33.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.572 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.575 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -105.44 131.81 52.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -91.28 94.85 9.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.83 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.4 ' C ' ' HB3' ' C' ' 47' ' ' ASP . . . -83.55 156.89 22.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.118 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 7.3 pt-20 -162.34 115.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' PHE . . . . . 0.683 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 30.3 m-85 -60.4 154.18 21.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.539 0.685 . . . . 0.0 112.691 165.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.58 -27.83 17.11 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.219 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.34 170.15 52.06 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.416 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.27 67.22 2.69 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.795 2.33 . . . . 0.0 112.371 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.446 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 90.2 m-85 -133.28 -174.96 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.29 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' C' ' 47' ' ' ASP . . . -66.02 -160.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.255 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' C' ' 46' ' ' ALA . 3.6 m-20 99.95 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.594 1.158 . . . . 0.0 111.625 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.08 -152.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.193 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 121.39 18.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.125 0.488 . . . . 0.0 110.158 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.06 146.56 44.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.93 136.48 51.7 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.741 0.651 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.04 92.34 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.22 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.64 -32.75 73.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.518 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -73.41 -42.63 61.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.662 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' C' ' 37' ' ' ALA . 57.9 t -68.06 -26.22 33.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.747 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.39 74.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.089 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.8 -30.07 4.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.242 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.96 7.4 45.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.408 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 23.2 tptm -58.19 108.6 1.35 Allowed Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.581 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.612 ' HB2' HD13 ' C' ' 26' ' ' ILE . 54.9 Cg_endo -104.76 -148.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 124.072 3.181 . . . . 0.0 111.872 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.71 124.05 27.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.758 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.18 121.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 122.388 1.09 . . . . 0.0 110.476 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.98 30.78 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.247 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.53 -172.12 42.74 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.953 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 95.2 m-85 -124.67 112.1 16.38 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.961 0.41 . . . . 0.0 110.778 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 22.1 tp -85.76 147.45 26.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.518 ' HB2' ' CG2' ' C' ' 21' ' ' VAL . 39.3 p90 -147.09 153.18 39.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.52 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 3.9 ptp85 -146.8 145.0 29.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.24 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 88.6 p -115.07 -177.36 3.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.014 0.435 . . . . 0.0 111.513 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -56.83 -42.11 79.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.814 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.76 3.98 15.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.049 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.93 27.98 59.54 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.902 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 42.7 mt-10 -75.52 105.93 6.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' C' ' 75' ' ' LEU . 2.9 tm? -107.85 130.18 55.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.363 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' C' ' 74' ' ' LEU . 57.7 mt -168.06 162.73 13.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.638 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -129.3 148.16 51.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 33.2 ttm -152.79 149.51 28.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.653 0.263 . . . . 0.0 111.225 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 15.7 p -68.82 146.91 52.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.144 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 21.5 pttp -56.52 -29.54 61.98 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -166.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -60.4 -55.24 35.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.076 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.91 45.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 55.8 t80 -59.16 -49.31 78.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.069 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.528 ' HA ' HG23 ' C' ' 87' ' ' THR . 7.5 pt-20 -73.18 -32.56 64.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.658 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.64 -26.03 61.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.175 -172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 45.9 m-80 -99.87 -37.37 9.07 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.615 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.1 OUTLIER -135.21 72.23 1.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.528 HG23 ' HA ' ' C' ' 83' ' ' GLU . 51.0 p . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 166.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.701 ' CB ' ' HA ' ' C' ' 86' ' ' TYR . 76.0 m-85 -140.0 -161.61 1.22 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.635 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -129.09 132.82 47.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.355 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.665 ' HA ' ' O ' ' C' ' 84' ' ' ALA . 3.7 p-10 -86.65 -153.0 0.19 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.734 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.68 67.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -167.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.88 4.21 23.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.591 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.52 24.77 6.01 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.66 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.1 t -86.84 133.03 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 140.42 36.88 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.881 0.848 . . . . 0.0 109.91 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.3 145.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.242 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 6.3 m -105.82 131.53 53.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.0 117.06 33.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.614 0.721 . . . . 0.0 110.935 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.45 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.6 mp -96.33 111.77 57.77 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 24' ' ' LEU . 6.7 Cg_exo -73.31 114.34 4.01 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.543 2.162 . . . . 0.0 112.42 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' C' ' 66' ' ' LEU . 42.0 mt -79.0 107.2 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -75.57 -57.7 3.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.172 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.33 163.29 39.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.735 0.302 . . . . 0.0 111.078 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 62.7 mt -142.01 146.67 22.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.848 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.516 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 21.1 ptmt -133.25 144.53 49.81 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.29 123.89 50.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.822 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 167.91 12.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.441 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.19 -11.28 60.25 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.034 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -93.31 -5.87 48.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.953 0.406 . . . . 0.0 110.573 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.05 -16.83 42.2 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.793 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -71.46 140.99 50.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -112.85 120.24 40.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.134 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 5.7 t30 -83.3 119.26 24.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.008 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.706 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -114.22 124.94 53.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.98 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.55 131.49 54.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.021 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.84 154.68 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.612 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -87.12 74.13 9.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.128 0.966 . . . . 0.0 110.017 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.74 -171.6 43.84 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.246 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.69 50.9 3.58 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.079 2.52 . . . . 0.0 111.869 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.36 -176.55 3.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.31 166.41 18.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.854 0.835 . . . . 0.0 112.926 -174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.706 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 6.6 p-10 -149.63 85.66 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.105 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 77.7 mt-30 -149.12 154.68 39.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.791 -163.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 8.3 p90 -89.26 112.41 23.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.571 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.6 mtp -85.18 147.07 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.121 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' C' ' 53' ' ' GLN . 0.7 OUTLIER -52.06 141.09 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.996 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.87 -22.84 65.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.18 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' C' ' 51' ' ' SER . 12.1 pt20 -68.6 -38.51 80.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.9 m -77.78 -38.51 46.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.786 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.33 -18.58 19.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.288 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.53 80.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.022 0.439 . . . . 0.0 110.502 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.8 -33.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.307 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -109.54 22.65 15.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 19.5 ptmt -48.79 106.07 0.57 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.4 0.437 . . . . 0.0 111.433 174.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 1.6 Cg_endo -83.83 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.851 2.368 . . . . 0.0 112.112 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -136.0 138.85 42.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.9 105.02 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 11.17 60.11 Favored Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.089 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.2 -160.15 35.78 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.56 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.67 134.46 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.12 0.486 . . . . 0.0 111.163 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' C' ' 26' ' ' ILE . 48.1 tp -115.87 111.58 20.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.076 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -108.9 144.47 36.77 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.543 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.464 ' HB3' ' CD2' ' C' ' 74' ' ' LEU . 28.5 ptt180 -123.06 142.53 50.77 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.251 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 59.3 p -94.33 -174.87 3.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -54.46 -43.37 71.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.548 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -79.33 2.32 21.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.287 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.7 22.94 71.13 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.249 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.78 118.4 20.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' C' ' 68' ' ' ARG . 6.8 mt -99.97 126.92 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.259 0.552 . . . . 0.0 112.103 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.42 HD22 ' C ' ' C' ' 74' ' ' LEU . 3.2 mm? -132.41 140.84 48.62 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.636 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' C' ' 77' ' ' MET . 27.1 p90 -112.98 157.41 21.54 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.508 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -178.23 166.29 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.23 0.331 . . . . 0.0 110.524 172.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 78' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' C' ' 77' ' ' MET . 6.3 p -74.52 -156.76 0.05 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -67.93 -41.89 81.88 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -168.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 16.8 p -44.76 -63.58 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.75 0.656 . . . . 0.0 112.358 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' ALA . . . . . 0.402 ' HB3' ' HG2' ' C' ' 77' ' ' MET . . . -68.2 -37.18 80.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.758 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.701 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 28.9 t80 -59.72 -42.2 92.57 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.81 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 40.9 tt0 -62.97 -24.88 68.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.851 0.834 . . . . 0.0 110.669 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' C' ' 15' ' ' ASP . . . -89.63 2.14 55.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' C' ' 15' ' ' ASP . 16.7 m-80 -119.94 -19.69 7.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.978 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.81 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 5.9 p90 -115.11 7.24 15.35 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.21 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.224 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.629 ' HB3' ' O ' ' C' ' 86' ' ' TYR . 26.5 m-85 -106.83 162.85 13.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.373 -169.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.498 ' H ' ' HA ' ' C' ' 87' ' ' THR . 98.8 mttt -150.09 152.82 35.39 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -164.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.578 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -90.65 -156.99 0.46 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.735 175.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.91 -51.85 55.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.27 -8.36 23.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.564 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.77 16.63 2.7 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.763 -1.208 . . . . 0.0 113.206 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.578 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 76.3 t -76.9 101.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 173.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' C' ' 14' ' ' LYS . 2.8 p90 -81.19 168.58 18.37 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.627 0.727 . . . . 0.0 110.511 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -146.89 140.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.179 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -86.44 141.65 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -108.28 117.4 34.04 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.453 0.644 . . . . 0.0 110.598 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.427 HD22 ' N ' ' C' ' 24' ' ' LEU . 1.5 mm? -104.25 100.52 22.01 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.354 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.447 ' HB2' ' OD1' ' C' ' 42' ' ' ASP . 16.3 Cg_exo -68.42 121.1 8.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.316 2.011 . . . . 0.0 112.358 -172.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' C' ' 60' ' ' PRO . 40.0 mt -79.87 101.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.194 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 22.8 ttmm -67.92 -69.31 0.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.443 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.86 148.21 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 41.3 mt -132.16 151.81 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.131 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -135.68 116.45 14.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.268 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.98 119.3 31.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.084 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.4 161.84 13.91 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.994 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.59 -11.64 61.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.011 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.81 -13.86 38.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 -31.22 6.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.741 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -68.44 141.58 55.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.95 55.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 8.1 t30 -88.95 116.37 27.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.57 162.37 14.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.477 ' CA ' ' HB3' ' C' ' 47' ' ' ASP . 38.4 mt-10 -154.07 127.25 8.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.4 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.02 155.88 17.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' C' ' 25' ' ' PRO . 6.0 p-10 -110.41 171.45 7.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -155.9 23.54 Favored Glycine 0 C--N 1.307 -1.05 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -169.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.37 39.8 0.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.671 2.247 . . . . 0.0 112.021 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.96 159.53 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 111.724 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.48 179.93 3.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.077 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.477 ' HB3' ' CA ' ' C' ' 40' ' ' GLU . 3.8 t0 -167.62 169.5 11.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 165.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -149.49 179.75 7.72 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.475 -158.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.6 p90 -85.57 125.38 33.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 95.3 mmm -122.25 156.58 33.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.945 0.403 . . . . 0.0 111.487 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.75 151.9 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.355 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.13 77.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.36 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.09 -38.87 84.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.465 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.4 m -73.32 -41.23 63.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.965 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.55 -12.07 13.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.87 61.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.984 0.421 . . . . 0.0 110.253 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.38 -33.9 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.035 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -105.11 22.63 15.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.941 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 53.6 pttt -53.86 107.53 0.88 Allowed Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.518 0.512 . . . . 0.0 111.011 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.504 ' HB2' HD13 ' C' ' 26' ' ' ILE . 6.9 Cg_endo -93.61 -156.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.159 2.572 . . . . 0.0 112.367 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -143.4 130.44 20.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.992 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.42 100.66 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.133 0.492 . . . . 0.0 110.227 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.49 -25.39 5.1 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.312 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.27 -165.28 37.66 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.194 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.26 126.39 48.07 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.655 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.37 140.07 29.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 45.4 p90 -137.37 159.66 41.3 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.675 -173.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 48.0 ttt180 -139.19 135.65 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.784 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 87.0 p -107.33 -178.63 3.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.98 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.42 -28.63 69.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -75.62 -14.46 60.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.581 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 20.86 34.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 7.1 tp10 -69.44 101.03 1.48 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt -103.36 108.45 19.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.644 0.735 . . . . 0.0 110.972 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 98.6 mt -146.46 177.39 9.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.149 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -130.18 143.68 50.92 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -148.62 136.16 20.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.994 0.426 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -69.4 150.57 47.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.166 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.25 -38.87 59.36 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.31 -59.02 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 111.824 -176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.17 -33.3 61.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.504 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 56.4 t80 -58.99 -47.53 84.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.171 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.59 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 4.7 tp10 -62.64 -40.95 98.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.94 -18.43 40.08 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.819 -0.55 . . . . 0.0 111.613 -166.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.451 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.1 m-80 -121.09 -31.53 4.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.629 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 2.3 m-85 -117.91 13.84 14.09 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -171.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.6 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 13.7 p . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 118.647 0.658 . . . . 0.0 109.586 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.68 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 22.1 m-85 -92.92 156.05 17.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.834 -0.166 . . . . 0.0 110.762 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 23.8 ttpp -124.74 136.41 53.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.371 0.605 . . . . 0.0 110.38 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.552 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -81.5 -164.95 0.85 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.174 176.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.85 -56.43 10.41 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -98.94 -1.37 40.12 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.791 -168.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.66 13.92 2.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.289 -1.434 . . . . 0.0 114.037 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 61.2 t -80.6 125.34 39.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -96.73 174.38 6.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.331 -0.547 . . . . 0.0 109.828 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -148.66 139.81 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -175.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 46.1 m -77.8 142.08 38.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.6 117.7 34.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.352 0.596 . . . . 0.0 109.8 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 1.2 mm? -112.44 98.15 42.63 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.872 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.16 104.23 0.71 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.537 2.158 . . . . 0.0 111.806 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' C' ' 66' ' ' LEU . 8.4 mt -72.13 94.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -75.43 -59.23 2.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.154 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -155.61 148.18 24.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.943 0.401 . . . . 0.0 111.573 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 32.9 mt -137.68 131.63 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.969 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -124.52 110.45 14.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.89 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.18 115.42 6.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.167 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.4 -174.89 5.44 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.039 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.23 -26.27 52.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.182 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.73 -20.64 30.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.122 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.25 -32.55 4.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.916 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -65.09 157.99 27.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.98 131.37 49.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.939 0.399 . . . . 0.0 111.623 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 71.7 m-20 -77.42 126.95 31.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.766 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -105.19 153.9 20.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -136.25 122.1 19.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.871 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -122.32 -179.3 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.17 -39.9 73.06 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.83 -73.24 0.06 OUTLIER Glycine 0 C--N 1.316 -0.582 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.713 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.89 14.88 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.862 2.374 . . . . 0.0 113.913 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -128.8 -175.77 3.64 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.92 119.77 2.1 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 0.5 OUTLIER -133.8 61.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.261 168.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -167.64 175.04 7.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.299 -169.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 26.2 p90 -73.27 133.56 43.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 82.5 mtp -108.74 144.08 37.02 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.08 136.7 47.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.394 0.616 . . . . 0.0 111.312 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.88 76.4 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.316 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.504 0.668 . . . . 0.0 109.552 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -72.33 -40.99 67.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.719 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 72.4 t -74.67 -16.83 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.32 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.58 -35.5 67.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.82 -33.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.123 0.487 . . . . 0.0 110.092 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' PHE . . . . . 0.436 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 83.1 m-85 -102.83 18.0 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.445 -172.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' C' ' 59' ' ' LYS . 0.1 OUTLIER -71.0 110.12 6.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.088 170.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 56.7 Cg_endo -96.83 -100.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.708 2.272 . . . . 0.0 112.149 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -153.48 143.4 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' C' ' 28' ' ' ALA . 69.0 t -82.49 110.31 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.049 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.52 11.12 36.55 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.824 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.58 -163.41 29.25 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.164 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -132.16 123.73 27.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 15.2 tp -100.43 156.41 17.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.1 p90 -142.13 147.35 36.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.346 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -128.83 115.46 17.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 16.0 p -96.97 163.96 12.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.398 0.618 . . . . 0.0 110.125 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -73.5 -0.41 14.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.677 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.35 -4.55 58.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.04 24.11 46.1 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.527 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.431 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 7.0 tp10 -99.9 121.32 41.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.411 ' C ' HD22 ' C' ' 75' ' ' LEU . 6.5 mp -125.76 112.34 15.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.525 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 2.8 mm? -135.11 169.68 17.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.502 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -124.25 154.56 40.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 20.4 ptp -178.12 -178.79 0.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.36 0.413 . . . . 0.0 109.992 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 9.1 p -67.48 125.83 27.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -65.92 -23.54 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -59.54 -40.62 87.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.027 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.83 51.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.4 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 11.7 t80 -68.43 -42.05 79.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.74 -27.72 68.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.19 0.519 . . . . 0.0 111.085 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.39 -34.45 63.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.193 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.44 -33.47 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.318 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 25.6 m-85 -90.79 -57.33 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -169.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.68 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 43.5 p . . . . . 0 C--N 1.317 -0.836 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.592 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.95 163.2 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -166.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 12.8 mptt -118.69 -173.7 2.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.51 0.672 . . . . 0.0 111.742 -167.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.533 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.6 OUTLIER -127.84 -148.57 0.38 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.515 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.91 -40.98 71.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.73 -12.69 13.33 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.491 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.79 26.16 1.3 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.522 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 68.5 t -83.88 124.44 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -91.15 175.27 7.0 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.447 0.641 . . . . 0.0 110.817 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.28 134.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 37.3 m -78.19 141.04 38.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.452 ' C ' HD23 ' C' ' 24' ' ' LEU . . . -127.9 137.46 52.31 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 0.4 OUTLIER -116.16 97.57 49.78 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.41 ' HD2' ' OD2' ' C' ' 42' ' ' ASP . 33.4 Cg_exo -61.95 122.34 10.82 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.34 2.027 . . . . 0.0 111.3 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.0 mt -83.58 107.69 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -69.95 -64.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.09 159.4 36.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -139.02 141.9 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.473 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -120.74 109.09 14.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.448 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.01 108.42 15.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.088 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.83 145.95 26.97 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -61.36 -18.88 60.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.887 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.83 -20.74 57.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.15 -38.17 2.07 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.204 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -73.64 152.94 40.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.407 . . . . 0.0 111.027 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.7 128.71 25.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.4 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 24.9 p30 -80.57 149.01 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.348 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -135.37 133.39 38.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.663 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.24 138.8 54.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.192 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' C' ' 45' ' ' TYR . 53.0 m-85 -112.38 -177.48 3.17 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' C' ' 25' ' ' PRO . 6.0 p-10 -52.68 -51.61 59.51 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -172.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.64 -144.0 7.59 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.239 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.78 62.38 5.65 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.54 2.827 . . . . 0.0 111.671 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' C' ' 41' ' ' PHE . 93.7 m-85 -115.43 -173.94 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.242 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 144.34 10.89 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.755 0.788 . . . . 0.0 112.523 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.588 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 28.1 t70 -148.02 80.84 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.656 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 9.2 pt20 -152.84 158.28 41.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -166.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 78.9 m-85 -79.33 114.25 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.883 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.7 mmt -84.01 145.01 28.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.08 171.0 4.96 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.92 -48.82 67.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.226 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.464 ' O ' HG23 ' C' ' 57' ' ' VAL . 78.0 mt-30 -63.44 -31.53 72.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.262 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -73.87 -51.82 14.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.604 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 24.1 t -64.53 -31.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.414 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.02 70.97 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.198 -0.314 . . . . 0.0 111.712 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' VAL . . . . . 0.464 HG23 ' O ' ' C' ' 53' ' ' GLN . 2.9 t -97.09 -30.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' PHE . . . . . 0.439 ' CD1' HD21 ' C' ' 75' ' ' LEU . 34.9 m-85 -109.26 14.54 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.091 -171.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 18.9 ptpt -53.88 117.73 13.38 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-O 121.177 0.513 . . . . 0.0 112.383 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -105.14 -152.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 124.153 3.235 . . . . 0.0 111.291 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.67 154.49 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.63 130.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.822 0.82 . . . . 0.0 109.86 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 -10.37 39.77 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.378 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' C' ' 76' ' ' TYR . . . -98.91 -158.55 29.42 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.098 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -129.29 138.34 51.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 57.9 mt -91.34 169.55 10.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' C' ' 22' ' ' SER . 13.9 p90 -170.28 167.06 8.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.991 0.359 . . . . 0.0 110.22 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 73.8 ttt180 -151.78 129.18 11.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.573 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -110.87 159.39 17.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -70.83 -10.51 59.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.405 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -86.63 -12.32 48.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.518 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.96 7.95 28.4 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.89 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 5.6 mp0 -75.04 121.11 21.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.599 0.699 . . . . 0.0 109.572 174.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' C' ' 75' ' ' LEU . 5.5 mt -131.94 167.51 19.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.363 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' C' ' 66' ' ' LEU . 91.2 mt 84.33 -139.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.304 1.003 . . . . 0.0 112.522 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' C' ' 64' ' ' GLY . 50.9 t80 -91.59 135.51 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.468 0.652 . . . . 0.0 111.355 -165.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.6 ptm -118.49 130.18 55.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.869 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -95.77 162.57 13.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.253 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 0.0 OUTLIER -56.97 -34.77 68.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.9 p -56.13 -48.17 76.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 0.0 111.176 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.22 -50.08 24.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.498 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.0 t80 -37.75 -62.25 0.56 Allowed 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.964 1.415 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.18 -54.44 29.55 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.96 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.11 -34.86 14.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -161.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -82.46 -28.55 31.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.177 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 34.6 m-85 -99.9 -71.12 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.415 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 51.3 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.683 -173.516 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.488 HD12 ' OH ' ' C' ' 20' ' ' TYR . 47.9 mt . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 66.6 m-85 -111.82 -169.97 1.56 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -157.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 19.9 pttm -156.09 159.95 39.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 120.956 0.408 . . . . 0.0 110.2 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.752 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 21.0 p-10 -84.52 -140.56 0.07 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.858 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.04 -44.65 19.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.784 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.78 -14.13 18.15 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.938 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.17 26.66 1.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.077 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.515 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 47.9 t -77.29 125.56 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' TYR . . . . . 0.488 ' OH ' HD12 ' C' ' 12' ' ' LEU . 76.9 t80 -73.69 142.67 46.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.93 0.871 . . . . 0.0 110.779 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.08 138.99 40.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.802 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.417 ' HA ' HD13 ' C' ' 12' ' ' LEU . 7.5 m -88.86 134.91 33.79 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.203 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.67 121.53 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.275 0.56 . . . . 0.0 110.324 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.8 mp -107.5 97.35 19.25 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.437 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 19.4 Cg_exo -68.98 118.77 5.88 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.57 2.18 . . . . 0.0 111.817 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mt -82.08 100.89 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 0.1 OUTLIER -68.86 -53.07 23.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.217 179.016 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.88 166.49 19.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.732 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.49 146.51 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.947 0.403 . . . . 0.0 110.178 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.7 tmtp? -130.28 115.67 17.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.292 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -85.24 117.44 24.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.49 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.38 146.76 26.84 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.215 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -60.53 -17.65 47.09 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.874 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.83 -13.55 55.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.525 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 -35.23 4.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.76 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 68.5 p -62.54 140.86 58.64 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.094 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.41 123.9 48.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -91.42 114.85 27.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -99.3 111.36 23.75 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 38.4 mt-10 -73.71 102.52 3.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.531 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.06 153.98 17.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 110.161 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -119.44 127.35 53.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.04 -128.2 7.12 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.161 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.37 9.35 3.45 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.748 2.299 . . . . 0.0 112.562 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.438 ' CE2' ' HG ' ' C' ' 24' ' ' LEU . 86.0 m-85 -135.06 145.35 47.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.381 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.82 -164.37 1.13 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.508 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 5.9 p-10 -84.86 144.6 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.154 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -149.03 141.16 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.527 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -88.35 139.24 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.6 tpt -122.62 146.66 47.25 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.0 135.36 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.684 0.615 . . . . 0.0 111.576 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.39 -38.25 90.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.363 -172.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -61.76 -34.97 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.545 0.688 . . . . 0.0 109.639 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 7.2 m -73.06 -42.04 63.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.4 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 54.1 t -68.25 -22.94 27.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.429 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.27 82.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.792 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.06 -33.2 4.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.451 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.94 20.09 18.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.799 -170.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 40.0 tttm -50.98 124.28 20.54 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.474 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 50.0 Cg_endo -99.89 -153.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.527 2.818 . . . . 0.0 111.429 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -149.85 164.63 34.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.664 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.16 128.53 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.96 0.886 . . . . 0.0 109.609 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.08 49.65 Favored Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.18 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -166.08 37.4 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.123 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -124.32 126.83 46.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.329 0.585 . . . . 0.0 111.476 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 34.7 tp -97.28 155.05 17.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.9 p90 -147.65 160.97 42.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.234 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -139.17 130.53 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.705 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 96.7 p -99.78 170.0 8.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.268 0.556 . . . . 0.0 110.241 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 70' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 11.2 mm100 -69.94 -9.1 53.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.069 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -90.38 -0.8 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.151 0.5 . . . . 0.0 109.985 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 17.62 64.5 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.765 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.431 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 21.0 mm-40 -92.09 122.16 34.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.947 0.403 . . . . 0.0 110.574 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.38 130.88 43.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.941 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 73.3 mt -151.43 157.85 42.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.994 -174.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -96.25 131.07 43.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.221 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.458 ' HA ' ' CE ' ' C' ' 77' ' ' MET . 0.9 OUTLIER -143.04 140.23 30.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 110.693 178.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -69.33 158.4 35.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.744 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' C' ' 80' ' ' THR . 1.5 ptmt -55.42 -32.43 62.68 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -168.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 5.7 p -55.33 -58.94 5.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.437 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.66 74.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.805 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.16 -44.07 92.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.54 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 24.3 tt0 -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.94 -27.85 63.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.848 -167.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 86.4 m-20 -105.58 -30.7 9.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.466 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -142.79 70.66 1.33 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 80.5 p . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 123.825 0.85 . . . . 0.0 109.067 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.454 HD12 ' OH ' ' C' ' 20' ' ' TYR . 93.1 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' C' ' 86' ' ' TYR . 82.0 m-85 -111.13 -167.63 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -164.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 0.0 OUTLIER -158.7 164.37 35.98 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.998 0.428 . . . . 0.0 110.03 -167.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.588 ' OD2' ' HB ' ' C' ' 19' ' ' VAL . 2.4 p30 -103.07 -139.21 0.35 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.079 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -60.39 3.48 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -161.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.25 -4.98 50.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.283 0.563 . . . . 0.0 109.808 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.87 27.92 4.41 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.767 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.588 ' HB ' ' OD2' ' C' ' 15' ' ' ASP . 62.8 t -64.73 127.57 25.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' TYR . . . . . 0.454 ' OH ' HD12 ' C' ' 12' ' ' LEU . 50.8 t80 -81.93 134.99 35.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.032 0.92 . . . . 0.0 111.091 -172.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.75 131.87 4.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.65 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -90.71 152.05 20.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.654 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.406 ' HB2' ' HE2' ' C' ' 86' ' ' TYR . . . -106.04 116.28 31.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.356 0.598 . . . . 0.0 109.696 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.67 ' O ' ' HB3' ' C' ' 66' ' ' LEU . 16.8 mt -118.2 98.92 51.74 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.213 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.571 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -66.25 152.05 82.0 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 121.655 1.57 . . . . 0.0 111.267 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mt -82.7 98.04 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.672 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -86.12 -60.79 1.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.514 -163.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' C' ' 39' ' ' ALA . . . -154.56 154.53 33.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.366 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 73.7 mt -140.79 143.05 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.472 0.653 . . . . 0.0 110.558 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -135.84 124.76 24.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.263 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -85.37 118.72 25.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 110.009 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.402 ' HB2' HD21 ' C' ' 38' ' ' ASN . . . -86.81 -163.62 0.94 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.558 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.297 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -97.8 17.24 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.09 87.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.705 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 18.2 p -72.92 138.59 46.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.863 0.363 . . . . 0.0 110.371 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -100.28 113.97 27.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 15.5 m-80 -90.07 108.26 19.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.722 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 28' ' ' ALA . . . -87.73 89.11 7.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.149 0.499 . . . . 0.0 111.233 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 38.1 mt-10 -76.55 106.47 8.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.747 -174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' PHE . . . . . 0.598 ' CG ' ' HB2' ' C' ' 45' ' ' TYR . 1.6 m-85 -59.33 138.61 57.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.549 0.69 . . . . 0.0 112.164 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.22 -33.52 16.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.619 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.12 179.48 35.48 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.775 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 56.85 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.007 2.472 . . . . 0.0 113.103 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.598 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 89.9 m-85 -131.6 -177.95 4.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.046 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.7 -179.0 6.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.224 0.535 . . . . 0.0 111.533 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -111.48 127.38 55.68 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.84 124.77 40.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.584 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -87.21 112.11 21.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' MET . . . . . 0.418 ' CG ' ' HB3' ' C' ' 37' ' ' ALA . 22.4 ptp -110.37 129.52 55.74 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.759 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' SER . . . . . 0.461 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.6 OUTLIER -62.35 159.42 15.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.057 -176.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.46 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' C' ' 53' ' ' GLN . 0.2 OUTLIER -58.26 -40.14 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 109.144 173.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -72.96 -40.12 65.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 79.4 t -67.56 -22.45 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.283 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.7 74.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.08 -31.44 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.487 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -113.17 19.8 16.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 52.1 tttm -48.7 107.45 0.76 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.495 0.497 . . . . 0.0 111.526 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 85.9 Cg_endo -106.03 -154.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 123.809 3.006 . . . . 0.0 111.83 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.51 153.81 45.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.687 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.47 125.0 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.926 0.87 . . . . 0.0 109.753 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.31 -10.35 28.73 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.434 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.45 -158.24 27.95 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.042 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.35 156.95 34.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.915 0.388 . . . . 0.0 111.133 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.67 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 23.5 tp -147.08 154.03 40.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.12 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -151.5 163.6 38.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -143.33 132.9 23.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 31.2 p -102.55 178.28 4.62 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.442 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -55.28 -33.71 63.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.896 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' C' ' 73' ' ' GLU . 44.7 m-85 -72.52 -5.77 39.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.3 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.38 1.93 83.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.378 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' C' ' 71' ' ' TYR . 9.4 pt-20 -91.11 140.33 29.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.269 0.557 . . . . 0.0 110.478 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.471 HD23 ' N ' ' C' ' 74' ' ' LEU . 0.6 OUTLIER -131.13 155.34 47.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.895 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.553 ' O ' HD12 ' C' ' 66' ' ' LEU . 71.6 mt -148.44 157.27 43.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -91.7 138.06 31.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.019 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.531 ' HB2' ' HB3' ' C' ' 81' ' ' ALA . 0.4 OUTLIER -162.24 -179.81 7.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.196 0.522 . . . . 0.0 111.619 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.5 p -122.49 -174.91 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.068 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' C' ' 82' ' ' PHE . 18.5 ptpt -57.04 -28.5 62.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 8.6 p -54.27 -54.96 33.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' C' ' 77' ' ' MET . . . -74.21 -33.23 63.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.9 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.62 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 2.6 t80 -50.13 -49.59 51.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.309 0.576 . . . . 0.0 109.504 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.792 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 10.8 tp10 -60.85 -45.15 95.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.187 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.6 -26.02 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' C' ' 15' ' ' ASP . 5.2 m-20 -91.77 -27.39 18.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.63 ' O ' HG23 ' C' ' 87' ' ' THR . 0.2 OUTLIER -167.88 78.54 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.792 ' OG1' ' HA ' ' C' ' 83' ' ' GLU . 6.6 p . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 124.142 0.977 . . . . 0.0 109.52 162.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' C' ' 22' ' ' SER . 23.1 mt . . . . . 0 CA--C 1.523 -0.07 0 CA-C-O 120.653 0.264 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' C' ' 82' ' ' PHE . 2.8 m-85 -91.7 136.96 32.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.236 -174.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.501 ' H ' ' HB3' ' C' ' 86' ' ' TYR . 93.2 mttt -116.02 105.89 13.14 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.005 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -72.44 -166.26 0.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.505 -171.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.7 -50.64 72.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -170.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.36 -6.53 14.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.16 14.07 3.42 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.602 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 97.8 t -74.23 103.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' TYR . . . . . 0.448 ' OH ' ' HE2' ' C' ' 14' ' ' LYS . 1.2 m-85 -76.7 151.68 36.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.496 1.141 . . . . 0.0 112.261 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -148.8 120.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.81 -1.995 . . . . 0.0 108.952 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.454 ' HA ' HD22 ' C' ' 12' ' ' LEU . 23.0 t -78.04 148.86 34.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.114 -177.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.57 117.87 35.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.828 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.487 ' HB2' HD13 ' C' ' 66' ' ' LEU . 2.1 mm? -99.78 114.43 65.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.666 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.32 125.97 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 55.8 mt -80.35 96.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -67.22 -45.99 75.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.137 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' C' ' 62' ' ' VAL . . . -157.25 159.49 37.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 0.0 111.988 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.5 mt -145.71 145.58 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.982 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -131.42 132.03 44.04 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -94.3 136.0 35.09 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.916 -172.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.2 131.38 56.48 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.993 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -60.34 -19.85 57.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.329 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.81 -21.74 61.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.803 0.335 . . . . 0.0 110.78 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.98 -26.35 4.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.246 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 10.1 m -72.67 161.51 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.989 0.423 . . . . 0.0 110.883 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -141.07 122.53 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 9.0 t-20 -77.26 128.92 35.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -115.17 147.95 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.211 0.529 . . . . 0.0 112.179 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.03 110.35 11.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.859 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -102.3 156.47 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.33 132.49 33.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.72 -178.93 19.54 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.252 -174.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.77 58.31 6.91 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.883 2.389 . . . . 0.0 111.857 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -122.19 -176.51 3.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.6 50.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.734 0.778 . . . . 0.0 112.908 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.0 p-10 -132.78 79.91 1.87 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -152.62 169.16 23.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.205 -164.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 50.3 p90 -92.55 138.28 31.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.054 0.454 . . . . 0.0 110.747 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.3 mmt -103.64 140.75 37.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.234 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' SER . . . . . 0.45 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 1.3 p -61.08 154.61 22.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.422 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -30.19 71.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' GLN . . . . . 0.45 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 23.4 mp0 -58.45 -44.77 89.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.756 0.789 . . . . 0.0 109.057 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -67.89 -43.6 78.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.949 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.2 t -65.63 -27.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.585 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -29.91 69.34 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.298 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.72 -34.11 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.51 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.14 24.53 11.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 0.0 OUTLIER -46.08 117.86 4.19 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 121.299 0.571 . . . . 0.0 111.36 175.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 83.6 Cg_endo -106.37 -156.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 123.403 2.735 . . . . 0.0 111.876 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.437 ' HB2' ' CZ ' ' C' ' 76' ' ' TYR . 48.1 mt-10 -149.18 142.65 25.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.05 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' C' ' 28' ' ' ALA . 5.2 p -78.27 111.63 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.834 0.826 . . . . 0.0 109.977 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.96 -18.68 7.47 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.74 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.8 -155.11 31.47 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.402 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -131.8 142.55 49.77 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' C' ' 24' ' ' LEU . 0.0 OUTLIER -118.84 134.88 54.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 44.0 p90 -109.56 158.04 18.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.758 -172.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -134.32 129.51 35.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' SER . . . . . 0.476 ' HA ' ' HB ' ' C' ' 21' ' ' VAL . 40.5 p -95.35 178.0 5.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.002 0.43 . . . . 0.0 111.001 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.34 -9.49 58.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.991 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -85.04 -6.34 59.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.09 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.52 12.07 78.85 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.53 127.15 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.07 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.3 pt? -130.53 140.27 50.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.074 0.464 . . . . 0.0 110.843 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.511 HD22 ' C ' ' C' ' 74' ' ' LEU . 2.1 mm? -148.22 160.81 42.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.405 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 61' ' ' GLU . 71.7 t80 -92.52 141.57 28.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' C' ' 81' ' ' ALA . 40.6 tpp -155.86 147.38 22.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 111.134 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' C' ' 77' ' ' MET . 20.3 p -89.71 158.34 17.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 13.6 ptmm? -66.91 -13.01 61.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 11.3 p -60.38 -61.83 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.511 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' ALA . . . . . 0.482 ' HB3' ' SD ' ' C' ' 77' ' ' MET . . . -69.83 -38.01 76.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.694 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.523 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -50.8 -52.92 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.265 177.336 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.98 -36.52 64.54 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.16 25.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.786 -169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.09 -29.15 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.303 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.501 ' HB3' ' H ' ' C' ' 14' ' ' LYS . 23.0 m-85 -103.08 -73.01 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.748 -173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 C--N 1.317 -0.822 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -167.453 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 mt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' C' ' 86' ' ' TYR . 79.8 m-85 -145.63 -161.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.144 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -146.34 145.59 30.37 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.258 0.552 . . . . 0.0 109.916 -168.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.614 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -87.67 -165.08 1.21 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.536 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.36 -52.25 54.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.31 -6.96 22.5 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -170.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.37 26.18 1.22 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.385 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.614 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.3 t -83.54 117.56 29.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.038 0.446 . . . . 0.0 110.173 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -87.69 132.84 33.97 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 109.574 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.4 OUTLIER -150.74 139.36 14.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.876 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -105.23 163.89 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.596 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.433 ' HB1' ' CD2' ' C' ' 65' ' ' TYR . . . -108.66 117.29 33.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.125 0.488 . . . . 0.0 110.335 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.472 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.4 mp -107.37 115.26 59.89 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.922 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.427 ' HB2' ' HB3' ' C' ' 42' ' ' ASP . 3.0 Cg_exo -72.22 138.4 30.42 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.744 1.63 . . . . 0.0 112.206 -173.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.56 117.42 37.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.935 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -79.03 -60.79 2.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.996 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 151.27 9.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.816 0.341 . . . . 0.0 111.131 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 54.9 mt -132.11 140.87 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.912 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.3 114.48 16.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -65.56 104.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.584 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.84 170.99 15.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.606 0.717 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -69.75 -14.08 62.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.06 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.18 -18.4 21.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.475 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.93 -37.25 2.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.103 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -60.08 146.49 42.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.434 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -112.73 120.51 41.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 19.0 m120 -71.77 117.43 13.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.836 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -106.47 107.86 19.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 0.0 112.104 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' C' ' 47' ' ' ASP . 43.6 mt-10 -89.45 114.37 25.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.054 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -99.43 148.1 24.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.871 0.367 . . . . 0.0 110.302 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 25' ' ' PRO . 21.3 t70 -83.22 125.85 32.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 0.0 109.929 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.63 17.65 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.201 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.95 59.37 6.89 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.551 2.168 . . . . 0.0 112.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.56 -175.76 3.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.432 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.01 152.9 43.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.562 -176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.703 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 8.3 p-10 -149.7 92.01 1.87 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 168.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.629 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 46.3 mt-30 -149.44 174.7 12.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 -164.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.93 112.65 9.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.9 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 51.6 tpp -91.2 129.78 37.15 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.03 135.35 31.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.337 0.589 . . . . 0.0 111.554 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.47 95.65 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.547 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -63.75 -31.49 72.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.405 0.622 . . . . 0.0 109.903 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 19.3 m -74.11 -40.93 62.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.679 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' C' ' 37' ' ' ALA . 77.7 t -70.53 -20.78 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.423 0.63 . . . . 0.0 110.308 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.46 73.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.87 -28.0 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.677 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -106.16 15.03 26.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.209 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 55.1 pttt -51.44 114.97 5.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.5 Cg_endo -102.99 -151.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.85 3.034 . . . . 0.0 111.123 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -138.23 143.03 39.93 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -80.1 119.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.279 1.038 . . . . 0.0 109.827 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.19 20.27 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.811 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 -155.09 30.06 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.577 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' TYR . . . . . 0.433 ' CD2' ' HB1' ' C' ' 23' ' ' ALA . 50.7 m-85 -122.23 146.82 46.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.291 0.567 . . . . 0.0 112.017 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.23 136.33 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 54.5 p90 -121.77 159.53 26.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.574 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -134.85 128.09 32.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.46 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 94.6 p -103.39 -170.19 1.75 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.221 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -65.17 -45.99 82.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.434 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.09 18.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.22 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.97 34.05 70.63 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.322 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 32.3 mt-10 -89.7 123.88 34.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.4 pt? -130.71 132.38 45.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.046 0.451 . . . . 0.0 110.169 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.5 mt -153.44 -171.14 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.721 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.77 135.54 33.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.425 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 4.9 ttp -103.76 118.04 35.78 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 111.545 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 19.1 p -106.31 -169.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -76.87 -30.87 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.491 1.041 . . . . 0.0 111.026 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.0 p -60.73 -31.58 70.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.741 0.782 . . . . 0.0 109.885 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.67 33.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.129 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' C' ' 86' ' ' TYR . 62.8 t80 -56.56 -40.61 75.48 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.356 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.53 -49.51 66.24 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.895 -0.503 . . . . 0.0 111.655 174.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.28 77.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.861 0.362 . . . . 0.0 110.952 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.458 ' HB3' HG11 ' C' ' 21' ' ' VAL . 91.0 m-20 -105.12 -24.68 12.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.833 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.528 ' HA ' ' HB2' ' C' ' 13' ' ' TYR . 6.7 m-85 -120.92 33.39 5.58 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 47.4 p . . . . . 0 C--N 1.314 -0.939 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.066 178.239 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' C' ' 12' ' ' LEU . 3.4 mm? . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.692 ' HB2' HG13 ' C' ' 21' ' ' VAL . 48.4 m-85 -93.19 141.65 28.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -133.85 123.34 24.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.583 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -90.64 -164.64 1.2 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.511 -177.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.472 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -63.07 -49.72 73.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -172.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.5 -4.2 17.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.589 -0.445 . . . . 0.0 112.107 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.01 18.25 2.38 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.771 -1.204 . . . . 0.0 113.575 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.583 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.7 t -73.74 133.88 30.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.09 160.86 30.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.684 0.754 . . . . 0.0 110.995 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.79 137.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.185 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 31.4 m -78.88 151.22 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.54 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.54 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . . . -119.42 128.44 54.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.758 0.314 . . . . 0.0 110.497 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.506 HD12 HD23 ' C' ' 66' ' ' LEU . 1.5 mt -105.35 105.68 53.11 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' C' ' 42' ' ' ASP . 13.9 Cg_exo -67.65 115.25 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.101 1.867 . . . . 0.0 111.395 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 27.9 mt -78.8 111.97 16.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.237 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.415 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 53.1 tttm -85.94 -63.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.04 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.32 158.39 32.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 70.0 mt -115.51 132.78 63.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.865 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 6.0 mmpt? -91.98 94.61 9.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.029 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -84.06 112.78 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.114 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.79 135.63 33.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -58.29 -19.89 38.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.491 -172.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.8 -20.25 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.714 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.11 -45.12 1.16 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.761 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' C' ' 50' ' ' MET . 2.3 m -60.71 158.48 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.034 0.445 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -145.47 179.09 7.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.618 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 0.2 OUTLIER -162.06 127.73 3.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 173.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -92.05 129.52 37.99 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.508 -172.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -90.9 130.2 36.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.44 146.7 35.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' C' ' 25' ' ' PRO . 44.6 m-20 -78.37 88.83 4.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.132 0.492 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.3 -148.42 17.65 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.063 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.75 26.09 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.41 2.74 . . . . 0.0 112.454 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -129.59 120.09 24.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.2 -161.02 0.6 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.668 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 7.6 p-10 -76.08 126.74 31.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.11 171.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.79 104.93 3.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.618 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 9.4 m-85 -154.91 -166.45 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 50' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' C' ' 36' ' ' SER . 44.3 tpp -159.21 -67.11 0.08 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.624 0.647 . . . . 0.0 112.427 -171.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' SER . . . . . 0.414 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.3 OUTLIER -104.09 134.13 47.87 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.29 0.567 . . . . 0.0 111.455 -175.171 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.53 92.31 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.584 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -65.98 -31.05 71.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.562 0.696 . . . . 0.0 109.823 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.6 m -75.24 -38.01 60.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.577 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 74.8 t -70.21 -22.15 24.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.178 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.72 80.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.21 -29.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.861 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.53 9.63 31.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.96 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 87.1 tttt -70.95 113.43 18.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.764 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -101.06 -146.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.876 3.051 . . . . 0.0 111.828 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.0 131.61 45.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.068 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.13 121.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 122.232 1.015 . . . . 0.0 109.915 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.26 -23.02 9.35 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.484 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.34 36.37 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.227 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -125.51 130.76 52.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.764 0.316 . . . . 0.0 111.436 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.506 HD23 HD12 ' C' ' 24' ' ' LEU . 8.6 tp -87.42 172.54 9.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' C' ' 22' ' ' SER . 27.4 p90 -158.43 158.14 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.462 0.573 . . . . 0.0 110.902 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 60.9 ttt180 -148.9 114.83 5.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 77.3 p -95.37 175.88 6.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.459 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.19 -8.48 56.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.813 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -90.12 -7.11 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.076 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.84 14.31 56.69 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.848 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 31.5 mt-10 -78.09 121.58 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 33.3 tp -131.36 87.0 2.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 96.5 mt -134.5 -173.98 3.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.206 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.82 153.74 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.517 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.426 ' HE3' ' HA ' ' C' ' 81' ' ' ALA . 54.6 mtm -145.15 160.9 40.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 0.0 110.675 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 18.4 p -110.75 -87.32 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.242 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -77.94 -31.38 50.93 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.287 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 3.9 p -65.67 -18.3 65.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.219 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' ALA . . . . . 0.426 ' HA ' ' HE3' ' C' ' 77' ' ' MET . . . -70.4 -50.1 42.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.787 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.28 -47.93 80.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.315 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.565 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 34.3 tt0 -60.2 -20.2 57.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.702 0.286 . . . . 0.0 111.67 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' C' ' 13' ' ' TYR . . . -93.39 -19.66 21.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' C' ' 13' ' ' TYR . 1.1 m-80 -68.85 -17.41 63.99 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.774 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.565 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 4.3 p90 -132.01 -12.01 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.507 HG23 ' CD2' ' C' ' 86' ' ' TYR . 39.5 p . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 118.563 -1.255 . . . . 0.0 113.718 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.546 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 63.2 m-85 -92.98 143.26 26.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 67.0 mttm -117.06 139.71 50.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -170.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p-10 -46.98 136.18 8.68 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.14 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.88 -55.85 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.32 167.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.72 -7.04 47.81 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.65 26.81 1.24 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.767 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 54.3 t -116.24 119.86 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -97.87 138.66 34.88 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -148.15 124.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.646 -172.117 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -83.17 147.77 27.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.091 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.539 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.02 128.19 53.67 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.191 0.519 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 5.2 mp -98.74 98.7 6.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.242 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.8 Cg_exo -64.77 114.8 2.91 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.159 2.573 . . . . 0.0 113.116 -174.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 26' ' ' ILE . . . . . 0.583 HD11 ' HG ' ' C' ' 66' ' ' LEU . 12.0 mt -84.54 99.05 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' C' ' 27' ' ' LYS . 5.7 tmtm? -63.24 -69.57 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.65 162.15 41.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.374 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.82 132.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 0.0 109.932 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.456 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 11.5 mmpt? -105.87 100.29 9.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.427 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -73.98 112.4 10.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.161 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 153.26 28.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.709 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.28 -15.62 62.92 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.046 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.26 -21.63 31.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.348 . . . . 0.0 110.669 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.66 -26.19 5.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.109 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -70.09 165.73 21.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -140.58 122.31 15.33 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.955 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' C' ' 48' ' ' GLN . 5.1 t30 -83.83 114.86 21.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -94.69 155.78 16.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.452 -172.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -130.17 119.15 22.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.071 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 14.6 m-85 -126.13 179.49 5.22 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -175.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -36.27 -55.0 0.82 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.079 0.952 . . . . 0.0 113.405 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.8 -81.82 0.06 OUTLIER Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.185 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.63 45.17 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.094 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' C' ' 41' ' ' PHE . 97.4 m-85 -138.38 -173.48 3.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.082 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.33 116.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 0.0 112.078 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 9.8 p-10 -137.83 42.71 2.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.49 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.431 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 2.0 pp0? -165.32 173.92 10.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.841 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 29.3 p90 -97.11 132.51 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -109.43 166.8 10.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.05 144.41 12.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 112.368 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.38 90.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.057 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.539 0.685 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -74.13 -39.17 63.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.67 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.98 -32.31 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.8 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.7 68.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.787 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.68 -23.25 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.351 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.64 6.78 28.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.065 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -54.9 113.33 5.21 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -92.76 -99.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.231 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -156.95 140.6 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.633 0.373 . . . . 0.0 110.011 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.84 107.85 17.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.712 0.767 . . . . 0.0 109.806 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.04 -5.53 39.35 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.727 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.87 -158.85 34.56 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.147 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.27 123.64 28.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.918 0.389 . . . . 0.0 111.067 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 20.7 mt -79.28 163.53 24.86 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 43.8 p90 -148.21 147.9 29.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -134.92 120.55 19.39 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -94.67 164.44 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -79.72 19.11 0.69 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.624 -173.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.2 -6.41 18.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.444 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.29 -5.52 55.46 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.505 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.22 123.93 33.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.178 0.513 . . . . 0.0 111.111 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.456 HD23 ' N ' ' C' ' 74' ' ' LEU . 1.5 pt? -131.43 138.69 49.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.889 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 83.3 mt -150.1 179.62 7.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -107.72 141.38 39.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 34.4 mmm -150.12 144.07 25.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.855 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 33.0 p -65.38 126.55 28.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 167.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -61.01 -27.74 68.54 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.221 -171.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 17.3 p -52.91 -47.64 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.44 -38.46 55.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.157 0.503 . . . . 0.0 111.414 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.439 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 0.8 OUTLIER -74.16 -39.94 62.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.0 110.261 -175.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.13 -26.25 68.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.185 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.27 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.966 -172.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.22 -31.55 12.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 5.1 m-85 -97.1 -69.25 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 50.2 p . . . . . 0 C--N 1.319 -0.742 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -171.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' C' ' 86' ' ' TYR . 95.4 m-85 -125.84 155.86 40.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.401 -166.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -156.51 158.38 37.09 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -165.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.592 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 9.6 p-10 -96.17 -144.82 0.28 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.616 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.24 -40.85 36.01 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.29 -18.28 17.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.625 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.67 22.29 1.84 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.475 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.592 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.9 t -66.73 107.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -84.15 143.16 29.83 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.187 0.994 . . . . 0.0 111.803 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.49 137.27 18.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.482 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 25.9 t -81.79 144.26 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.523 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -105.96 122.72 46.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.591 0.71 . . . . 0.0 110.983 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.9 mm? -101.52 96.74 6.62 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.476 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 2.6 Cg_exo -76.37 104.26 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.778 2.319 . . . . 0.0 111.527 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 44.5 mt -71.29 90.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.718 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.786 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 27.9 tptp -66.65 -51.61 54.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.814 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.62 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -166.05 166.66 17.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.821 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ILE . . . . . 0.47 ' CG2' ' HB1' ' C' ' 37' ' ' ALA . 73.1 mt -135.62 141.62 41.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' C' ' 30' ' ' LYS . 1.5 tpmt? -104.06 99.78 9.54 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.092 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -79.94 106.68 12.15 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.53 168.4 19.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.778 0.799 . . . . 0.0 110.316 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.15 -10.36 59.2 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.414 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.37 -15.47 37.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.182 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.06 -28.71 6.51 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.977 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -72.09 158.64 35.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.762 0.315 . . . . 0.0 110.411 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.47 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -134.12 162.21 32.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.697 0.284 . . . . 0.0 111.15 -177.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 13.5 m120 -125.92 124.04 39.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.85 106.61 18.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.238 0.542 . . . . 0.0 111.198 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.786 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 23.6 mt-10 -77.77 89.73 4.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.382 -177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -91.18 141.64 28.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.28 -8.13 9.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.59 -124.63 0.72 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.409 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.09 11.25 2.87 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.822 2.348 . . . . 0.0 113.028 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.68 161.55 36.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.879 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.73 -165.0 1.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.31 133.21 36.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 46.8 mm-40 -132.92 139.19 47.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.949 -0.114 . . . . 0.0 110.867 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -75.66 154.47 36.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.876 0.369 . . . . 0.0 110.27 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.8 ptp -150.29 128.08 11.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.575 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 151.19 44.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.665 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.99 77.35 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.91 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.32 -35.2 80.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.401 0.62 . . . . 0.0 109.788 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -71.18 -36.62 72.02 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.282 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 55.5 t -70.18 -23.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.438 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.36 -31.48 67.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.779 0.323 . . . . 0.0 111.026 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.03 -29.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.639 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -116.1 21.96 13.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 20.2 ptmt -52.71 110.82 2.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.309 0.381 . . . . 0.0 111.034 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.2 Cg_endo -100.14 -151.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.411 2.741 . . . . 0.0 111.742 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.416 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 43.0 mt-10 -138.36 131.13 29.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.358 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.62 HG13 ' HA ' ' C' ' 28' ' ' ALA . 95.6 t -72.99 105.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 0.0 109.781 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.85 -23.12 4.47 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.457 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.0 -165.22 38.05 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.878 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -116.44 135.27 53.99 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.894 0.378 . . . . 0.0 110.991 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.525 HD12 ' O ' ' C' ' 75' ' ' LEU . 36.4 tp -106.32 149.93 26.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -148.29 154.92 40.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.221 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -121.9 121.96 38.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 5.2 p -106.56 -175.45 2.8 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.019 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.08 -46.91 88.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -69.9 -8.73 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.677 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.27 41.92 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.09 136.67 48.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 110.243 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.494 ' O ' HD22 ' C' ' 75' ' ' LEU . 1.6 pt? -130.7 128.43 40.85 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.525 ' O ' HD12 ' C' ' 66' ' ' LEU . 1.6 mm? -138.97 169.51 17.65 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.792 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' C' ' 77' ' ' MET . 24.2 p90 -122.35 156.87 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' C' ' 76' ' ' TYR . 35.7 tpp -177.21 166.12 2.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.411 0.444 . . . . 0.0 110.408 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 24.9 p -77.03 -147.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.703 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -75.09 -24.75 58.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.3 p -47.92 -45.6 30.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.654 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 77' ' ' MET . . . -82.16 -33.43 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.704 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.717 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 70.5 t80 -53.96 -40.44 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 110.947 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -74.12 -45.07 51.24 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.824 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.39 -30.85 27.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -115.79 -13.89 11.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.717 ' CD1' ' HA ' ' C' ' 82' ' ' PHE . 0.8 OUTLIER -104.75 -11.61 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.412 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 111.682 -175.182 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 58.1 m-85 -132.95 -169.76 2.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -168.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 9.8 mtmp? -141.25 135.31 30.54 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -170.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.735 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -77.94 -169.83 1.69 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.555 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -58.28 -45.72 87.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -102.23 -9.46 20.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.193 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.66 16.58 2.74 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.222 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.577 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 44.7 t -67.88 116.38 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.14 134.8 36.19 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.775 0.798 . . . . 0.0 110.185 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.75 136.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.57 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.3 m -86.48 144.09 27.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.265 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.68 117.34 33.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.566 0.698 . . . . 0.0 109.971 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.21 104.79 54.94 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.688 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.02 122.59 9.19 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.363 2.042 . . . . 0.0 112.275 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' ILE . . . . . 0.437 HG12 ' CZ ' ' C' ' 41' ' ' PHE . 38.1 mt -78.29 110.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -77.47 -46.94 20.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -157.18 160.55 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.984 0.421 . . . . 0.0 111.817 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.1 mt -146.56 143.47 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.659 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -130.48 111.99 12.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.413 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -82.61 104.56 12.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.27 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.44 165.12 25.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.745 0.783 . . . . 0.0 110.363 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.21 -19.33 65.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.193 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -84.8 -22.05 29.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.318 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.62 -25.96 6.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.559 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 60.0 p -66.47 148.66 51.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.423 . . . . 0.0 110.772 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.23 123.89 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 5.3 t30 -87.0 120.91 28.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.56 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.698 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -96.65 160.53 14.34 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.924 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -141.66 118.5 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.798 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' C' ' 26' ' ' ILE . 50.5 m-85 -117.31 171.85 7.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.75 -57.8 4.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.097 0.475 . . . . 0.0 111.474 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.7 -168.04 33.42 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.888 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.05 41.01 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.336 2.69 . . . . 0.0 112.493 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.33 -173.32 2.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.068 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -36.06 114.77 0.3 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 124.059 0.849 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.698 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 33.4 t70 -149.02 66.12 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.244 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.681 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 2.2 pp0? -168.81 163.26 11.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.036 -168.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' C' ' 38' ' ' ASN . 96.3 m-85 -80.07 111.76 16.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tpt -86.53 145.85 26.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.35 132.09 16.61 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.777 0.673 . . . . 0.0 111.722 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.55 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -62.13 -35.64 79.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.627 0.727 . . . . 0.0 109.63 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.6 m -74.83 -40.16 61.22 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.577 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 44.2 t -69.04 -25.71 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.88 91.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.837 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.7 -24.7 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.101 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -116.15 14.74 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -170.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 8.9 ptpp? -52.74 116.79 9.6 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.786 0.326 . . . . 0.0 111.447 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 5.5 Cg_endo -88.2 -149.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.179 2.586 . . . . 0.0 111.477 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.2 132.06 48.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.276 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.23 106.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.96 0.886 . . . . 0.0 109.967 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.86 33.42 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.067 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.17 -159.31 25.24 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.265 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.6 121.36 40.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 tp -96.43 157.66 15.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 46.9 p90 -148.84 153.95 38.8 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.745 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -149.38 142.88 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.276 0.36 . . . . 0.0 110.254 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 20.4 p -115.08 -175.81 2.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.269 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -69.37 -35.75 76.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.889 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.69 -4.7 28.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.156 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.95 19.53 57.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.85 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -86.05 109.09 18.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 109.895 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.3 pt? -130.32 139.62 50.69 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.838 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.656 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 67.8 mt -157.94 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.208 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -118.99 144.17 46.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.445 ' CE ' ' HA ' ' C' ' 77' ' ' MET . 1.8 mmt -147.11 145.94 29.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.738 0.304 . . . . 0.0 110.75 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 29.5 p -73.33 145.5 45.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.515 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 17.6 ptpt -51.12 -31.87 20.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -167.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -59.74 -57.32 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.25 -38.77 68.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.323 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 70.7 t80 -54.62 -44.37 73.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.49 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 27.8 tt0 -56.66 -51.25 69.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.901 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.44 41.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.893 0.378 . . . . 0.0 110.688 -167.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 87.1 m-20 -93.25 -33.42 13.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.026 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -148.82 66.64 1.05 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.566 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 31.1 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.72 ' HB2' HG22 ' C' ' 21' ' ' VAL . 15.4 m-30 -93.25 160.13 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.873 -168.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' C' ' 86' ' ' TYR . 55.9 mttp -138.58 120.07 14.98 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -174.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.522 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -82.25 -165.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.659 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.467 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.81 -41.69 71.24 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.42 -8.71 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.56 9.02 5.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.398 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.522 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 78.7 t -77.6 100.04 2.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -84.15 163.12 19.97 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' C' ' 13' ' ' TYR . 3.7 m -147.98 139.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.388 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.42 153.22 24.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.872 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 127.73 55.16 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.379 0.609 . . . . 0.0 110.569 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.467 HD22 ' N ' ' C' ' 24' ' ' LEU . 2.4 mm? -112.2 98.0 41.22 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.993 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' C' ' 42' ' ' ASP . 20.8 Cg_exo -66.02 118.98 5.95 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.932 2.422 . . . . 0.0 112.94 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mt -85.4 96.0 4.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.069 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 60.3 tptt -66.72 -54.44 22.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.698 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -164.23 164.77 22.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.894 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.6 144.08 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.0 110.996 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -120.28 108.2 13.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.657 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.25 106.45 15.03 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.754 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 162.77 20.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.794 0.806 . . . . 0.0 110.789 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -77.14 -11.72 59.85 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.042 -171.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.23 -12.41 43.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.93 -37.1 3.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.22 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -67.02 131.75 46.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.325 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.69 121.31 41.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.625 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 2.3 m-20 -86.76 113.07 22.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.27 126.37 52.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.45 0.643 . . . . 0.0 112.359 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 39.9 mt-10 -86.26 108.25 18.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.318 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -107.66 160.81 15.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' ASP . . . . . 0.508 ' O ' ' HD2' ' C' ' 25' ' ' PRO . 1.9 m-20 -113.61 147.88 37.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.362 172.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.5 13.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.69 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 -31.12 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.808 2.339 . . . . 0.0 112.18 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -86.97 140.52 29.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.219 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.47 -162.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' HG2' ' C' ' 40' ' ' GLU . 2.1 m-20 -64.99 119.24 10.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -154.66 146.18 23.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.056 0.455 . . . . 0.0 111.627 -175.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.2 p90 -93.49 131.34 38.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.499 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.24 137.74 37.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.54 139.52 37.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.712 0.633 . . . . 0.0 111.298 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.56 75.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.473 -173.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -66.41 -34.92 79.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.53 0.681 . . . . 0.0 109.401 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m -71.98 -40.21 68.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.7 t -70.13 -26.66 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.447 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.17 79.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.87 -31.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.586 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.24 20.17 17.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' C' ' 59' ' ' LYS . 0.0 OUTLIER -49.27 110.12 1.44 Allowed Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.253 0.345 . . . . 0.0 110.413 172.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 9.7 Cg_endo -91.33 -155.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.86 2.373 . . . . 0.0 112.772 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.25 137.34 49.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.024 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' C' ' 28' ' ' ALA . 39.2 t -72.49 100.51 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.52 7.38 54.01 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.332 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.55 -166.38 40.0 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.563 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.61 130.41 56.72 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.93 0.395 . . . . 0.0 111.256 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 56.8 tp -119.07 139.53 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 29.5 p90 -146.03 156.29 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.956 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -147.44 139.27 24.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 89.7 p -110.57 179.7 4.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.89 -38.38 90.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.444 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -68.31 -18.8 64.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.093 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.29 12.78 32.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.1 119.78 25.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.0 pt? -130.91 130.62 43.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.2 mt -145.26 158.51 43.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -113.9 151.17 32.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' C' ' 81' ' ' ALA . 9.4 ttm -175.54 175.31 2.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.726 0.298 . . . . 0.0 110.455 170.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 23.6 p -81.89 -149.78 0.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.496 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.5 ptmt -66.78 -20.52 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -58.18 -64.82 0.78 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.131 0.491 . . . . 0.0 111.308 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' C' ' 77' ' ' MET . . . -62.53 -37.58 86.63 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.595 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 20.5 t80 -48.47 -55.87 9.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.532 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.832 ' HA ' ' CE2' ' C' ' 86' ' ' TYR . 35.2 tt0 -64.69 -22.21 66.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.373 0.606 . . . . 0.0 111.384 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.23 -6.53 56.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.618 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 9.9 m-80 -107.32 -39.3 5.71 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.048 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.832 ' CE2' ' HA ' ' C' ' 83' ' ' GLU . 13.2 p90 -94.75 -7.34 40.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.356 -1.338 . . . . 0.0 112.318 -173.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.596 HG23 ' CD1' ' C' ' 86' ' ' TYR . 35.0 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.388 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.769 HD13 ' HA ' ' C' ' 22' ' ' SER . 52.5 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.582 ' HA ' HG21 ' C' ' 87' ' ' THR . 7.6 m-85 -92.31 166.03 12.8 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.92 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' C' ' 87' ' ' THR . 28.3 mmmt -115.38 154.46 29.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.55 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -93.55 -167.44 1.7 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.77 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -71.64 -42.07 68.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -170.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.75 -8.52 24.15 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.131 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.61 10.08 5.09 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.907 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.55 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.0 t -71.23 141.96 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 20' ' ' TYR . . . . . 0.442 ' HH ' ' N ' ' C' ' 12' ' ' LEU . 8.4 t80 -91.86 136.08 33.43 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.865 0.841 . . . . 0.0 109.447 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 20.0 m -134.26 135.31 54.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.356 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.769 ' HA ' HD13 ' C' ' 12' ' ' LEU . 14.3 m -73.94 147.27 43.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.631 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.77 115.15 29.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.102 0.477 . . . . 0.0 110.67 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.92 96.91 50.54 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.326 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.669 ' O ' ' HE3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -69.59 177.01 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.488 2.126 . . . . 0.0 111.655 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 26' ' ' ILE . . . . . 0.661 ' HB ' ' H ' ' C' ' 63' ' ' GLY . 0.1 OUTLIER -120.29 86.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.448 0.642 . . . . 0.0 109.753 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.695 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -87.36 -54.44 4.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.268 -163.024 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' C' ' 40' ' ' GLU . . . -158.89 151.4 21.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.994 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.81 143.8 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.2 0.524 . . . . 0.0 110.724 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.47 ' HB2' ' OD1' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -128.82 109.07 10.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.571 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -88.72 111.43 21.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.599 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.97 171.52 14.89 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.822 0.82 . . . . 0.0 110.49 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -78.52 -8.47 58.6 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.892 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -99.46 -7.52 25.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.915 0.388 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -19.69 29.3 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.599 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.53 155.02 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 110.442 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -141.35 143.57 34.08 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.989 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' C' ' 30' ' ' LYS . 1.8 p-10 -116.4 147.73 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.97 91.46 3.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.692 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' C' ' 28' ' ' ALA . 6.1 tp10 -64.16 101.34 0.4 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.859 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 41' ' ' PHE . . . . . 0.624 ' CD2' ' HE2' ' C' ' 27' ' ' LYS . 0.5 OUTLIER -62.36 161.9 10.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 113.396 169.363 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.84 -19.06 4.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.755 167.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' GLY . . . . . 0.449 ' H ' ' HD1' ' C' ' 41' ' ' PHE . . . -82.82 -150.67 9.35 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.872 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.39 35.87 0.56 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.323 2.682 . . . . 0.0 114.317 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.503 ' HB2' ' CD2' ' C' ' 41' ' ' PHE . 96.0 m-85 -140.96 -177.46 5.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' C' ' 41' ' ' PHE . . . -100.22 -164.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.634 -177.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.73 118.55 31.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -95.93 120.96 37.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 44.2 p90 -104.7 139.45 39.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.079 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.55 147.75 46.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.5 154.26 29.16 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.517 0.511 . . . . 0.0 111.704 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.01 -57.46 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -59.68 -27.72 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.415 0.626 . . . . 0.0 110.259 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.8 m -75.64 -37.26 59.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.055 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.08 -14.17 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.382 0.61 . . . . 0.0 110.061 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.44 68.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.41 -37.93 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.549 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.12 20.14 17.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.138 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 0.1 OUTLIER -49.16 114.77 4.12 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 123.515 0.509 . . . . 0.0 111.742 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' C' ' 65' ' ' TYR . 19.4 Cg_endo -98.14 -161.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 123.209 2.606 . . . . 0.0 112.289 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.585 ' O ' HG21 ' C' ' 26' ' ' ILE . 40.2 mt-10 -155.44 143.72 20.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.564 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -69.08 109.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.661 ' H ' ' HB ' ' C' ' 26' ' ' ILE . . . 93.24 15.21 52.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.011 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 64' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' C' ' 76' ' ' TYR . . . -136.79 63.79 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.947 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' TYR . . . . . 0.606 ' N ' HG12 ' C' ' 26' ' ' ILE . 0.1 OUTLIER -151.9 -171.44 3.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.341 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' C' ' 82' ' ' PHE . 0.5 OUTLIER -168.25 -79.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.24 -171.483 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -150.38 169.56 21.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.432 -165.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 55.8 ttt180 -151.81 131.09 12.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.153 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 97.0 p -97.02 175.38 6.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.845 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.93 -1.49 22.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.186 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -104.62 2.14 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.568 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.89 20.05 60.23 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.42 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 33.6 mt-10 -89.01 110.44 21.14 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.11 133.54 46.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.037 0.446 . . . . 0.0 110.297 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.77 167.96 18.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.676 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 76' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 64' ' ' GLY . 0.8 OUTLIER -118.71 150.6 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 19.4 ttm -179.58 -175.76 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -78.8 103.99 9.12 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 160.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.82 -26.9 62.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.612 -170.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 18.1 p -58.78 -33.91 70.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.119 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.85 -49.16 63.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 110.2 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.656 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 48.5 t80 -64.22 -53.53 47.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.819 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.07 -23.61 63.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.731 -174.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.05 -12.96 27.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.451 . . . . 0.0 110.849 -171.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -98.36 -32.1 11.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.217 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.656 ' HD1' ' O ' ' C' ' 82' ' ' PHE . 15.3 m-85 -97.84 -58.34 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.511 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.582 HG21 ' HA ' ' C' ' 13' ' ' TYR . 64.9 p . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.204 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.622 ' HA ' HG22 ' C' ' 87' ' ' THR . 50.9 m-85 -92.25 123.92 35.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.601 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -86.93 170.06 11.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.38 1.086 . . . . 0.0 111.157 -171.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -49.63 151.93 1.55 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.52 -2.127 . . . . 0.0 115.31 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.16 -54.7 2.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.113 -2.312 . . . . 0.0 108.614 163.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.43 -7.84 19.57 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.241 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.86 35.97 0.53 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.731 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.48 160.04 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.65 155.69 29.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.66 136.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.808 -170.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -74.33 154.41 38.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.57 130.88 52.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.464 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.62 98.48 49.54 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.598 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' C' ' 42' ' ' ASP . 7.4 Cg_exo -76.76 105.99 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.621 2.214 . . . . 0.0 111.202 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.59 117.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.229 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -93.71 -55.0 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.729 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.6 158.13 37.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.536 0.208 . . . . 0.0 111.062 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.56 145.23 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' C' ' 30' ' ' LYS . 27.2 mtpp -133.71 133.24 41.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.866 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -101.48 117.87 35.82 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.28 -172.62 3.88 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.144 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -74.71 -42.91 57.47 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.965 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.36 -20.23 62.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.74 -25.83 6.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.809 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 30.1 p -63.26 143.94 57.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -120.86 144.68 48.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 111.748 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 28.8 t-20 -106.54 127.65 53.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.749 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -111.66 116.58 31.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.35 121.58 25.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -110.95 147.08 35.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.959 0.409 . . . . 0.0 110.629 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' C' ' 25' ' ' PRO . 21.3 t70 -101.77 150.39 23.2 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.81 -139.66 15.29 Favored Glycine 0 C--N 1.313 -0.704 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.979 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.53 28.35 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.794 2.329 . . . . 0.0 112.467 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.93 165.68 25.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.29 -162.99 0.85 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.675 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.9 p-10 -93.91 150.41 20.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.67 153.36 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 46.9 p90 -109.34 143.17 39.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtt -127.69 148.18 50.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.901 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 152.92 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.71 98.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.49 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -56.61 -38.66 72.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.515 0.674 . . . . 0.0 110.165 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -69.04 -44.55 72.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.565 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 49.5 t -69.62 -27.37 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.821 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.86 76.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.357 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.57 -31.66 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.504 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.8 9.98 36.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 41.6 ttmt -55.58 114.19 6.91 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 98.9 Cg_endo -98.19 -145.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 123.525 2.817 . . . . 0.0 110.68 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' C' ' 76' ' ' TYR . 42.9 mm-40 -135.86 142.77 44.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.931 0.396 . . . . 0.0 110.701 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.1 127.19 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.781 0.8 . . . . 0.0 109.543 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.59 -8.74 56.79 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 -172.9 36.96 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.955 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 65' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' C' ' 79' ' ' LYS . 58.5 m-85 -146.51 149.33 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -173.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -175.24 -144.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.565 ' HE1' ' CE1' ' C' ' 82' ' ' PHE . 6.9 p90 -153.62 -179.3 7.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -140.09 126.37 20.0 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 42.0 p -98.59 177.21 5.39 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.863 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.56 16.12 1.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.86 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -107.99 3.07 23.7 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.24 89.57 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.222 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -78.21 114.52 17.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.118 0.485 . . . . 0.0 110.899 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.511 HD13 ' N ' ' C' ' 75' ' ' LEU . 3.4 tm? -100.08 137.8 38.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.511 ' N ' HD13 ' C' ' 74' ' ' LEU . 98.3 mt -142.24 158.62 43.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' C' ' 61' ' ' GLU . 17.8 t80 -126.73 147.81 49.94 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.765 0.665 . . . . 0.0 110.461 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.527 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -166.78 175.95 7.46 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 78' ' ' SER . . . . . 0.527 ' H ' ' HG3' ' C' ' 77' ' ' MET . 12.4 p -82.85 122.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 61.0 pttt -52.44 -46.68 66.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.424 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 30.9 p -51.9 -38.95 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.449 0.468 . . . . 0.0 112.164 -173.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.23 -57.08 4.27 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.294 0.569 . . . . 0.0 111.205 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.565 ' CE1' ' HE1' ' C' ' 67' ' ' PHE . 0.5 OUTLIER -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.344 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 83' ' ' GLU . . . . . 0.621 ' HG3' ' OG1' ' C' ' 87' ' ' THR . 12.9 tt0 -56.02 -39.89 72.62 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.851 0.46 . . . . 0.0 111.824 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.46 84.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.482 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.522 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 43.2 m-80 -98.22 -36.95 9.87 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.974 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.522 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.4 m-85 -120.99 59.77 0.93 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -171.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.622 HG22 ' HA ' ' C' ' 13' ' ' TYR . 71.9 p . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.424 ' CD2' ' HA ' ' C' ' 22' ' ' SER . 10.9 mp . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -132.83 170.16 15.7 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.678 -172.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.45 125.23 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.537 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -75.36 -167.76 0.7 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.313 0.383 . . . . 0.0 111.771 -171.387 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.82 -47.45 75.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.6 -13.56 31.72 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.399 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.72 17.55 2.56 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.031 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.537 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 41.7 t -67.28 110.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 109.903 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -90.76 140.15 30.06 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.451 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -139.72 136.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.365 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.424 ' HA ' ' CD2' ' C' ' 12' ' ' LEU . 22.9 m -92.26 139.68 30.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.256 175.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.07 117.24 33.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.43 0.633 . . . . 0.0 110.899 -174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.405 HD22 ' N ' ' C' ' 24' ' ' LEU . 1.4 mm? -107.12 106.81 59.3 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.699 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.35 128.05 15.83 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.277 1.985 . . . . 0.0 112.644 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.51 107.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.108 0.48 . . . . 0.0 109.921 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 76.0 tttt -76.45 -59.93 2.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.925 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.08 166.14 17.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.0 mt -144.8 141.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 110.063 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.468 ' HB3' ' ND2' ' C' ' 38' ' ' ASN . 19.3 tptm -96.33 100.0 11.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.935 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -90.95 120.87 32.3 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.03 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.93 158.11 18.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.494 0.664 . . . . 0.0 109.56 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -71.24 -10.72 60.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.714 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.07 -26.22 20.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.016 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.22 -35.36 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -63.7 152.55 38.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 0.0 110.27 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -150.3 173.8 13.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.749 -177.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 1.3 p30 -145.71 140.08 26.98 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.43 157.58 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -167.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 42.4 mt-10 -126.42 107.28 10.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.51 171.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 41' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' C' ' 46' ' ' ALA . 84.2 m-85 -100.47 151.29 21.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.17 129.98 35.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 109.77 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.55 -179.67 26.75 Favored Glycine 0 C--N 1.31 -0.917 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.755 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.92 61.35 7.6 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.771 2.314 . . . . 0.0 111.852 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -124.76 -174.05 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.59 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.447 ' O ' ' HD1' ' C' ' 41' ' ' PHE . . . -43.49 121.68 2.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.612 0.72 . . . . 0.0 112.59 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.31 59.22 1.1 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.704 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 174.51 165.14 0.23 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.278 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.65 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER -155.49 -165.7 2.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.381 161.375 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -160.04 -129.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.455 0.57 . . . . 0.0 111.63 -167.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.29 136.58 3.95 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.655 0.782 . . . . 0.0 112.931 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.22 67.46 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.843 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -61.15 -39.65 90.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.401 0.619 . . . . 0.0 109.337 173.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.2 m -71.19 -40.55 71.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.675 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.715 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 67.5 t -78.46 -7.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.818 -176.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.56 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.41 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.25 -33.62 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.183 0.516 . . . . 0.0 109.655 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.85 21.56 16.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -174.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 20.6 ttmm -68.21 113.99 18.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.923 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 74.3 Cg_endo -100.98 -150.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.514 2.809 . . . . 0.0 111.356 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -146.06 128.61 16.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.31 123.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.166 0.984 . . . . 0.0 110.108 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.41 -28.14 5.85 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.139 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.9 37.72 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.371 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 65' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 43.6 m-85 -112.48 135.99 52.52 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.809 0.338 . . . . 0.0 110.685 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.37 125.46 37.99 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 47.7 p90 -124.3 147.19 48.31 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.453 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.407 ' CB ' ' HG ' ' C' ' 74' ' ' LEU . 7.3 ptm180 -124.31 148.41 47.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.665 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 58.8 p -121.31 173.94 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.604 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' GLN . . . . . 0.525 ' CD ' ' H ' ' C' ' 70' ' ' GLN . 20.2 mp0 -59.58 -42.13 91.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.465 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -72.47 0.97 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.649 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.42 28.44 55.53 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.964 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.37 104.61 17.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 5.7 mp -109.74 108.72 19.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.502 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.0 mm? -129.52 175.55 8.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.449 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' C' ' 60' ' ' PRO . 35.6 p90 -122.76 146.45 47.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 46.0 tpp -153.25 139.74 18.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.911 0.386 . . . . 0.0 110.413 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -60.75 138.91 58.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.427 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.483 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 61.5 pttt -64.07 -25.27 68.03 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.3 p -61.04 -52.22 65.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 110.283 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.53 63.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.7 t80 -57.27 -42.83 82.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.639 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.32 -34.83 79.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.362 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.65 -30.43 14.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.985 -167.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -70.28 -30.07 67.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.475 ' CD2' ' N ' ' C' ' 86' ' ' TYR . 6.3 m-85 -100.19 -75.51 0.57 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.381 -175.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.718 -176.353 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.468 HD22 ' H ' ' C' ' 23' ' ' ALA . 59.9 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.552 ' HB2' HG13 ' C' ' 21' ' ' VAL . 3.6 m-85 -93.04 143.25 26.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.171 0.51 . . . . 0.0 111.892 -166.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' LYS . . . . . 0.495 ' H ' HG23 ' C' ' 87' ' ' THR . 53.1 mtmt -129.45 112.47 13.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.626 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -70.18 -169.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.029 0.443 . . . . 0.0 111.873 -169.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -55.53 -53.98 49.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.438 -170.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.48 -14.26 26.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.174 0.512 . . . . 0.0 110.415 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.93 30.91 1.06 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.289 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.626 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.3 t -76.36 113.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -78.01 137.41 38.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.797 0.808 . . . . 0.0 110.528 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 21' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.44 125.82 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.355 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -88.74 162.02 16.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.468 ' H ' HD22 ' C' ' 12' ' ' LEU . . . -106.74 119.86 40.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.93 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.85 97.79 42.83 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.809 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.18 134.52 59.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.417 2.078 . . . . 0.0 111.569 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mt -76.2 93.67 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 21.9 tptm -70.57 -74.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.978 -172.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.85 143.75 24.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.865 0.364 . . . . 0.0 111.527 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.93 143.9 33.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.013 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.529 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 11.7 ptmm? -131.59 147.48 52.53 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -110.53 133.93 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.519 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.82 141.36 35.75 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.236 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -64.77 -15.09 61.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.167 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.44 -10.21 59.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.697 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.25 -34.03 4.75 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.417 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -64.45 164.38 11.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.784 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -142.12 146.15 35.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.529 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 6.3 t30 -106.42 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.485 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.58 ' HB3' ' OD1' ' C' ' 47' ' ' ASP . . . -119.35 175.91 5.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -173.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 10.3 pt-20 -160.28 144.55 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 165.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 41' ' ' PHE . . . . . 0.686 ' O ' ' HB2' ' C' ' 45' ' ' TYR . 88.4 m-85 -117.07 155.04 29.93 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.915 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 42' ' ' ASP . . . . . 0.47 ' OD1' ' HD2' ' C' ' 44' ' ' PRO . 19.9 t70 69.07 -64.06 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.121 0.968 . . . . 0.0 111.877 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.35 -73.15 0.2 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.532 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 71.6 Cg_endo -79.45 -3.96 13.33 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.798 2.332 . . . . 0.0 112.36 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 45' ' ' TYR . . . . . 0.686 ' HB2' ' O ' ' C' ' 41' ' ' PHE . 17.4 m-85 -85.34 155.29 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.131 0.491 . . . . 0.0 110.426 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.74 -174.18 2.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.023 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.58 ' OD1' ' HB3' ' C' ' 39' ' ' ALA . 14.9 t70 -174.45 -63.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.297 170.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.521 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 1.4 mp0 75.37 -159.3 0.05 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.027 0.931 . . . . 0.0 111.686 175.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 76.2 m-85 -75.02 140.67 43.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.377 0.608 . . . . 0.0 112.396 -172.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 44.8 ttp -129.79 148.49 51.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.401 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.67 137.26 25.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.522 0.677 . . . . 0.0 111.837 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.87 -41.27 91.16 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.956 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.79 -33.94 75.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 0.0 109.467 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -74.91 -40.65 60.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.471 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.38 -28.02 38.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.471 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.78 72.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.635 0.255 . . . . 0.0 111.041 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.374 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 58' ' ' PHE . . . . . 0.581 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 63.7 m-85 -95.41 14.84 21.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.596 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -81.65 99.91 0.65 Allowed Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 73.5 Cg_endo -101.07 -102.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.052 2.501 . . . . 0.0 112.917 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -143.61 123.45 13.45 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.8 t -72.18 101.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.15 -21.53 3.89 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.598 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.69 -159.6 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.163 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -124.04 120.26 31.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.059 0.456 . . . . 0.0 111.172 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.456 HD21 HD23 ' C' ' 74' ' ' LEU . 18.8 tp -93.96 154.95 17.4 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 50.9 p90 -139.47 146.99 40.71 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.563 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.99 123.76 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -172.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 25.8 p -91.81 167.29 12.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 109.957 175.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.12 11.18 0.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.38 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -109.72 -4.37 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 0.0 110.086 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.22 23.01 33.21 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.749 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 43.2 tt0 -99.22 120.44 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.456 HD23 HD21 ' C' ' 66' ' ' LEU . 6.4 mp -125.63 116.26 21.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.1 mm? -128.06 169.2 14.33 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -132.27 155.93 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.8 ptp -175.89 -175.77 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.316 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -70.58 121.05 17.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' C' ' 79' ' ' LYS . 11.7 ptmt -64.96 -24.65 67.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.75 -173.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 13.6 p -61.24 -32.13 71.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.963 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.52 -50.18 19.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.1 0.476 . . . . 0.0 111.011 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.525 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 8.0 t80 -72.89 -41.37 64.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.18 -31.71 71.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.422 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.59 -35.06 67.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.772 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.21 -25.8 60.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' TYR . . . . . 0.525 ' HD2' ' O ' ' C' ' 82' ' ' PHE . 14.7 m-85 -120.54 -85.94 0.65 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.374 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.495 HG23 ' H ' ' C' ' 14' ' ' LYS . 69.5 p . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -164.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' C' ' 12' ' ' LEU . 3.4 mm? . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.627 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 30.0 m-85 -105.42 164.0 12.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.637 -170.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.44 -176.88 3.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ASP . . . . . 0.586 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -120.92 -164.35 1.1 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.271 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 16' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -61.54 -35.87 78.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.21 -11.87 12.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.3 20.04 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.935 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.586 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 55.4 t -70.05 131.35 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -82.31 141.5 32.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.779 0.799 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.81 140.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.368 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -98.59 143.35 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' C' ' 67' ' ' PHE . . . -106.5 132.75 52.16 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.712 0.768 . . . . 0.0 111.248 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.519 ' N ' HD12 ' C' ' 24' ' ' LEU . 3.3 mp -101.39 99.4 11.12 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.834 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.2 Cg_exo -64.99 105.64 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.699 2.266 . . . . 0.0 112.371 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 26' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' C' ' 66' ' ' LEU . 16.9 mt -73.25 110.88 7.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -98.1 -43.63 6.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.31 162.33 30.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -139.52 134.3 39.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 7.4 mmpt? -91.55 90.07 7.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.222 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -76.5 101.18 5.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.02 140.07 29.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.617 0.723 . . . . 0.0 110.329 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -63.63 -17.99 63.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.93 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -71.98 -18.48 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 110.805 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.5 -47.93 0.99 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.066 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 77.2 p -70.41 176.71 3.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.328 0.585 . . . . 0.0 110.969 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -155.14 -164.47 1.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.061 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.601 ' HB2' ' HA ' ' C' ' 48' ' ' GLN . 0.4 OUTLIER -166.83 145.33 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 168.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 39' ' ' ALA . . . . . 0.671 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -103.61 135.39 45.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.45 119.58 39.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.476 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -111.75 144.31 41.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 110.742 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.72 -25.91 44.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.706 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.07 -178.92 48.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.502 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.52 67.47 3.67 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.686 2.257 . . . . 0.0 111.524 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.25 -174.42 3.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.752 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.87 168.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.354 1.073 . . . . 0.0 113.83 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 16.2 p-10 -148.22 51.33 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.018 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 48' ' ' GLN . . . . . 0.601 ' HA ' ' HB2' ' C' ' 38' ' ' ASN . 28.0 mt-30 -163.99 144.35 8.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -157.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 49' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' C' ' 37' ' ' ALA . 9.2 m-85 -148.06 -166.76 2.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 160.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -179.02 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.439 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' SER . . . . . 0.407 ' O ' HG23 ' C' ' 55' ' ' VAL . 3.9 p -86.66 105.76 17.13 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.295 0.569 . . . . 0.0 111.477 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.78 82.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.732 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.14 -35.33 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.392 0.615 . . . . 0.0 110.183 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 41.8 m -77.48 -41.0 41.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.286 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 85.9 t -74.83 -14.75 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.936 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -36.52 58.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.7 -30.18 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.268 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -103.38 14.57 31.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.843 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 24.8 pttm -60.09 119.89 45.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 59.8 Cg_endo -97.54 -150.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.362 2.708 . . . . 0.0 110.579 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -135.42 157.57 46.55 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 95.0 t -87.67 105.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.197 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 -19.63 5.44 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.135 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.5 -171.76 47.35 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.315 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.49 107.78 15.18 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.991 0.424 . . . . 0.0 110.723 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.478 HD23 HD22 ' C' ' 24' ' ' LEU . 37.1 tp -78.67 152.28 31.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 67' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 50.1 p90 -146.0 151.3 37.56 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.538 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 38.3 ttm180 -143.69 140.09 29.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.303 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p -103.27 170.78 7.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.191 0.519 . . . . 0.0 110.576 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.9 -21.41 66.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.398 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -81.36 -6.87 59.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.549 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.2 56.49 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.646 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 34.5 tt0 -87.5 121.48 29.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.55 139.41 49.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 0.0 111.249 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 93.4 mt -153.1 169.27 23.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.31 145.57 46.96 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.399 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -157.85 144.94 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.403 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -64.05 129.58 40.57 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -62.51 -27.59 69.25 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.734 -167.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -56.11 -39.59 72.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.823 0.344 . . . . 0.0 111.876 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -44.07 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.989 0.423 . . . . 0.0 111.189 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -27.19 36.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -172.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.42 -32.32 62.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.982 0.42 . . . . 0.0 110.191 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.61 -62.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.528 -171.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -75.12 -25.31 58.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -96.2 -57.69 2.27 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' THR . . . . . 0.627 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 20.4 p . . . . . 0 C--N 1.324 -0.505 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.648 0.261 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.13 71.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.735 0.778 . . . . 0.0 109.767 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.08 130.97 23.88 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.532 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.08 13.84 1.44 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.428 2.085 . . . . 0.0 113.15 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.5 m120 52.48 43.31 31.14 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.169 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' C' ' 7' ' ' THR . 38.7 p90 -70.05 -33.92 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.401 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.433 HG23 ' CE1' ' C' ' 6' ' ' PHE . 1.2 p -78.27 123.19 85.92 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.296 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.42 45.31 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.761 2.308 . . . . 0.0 112.639 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 8.7 m -77.23 -56.48 4.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.294 0.569 . . . . 0.0 109.633 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -80.56 127.53 75.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.335 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.91 102.17 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.92 1.747 . . . . 0.0 112.333 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.538 HD22 ' HA ' ' C' ' 22' ' ' SER . 8.1 mt -97.41 148.39 23.23 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.708 ' CB ' ' HA ' ' C' ' 87' ' ' THR . 52.5 m-85 -117.71 -161.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -166.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -122.63 127.98 50.06 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 -157.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.554 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -74.84 -165.92 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.184 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.481 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.73 -44.69 96.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.93 -9.7 14.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.235 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.89 23.62 1.43 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.445 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.554 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 77.6 t -83.57 150.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' C' ' 70' ' ' GLN . 0.2 OUTLIER -83.54 148.02 27.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.131 0.967 . . . . 0.0 111.084 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.0 144.9 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.395 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.538 ' HA ' HD22 ' C' ' 12' ' ' LEU . 22.8 t -94.93 142.93 26.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.57 39.88 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.405 0.621 . . . . 0.0 110.313 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.427 ' N ' HD12 ' C' ' 24' ' ' LEU . 5.1 mp -108.09 97.95 24.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.764 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.7 101.64 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.431 2.087 . . . . 0.0 112.233 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.4 mt -66.36 110.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.426 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -81.01 -74.02 0.34 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.473 0.654 . . . . 0.0 109.496 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.94 169.97 16.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.212 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.423 0.63 . . . . 0.0 110.847 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.495 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.4 tmtp? -103.04 101.4 11.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.413 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -87.87 104.78 16.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.763 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 143.84 29.57 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.546 0.688 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -66.38 -13.13 60.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.174 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -76.22 -20.89 57.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.58 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.03 -37.63 2.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.496 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 69.7 p -74.85 157.77 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.893 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.12 139.77 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 2.5 p-10 -110.02 129.23 55.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.39 125.58 38.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.263 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -89.39 118.21 28.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.25 152.03 33.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.95 32.68 5.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' C' ' 45' ' ' TYR . . . -115.38 -137.49 6.28 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.846 172.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.85 30.07 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.553 2.169 . . . . 0.0 111.539 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' C' ' 43' ' ' GLY . 88.3 m-85 -142.45 139.81 31.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.778 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.36 -160.78 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.191 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.08 133.78 53.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 51.2 mm-40 -127.13 108.74 11.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -80.07 128.52 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.381 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.8 mmm -117.39 144.95 44.43 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' SER . . . . . 0.569 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 0.0 OUTLIER -65.25 156.76 30.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -57.34 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.569 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 0.8 OUTLIER -61.72 -26.36 68.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.108 0.48 . . . . 0.0 110.395 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -75.76 -41.75 52.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.347 0.594 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.5 t -70.14 -17.2 20.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.382 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.2 -27.7 47.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.0 -32.2 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.364 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.96 16.19 26.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 49.4 pttt -59.53 107.09 0.86 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 111.399 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 87.7 Cg_endo -102.24 -150.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.649 2.899 . . . . 0.0 112.011 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.05 142.86 51.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.417 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.18 121.74 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 122.126 0.965 . . . . 0.0 109.683 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.63 28.8 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.472 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.27 -165.07 33.72 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.992 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -132.7 131.25 41.06 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' C' ' 75' ' ' LEU . 8.8 tt -114.13 154.52 27.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 53.4 p90 -134.14 159.57 40.46 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.173 -0.329 . . . . 0.0 110.272 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -133.36 116.0 15.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 71.7 p -100.01 162.69 12.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.833 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 78.9 mm-40 -63.25 -15.73 58.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.775 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -81.08 -10.7 59.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.79 8.98 61.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.63 114.62 26.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.9 pt? -126.86 128.71 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 72.8 mt -150.48 159.9 44.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.894 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 139.95 34.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 1.7 mmt -137.43 163.16 31.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.381 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -81.04 143.33 32.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.9 pttp -52.36 -36.45 53.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -167.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.2 p -58.7 -49.35 77.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 111.356 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.79 -42.08 58.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.272 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 78.0 t80 -54.04 -52.31 61.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.93 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.65 -37.3 84.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.068 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.36 -19.6 31.19 Favored 'General case' 0 C--N 1.315 -0.929 0 O-C-N 121.869 -0.519 . . . . 0.0 111.291 -168.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.7 m-80 -113.74 -25.84 8.48 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.762 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.2 m-85 -128.66 25.57 5.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.708 ' HA ' ' CB ' ' C' ' 13' ' ' TYR . 16.7 p -150.84 -34.17 0.15 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.93 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 58.5 m -95.61 -70.35 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -170.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' C' ' 90' ' ' SER . . . 59.46 66.92 0.95 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -170.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' C' ' 89' ' ' ALA . 49.7 m 76.38 148.86 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.245 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.0 57.94 2.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.648 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 16.4 m -150.6 -43.61 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 60.9 t 69.15 -78.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.5 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.23 -7.6 24.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.24 0.543 . . . . 0.0 110.799 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 60.45 39.49 18.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.41 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.25 3.58 12.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.403 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -78.78 -36.41 42.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' THR . . . . . 0.449 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 0.0 OUTLIER -79.0 -18.99 52.7 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.166 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.53 -150.2 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.187 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.2 -23.23 28.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.314 . . . . 0.0 110.98 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -72.45 -27.16 62.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.671 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt 57.93 22.23 8.51 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.289 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' C' ' 106' ' ' ARG . 3.0 p -142.23 44.52 1.66 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.421 0.629 . . . . 0.0 111.054 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' C' ' 98' ' ' THR . 21.0 p -83.39 -80.45 0.18 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.418 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -119.61 6.05 11.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.86 0.838 . . . . 0.0 109.181 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' C' ' 103' ' ' SER . 66.6 mtt180 -132.01 151.09 51.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.241 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p -121.23 98.78 6.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.122 0.487 . . . . 0.0 110.06 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.31 74.52 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.071 -174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 23.9 p 49.01 50.83 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.496 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.28 130.24 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 13.0 p -92.0 33.05 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.953 0.406 . . . . 0.0 111.521 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.36 -93.44 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.168 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.39 63.51 7.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.126 0.489 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.35 129.25 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.326 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.3 p -58.43 -32.76 68.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.426 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.3 9.4 58.07 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.861 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -134.45 -43.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.48 87.55 2.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.817 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 19.4 m -68.28 135.22 51.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 68.59 -75.92 0.06 Allowed 'General case' 0 C--N 1.346 0.413 0 C-N-CA 123.337 0.655 . . . . 0.0 111.658 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -164.24 172.78 13.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.46 72.47 1.26 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.755 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -68.39 149.3 49.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.959 0.409 . . . . 0.0 111.154 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.56 157.41 24.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.718 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 74.68 145.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.275 0.985 . . . . 0.0 110.24 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 39.9 t 59.52 74.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.54 . . . . 0.0 109.701 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 24.2 p 51.16 -100.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.893 -175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 75.2 mt -136.02 -40.68 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.526 0.679 . . . . 0.0 109.996 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -146.51 136.97 23.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.146 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 39.9 p -66.23 -28.88 69.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.894 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -107.6 97.66 7.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 174.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 46.6 m -141.24 33.35 1.7 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 0.0 109.961 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.18 44.07 0.46 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.054 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.248 1.012 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.81 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.91 -25.69 32.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 111.314 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' C' ' 6' ' ' PHE . 7.8 t-20 -126.94 78.43 73.97 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.189 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.93 -32.58 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.383 2.056 . . . . 0.0 113.672 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -123.78 25.82 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -172.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' PHE . . . . . 0.41 ' HA ' ' OD1' ' C' ' 3' ' ' ASN . 96.6 m-85 69.08 -72.07 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.949 0.5 . . . . 0.0 111.467 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' C' ' 8' ' ' PRO . 92.0 m 65.26 117.69 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.784 0.433 . . . . 0.0 111.469 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' C' ' 7' ' ' THR . 11.6 Cg_endo -54.48 103.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.92 2.414 . . . . 0.0 112.417 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -132.94 44.05 2.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.434 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.18 11.68 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.691 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.38 179.99 2.65 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.906 1.737 . . . . 0.0 110.594 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.639 ' HB2' ' CZ ' ' C' ' 20' ' ' TYR . 2.2 mm? -83.49 177.36 8.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.203 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.494 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 29.7 m-85 -95.59 -179.54 4.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -166.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 93.3 mttt -140.03 131.64 27.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -170.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -77.33 -168.41 1.13 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.736 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.63 -38.29 86.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -105.85 -0.34 25.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.269 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.48 13.27 6.92 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.292 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 51.7 t -70.23 119.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' TYR . . . . . 0.639 ' CZ ' ' HB2' ' C' ' 12' ' ' LEU . 33.5 t80 -77.78 137.72 38.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 109.736 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.6 131.75 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.54 -171.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.423 ' HA ' ' HG ' ' C' ' 12' ' ' LEU . 12.1 m -89.21 141.48 28.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.61 117.48 34.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.625 0.726 . . . . 0.0 110.647 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.464 HD22 ' N ' ' C' ' 24' ' ' LEU . 2.3 mm? -113.51 101.32 53.52 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.518 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.683 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 23.0 Cg_exo -63.46 143.01 87.19 Favored 'Trans proline' 0 C--O 1.221 -0.368 0 C-N-CA 121.678 1.585 . . . . 0.0 110.775 -174.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' C' ' 60' ' ' PRO . 72.1 mt -78.55 106.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' C' ' 25' ' ' PRO . 0.0 OUTLIER -90.83 -73.69 0.52 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.67 -162.161 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HB3' ' HG3' ' C' ' 40' ' ' GLU . . . -156.11 144.27 19.83 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -142.83 153.94 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.567 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -146.67 144.06 29.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -93.27 126.11 38.22 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.61 176.92 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.41 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -60.7 -52.92 63.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.438 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.44 -28.79 68.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.665 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.84 -25.19 3.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.328 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 40.2 m -57.18 144.9 33.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.572 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.575 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -105.44 131.81 52.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -91.28 94.85 9.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.83 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.4 ' C ' ' HB3' ' C' ' 47' ' ' ASP . . . -83.55 156.89 22.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.118 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 7.3 pt-20 -162.34 115.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' PHE . . . . . 0.683 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 30.3 m-85 -60.4 154.18 21.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.539 0.685 . . . . 0.0 112.691 165.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.58 -27.83 17.11 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.219 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.34 170.15 52.06 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.416 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.27 67.22 2.69 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.795 2.33 . . . . 0.0 112.371 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.446 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 90.2 m-85 -133.28 -174.96 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.29 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' C' ' 47' ' ' ASP . . . -66.02 -160.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.255 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' C' ' 46' ' ' ALA . 3.6 m-20 99.95 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.594 1.158 . . . . 0.0 111.625 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.08 -152.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.193 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 121.39 18.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.125 0.488 . . . . 0.0 110.158 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.06 146.56 44.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.93 136.48 51.7 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.741 0.651 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.04 92.34 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.22 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.64 -32.75 73.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.518 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -73.41 -42.63 61.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.662 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' C' ' 37' ' ' ALA . 57.9 t -68.06 -26.22 33.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.747 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.39 74.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.089 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.8 -30.07 4.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.242 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.96 7.4 45.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.408 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 23.2 tptm -58.19 108.6 1.35 Allowed Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.581 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.612 ' HB2' HD13 ' C' ' 26' ' ' ILE . 54.9 Cg_endo -104.76 -148.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 124.072 3.181 . . . . 0.0 111.872 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.71 124.05 27.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.758 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.18 121.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 122.388 1.09 . . . . 0.0 110.476 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.98 30.78 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.247 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.53 -172.12 42.74 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.953 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 95.2 m-85 -124.67 112.1 16.38 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.961 0.41 . . . . 0.0 110.778 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 22.1 tp -85.76 147.45 26.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.518 ' HB2' ' CG2' ' C' ' 21' ' ' VAL . 39.3 p90 -147.09 153.18 39.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.52 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 3.9 ptp85 -146.8 145.0 29.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.24 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 88.6 p -115.07 -177.36 3.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.014 0.435 . . . . 0.0 111.513 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -56.83 -42.11 79.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.814 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.76 3.98 15.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.049 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.93 27.98 59.54 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.902 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 42.7 mt-10 -75.52 105.93 6.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' C' ' 75' ' ' LEU . 2.9 tm? -107.85 130.18 55.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.363 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' C' ' 74' ' ' LEU . 57.7 mt -168.06 162.73 13.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.638 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -129.3 148.16 51.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 33.2 ttm -152.79 149.51 28.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.653 0.263 . . . . 0.0 111.225 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 15.7 p -68.82 146.91 52.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.144 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 21.5 pttp -56.52 -29.54 61.98 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -166.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -60.4 -55.24 35.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.076 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.91 45.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 55.8 t80 -59.16 -49.31 78.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.069 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.528 ' HA ' HG23 ' C' ' 87' ' ' THR . 7.5 pt-20 -73.18 -32.56 64.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.658 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.64 -26.03 61.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.175 -172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 45.9 m-80 -99.87 -37.37 9.07 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.615 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.1 OUTLIER -135.21 72.23 1.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.528 HG23 ' HA ' ' C' ' 83' ' ' GLU . 51.0 p -165.11 -54.4 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 166.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -60.67 -77.5 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.702 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.18 55.5 6.27 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 50.7 m -147.48 175.42 10.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.255 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.55 94.0 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.384 -0.436 . . . . 0.0 113.676 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -66.52 -27.5 67.82 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.6 -0.353 . . . . 0.0 111.641 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t 65.23 -81.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 123.578 0.549 . . . . 0.0 111.122 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.21 6.59 28.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.24 0.543 . . . . 0.0 109.688 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' C' ' 99' ' ' ALA . 8.1 m120 66.6 45.98 1.92 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.823 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.83 25.78 2.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.081 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -136.97 -63.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.6 t -88.29 63.69 7.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.279 1.037 . . . . 0.0 108.316 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' C' ' 95' ' ' ASN . . . -64.17 92.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.947 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.84 -36.64 56.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.963 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -91.01 -31.53 16.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.05 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 6.6 mp 64.9 163.78 0.14 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.259 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' SER . . . . . 0.426 ' HB3' ' HB ' ' C' ' 108' ' ' ILE . 49.8 m 63.63 22.55 13.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.066 174.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 8.4 t -99.2 -2.49 36.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -173.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.73 29.33 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -136.55 14.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.557 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p 41.87 39.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' C' ' 103' ' ' SER . 79.6 mt -77.43 97.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 77.1 p 58.62 28.82 17.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.693 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -89.63 140.62 29.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.8 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 3.0 p -74.74 76.01 2.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.195 0.521 . . . . 0.0 110.987 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.96 -75.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.321 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.536 ' H ' ' HB2' ' C' ' 118' ' ' ALA . . . -156.71 122.6 4.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.513 HG12 ' H ' ' C' ' 115' ' ' THR . 16.0 t 65.92 171.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.444 0.465 . . . . 0.0 109.768 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.513 ' H ' HG12 ' C' ' 114' ' ' VAL . 12.8 p -66.52 -23.1 66.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 111.581 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.81 63.64 0.15 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.378 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 16.2 t -150.23 18.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.083 0.468 . . . . 0.0 110.464 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 118' ' ' ALA . . . . . 0.536 ' HB2' ' H ' ' C' ' 113' ' ' ALA . . . -74.46 -56.19 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.3 p 43.02 65.15 1.0 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.25 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.21 154.47 40.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.401 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -157.23 169.26 25.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.57 -65.7 3.91 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.182 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 46.7 m 59.54 40.41 20.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.999 0.428 . . . . 0.0 111.22 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' C' ' 128' ' ' ILE . . . -92.45 121.04 33.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.8 -26.67 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.033 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -71.84 -74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.722 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 14.0 p -92.52 3.16 56.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' C' ' 124' ' ' ALA . 65.3 mt 72.98 -49.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.904 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -119.67 152.03 37.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 41.1 p 50.36 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.843 0.857 . . . . 0.0 113.279 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 7.3 p -64.25 -40.72 96.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.44 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 27.4 t 179.28 -45.42 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.716 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -171.51 -138.2 2.49 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.361 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.282 179.092 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.454 ' O ' ' HD3' ' C' ' 4' ' ' PRO . . . -91.53 -6.56 52.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.919 0.39 . . . . 0.0 110.803 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -102.49 100.06 14.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.585 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' C' ' 2' ' ' ALA . 98.3 Cg_endo -82.09 57.35 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.8 2.333 . . . . 0.0 112.072 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -91.83 -2.96 56.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.65 22.53 0.9 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.969 0.414 . . . . 0.0 110.85 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.536 ' H ' ' HD2' ' C' ' 8' ' ' PRO . 19.8 m -118.55 -54.21 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' H ' ' C' ' 7' ' ' THR . 72.9 Cg_endo -75.41 90.96 1.08 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 121.793 1.662 . . . . 0.0 113.49 -171.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 9.6 t -84.25 -60.91 1.94 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.97 88.9 35.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.03 105.37 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.226 2.617 . . . . 0.0 112.75 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.09 108.33 18.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.299 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.701 ' CB ' ' HA ' ' C' ' 86' ' ' TYR . 76.0 m-85 -140.0 -161.61 1.22 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.635 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -129.09 132.82 47.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.355 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.665 ' HA ' ' O ' ' C' ' 84' ' ' ALA . 3.7 p-10 -86.65 -153.0 0.19 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.734 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.68 67.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -167.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.88 4.21 23.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.591 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.52 24.77 6.01 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.66 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.1 t -86.84 133.03 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 140.42 36.88 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.881 0.848 . . . . 0.0 109.91 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.3 145.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.242 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 6.3 m -105.82 131.53 53.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.0 117.06 33.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.614 0.721 . . . . 0.0 110.935 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.45 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.6 mp -96.33 111.77 57.77 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 24' ' ' LEU . 6.7 Cg_exo -73.31 114.34 4.01 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.543 2.162 . . . . 0.0 112.42 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' C' ' 66' ' ' LEU . 42.0 mt -79.0 107.2 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -75.57 -57.7 3.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.172 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.33 163.29 39.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.735 0.302 . . . . 0.0 111.078 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 62.7 mt -142.01 146.67 22.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.848 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.516 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 21.1 ptmt -133.25 144.53 49.81 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.29 123.89 50.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.822 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 167.91 12.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.441 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.19 -11.28 60.25 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.034 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -93.31 -5.87 48.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.953 0.406 . . . . 0.0 110.573 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.05 -16.83 42.2 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.793 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -71.46 140.99 50.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -112.85 120.24 40.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.134 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 5.7 t30 -83.3 119.26 24.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.008 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.706 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -114.22 124.94 53.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.98 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.55 131.49 54.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.021 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.84 154.68 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.612 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -87.12 74.13 9.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.128 0.966 . . . . 0.0 110.017 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.74 -171.6 43.84 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.246 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.69 50.9 3.58 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.079 2.52 . . . . 0.0 111.869 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.36 -176.55 3.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.31 166.41 18.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.854 0.835 . . . . 0.0 112.926 -174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.706 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 6.6 p-10 -149.63 85.66 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.105 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 77.7 mt-30 -149.12 154.68 39.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.791 -163.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 8.3 p90 -89.26 112.41 23.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.571 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.6 mtp -85.18 147.07 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.121 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' C' ' 53' ' ' GLN . 0.7 OUTLIER -52.06 141.09 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.996 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.87 -22.84 65.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.18 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' C' ' 51' ' ' SER . 12.1 pt20 -68.6 -38.51 80.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.9 m -77.78 -38.51 46.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.786 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.33 -18.58 19.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.288 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.53 80.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.022 0.439 . . . . 0.0 110.502 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.8 -33.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.307 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -109.54 22.65 15.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 19.5 ptmt -48.79 106.07 0.57 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.4 0.437 . . . . 0.0 111.433 174.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 1.6 Cg_endo -83.83 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.851 2.368 . . . . 0.0 112.112 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -136.0 138.85 42.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.9 105.02 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 11.17 60.11 Favored Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.089 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.2 -160.15 35.78 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.56 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.67 134.46 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.12 0.486 . . . . 0.0 111.163 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' C' ' 26' ' ' ILE . 48.1 tp -115.87 111.58 20.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.076 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -108.9 144.47 36.77 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.543 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.464 ' HB3' ' CD2' ' C' ' 74' ' ' LEU . 28.5 ptt180 -123.06 142.53 50.77 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.251 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 59.3 p -94.33 -174.87 3.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -54.46 -43.37 71.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.548 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -79.33 2.32 21.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.287 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.7 22.94 71.13 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.249 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.78 118.4 20.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' C' ' 68' ' ' ARG . 6.8 mt -99.97 126.92 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.259 0.552 . . . . 0.0 112.103 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.42 HD22 ' C ' ' C' ' 74' ' ' LEU . 3.2 mm? -132.41 140.84 48.62 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.636 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' C' ' 77' ' ' MET . 27.1 p90 -112.98 157.41 21.54 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.508 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -178.23 166.29 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.23 0.331 . . . . 0.0 110.524 172.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 78' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' C' ' 77' ' ' MET . 6.3 p -74.52 -156.76 0.05 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -67.93 -41.89 81.88 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -168.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 16.8 p -44.76 -63.58 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.75 0.656 . . . . 0.0 112.358 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' ALA . . . . . 0.402 ' HB3' ' HG2' ' C' ' 77' ' ' MET . . . -68.2 -37.18 80.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.758 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.701 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 28.9 t80 -59.72 -42.2 92.57 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.81 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 40.9 tt0 -62.97 -24.88 68.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.851 0.834 . . . . 0.0 110.669 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' C' ' 15' ' ' ASP . . . -89.63 2.14 55.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' C' ' 15' ' ' ASP . 16.7 m-80 -119.94 -19.69 7.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.978 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.81 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 5.9 p90 -115.11 7.24 15.35 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.21 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -155.34 -63.14 0.12 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.524 ' C ' ' H ' ' C' ' 90' ' ' SER . 20.0 t 68.72 -60.78 0.43 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.858 172.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' C' ' 90' ' ' SER . . . 72.95 -27.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.777 0.831 . . . . 0.0 110.91 -172.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.524 ' H ' ' C ' ' C' ' 88' ' ' SER . 9.2 t 163.15 -41.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.138 0.975 . . . . 0.0 108.488 -174.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.98 -118.51 0.94 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 12.9 m -89.54 80.5 6.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.45 -43.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.424 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.64 47.86 1.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.748 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ASN . . . . . 0.593 ' O ' HG22 ' C' ' 98' ' ' THR . 23.5 p30 -164.63 143.82 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.44 1.93 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.488 ' HA ' ' HB3' ' C' ' 101' ' ' LYS . 32.4 mt-10 -72.38 -29.32 63.65 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.593 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' THR . . . . . 0.593 HG22 ' O ' ' C' ' 95' ' ' ASN . 5.1 t -76.14 -15.56 60.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.254 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.76 -94.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -108.12 2.61 23.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -170.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' LYS . . . . . 0.488 ' HB3' ' HA ' ' C' ' 97' ' ' GLU . 59.9 tttp -73.25 -52.42 14.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.719 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 mt 72.95 -45.54 0.63 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.476 0.71 . . . . 0.0 111.541 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -88.39 54.23 2.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.385 0.612 . . . . 0.0 111.127 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 97' ' ' GLU . 0.9 OUTLIER -101.17 -2.58 31.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.98 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -133.09 26.66 4.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.648 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' C' ' 106' ' ' ARG . 11.4 mmp_? 61.71 21.82 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.729 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 5.2 p -91.64 -21.74 20.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.896 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 54.1 mt 66.82 -81.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 23.3 p -92.27 2.01 56.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.86 148.85 48.04 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.636 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 6.8 p -82.51 70.8 9.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.192 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 46.99 92.72 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.191 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -131.68 152.17 51.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.91 0.386 . . . . 0.0 110.854 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.02 158.45 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.778 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 11.3 p -50.3 -42.35 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.27 8.79 79.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.404 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t 56.9 25.25 10.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.32 0.648 . . . . 0.0 111.333 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 60.81 20.21 10.38 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -110.64 163.56 13.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.312 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.54 41.32 1.14 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.45 0.643 . . . . 0.0 109.818 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -145.83 151.6 38.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.677 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.63 0.92 88.3 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.158 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 14.1 m -64.12 -53.68 45.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.09 0.156 . . . . 0.0 110.603 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 53.11 65.08 1.62 Allowed 'General case' 0 C--O 1.234 0.244 0 O-C-N 123.561 0.538 . . . . 0.0 111.742 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -112.99 148.15 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 29.8 t -113.39 82.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.88 -57.53 2.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.148 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 21.2 mt 52.39 62.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.398 0.618 . . . . 0.0 110.269 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.95 78.92 9.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p 46.94 64.04 1.7 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.646 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 16.0 p -72.68 -55.96 6.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.482 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 24.2 p -135.05 -40.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.878 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.2 16.38 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.722 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.46 178.526 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.51 33.57 20.51 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.63 0.581 . . . . 0.0 112.114 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -124.31 138.69 31.35 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.86 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.62 -63.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.155 1.903 . . . . 0.0 112.111 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 47.49 53.55 10.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.309 0.644 . . . . 0.0 111.221 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -75.06 153.4 38.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.074 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.434 ' HB ' ' HD3' ' C' ' 8' ' ' PRO . 3.6 m -53.86 -52.91 63.53 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' C' ' 7' ' ' THR . 96.6 Cg_endo -76.22 50.13 2.79 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.305 2.003 . . . . 0.0 113.207 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 56.47 0.82 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 110.144 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -63.07 154.8 76.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.06 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.29 102.49 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.17 1.914 . . . . 0.0 110.657 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.61 -178.94 5.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.264 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.629 ' HB3' ' O ' ' C' ' 86' ' ' TYR . 26.5 m-85 -106.83 162.85 13.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.373 -169.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.498 ' H ' ' HA ' ' C' ' 87' ' ' THR . 98.8 mttt -150.09 152.82 35.39 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -164.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.578 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -90.65 -156.99 0.46 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.735 175.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.91 -51.85 55.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.27 -8.36 23.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.564 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.77 16.63 2.7 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.763 -1.208 . . . . 0.0 113.206 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.578 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 76.3 t -76.9 101.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 173.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' C' ' 14' ' ' LYS . 2.8 p90 -81.19 168.58 18.37 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.627 0.727 . . . . 0.0 110.511 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -146.89 140.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.179 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -86.44 141.65 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -108.28 117.4 34.04 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.453 0.644 . . . . 0.0 110.598 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.427 HD22 ' N ' ' C' ' 24' ' ' LEU . 1.5 mm? -104.25 100.52 22.01 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.354 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.447 ' HB2' ' OD1' ' C' ' 42' ' ' ASP . 16.3 Cg_exo -68.42 121.1 8.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.316 2.011 . . . . 0.0 112.358 -172.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' C' ' 60' ' ' PRO . 40.0 mt -79.87 101.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.194 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 22.8 ttmm -67.92 -69.31 0.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.443 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.86 148.21 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 41.3 mt -132.16 151.81 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.131 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -135.68 116.45 14.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.268 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.98 119.3 31.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.084 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.4 161.84 13.91 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.994 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.59 -11.64 61.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.011 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.81 -13.86 38.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 -31.22 6.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.741 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -68.44 141.58 55.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.95 55.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 8.1 t30 -88.95 116.37 27.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.57 162.37 14.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.477 ' CA ' ' HB3' ' C' ' 47' ' ' ASP . 38.4 mt-10 -154.07 127.25 8.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.4 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.02 155.88 17.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' C' ' 25' ' ' PRO . 6.0 p-10 -110.41 171.45 7.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -155.9 23.54 Favored Glycine 0 C--N 1.307 -1.05 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -169.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.37 39.8 0.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.671 2.247 . . . . 0.0 112.021 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.96 159.53 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 111.724 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.48 179.93 3.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.077 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.477 ' HB3' ' CA ' ' C' ' 40' ' ' GLU . 3.8 t0 -167.62 169.5 11.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 165.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -149.49 179.75 7.72 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.475 -158.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.6 p90 -85.57 125.38 33.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 95.3 mmm -122.25 156.58 33.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.945 0.403 . . . . 0.0 111.487 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.75 151.9 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.355 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.13 77.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.36 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.09 -38.87 84.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.465 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.4 m -73.32 -41.23 63.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.965 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.55 -12.07 13.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.87 61.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.984 0.421 . . . . 0.0 110.253 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.38 -33.9 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.035 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -105.11 22.63 15.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.941 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 53.6 pttt -53.86 107.53 0.88 Allowed Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.518 0.512 . . . . 0.0 111.011 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.504 ' HB2' HD13 ' C' ' 26' ' ' ILE . 6.9 Cg_endo -93.61 -156.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.159 2.572 . . . . 0.0 112.367 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -143.4 130.44 20.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.992 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.42 100.66 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.133 0.492 . . . . 0.0 110.227 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.49 -25.39 5.1 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.312 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.27 -165.28 37.66 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.194 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.26 126.39 48.07 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.655 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.37 140.07 29.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 45.4 p90 -137.37 159.66 41.3 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.675 -173.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 48.0 ttt180 -139.19 135.65 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.784 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 87.0 p -107.33 -178.63 3.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.98 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.42 -28.63 69.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -75.62 -14.46 60.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.581 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 20.86 34.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 7.1 tp10 -69.44 101.03 1.48 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt -103.36 108.45 19.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.644 0.735 . . . . 0.0 110.972 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 98.6 mt -146.46 177.39 9.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.149 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -130.18 143.68 50.92 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -148.62 136.16 20.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.994 0.426 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -69.4 150.57 47.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.166 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.25 -38.87 59.36 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.31 -59.02 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 111.824 -176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.17 -33.3 61.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.504 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 56.4 t80 -58.99 -47.53 84.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.171 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.59 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 4.7 tp10 -62.64 -40.95 98.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.94 -18.43 40.08 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.819 -0.55 . . . . 0.0 111.613 -166.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.451 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.1 m-80 -121.09 -31.53 4.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.629 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 2.3 m-85 -117.91 13.84 14.09 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -171.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.6 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 13.7 p -143.13 -53.11 0.38 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.647 0.658 . . . . 0.0 109.586 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -86.57 159.4 19.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 174.71 -50.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t 73.2 -52.91 0.7 Allowed 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.873 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.74 -38.76 3.17 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' SER . . . . . 0.483 ' HB3' ' OE1' ' C' ' 97' ' ' GLU . 16.0 m -77.22 8.07 4.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 111.4 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.79 -55.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -114.83 16.02 17.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -166.01 -53.32 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' C' ' 92' ' ' SER . . . -74.2 5.3 4.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' C' ' 92' ' ' SER . 32.2 mt-10 -144.81 58.71 1.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 30.7 p 69.75 -35.6 0.32 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.177 1.391 . . . . 0.0 113.974 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.02 27.62 14.26 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.796 0.439 . . . . 0.0 110.879 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.58 -69.09 0.22 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.787 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' C' ' 103' ' ' SER . 0.1 OUTLIER -111.45 -17.83 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.259 -0.276 . . . . 0.0 110.956 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.79 -11.49 0.33 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 111.849 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' SER . . . . . 0.528 ' H ' ' HG3' ' C' ' 101' ' ' LYS . 53.9 p 53.4 37.87 26.56 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.283 1.033 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 25.8 p -69.29 -13.31 62.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.97 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -49.57 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.001 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -118.35 0.42 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.662 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 37.9 p 47.72 53.01 11.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.168 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.61 67.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' THR . . . . . 0.419 ' HA ' ' OG ' ' C' ' 103' ' ' SER . 5.0 p -16.05 74.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 O-C-N 125.316 1.635 . . . . 0.0 115.317 -172.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.42 HD11 HG23 ' C' ' 115' ' ' THR . 1.8 mm? -126.47 122.47 35.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.505 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 11.4 p -110.15 -35.15 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.094 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.8 147.18 18.48 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.64 -37.42 0.39 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 112.399 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.432 ' O ' HG12 ' C' ' 114' ' ' VAL . 23.5 t 72.84 2.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.333 0.587 . . . . 0.0 110.876 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.42 HG23 HD11 ' C' ' 110' ' ' LEU . 19.2 p 48.99 33.54 4.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.204 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.73 -100.7 0.2 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.514 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 16.5 t -118.38 21.69 12.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.059 0.456 . . . . 0.0 109.903 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 55.9 41.2 30.26 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.564 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 8.9 m -78.31 73.63 4.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.732 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -74.39 -41.01 61.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 110.177 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 -68.37 0.19 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.111 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.62 -175.7 17.99 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.581 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 23.5 p -119.35 129.95 55.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.48 15.35 8.72 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -102.76 -7.08 21.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 55.2 t 66.3 -80.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.775 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 2.7 p -139.82 -72.64 0.37 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.284 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 18.3 mm 57.1 35.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 122.007 0.908 . . . . 0.0 109.298 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -98.11 -31.3 12.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.344 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.7 p -88.65 58.31 4.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.552 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 131' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' C' ' 132' ' ' SER . 22.2 p -81.73 -64.72 1.12 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 132' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' C' ' 131' ' ' THR . 15.3 t 174.68 -34.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.032 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.12 -151.56 22.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.623 178.196 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.38 -61.22 1.9 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.874 0.845 . . . . 0.0 110.398 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -128.06 88.85 51.88 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.869 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.8 -61.45 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.839 2.36 . . . . 0.0 112.876 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' C' ' 7' ' ' THR . 40.2 m-80 -148.92 -59.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.525 0.202 . . . . 0.0 111.297 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' C' ' 5' ' ' ASN . 59.4 m-85 71.92 -36.27 0.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.746 0.818 . . . . 0.0 111.7 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.419 ' H ' ' C ' ' C' ' 5' ' ' ASN . 8.0 t -148.56 134.69 9.88 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 110.17 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.47 -10.81 25.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.541 2.161 . . . . 0.0 111.931 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -96.99 74.62 2.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.661 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -64.8 123.65 84.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.49 142.09 10.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.611 2.207 . . . . 0.0 112.613 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 mp -104.34 166.85 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.68 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 22.1 m-85 -92.92 156.05 17.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.834 -0.166 . . . . 0.0 110.762 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 23.8 ttpp -124.74 136.41 53.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.371 0.605 . . . . 0.0 110.38 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.552 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -81.5 -164.95 0.85 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.174 176.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.85 -56.43 10.41 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' C' ' 96' ' ' ALA . 1.6 p-10 -98.94 -1.37 40.12 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.791 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.66 13.92 2.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.289 -1.434 . . . . 0.0 114.037 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 61.2 t -80.6 125.34 39.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -96.73 174.38 6.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.331 -0.547 . . . . 0.0 109.828 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -148.66 139.81 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -175.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 46.1 m -77.8 142.08 38.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.6 117.7 34.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.352 0.596 . . . . 0.0 109.8 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 1.2 mm? -112.44 98.15 42.63 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.872 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.16 104.23 0.71 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.537 2.158 . . . . 0.0 111.806 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' C' ' 66' ' ' LEU . 8.4 mt -72.13 94.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -75.43 -59.23 2.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.154 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -155.61 148.18 24.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.943 0.401 . . . . 0.0 111.573 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 32.9 mt -137.68 131.63 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.969 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -124.52 110.45 14.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.89 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.18 115.42 6.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.167 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.4 -174.89 5.44 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.039 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.23 -26.27 52.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.182 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.73 -20.64 30.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.122 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.25 -32.55 4.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.916 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -65.09 157.99 27.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.98 131.37 49.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.939 0.399 . . . . 0.0 111.623 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 71.7 m-20 -77.42 126.95 31.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.766 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -105.19 153.9 20.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -136.25 122.1 19.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.871 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -122.32 -179.3 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.17 -39.9 73.06 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.83 -73.24 0.06 OUTLIER Glycine 0 C--N 1.316 -0.582 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.713 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.89 14.88 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.862 2.374 . . . . 0.0 113.913 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -128.8 -175.77 3.64 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.92 119.77 2.1 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 0.5 OUTLIER -133.8 61.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.261 168.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -167.64 175.04 7.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.299 -169.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 26.2 p90 -73.27 133.56 43.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 82.5 mtp -108.74 144.08 37.02 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.08 136.7 47.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.394 0.616 . . . . 0.0 111.312 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.88 76.4 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.316 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.504 0.668 . . . . 0.0 109.552 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -72.33 -40.99 67.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.719 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 72.4 t -74.67 -16.83 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.32 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.58 -35.5 67.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.82 -33.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.123 0.487 . . . . 0.0 110.092 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' PHE . . . . . 0.436 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 83.1 m-85 -102.83 18.0 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.445 -172.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' C' ' 59' ' ' LYS . 0.1 OUTLIER -71.0 110.12 6.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.088 170.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 56.7 Cg_endo -96.83 -100.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.708 2.272 . . . . 0.0 112.149 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -153.48 143.4 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' C' ' 28' ' ' ALA . 69.0 t -82.49 110.31 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.049 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.52 11.12 36.55 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.824 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.58 -163.41 29.25 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.164 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -132.16 123.73 27.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 15.2 tp -100.43 156.41 17.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.1 p90 -142.13 147.35 36.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.346 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -128.83 115.46 17.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 16.0 p -96.97 163.96 12.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.398 0.618 . . . . 0.0 110.125 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -73.5 -0.41 14.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.677 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.35 -4.55 58.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.04 24.11 46.1 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.527 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.431 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 7.0 tp10 -99.9 121.32 41.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.411 ' C ' HD22 ' C' ' 75' ' ' LEU . 6.5 mp -125.76 112.34 15.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.525 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 2.8 mm? -135.11 169.68 17.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.502 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -124.25 154.56 40.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 20.4 ptp -178.12 -178.79 0.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.36 0.413 . . . . 0.0 109.992 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 9.1 p -67.48 125.83 27.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -65.92 -23.54 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -59.54 -40.62 87.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.027 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.83 51.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.4 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 11.7 t80 -68.43 -42.05 79.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.74 -27.72 68.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.19 0.519 . . . . 0.0 111.085 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.39 -34.45 63.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.193 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.44 -33.47 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.318 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 25.6 m-85 -90.79 -57.33 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -169.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.68 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 43.5 p -84.29 -38.0 20.99 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.592 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 4.9 t -82.11 170.21 15.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.023 0.439 . . . . 0.0 110.894 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 58.4 29.66 18.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.012 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -113.25 0.22 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.803 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.32 96.88 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.588 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' SER . . . . . 0.52 ' H ' ' HG3' ' C' ' 97' ' ' GLU . 37.9 m 70.69 -6.05 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.419 0.688 . . . . 0.0 112.147 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.74 -18.3 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.51 0.671 . . . . 0.0 109.706 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.84 -12.32 59.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.781 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' C' ' 97' ' ' GLU . 5.9 m-20 72.93 -41.85 0.52 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.485 174.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 96' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' C' ' 17' ' ' ASP . . . -72.1 10.25 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.05 0.453 . . . . 0.0 111.18 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' C' ' 92' ' ' SER . 77.4 mm-40 -79.51 -11.86 59.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m 65.49 26.6 11.79 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.346 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.7 -164.57 0.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.423 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.66 -37.52 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.955 0.407 . . . . 0.0 110.848 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -76.19 -15.34 60.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.99 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 84.8 mt 60.81 -97.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.003 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 7.5 p -151.78 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 112.08 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -88.9 -81.74 0.26 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.724 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.69 12.53 1.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.586 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -99.0 -63.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.498 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' C' ' 110' ' ' LEU . 34.5 p -72.31 -78.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.372 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm 72.54 -47.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.181 0.592 . . . . 0.0 111.659 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -81.24 -6.12 58.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 0.0 111.767 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' C' ' 107' ' ' THR . 4.6 mm? -94.24 34.59 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.433 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 22.9 p -88.82 123.55 33.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.325 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.63 -92.39 1.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.222 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.31 51.73 1.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.553 0.216 . . . . 0.0 110.674 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 60.2 t 66.03 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.454 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 p -80.56 48.83 1.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.73 -86.68 0.11 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.223 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 8.6 t -149.35 77.59 1.35 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 70.72 -64.64 0.37 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.595 0.758 . . . . 0.0 112.125 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 62.9 p -120.51 -170.7 2.03 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -56.83 -54.37 47.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.519 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -129.54 -70.09 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.998 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.23 -166.76 31.33 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.4 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 6.0 t 60.08 41.15 17.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.671 . . . . 0.0 110.474 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.37 0.38 55.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.197 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -86.44 36.73 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.24 95.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.285 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 15.5 p -87.08 -50.89 6.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.208 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 55.1 mt 59.71 75.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.528 0.68 . . . . 0.0 109.868 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.78 -22.71 59.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.562 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -77.33 111.51 13.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 5.2 p -73.88 -26.56 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.16 0.505 . . . . 0.0 110.373 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -155.98 -42.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.877 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.72 -100.41 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.066 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.805 -178.462 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.772 0.32 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 -57.88 2.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.027 0.441 . . . . 0.0 111.387 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.453 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 57.9 m-80 -63.0 -52.55 62.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.267 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' C' ' 3' ' ' ASN . 38.1 Cg_endo -66.42 -20.65 54.51 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.882 1.722 . . . . 0.0 112.788 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -111.59 47.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.158 0.504 . . . . 0.0 110.174 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -66.62 148.01 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.75 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -114.35 89.41 17.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.62 3.07 7.35 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.946 2.431 . . . . 0.0 113.833 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -57.27 -46.0 83.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -103.19 128.79 26.84 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.449 ' C ' HD12 ' C' ' 12' ' ' LEU . 72.1 Cg_endo -82.43 99.27 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.795 1.664 . . . . 0.0 112.58 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.449 HD12 ' C ' ' C' ' 11' ' ' PRO . 8.4 mp -133.17 153.93 51.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.95 163.2 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -166.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 12.8 mptt -118.69 -173.7 2.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.51 0.672 . . . . 0.0 111.742 -167.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.533 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.6 OUTLIER -127.84 -148.57 0.38 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.515 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.91 -40.98 71.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.73 -12.69 13.33 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.491 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.79 26.16 1.3 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.522 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 68.5 t -83.88 124.44 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -91.15 175.27 7.0 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.447 0.641 . . . . 0.0 110.817 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.28 134.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 37.3 m -78.19 141.04 38.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.452 ' C ' HD23 ' C' ' 24' ' ' LEU . . . -127.9 137.46 52.31 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 0.4 OUTLIER -116.16 97.57 49.78 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.41 ' HD2' ' OD2' ' C' ' 42' ' ' ASP . 33.4 Cg_exo -61.95 122.34 10.82 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.34 2.027 . . . . 0.0 111.3 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.0 mt -83.58 107.69 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -69.95 -64.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.09 159.4 36.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -139.02 141.9 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.473 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -120.74 109.09 14.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.448 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.01 108.42 15.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.088 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.83 145.95 26.97 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -61.36 -18.88 60.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.887 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.83 -20.74 57.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.15 -38.17 2.07 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.204 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -73.64 152.94 40.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.407 . . . . 0.0 111.027 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.7 128.71 25.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.4 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 24.9 p30 -80.57 149.01 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.348 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -135.37 133.39 38.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.663 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.24 138.8 54.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.192 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' C' ' 45' ' ' TYR . 53.0 m-85 -112.38 -177.48 3.17 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' C' ' 25' ' ' PRO . 6.0 p-10 -52.68 -51.61 59.51 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -172.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.64 -144.0 7.59 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.239 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.78 62.38 5.65 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.54 2.827 . . . . 0.0 111.671 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' C' ' 41' ' ' PHE . 93.7 m-85 -115.43 -173.94 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.242 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 144.34 10.89 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.755 0.788 . . . . 0.0 112.523 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.588 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 28.1 t70 -148.02 80.84 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.656 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 9.2 pt20 -152.84 158.28 41.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -166.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 78.9 m-85 -79.33 114.25 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.883 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.7 mmt -84.01 145.01 28.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.08 171.0 4.96 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.92 -48.82 67.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.226 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.464 ' O ' HG23 ' C' ' 57' ' ' VAL . 78.0 mt-30 -63.44 -31.53 72.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.262 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -73.87 -51.82 14.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.604 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 24.1 t -64.53 -31.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.414 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.02 70.97 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.198 -0.314 . . . . 0.0 111.712 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' VAL . . . . . 0.464 HG23 ' O ' ' C' ' 53' ' ' GLN . 2.9 t -97.09 -30.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' PHE . . . . . 0.439 ' CD1' HD21 ' C' ' 75' ' ' LEU . 34.9 m-85 -109.26 14.54 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.091 -171.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 18.9 ptpt -53.88 117.73 13.38 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-O 121.177 0.513 . . . . 0.0 112.383 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -105.14 -152.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 124.153 3.235 . . . . 0.0 111.291 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.67 154.49 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.63 130.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.822 0.82 . . . . 0.0 109.86 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 -10.37 39.77 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.378 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' C' ' 76' ' ' TYR . . . -98.91 -158.55 29.42 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.098 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -129.29 138.34 51.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 57.9 mt -91.34 169.55 10.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' C' ' 22' ' ' SER . 13.9 p90 -170.28 167.06 8.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.991 0.359 . . . . 0.0 110.22 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 73.8 ttt180 -151.78 129.18 11.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.573 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -110.87 159.39 17.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -70.83 -10.51 59.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.405 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -86.63 -12.32 48.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.518 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.96 7.95 28.4 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.89 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 5.6 mp0 -75.04 121.11 21.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.599 0.699 . . . . 0.0 109.572 174.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' C' ' 75' ' ' LEU . 5.5 mt -131.94 167.51 19.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.363 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' C' ' 66' ' ' LEU . 91.2 mt 84.33 -139.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.304 1.003 . . . . 0.0 112.522 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' C' ' 64' ' ' GLY . 50.9 t80 -91.59 135.51 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.468 0.652 . . . . 0.0 111.355 -165.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.6 ptm -118.49 130.18 55.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.869 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -95.77 162.57 13.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.253 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 0.0 OUTLIER -56.97 -34.77 68.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.9 p -56.13 -48.17 76.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 0.0 111.176 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.22 -50.08 24.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.498 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.0 t80 -37.75 -62.25 0.56 Allowed 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.964 1.415 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.18 -54.44 29.55 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.96 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.11 -34.86 14.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -161.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -82.46 -28.55 31.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.177 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 34.6 m-85 -99.9 -71.12 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.415 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 51.3 p -83.89 -46.7 11.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.683 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t 60.81 -165.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.239 0.542 . . . . 0.0 111.426 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 177.0 -48.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.113 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -141.96 43.6 1.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.862 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.39 -79.67 0.54 Allowed Glycine 0 C--N 1.32 -0.347 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.433 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' SER . . . . . 0.426 ' OG ' ' HA ' ' C' ' 100' ' ' ASP . 4.4 m -79.63 -17.02 54.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 109.722 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' C' ' 92' ' ' SER . 90.1 t 78.53 -62.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.542 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.09 -25.6 13.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.493 0.663 . . . . 0.0 110.31 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 59.16 30.42 20.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.529 171.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -110.68 9.84 22.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.68 7.77 12.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.324 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.0 m 57.41 55.04 6.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.276 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.98 44.66 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.855 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ASP . . . . . 0.426 ' HA ' ' OG ' ' C' ' 92' ' ' SER . 4.7 p-10 -75.45 -11.33 60.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.946 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -88.03 -25.67 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 7.8 mp 61.64 -80.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.703 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 47.7 m -128.84 -3.0 5.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.723 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 20.3 p -86.29 123.5 31.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.722 0.296 . . . . 0.0 110.785 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 73.41 -37.01 0.37 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.735 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -138.35 124.01 19.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 37.5 p -84.14 66.81 9.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.321 0.582 . . . . 0.0 110.589 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.74 -28.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.181 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 31.3 p -83.99 -0.03 49.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' C' ' 110' ' ' LEU . 4.1 mm? 59.12 39.12 23.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.7 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 7.6 p -79.28 34.89 0.26 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.543 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.36 -83.49 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -136.94 -92.79 0.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.526 0.203 . . . . 0.0 110.56 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' C' ' 117' ' ' SER . 6.7 t -140.6 155.48 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -48.76 77.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 111.495 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.95 71.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.485 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' SER . . . . . 0.516 ' HB3' HG11 ' C' ' 114' ' ' VAL . 33.1 t -148.76 -66.96 0.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.837 -0.214 . . . . 0.0 110.988 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.25 -57.01 14.05 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.837 0.351 . . . . 0.0 111.587 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 14.4 m -115.95 30.52 7.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.258 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 59.0 -152.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.933 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.15 -34.14 24.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.75 -71.98 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.905 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 7.9 p -128.12 139.93 52.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.01 -45.61 11.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -100.88 -17.8 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.238 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.7 76.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.054 0.454 . . . . 0.0 110.768 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 31.8 p -105.37 112.04 24.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.2 -45.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.763 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -105.21 -40.18 5.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' C' ' 133' ' ' GLY . 21.0 p -83.08 43.79 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.417 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 1.9 p -78.72 68.63 4.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 29.6 t 174.0 -33.58 0.0 OUTLIER 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' C' ' 130' ' ' THR . . . 176.21 -113.56 0.44 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.429 174.762 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.79 38.54 27.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.567 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -138.24 97.19 9.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.006 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.6 -29.58 43.72 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.057 2.505 . . . . 0.0 112.579 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.17 -36.48 13.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -103.61 60.59 0.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.356 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' C' ' 8' ' ' PRO . 15.8 m -62.01 -47.04 91.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.737 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 7' ' ' THR . 31.2 Cg_endo -64.6 89.01 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.036 1.824 . . . . 0.0 112.487 175.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -64.28 -33.08 75.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.186 0.517 . . . . 0.0 110.65 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -75.17 125.07 89.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.432 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.72 115.02 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.286 1.99 . . . . 0.0 110.11 171.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.488 HD12 ' OH ' ' C' ' 20' ' ' TYR . 47.9 mt -65.11 157.32 28.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.017 0.437 . . . . 0.0 110.519 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 66.6 m-85 -111.82 -169.97 1.56 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -157.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 19.9 pttm -156.09 159.95 39.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 120.956 0.408 . . . . 0.0 110.2 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.752 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 21.0 p-10 -84.52 -140.56 0.07 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.858 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.04 -44.65 19.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.784 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.78 -14.13 18.15 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.938 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.17 26.66 1.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.077 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.515 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 47.9 t -77.29 125.56 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' TYR . . . . . 0.488 ' OH ' HD12 ' C' ' 12' ' ' LEU . 76.9 t80 -73.69 142.67 46.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.93 0.871 . . . . 0.0 110.779 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.08 138.99 40.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.802 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.417 ' HA ' HD13 ' C' ' 12' ' ' LEU . 7.5 m -88.86 134.91 33.79 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.203 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.67 121.53 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.275 0.56 . . . . 0.0 110.324 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.8 mp -107.5 97.35 19.25 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.437 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 19.4 Cg_exo -68.98 118.77 5.88 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.57 2.18 . . . . 0.0 111.817 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mt -82.08 100.89 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 0.1 OUTLIER -68.86 -53.07 23.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.217 179.016 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.88 166.49 19.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.732 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.49 146.51 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.947 0.403 . . . . 0.0 110.178 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.7 tmtp? -130.28 115.67 17.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.292 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -85.24 117.44 24.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.49 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.38 146.76 26.84 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.215 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -60.53 -17.65 47.09 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.874 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.83 -13.55 55.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.525 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 -35.23 4.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.76 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 68.5 p -62.54 140.86 58.64 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.094 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.41 123.9 48.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -91.42 114.85 27.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -99.3 111.36 23.75 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 38.4 mt-10 -73.71 102.52 3.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.531 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.06 153.98 17.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 110.161 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -119.44 127.35 53.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.04 -128.2 7.12 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.161 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.37 9.35 3.45 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.748 2.299 . . . . 0.0 112.562 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.438 ' CE2' ' HG ' ' C' ' 24' ' ' LEU . 86.0 m-85 -135.06 145.35 47.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.381 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.82 -164.37 1.13 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.508 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 5.9 p-10 -84.86 144.6 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.154 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -149.03 141.16 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.527 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -88.35 139.24 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.6 tpt -122.62 146.66 47.25 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.0 135.36 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.684 0.615 . . . . 0.0 111.576 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.39 -38.25 90.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.363 -172.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -61.76 -34.97 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.545 0.688 . . . . 0.0 109.639 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 7.2 m -73.06 -42.04 63.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.4 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 54.1 t -68.25 -22.94 27.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.429 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.27 82.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.792 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.06 -33.2 4.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.451 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.94 20.09 18.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.799 -170.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 40.0 tttm -50.98 124.28 20.54 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.474 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 50.0 Cg_endo -99.89 -153.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.527 2.818 . . . . 0.0 111.429 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -149.85 164.63 34.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.664 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.16 128.53 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.96 0.886 . . . . 0.0 109.609 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.08 49.65 Favored Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.18 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -166.08 37.4 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.123 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -124.32 126.83 46.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.329 0.585 . . . . 0.0 111.476 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 34.7 tp -97.28 155.05 17.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.9 p90 -147.65 160.97 42.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.234 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -139.17 130.53 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.705 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 96.7 p -99.78 170.0 8.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.268 0.556 . . . . 0.0 110.241 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 11.2 mm100 -69.94 -9.1 53.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.069 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -90.38 -0.8 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.151 0.5 . . . . 0.0 109.985 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 17.62 64.5 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.765 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.431 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 21.0 mm-40 -92.09 122.16 34.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.947 0.403 . . . . 0.0 110.574 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.38 130.88 43.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.941 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 73.3 mt -151.43 157.85 42.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.994 -174.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -96.25 131.07 43.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.221 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.458 ' HA ' ' CE ' ' C' ' 77' ' ' MET . 0.9 OUTLIER -143.04 140.23 30.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 110.693 178.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -69.33 158.4 35.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.744 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' C' ' 80' ' ' THR . 1.5 ptmt -55.42 -32.43 62.68 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -168.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 5.7 p -55.33 -58.94 5.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.437 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.66 74.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.805 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.16 -44.07 92.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.54 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 24.3 tt0 -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.94 -27.85 63.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.848 -167.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 86.4 m-20 -105.58 -30.7 9.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.466 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -142.79 70.66 1.33 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 80.5 p -166.54 -35.43 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.825 0.85 . . . . 0.0 109.067 169.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -64.33 171.07 3.32 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.678 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.34 42.62 5.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.232 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.0 p -69.78 -18.13 63.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.113 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.33 26.64 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 11.9 t -114.37 -9.35 12.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.075 0.464 . . . . 0.0 110.541 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.613 ' HB ' ' OD1' ' C' ' 95' ' ' ASN . 18.4 t 63.99 3.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.52 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 94' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' C' ' 97' ' ' GLU . . . 62.06 31.41 17.89 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ASN . . . . . 0.613 ' OD1' ' HB ' ' C' ' 93' ' ' VAL . 15.8 m120 -62.19 -58.11 8.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.412 -177.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.52 9.59 40.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.375 0.607 . . . . 0.0 109.963 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' C' ' 94' ' ' ALA . 8.9 mp0 -97.4 -56.55 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.541 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' THR . . . . . 0.441 HG22 HG22 ' C' ' 107' ' ' THR . 48.1 p -97.86 -15.98 19.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.268 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.31 -168.83 0.21 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.414 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -83.02 -28.9 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 110.962 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' LYS . . . . . 0.476 ' HG3' ' H ' ' C' ' 103' ' ' SER . 1.1 ptpm? -80.88 -11.88 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.213 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 72.3 mt 58.01 25.89 12.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.926 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' SER . . . . . 0.476 ' H ' ' HG3' ' C' ' 101' ' ' LYS . 49.1 m -151.77 79.53 1.27 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.784 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -160.19 140.95 12.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.771 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 58.83 -99.31 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.887 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' C' ' 106' ' ' ARG . 14.3 mmt85 -104.34 21.63 16.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -172.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.441 HG22 HG22 ' C' ' 98' ' ' THR . 7.4 p -69.78 -68.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.35 0.595 . . . . 0.0 111.009 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 108' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' C' ' 110' ' ' LEU . 5.5 mt -107.34 5.93 9.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 65.2 p 61.52 -28.05 0.06 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.295 1.438 . . . . 0.0 113.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' C' ' 108' ' ' ILE . 4.2 mm? -121.41 77.76 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.06 34.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.233 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.72 19.61 67.71 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.42 165.03 37.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.021 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.438 HG12 ' H ' ' C' ' 116' ' ' GLY . 67.3 t -93.59 127.6 45.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.3 p -64.32 -26.7 68.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.438 ' H ' HG12 ' C' ' 114' ' ' VAL . . . -68.19 -81.66 0.18 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.983 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 15.6 p -84.2 2.89 37.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 67.85 4.79 4.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.214 0.605 . . . . 0.0 111.107 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.8 p 47.42 38.33 7.42 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.081 0.952 . . . . 0.0 112.968 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.86 -4.64 36.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.335 0.588 . . . . 0.0 110.215 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -98.69 54.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.668 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.32 126.79 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.179 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 18.6 t 72.74 -32.88 0.25 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.732 0.813 . . . . 0.0 112.039 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.67 -28.01 60.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 111.059 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -132.68 133.95 44.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.815 0.341 . . . . 0.0 110.813 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.27 119.54 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.666 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 24.7 p -86.49 -94.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.363 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.06 -56.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 110.481 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' C' ' 129' ' ' GLU . 0.3 OUTLIER -100.03 40.83 1.21 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.795 -172.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 3.0 p -68.07 -73.77 0.14 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.47 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -122.28 16.81 10.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.399 0.618 . . . . 0.0 110.451 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 28.8 m -128.62 23.3 5.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -154.19 43.86 0.59 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.567 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.708 -179.032 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.571 0.224 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.12 -51.59 2.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.468 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -136.11 76.35 51.65 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.546 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.26 -24.97 26.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 113.312 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -75.91 -51.26 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.55 143.24 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -91.57 112.59 55.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.804 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.96 110.28 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.4 m -68.82 -35.63 77.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.317 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -81.68 130.47 61.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.839 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.87 105.38 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.192 1.928 . . . . 0.0 111.479 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.454 HD12 ' OH ' ' C' ' 20' ' ' TYR . 93.1 mt -70.13 147.11 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' C' ' 86' ' ' TYR . 82.0 m-85 -111.13 -167.63 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -164.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 0.0 OUTLIER -158.7 164.37 35.98 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.998 0.428 . . . . 0.0 110.03 -167.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.588 ' OD2' ' HB ' ' C' ' 19' ' ' VAL . 2.4 p30 -103.07 -139.21 0.35 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.079 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -60.39 3.48 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -161.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.25 -4.98 50.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.283 0.563 . . . . 0.0 109.808 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.87 27.92 4.41 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.767 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.588 ' HB ' ' OD2' ' C' ' 15' ' ' ASP . 62.8 t -64.73 127.57 25.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' TYR . . . . . 0.454 ' OH ' HD12 ' C' ' 12' ' ' LEU . 50.8 t80 -81.93 134.99 35.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.032 0.92 . . . . 0.0 111.091 -172.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.75 131.87 4.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.65 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -90.71 152.05 20.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.654 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.406 ' HB2' ' HE2' ' C' ' 86' ' ' TYR . . . -106.04 116.28 31.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.356 0.598 . . . . 0.0 109.696 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.67 ' O ' ' HB3' ' C' ' 66' ' ' LEU . 16.8 mt -118.2 98.92 51.74 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.213 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.571 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -66.25 152.05 82.0 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 121.655 1.57 . . . . 0.0 111.267 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mt -82.7 98.04 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.672 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -86.12 -60.79 1.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.514 -163.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' C' ' 39' ' ' ALA . . . -154.56 154.53 33.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.366 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 73.7 mt -140.79 143.05 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.472 0.653 . . . . 0.0 110.558 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -135.84 124.76 24.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.263 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -85.37 118.72 25.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 110.009 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.402 ' HB2' HD21 ' C' ' 38' ' ' ASN . . . -86.81 -163.62 0.94 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.558 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.297 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -97.8 17.24 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.09 87.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.705 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 18.2 p -72.92 138.59 46.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.863 0.363 . . . . 0.0 110.371 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -100.28 113.97 27.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 15.5 m-80 -90.07 108.26 19.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.722 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 28' ' ' ALA . . . -87.73 89.11 7.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.149 0.499 . . . . 0.0 111.233 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 38.1 mt-10 -76.55 106.47 8.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.747 -174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' PHE . . . . . 0.598 ' CG ' ' HB2' ' C' ' 45' ' ' TYR . 1.6 m-85 -59.33 138.61 57.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.549 0.69 . . . . 0.0 112.164 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.22 -33.52 16.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.619 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.12 179.48 35.48 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.775 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 56.85 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.007 2.472 . . . . 0.0 113.103 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.598 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 89.9 m-85 -131.6 -177.95 4.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.046 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.7 -179.0 6.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.224 0.535 . . . . 0.0 111.533 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -111.48 127.38 55.68 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.84 124.77 40.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.584 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -87.21 112.11 21.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' MET . . . . . 0.418 ' CG ' ' HB3' ' C' ' 37' ' ' ALA . 22.4 ptp -110.37 129.52 55.74 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.759 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' SER . . . . . 0.461 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.6 OUTLIER -62.35 159.42 15.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.057 -176.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.46 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' C' ' 53' ' ' GLN . 0.2 OUTLIER -58.26 -40.14 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 109.144 173.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -72.96 -40.12 65.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 79.4 t -67.56 -22.45 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.283 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.7 74.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.08 -31.44 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.487 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -113.17 19.8 16.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 52.1 tttm -48.7 107.45 0.76 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.495 0.497 . . . . 0.0 111.526 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 85.9 Cg_endo -106.03 -154.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 123.809 3.006 . . . . 0.0 111.83 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.51 153.81 45.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.687 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.47 125.0 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.926 0.87 . . . . 0.0 109.753 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.31 -10.35 28.73 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.434 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.45 -158.24 27.95 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.042 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.35 156.95 34.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.915 0.388 . . . . 0.0 111.133 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.67 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 23.5 tp -147.08 154.03 40.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.12 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -151.5 163.6 38.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -143.33 132.9 23.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 31.2 p -102.55 178.28 4.62 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.442 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -55.28 -33.71 63.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.896 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' C' ' 73' ' ' GLU . 44.7 m-85 -72.52 -5.77 39.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.3 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.38 1.93 83.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.378 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' C' ' 71' ' ' TYR . 9.4 pt-20 -91.11 140.33 29.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.269 0.557 . . . . 0.0 110.478 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.471 HD23 ' N ' ' C' ' 74' ' ' LEU . 0.6 OUTLIER -131.13 155.34 47.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.895 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.553 ' O ' HD12 ' C' ' 66' ' ' LEU . 71.6 mt -148.44 157.27 43.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -91.7 138.06 31.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.019 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.531 ' HB2' ' HB3' ' C' ' 81' ' ' ALA . 0.4 OUTLIER -162.24 -179.81 7.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.196 0.522 . . . . 0.0 111.619 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.5 p -122.49 -174.91 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.068 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' C' ' 82' ' ' PHE . 18.5 ptpt -57.04 -28.5 62.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 8.6 p -54.27 -54.96 33.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' C' ' 77' ' ' MET . . . -74.21 -33.23 63.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.9 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.62 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 2.6 t80 -50.13 -49.59 51.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.309 0.576 . . . . 0.0 109.504 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.792 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 10.8 tp10 -60.85 -45.15 95.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.187 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.6 -26.02 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' C' ' 15' ' ' ASP . 5.2 m-20 -91.77 -27.39 18.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.63 ' O ' HG23 ' C' ' 87' ' ' THR . 0.2 OUTLIER -167.88 78.54 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.792 ' OG1' ' HA ' ' C' ' 83' ' ' GLU . 6.6 p -164.85 -28.55 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.142 0.977 . . . . 0.0 109.52 162.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 8.6 t -67.19 -179.32 0.96 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.867 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.12 1.76 3.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.788 0.835 . . . . 0.0 112.454 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.505 ' HB2' HG23 ' C' ' 93' ' ' VAL . 15.1 m 65.07 167.78 0.18 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.873 0.844 . . . . 0.0 113.154 172.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.3 -65.21 1.89 Allowed Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.251 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -104.86 87.66 2.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.552 0.692 . . . . 0.0 112.084 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' C' ' 90' ' ' SER . 87.3 t -126.65 -54.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.131 171.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.99 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.039 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ASN . . . . . 0.413 ' OD1' ' HG3' ' C' ' 14' ' ' LYS . 8.7 p30 -61.09 -12.95 13.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.05 9.39 7.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.692 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.43 -35.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.138 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 79.3 p -88.76 -64.59 1.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 46.91 45.94 15.43 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.964 0.79 . . . . 0.0 112.431 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -107.54 -67.13 0.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.933 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -113.28 -69.45 0.86 Allowed 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.835 -0.54 . . . . 0.0 109.914 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' C' ' 110' ' ' LEU . 7.0 mp 54.59 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.198 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 1.6 p -136.9 16.61 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 60.3 p -79.6 39.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.82 -89.24 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.61 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -140.98 -2.78 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.529 0.681 . . . . 0.0 109.412 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 12.5 p -86.62 159.21 19.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.507 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 35.8 mm -132.16 -51.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.637 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 19.1 p -82.37 26.42 0.55 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' C' ' 102' ' ' LEU . 60.9 mt -102.76 18.21 21.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.185 0.517 . . . . 0.0 110.433 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 11.6 p -85.12 36.8 0.64 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.377 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.62 -56.45 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.334 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.64 155.32 41.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.608 0.242 . . . . 0.0 110.477 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.74 94.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.868 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.9 p -56.96 -40.67 76.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.149 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.69 -17.13 62.2 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.891 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 41.2 t -103.84 -42.62 5.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.131 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.28 -23.14 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.614 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -57.39 -33.22 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.701 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.09 -55.49 3.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.178 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -152.97 -51.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.04 -172.63 27.03 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.445 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 22.3 t -157.02 138.91 14.33 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.3 77.85 9.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.149 0.499 . . . . 0.0 110.26 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.92 137.78 36.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.679 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 25.4 t -94.03 94.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.81 49.88 1.7 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.091 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 59.5 mt 64.76 -78.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.586 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 38.04 52.25 1.53 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.654 0.597 . . . . 0.0 112.058 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 48.6 p 50.16 27.48 2.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -126.99 133.54 50.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.824 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 48.4 m -149.75 31.37 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.286 0.565 . . . . 0.0 109.776 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.8 -63.67 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.458 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.486 179.374 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.59 -48.03 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.42 ' HB2' ' HD3' ' C' ' 4' ' ' PRO . 53.2 m-80 -62.2 -54.13 52.41 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.37 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' C' ' 3' ' ' ASN . 96.8 Cg_endo -77.48 26.74 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.749 1.633 . . . . 0.0 112.439 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -134.87 -60.0 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.127 0.489 . . . . 0.0 110.042 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -97.64 178.85 5.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.514 ' OG1' ' HD3' ' C' ' 8' ' ' PRO . 0.0 OUTLIER -81.24 -54.02 0.73 Allowed Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 177.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.514 ' HD3' ' OG1' ' C' ' 7' ' ' THR . 6.0 Cg_exo -75.29 156.22 41.68 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 111.635 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -65.74 -35.4 80.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.486 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -96.22 121.06 61.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.528 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.608 ' HB2' ' CZ ' ' C' ' 82' ' ' PHE . 68.6 Cg_endo -76.87 101.89 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.152 1.902 . . . . 0.0 111.406 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' C' ' 22' ' ' SER . 23.1 mt -86.81 155.15 20.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -172.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' C' ' 82' ' ' PHE . 2.8 m-85 -91.7 136.96 32.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.236 -174.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.501 ' H ' ' HB3' ' C' ' 86' ' ' TYR . 93.2 mttt -116.02 105.89 13.14 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.005 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -72.44 -166.26 0.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.505 -171.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.7 -50.64 72.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -170.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.36 -6.53 14.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.16 14.07 3.42 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.602 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 97.8 t -74.23 103.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' TYR . . . . . 0.448 ' OH ' ' HE2' ' C' ' 14' ' ' LYS . 1.2 m-85 -76.7 151.68 36.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.496 1.141 . . . . 0.0 112.261 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -148.8 120.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.81 -1.995 . . . . 0.0 108.952 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.454 ' HA ' HD22 ' C' ' 12' ' ' LEU . 23.0 t -78.04 148.86 34.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.114 -177.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.57 117.87 35.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.828 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.487 ' HB2' HD13 ' C' ' 66' ' ' LEU . 2.1 mm? -99.78 114.43 65.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.666 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.32 125.97 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 55.8 mt -80.35 96.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -67.22 -45.99 75.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.137 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' C' ' 62' ' ' VAL . . . -157.25 159.49 37.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 0.0 111.988 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.5 mt -145.71 145.58 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.982 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -131.42 132.03 44.04 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -94.3 136.0 35.09 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.916 -172.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.2 131.38 56.48 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.993 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -60.34 -19.85 57.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.329 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.81 -21.74 61.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.803 0.335 . . . . 0.0 110.78 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.98 -26.35 4.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.246 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 10.1 m -72.67 161.51 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.989 0.423 . . . . 0.0 110.883 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -141.07 122.53 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 9.0 t-20 -77.26 128.92 35.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -115.17 147.95 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.211 0.529 . . . . 0.0 112.179 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.03 110.35 11.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.859 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -102.3 156.47 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.33 132.49 33.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.72 -178.93 19.54 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.252 -174.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.77 58.31 6.91 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.883 2.389 . . . . 0.0 111.857 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -122.19 -176.51 3.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.6 50.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.734 0.778 . . . . 0.0 112.908 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.0 p-10 -132.78 79.91 1.87 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -152.62 169.16 23.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.205 -164.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 50.3 p90 -92.55 138.28 31.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.054 0.454 . . . . 0.0 110.747 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.3 mmt -103.64 140.75 37.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.234 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' SER . . . . . 0.45 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 1.3 p -61.08 154.61 22.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.422 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -30.19 71.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' GLN . . . . . 0.45 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 23.4 mp0 -58.45 -44.77 89.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.756 0.789 . . . . 0.0 109.057 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -67.89 -43.6 78.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.949 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.2 t -65.63 -27.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.585 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -29.91 69.34 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.298 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.72 -34.11 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.51 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.14 24.53 11.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 0.0 OUTLIER -46.08 117.86 4.19 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 121.299 0.571 . . . . 0.0 111.36 175.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 83.6 Cg_endo -106.37 -156.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 123.403 2.735 . . . . 0.0 111.876 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.437 ' HB2' ' CZ ' ' C' ' 76' ' ' TYR . 48.1 mt-10 -149.18 142.65 25.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.05 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' C' ' 28' ' ' ALA . 5.2 p -78.27 111.63 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.834 0.826 . . . . 0.0 109.977 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.96 -18.68 7.47 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.74 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.8 -155.11 31.47 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.402 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -131.8 142.55 49.77 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' C' ' 24' ' ' LEU . 0.0 OUTLIER -118.84 134.88 54.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 44.0 p90 -109.56 158.04 18.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.758 -172.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -134.32 129.51 35.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' SER . . . . . 0.476 ' HA ' ' HB ' ' C' ' 21' ' ' VAL . 40.5 p -95.35 178.0 5.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.002 0.43 . . . . 0.0 111.001 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.34 -9.49 58.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.991 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -85.04 -6.34 59.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.09 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.52 12.07 78.85 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.53 127.15 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.07 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.3 pt? -130.53 140.27 50.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.074 0.464 . . . . 0.0 110.843 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.511 HD22 ' C ' ' C' ' 74' ' ' LEU . 2.1 mm? -148.22 160.81 42.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.405 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 61' ' ' GLU . 71.7 t80 -92.52 141.57 28.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' C' ' 81' ' ' ALA . 40.6 tpp -155.86 147.38 22.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 111.134 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' C' ' 77' ' ' MET . 20.3 p -89.71 158.34 17.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 13.6 ptmm? -66.91 -13.01 61.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 11.3 p -60.38 -61.83 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.511 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' ALA . . . . . 0.482 ' HB3' ' SD ' ' C' ' 77' ' ' MET . . . -69.83 -38.01 76.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.694 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' C' ' 11' ' ' PRO . 0.2 OUTLIER -50.8 -52.92 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.265 177.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.98 -36.52 64.54 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.16 25.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.786 -169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.09 -29.15 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.303 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.501 ' HB3' ' H ' ' C' ' 14' ' ' LYS . 23.0 m-85 -103.08 -73.01 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.748 -173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 68.8 p -84.22 -9.36 58.59 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -167.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -63.91 -48.53 76.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.643 0.259 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.26 -76.65 0.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.454 -176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.4 t 57.28 35.43 26.1 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.905 0.859 . . . . 0.0 109.508 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.84 -81.12 0.43 Allowed Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.428 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' SER . . . . . 0.441 ' HB2' ' HA ' ' C' ' 95' ' ' ASN . 58.6 m -148.69 6.66 0.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.354 0.262 . . . . 0.0 110.562 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 50.4 t 63.21 -79.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 123.734 0.646 . . . . 0.0 111.376 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.36 -14.05 27.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.21 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' C' ' 92' ' ' SER . 48.8 m-80 74.95 -43.57 0.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.948 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.02 33.87 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.835 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' C' ' 95' ' ' ASN . 29.7 mm-40 -100.28 -49.55 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 10.9 t -74.65 -17.64 60.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.678 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.72 48.67 2.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.674 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.84 -24.18 48.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.121 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' LYS . . . . . 0.632 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 83.2 tttt -73.04 -13.52 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 110.851 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.95 -31.04 72.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -92.33 -28.35 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.545 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' THR . . . . . 0.632 ' OG1' ' HA ' ' C' ' 101' ' ' LYS . 42.2 p -85.32 -28.26 25.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.14 -31.75 11.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -98.94 -63.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.644 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 33.9 p -84.61 -54.79 4.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 70.0 mt 75.79 -31.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 12.8 p -76.94 2.0 16.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.63 -57.24 0.78 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.676 0.274 . . . . 0.0 110.522 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 23.7 p 50.46 -101.0 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.891 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.9 34.39 1.23 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.8 -73.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 40.1 t -136.72 133.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -78.28 56.15 1.65 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 111.97 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.59 -62.05 0.33 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.772 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -81.27 4.4 20.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.637 0.256 . . . . 0.0 111.502 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.92 -8.37 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.086 0.469 . . . . 0.0 110.08 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.9 t -67.83 103.69 1.51 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.628 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 67.94 -74.89 0.07 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-O 121.098 0.475 . . . . 0.0 110.609 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -163.66 -25.34 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.664 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.51 -165.84 29.12 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 10.7 t -164.65 -29.27 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.102 0.477 . . . . 0.0 110.211 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.44 -6.46 46.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.298 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -85.64 -17.64 35.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.575 HG12 ' H ' ' C' ' 128' ' ' ILE . 16.2 t -80.96 138.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 2.2 p -75.18 -2.13 26.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' ILE . . . . . 0.575 ' H ' HG12 ' C' ' 126' ' ' VAL . 10.3 mt 55.45 33.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.703 0.763 . . . . 0.0 110.95 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -97.31 159.2 15.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.825 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 7.3 p -71.41 108.09 4.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.635 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -78.26 56.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.435 0.636 . . . . 0.0 111.301 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 18.0 p -146.17 -56.62 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.459 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 152.23 -19.29 0.83 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.519 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.381 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.806 0.336 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.91 43.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.333 0.587 . . . . 0.0 110.164 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -143.86 115.37 5.59 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.749 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.89 4.07 2.46 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.913 2.409 . . . . 0.0 113.029 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 56.7 32.9 21.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.401 0.68 . . . . 0.0 111.549 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -70.28 -25.34 63.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.472 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -155.1 78.96 4.67 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.596 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.43 -16.12 38.77 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.59 2.194 . . . . 0.0 112.448 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -105.99 68.81 0.79 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -62.46 130.02 93.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.441 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.41 101.47 1.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.073 1.849 . . . . 0.0 111.296 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 mt -121.96 143.06 49.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.83 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' C' ' 86' ' ' TYR . 79.8 m-85 -145.63 -161.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.144 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' C' ' 89' ' ' ALA . 2.0 mptp? -146.34 145.59 30.37 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.258 0.552 . . . . 0.0 109.916 -168.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.614 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -87.67 -165.08 1.21 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.536 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' C' ' 90' ' ' SER . . . -65.36 -52.25 54.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.31 -6.96 22.5 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -170.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.432 ' HA2' ' OG ' ' C' ' 90' ' ' SER . . . 126.37 26.18 1.22 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.385 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.614 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.3 t -83.54 117.56 29.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.038 0.446 . . . . 0.0 110.173 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -87.69 132.84 33.97 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 109.574 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.4 OUTLIER -150.74 139.36 14.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.876 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -105.23 163.89 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.596 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.433 ' HB1' ' CD2' ' C' ' 65' ' ' TYR . . . -108.66 117.29 33.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.125 0.488 . . . . 0.0 110.335 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.472 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.4 mp -107.37 115.26 59.89 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.922 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.427 ' HB2' ' HB3' ' C' ' 42' ' ' ASP . 3.0 Cg_exo -72.22 138.4 30.42 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.744 1.63 . . . . 0.0 112.206 -173.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.56 117.42 37.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.935 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -79.03 -60.79 2.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.996 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 151.27 9.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.816 0.341 . . . . 0.0 111.131 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 54.9 mt -132.11 140.87 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.912 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.3 114.48 16.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -65.56 104.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.584 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.84 170.99 15.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.606 0.717 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -69.75 -14.08 62.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.06 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.18 -18.4 21.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.475 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.93 -37.25 2.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.103 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -60.08 146.49 42.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.434 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -112.73 120.51 41.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 19.0 m120 -71.77 117.43 13.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.836 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -106.47 107.86 19.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 0.0 112.104 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' C' ' 47' ' ' ASP . 43.6 mt-10 -89.45 114.37 25.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.054 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -99.43 148.1 24.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.871 0.367 . . . . 0.0 110.302 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 25' ' ' PRO . 21.3 t70 -83.22 125.85 32.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 0.0 109.929 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.63 17.65 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.201 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.95 59.37 6.89 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.551 2.168 . . . . 0.0 112.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.56 -175.76 3.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.432 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.01 152.9 43.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.562 -176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.703 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 8.3 p-10 -149.7 92.01 1.87 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 168.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.629 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 46.3 mt-30 -149.44 174.7 12.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 -164.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.93 112.65 9.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.9 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 51.6 tpp -91.2 129.78 37.15 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.03 135.35 31.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.337 0.589 . . . . 0.0 111.554 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.47 95.65 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.547 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -63.75 -31.49 72.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.405 0.622 . . . . 0.0 109.903 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 19.3 m -74.11 -40.93 62.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.679 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' C' ' 37' ' ' ALA . 77.7 t -70.53 -20.78 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.423 0.63 . . . . 0.0 110.308 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.46 73.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.87 -28.0 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.677 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -106.16 15.03 26.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.209 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 55.1 pttt -51.44 114.97 5.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.5 Cg_endo -102.99 -151.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.85 3.034 . . . . 0.0 111.123 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -138.23 143.03 39.93 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -80.1 119.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.279 1.038 . . . . 0.0 109.827 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.19 20.27 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.811 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 -155.09 30.06 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.577 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' TYR . . . . . 0.433 ' CD2' ' HB1' ' C' ' 23' ' ' ALA . 50.7 m-85 -122.23 146.82 46.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.291 0.567 . . . . 0.0 112.017 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.23 136.33 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 54.5 p90 -121.77 159.53 26.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.574 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -134.85 128.09 32.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.46 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 94.6 p -103.39 -170.19 1.75 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.221 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -65.17 -45.99 82.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.434 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.09 18.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.22 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.97 34.05 70.63 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.322 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 32.3 mt-10 -89.7 123.88 34.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.4 pt? -130.71 132.38 45.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.046 0.451 . . . . 0.0 110.169 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.5 mt -153.44 -171.14 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.721 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.77 135.54 33.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.425 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 4.9 ttp -103.76 118.04 35.78 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 111.545 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 19.1 p -106.31 -169.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -76.87 -30.87 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.491 1.041 . . . . 0.0 111.026 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.0 p -60.73 -31.58 70.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.741 0.782 . . . . 0.0 109.885 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.67 33.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.129 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' C' ' 86' ' ' TYR . 62.8 t80 -56.56 -40.61 75.48 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.356 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.53 -49.51 66.24 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.895 -0.503 . . . . 0.0 111.655 174.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.28 77.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.861 0.362 . . . . 0.0 110.952 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.458 ' HB3' HG11 ' C' ' 21' ' ' VAL . 91.0 m-20 -105.12 -24.68 12.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.833 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.528 ' HA ' ' HB2' ' C' ' 13' ' ' TYR . 6.7 m-85 -120.92 33.39 5.58 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 47.4 p -154.87 -40.5 0.09 Allowed 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.066 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' C' ' 16' ' ' ALA . 7.9 t -46.62 -38.51 9.73 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.901 0.751 . . . . 0.0 112.32 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ALA . . . . . 0.515 ' HA ' ' HB2' ' C' ' 14' ' ' LYS . . . 63.63 22.09 12.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.062 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' C' ' 16' ' ' ALA . 44.5 m 70.32 122.16 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 O-C-N 124.023 0.827 . . . . 0.0 112.07 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.87 -9.33 74.52 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' C' ' 95' ' ' ASN . 12.6 m -92.67 51.39 1.72 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.401 0.62 . . . . 0.0 110.701 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.88 -63.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.926 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.94 2.4 16.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.935 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' C' ' 92' ' ' SER . 9.2 p30 -154.22 160.28 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 67.02 17.02 10.45 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.021 0.825 . . . . 0.0 111.186 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.98 -25.39 27.79 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -68.05 -22.81 64.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.016 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' C' ' 102' ' ' LEU . . . 69.6 124.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.931 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.96 -12.44 60.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.268 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -79.8 0.61 30.12 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.376 0.608 . . . . 0.0 110.721 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' C' ' 127' ' ' THR . 3.7 mm? -72.25 114.53 10.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 103' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' C' ' 124' ' ' ALA . 22.1 m 78.94 23.91 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.294 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 82.6 p -88.09 -15.3 36.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.318 0.58 . . . . 0.0 110.247 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.56 -157.44 0.27 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.295 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' C' ' 110' ' ' LEU . 99.7 mtt180 -71.28 75.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.535 0.683 . . . . 0.0 110.143 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -106.41 -58.96 1.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.726 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 60.7 mt -148.81 -58.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.189 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 7.0 p -64.89 -60.39 3.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.004 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' C' ' 106' ' ' ARG . 82.3 mt -85.26 118.89 25.08 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -101.24 -31.29 11.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.75 -79.19 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.292 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.54 144.8 26.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' C' ' 117' ' ' SER . 41.0 t -65.49 144.75 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -70.35 62.27 0.23 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.72 -56.41 0.21 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' SER . . . . . 0.645 ' O ' ' HB ' ' C' ' 114' ' ' VAL . 27.6 t -144.97 137.73 26.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -85.29 43.89 1.05 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 110.168 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 24.3 t -92.11 -27.43 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.181 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 59.76 52.16 5.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.494 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.91 -14.03 58.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.711 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.03 -46.52 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.191 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 32.1 t 66.41 13.8 9.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.071 0.548 . . . . 0.0 111.451 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' C' ' 103' ' ' SER . . . -113.67 87.78 2.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.887 0.375 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -101.97 129.63 48.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.803 0.335 . . . . 0.0 110.596 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' C' ' 130' ' ' THR . 98.0 t 70.61 -64.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.824 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 127' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' C' ' 102' ' ' LEU . 40.9 p 48.36 -105.13 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.097 0.559 . . . . 0.0 111.284 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 46.8 mt -139.15 -52.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -90.87 11.83 21.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.569 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' C' ' 126' ' ' VAL . 33.6 p 53.37 -89.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.134 0.974 . . . . 0.0 112.004 -174.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -85.66 -73.44 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.998 0.428 . . . . 0.0 110.319 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 60.7 m -161.82 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.96 34.31 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.112 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.457 -179.501 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.64 0.257 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.01 38.38 17.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.405 ' HA ' ' HD3' ' C' ' 4' ' ' PRO . 85.0 m-20 -126.37 118.8 23.23 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 3' ' ' ASN . 35.1 Cg_exo -61.28 -19.07 62.34 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.102 2.534 . . . . 0.0 112.713 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.421 ' ND2' ' HE2' ' C' ' 14' ' ' LYS . 5.8 m-20 -77.67 -26.59 50.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.992 0.425 . . . . 0.0 110.706 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 6' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' C' ' 8' ' ' PRO . 60.9 m-85 -94.97 -15.81 23.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.146 0.498 . . . . 0.0 110.041 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -122.22 71.55 34.54 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.845 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' C' ' 6' ' ' PHE . 11.8 Cg_endo -90.23 107.99 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.134 2.556 . . . . 0.0 112.57 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -64.34 -41.15 96.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.2 0.524 . . . . 0.0 109.899 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.69 133.27 42.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.536 ' O ' HD22 ' C' ' 12' ' ' LEU . 74.0 Cg_endo -76.76 99.75 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.511 1.474 . . . . 0.0 111.885 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.536 HD22 ' O ' ' C' ' 11' ' ' PRO . 3.4 mm? -137.23 132.85 34.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.271 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.692 ' HB2' HG13 ' C' ' 21' ' ' VAL . 48.4 m-85 -93.19 141.65 28.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.421 ' HE2' ' ND2' ' C' ' 5' ' ' ASN . 28.3 mtpp -133.85 123.34 24.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.583 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -90.64 -164.64 1.2 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.511 -177.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.472 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -63.07 -49.72 73.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -172.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.5 -4.2 17.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.589 -0.445 . . . . 0.0 112.107 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.01 18.25 2.38 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.771 -1.204 . . . . 0.0 113.575 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.583 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.7 t -73.74 133.88 30.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.09 160.86 30.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.684 0.754 . . . . 0.0 110.995 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.79 137.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.185 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 31.4 m -78.88 151.22 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.54 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.54 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . . . -119.42 128.44 54.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.758 0.314 . . . . 0.0 110.497 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.506 HD12 HD23 ' C' ' 66' ' ' LEU . 1.5 mt -105.35 105.68 53.11 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' C' ' 42' ' ' ASP . 13.9 Cg_exo -67.65 115.25 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.101 1.867 . . . . 0.0 111.395 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 27.9 mt -78.8 111.97 16.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.237 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.415 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 53.1 tttm -85.94 -63.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.04 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.32 158.39 32.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 70.0 mt -115.51 132.78 63.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.865 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 6.0 mmpt? -91.98 94.61 9.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.029 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -84.06 112.78 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.114 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.79 135.63 33.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -58.29 -19.89 38.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.491 -172.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.8 -20.25 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.714 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.11 -45.12 1.16 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.761 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' C' ' 50' ' ' MET . 2.3 m -60.71 158.48 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.034 0.445 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -145.47 179.09 7.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.618 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 0.2 OUTLIER -162.06 127.73 3.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 173.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -92.05 129.52 37.99 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.508 -172.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -90.9 130.2 36.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.44 146.7 35.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' C' ' 25' ' ' PRO . 44.6 m-20 -78.37 88.83 4.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.132 0.492 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.3 -148.42 17.65 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.063 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.75 26.09 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.41 2.74 . . . . 0.0 112.454 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -129.59 120.09 24.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.2 -161.02 0.6 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.668 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 7.6 p-10 -76.08 126.74 31.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.11 171.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.79 104.93 3.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.618 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 9.4 m-85 -154.91 -166.45 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 50' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' C' ' 36' ' ' SER . 44.3 tpp -159.21 -67.11 0.08 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.624 0.647 . . . . 0.0 112.427 -171.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' SER . . . . . 0.414 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.3 OUTLIER -104.09 134.13 47.87 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.29 0.567 . . . . 0.0 111.455 -175.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.53 92.31 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.584 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -65.98 -31.05 71.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.562 0.696 . . . . 0.0 109.823 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.6 m -75.24 -38.01 60.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.577 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 74.8 t -70.21 -22.15 24.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.178 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.72 80.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.21 -29.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.861 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.53 9.63 31.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.96 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 87.1 tttt -70.95 113.43 18.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.764 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -101.06 -146.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.876 3.051 . . . . 0.0 111.828 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.0 131.61 45.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.068 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.13 121.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 122.232 1.015 . . . . 0.0 109.915 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.26 -23.02 9.35 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.484 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.34 36.37 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.227 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -125.51 130.76 52.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.764 0.316 . . . . 0.0 111.436 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.506 HD23 HD12 ' C' ' 24' ' ' LEU . 8.6 tp -87.42 172.54 9.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' C' ' 22' ' ' SER . 27.4 p90 -158.43 158.14 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.462 0.573 . . . . 0.0 110.902 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 60.9 ttt180 -148.9 114.83 5.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 77.3 p -95.37 175.88 6.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.459 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.19 -8.48 56.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.813 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -90.12 -7.11 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.076 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.84 14.31 56.69 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.848 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 31.5 mt-10 -78.09 121.58 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 33.3 tp -131.36 87.0 2.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 96.5 mt -134.5 -173.98 3.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.206 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.82 153.74 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.517 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.426 ' HE3' ' HA ' ' C' ' 81' ' ' ALA . 54.6 mtm -145.15 160.9 40.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 0.0 110.675 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 18.4 p -110.75 -87.32 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.242 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -77.94 -31.38 50.93 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.287 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 3.9 p -65.67 -18.3 65.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.219 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' ALA . . . . . 0.426 ' HA ' ' HE3' ' C' ' 77' ' ' MET . . . -70.4 -50.1 42.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.787 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.28 -47.93 80.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.315 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.565 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 34.3 tt0 -60.2 -20.2 57.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.702 0.286 . . . . 0.0 111.67 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' ALA . . . . . 0.448 ' HA ' ' CA ' ' C' ' 88' ' ' SER . . . -93.39 -19.66 21.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' C' ' 13' ' ' TYR . 1.1 m-80 -68.85 -17.41 63.99 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.774 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.565 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 4.3 p90 -132.01 -12.01 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.507 HG23 ' CD2' ' C' ' 86' ' ' TYR . 39.5 p -147.08 -51.7 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 118.563 -1.255 . . . . 0.0 113.718 -172.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.448 ' CA ' ' HA ' ' C' ' 84' ' ' ALA . 28.2 m 72.78 -35.51 0.33 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.213 1.005 . . . . 0.0 111.581 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' C' ' 87' ' ' THR . . . -126.07 -67.12 0.89 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.407 ' HB2' HG22 ' C' ' 93' ' ' VAL . 66.5 m -164.16 -179.98 6.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -77.59 1.23 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.763 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' SER . . . . . 0.413 ' HB3' ' OD1' ' C' ' 95' ' ' ASN . 49.2 m -71.28 -37.43 71.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 0.0 110.621 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.572 ' H ' ' HG3' ' C' ' 97' ' ' GLU . 46.4 t 78.15 -77.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.495 172.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.35 5.15 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.844 -173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' C' ' 97' ' ' GLU . 4.7 p-10 -150.37 135.45 17.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 69.25 -26.27 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.686 0.794 . . . . 0.0 113.141 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.572 ' HG3' ' H ' ' C' ' 93' ' ' VAL . 6.2 mm-40 -94.84 -47.06 6.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -76.67 -29.91 56.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.28 73.11 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.254 0.55 . . . . 0.0 110.499 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.24 -4.11 30.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.661 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -77.01 -17.29 58.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 85.6 mt 63.34 14.43 7.87 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.45 169.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m 56.54 73.13 0.46 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.432 0.634 . . . . 0.0 109.69 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 4.7 t -93.51 -171.88 2.75 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.867 -170.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.4 -41.81 63.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -171.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.503 ' HA ' HD23 ' C' ' 110' ' ' LEU . 96.7 mtt180 -126.11 77.47 1.68 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.76 -81.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.38 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 59.0 mt -86.79 -28.71 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.529 0.681 . . . . 0.0 109.8 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -63.6 -27.93 69.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.664 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' C' ' 106' ' ' ARG . 4.1 mm? -111.89 86.67 2.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.396 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 13.8 p -80.58 -55.46 4.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.344 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.98 35.4 1.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.44 155.67 24.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -176.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 80.2 t -90.94 127.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.001 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' C' ' 120' ' ' PHE . 25.5 p -60.39 -40.58 91.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.376 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.37 38.49 2.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.211 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 11.4 t -154.9 -45.48 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.74 27.25 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.2 m 61.1 61.29 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.097 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 120' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' C' ' 115' ' ' THR . 72.6 m-85 -132.82 102.6 5.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -121.52 133.88 55.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.75 -107.6 3.19 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.189 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 36.2 m 54.97 46.63 23.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.339 0.59 . . . . 0.0 110.264 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.46 31.64 4.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.69 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 71.41 150.46 0.1 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.021 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 46.8 t -80.79 93.96 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 5.9 p -82.53 83.66 7.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.311 0.577 . . . . 0.0 111.453 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.32 -36.31 77.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.144 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -115.15 147.95 39.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.267 175.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.5 p -132.01 117.71 18.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.687 0.279 . . . . 0.0 110.809 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 23.0 p -66.26 100.86 0.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.064 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -149.3 13.06 0.84 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.367 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.57 -1.0 10.09 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.889 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.421 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.959 0.409 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.57 56.59 0.64 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -97.98 123.92 49.57 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.258 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.96 32.1 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.933 2.422 . . . . 0.0 111.864 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -129.24 28.66 5.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -80.55 149.01 30.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.336 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -144.05 101.62 4.88 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.511 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.55 39.52 0.56 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.132 2.554 . . . . 0.0 112.661 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 33.7 t -70.79 -53.92 13.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -83.73 122.32 76.46 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.554 ' O ' ' HB3' ' C' ' 23' ' ' ALA . 72.7 Cg_endo -77.21 103.84 1.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.243 1.962 . . . . 0.0 112.293 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.4 HD22 ' C ' ' C' ' 11' ' ' PRO . 3.6 mm? -125.2 128.26 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.546 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 63.2 m-85 -92.98 143.26 26.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 67.0 mttm -117.06 139.71 50.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -170.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p-10 -46.98 136.18 8.68 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.14 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.88 -55.85 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.32 167.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.72 -7.04 47.81 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.65 26.81 1.24 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.767 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 54.3 t -116.24 119.86 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -97.87 138.66 34.88 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -148.15 124.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.646 -172.117 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -83.17 147.77 27.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.091 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' C' ' 11' ' ' PRO . . . -106.02 128.19 53.67 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.191 0.519 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 5.2 mp -98.74 98.7 6.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.242 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.8 Cg_exo -64.77 114.8 2.91 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.159 2.573 . . . . 0.0 113.116 -174.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 26' ' ' ILE . . . . . 0.583 HD11 ' HG ' ' C' ' 66' ' ' LEU . 12.0 mt -84.54 99.05 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' C' ' 27' ' ' LYS . 5.7 tmtm? -63.24 -69.57 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.65 162.15 41.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.374 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.82 132.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 0.0 109.932 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.456 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 11.5 mmpt? -105.87 100.29 9.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.427 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -73.98 112.4 10.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.161 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 153.26 28.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.709 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.28 -15.62 62.92 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.046 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.26 -21.63 31.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.348 . . . . 0.0 110.669 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.66 -26.19 5.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.109 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -70.09 165.73 21.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -140.58 122.31 15.33 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.955 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' C' ' 48' ' ' GLN . 5.1 t30 -83.83 114.86 21.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -94.69 155.78 16.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.452 -172.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -130.17 119.15 22.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.071 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 14.6 m-85 -126.13 179.49 5.22 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -175.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -36.27 -55.0 0.82 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.079 0.952 . . . . 0.0 113.405 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.8 -81.82 0.06 OUTLIER Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.185 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.63 45.17 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.094 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' C' ' 41' ' ' PHE . 97.4 m-85 -138.38 -173.48 3.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.082 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.33 116.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 0.0 112.078 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 9.8 p-10 -137.83 42.71 2.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.49 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.431 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 2.0 pp0? -165.32 173.92 10.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.841 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 29.3 p90 -97.11 132.51 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -109.43 166.8 10.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.05 144.41 12.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 112.368 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.38 90.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.057 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.539 0.685 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -74.13 -39.17 63.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.67 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.98 -32.31 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.8 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.7 68.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.787 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.68 -23.25 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.351 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.64 6.78 28.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.065 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -54.9 113.33 5.21 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -92.76 -99.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.231 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -156.95 140.6 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.633 0.373 . . . . 0.0 110.011 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.84 107.85 17.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.712 0.767 . . . . 0.0 109.806 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.04 -5.53 39.35 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.727 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.87 -158.85 34.56 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.147 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.27 123.64 28.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.918 0.389 . . . . 0.0 111.067 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 20.7 mt -79.28 163.53 24.86 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 43.8 p90 -148.21 147.9 29.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -134.92 120.55 19.39 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -94.67 164.44 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -79.72 19.11 0.69 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.624 -173.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.2 -6.41 18.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.444 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.29 -5.52 55.46 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.505 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.22 123.93 33.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.178 0.513 . . . . 0.0 111.111 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.456 HD23 ' N ' ' C' ' 74' ' ' LEU . 1.5 pt? -131.43 138.69 49.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.889 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 83.3 mt -150.1 179.62 7.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -107.72 141.38 39.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 34.4 mmm -150.12 144.07 25.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.855 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 33.0 p -65.38 126.55 28.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 167.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -61.01 -27.74 68.54 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.221 -171.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 17.3 p -52.91 -47.64 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.44 -38.46 55.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.157 0.503 . . . . 0.0 111.414 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.439 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 0.8 OUTLIER -74.16 -39.94 62.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.0 110.261 -175.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.13 -26.25 68.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.185 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.27 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.966 -172.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.22 -31.55 12.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 5.1 m-85 -97.1 -69.25 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 50.2 p -84.85 -20.98 30.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -171.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 13.1 t -58.6 -50.92 72.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 50.94 63.05 2.4 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.295 0.569 . . . . 0.0 110.861 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.3 m -133.14 147.76 52.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.123 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.53 68.92 Favored Glycine 0 CA--C 1.517 0.173 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.508 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 73.5 p -97.02 -9.38 28.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.474 0.654 . . . . 0.0 109.894 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t 69.96 -79.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.318 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.77 -13.93 43.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 61.67 31.51 18.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.143 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.95 5.35 3.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.146 0.498 . . . . 0.0 111.691 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.21 -28.13 32.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.572 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -111.48 11.59 21.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.956 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.04 -156.44 0.34 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.785 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.48 10.99 3.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 0.0 111.385 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -67.46 -12.98 61.6 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.938 -0.477 . . . . 0.0 111.044 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 32.0 mt -81.34 9.1 7.67 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.952 -0.468 . . . . 0.0 110.603 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -107.46 -30.71 8.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.172 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 52.5 p -64.43 109.02 1.8 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.72 0.295 . . . . 0.0 110.629 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 69.64 6.39 5.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.648 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -103.82 -44.88 4.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.033 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' C' ' 108' ' ' ILE . 34.2 p -91.69 -36.93 13.33 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 108' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' C' ' 107' ' ' THR . 50.1 mm 79.96 -37.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.041 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 2.4 p -75.87 43.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.468 0.652 . . . . 0.0 111.527 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 72.1 mt -81.64 161.46 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.341 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -101.9 18.11 21.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 110.733 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -154.86 169.06 32.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.29 112.43 24.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 0.0 110.941 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.87 137.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -69.49 61.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.062 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.9 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.665 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t -106.05 14.53 27.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 0.0 110.184 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 57.79 31.68 20.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.779 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 m 64.92 13.4 8.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.672 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 67.64 164.96 0.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.644 0.59 . . . . 0.0 111.314 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -166.28 157.5 13.18 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.42 23.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.218 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 15.3 m -82.65 104.11 12.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.65 73.49 6.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.145 0.498 . . . . 0.0 110.836 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.66 133.34 32.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.643 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.89 95.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.499 0.666 . . . . 0.0 111.525 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -126.45 6.81 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.329 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mm 62.12 36.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.225 1.012 . . . . 0.0 109.644 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -109.13 162.54 14.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.421 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.9 p -79.77 29.3 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 2.9 p -79.76 137.04 36.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -155.23 -45.48 0.08 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.239 0.542 . . . . 0.0 109.739 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.26 173.4 24.77 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.404 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.872 179.715 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mtp . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.97 -33.83 0.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.449 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -105.79 106.17 55.65 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.554 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.23 -21.07 48.66 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.555 2.17 . . . . 0.0 112.612 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.78 -75.23 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.668 0.27 . . . . 0.0 110.597 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -165.41 158.3 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.867 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' C' ' 8' ' ' PRO . 20.4 p -80.37 110.8 18.11 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 7' ' ' THR . 7.7 Cg_exo -72.87 54.93 2.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.048 2.499 . . . . 0.0 113.064 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.2 m -74.07 -48.9 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' TRP . . . . . 0.404 ' CE3' ' HB3' ' C' ' 44' ' ' PRO . 0.8 OUTLIER -90.05 124.79 62.5 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.61 178.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.02 160.53 26.93 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.507 2.138 . . . . 0.0 112.008 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -96.17 161.24 14.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' C' ' 86' ' ' TYR . 95.4 m-85 -125.84 155.86 40.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.401 -166.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' C' ' 89' ' ' ALA . 4.1 ptmm? -156.51 158.38 37.09 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -165.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.592 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 9.6 p-10 -96.17 -144.82 0.28 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.616 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.24 -40.85 36.01 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.29 -18.28 17.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.625 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.67 22.29 1.84 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.475 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.592 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.9 t -66.73 107.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -84.15 143.16 29.83 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.187 0.994 . . . . 0.0 111.803 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.49 137.27 18.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.482 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 25.9 t -81.79 144.26 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.523 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -105.96 122.72 46.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.591 0.71 . . . . 0.0 110.983 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.9 mm? -101.52 96.74 6.62 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.476 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 2.6 Cg_exo -76.37 104.26 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.778 2.319 . . . . 0.0 111.527 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 44.5 mt -71.29 90.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.718 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.786 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 27.9 tptp -66.65 -51.61 54.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.814 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.62 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -166.05 166.66 17.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.821 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.47 ' CG2' ' HB1' ' C' ' 37' ' ' ALA . 73.1 mt -135.62 141.62 41.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' C' ' 30' ' ' LYS . 1.5 tpmt? -104.06 99.78 9.54 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.092 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -79.94 106.68 12.15 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.53 168.4 19.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.778 0.799 . . . . 0.0 110.316 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.15 -10.36 59.2 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.414 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.37 -15.47 37.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.182 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.06 -28.71 6.51 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.977 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -72.09 158.64 35.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.762 0.315 . . . . 0.0 110.411 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.47 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -134.12 162.21 32.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.697 0.284 . . . . 0.0 111.15 -177.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 13.5 m120 -125.92 124.04 39.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.85 106.61 18.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.238 0.542 . . . . 0.0 111.198 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.786 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 23.6 mt-10 -77.77 89.73 4.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.382 -177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -91.18 141.64 28.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.28 -8.13 9.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.59 -124.63 0.72 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.409 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.404 ' HB3' ' CE3' ' C' ' 10' ' ' TRP . 74.3 Cg_endo -80.09 11.25 2.87 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.822 2.348 . . . . 0.0 113.028 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.68 161.55 36.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.879 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.73 -165.0 1.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.31 133.21 36.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 46.8 mm-40 -132.92 139.19 47.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.949 -0.114 . . . . 0.0 110.867 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -75.66 154.47 36.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.876 0.369 . . . . 0.0 110.27 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.8 ptp -150.29 128.08 11.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.575 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 151.19 44.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.665 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.99 77.35 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.91 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.32 -35.2 80.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.401 0.62 . . . . 0.0 109.788 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -71.18 -36.62 72.02 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.282 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 55.5 t -70.18 -23.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.438 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.36 -31.48 67.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.779 0.323 . . . . 0.0 111.026 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.03 -29.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.639 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -116.1 21.96 13.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 20.2 ptmt -52.71 110.82 2.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.309 0.381 . . . . 0.0 111.034 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.2 Cg_endo -100.14 -151.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.411 2.741 . . . . 0.0 111.742 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.416 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 43.0 mt-10 -138.36 131.13 29.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.358 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.62 HG13 ' HA ' ' C' ' 28' ' ' ALA . 95.6 t -72.99 105.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 0.0 109.781 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.85 -23.12 4.47 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.457 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.0 -165.22 38.05 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.878 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -116.44 135.27 53.99 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.894 0.378 . . . . 0.0 110.991 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.525 HD12 ' O ' ' C' ' 75' ' ' LEU . 36.4 tp -106.32 149.93 26.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -148.29 154.92 40.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.221 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -121.9 121.96 38.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 5.2 p -106.56 -175.45 2.8 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.019 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.08 -46.91 88.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -69.9 -8.73 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.677 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.27 41.92 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.09 136.67 48.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 110.243 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.494 ' O ' HD22 ' C' ' 75' ' ' LEU . 1.6 pt? -130.7 128.43 40.85 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.525 ' O ' HD12 ' C' ' 66' ' ' LEU . 1.6 mm? -138.97 169.51 17.65 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.792 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' C' ' 77' ' ' MET . 24.2 p90 -122.35 156.87 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' C' ' 76' ' ' TYR . 35.7 tpp -177.21 166.12 2.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.411 0.444 . . . . 0.0 110.408 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 24.9 p -77.03 -147.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.703 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -75.09 -24.75 58.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.3 p -47.92 -45.6 30.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.654 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 77' ' ' MET . . . -82.16 -33.43 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.704 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.717 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 70.5 t80 -53.96 -40.44 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 110.947 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -74.12 -45.07 51.24 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.824 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.39 -30.85 27.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -115.79 -13.89 11.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.717 ' CD1' ' HA ' ' C' ' 82' ' ' PHE . 0.8 OUTLIER -104.75 -11.61 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.412 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 40.9 p -140.25 -102.73 0.16 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 111.682 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t 49.65 -161.15 0.05 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.572 0.749 . . . . 0.0 111.391 175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ALA . . . . . 0.471 ' HB3' ' NZ ' ' C' ' 14' ' ' LYS . . . 52.67 55.59 8.83 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.319 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 39.6 m -70.98 105.96 3.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.703 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.08 -50.81 21.14 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.329 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 14.1 m -91.62 -26.76 18.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.587 0.232 . . . . 0.0 110.807 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 60.1 t 65.03 -82.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.319 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.25 -6.02 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.762 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 63.94 23.09 13.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.49 0.18 55.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.297 0.57 . . . . 0.0 110.85 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.96 -58.29 2.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.421 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -81.61 -16.94 49.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.14 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' C' ' 102' ' ' LEU . . . -136.94 73.99 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.567 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.43 -4.65 47.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.306 0.574 . . . . 0.0 110.174 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.55 13.4 28.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.438 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' C' ' 99' ' ' ALA . 89.1 mt -54.76 107.32 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 35.0 m 71.77 28.29 2.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.564 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 43.9 p -100.33 121.71 41.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.027 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.79 -91.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.191 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -139.18 44.92 1.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p -79.83 -105.28 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.9 -58.95 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 6.4 p -63.64 -43.33 97.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.066 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -118.65 126.48 52.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 48.1 p -87.83 -23.96 23.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.91 0.862 . . . . 0.0 108.893 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -129.52 131.13 6.58 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.058 173.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.58 32.44 0.51 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.127 0.463 . . . . 0.0 111.904 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' C' ' 117' ' ' SER . 61.3 t 65.96 110.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.471 0.653 . . . . 0.0 111.111 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.9 p -59.29 -31.69 69.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.926 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.4 24.0 19.05 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.475 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' SER . . . . . 0.403 ' HB3' ' HB ' ' C' ' 114' ' ' VAL . 33.3 t -139.39 -49.39 0.49 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.75 70.88 10.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.707 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -62.87 -44.74 95.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.248 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -100.13 -58.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -152.57 -25.06 0.17 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.109 0.481 . . . . 0.0 110.424 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.44 45.15 6.26 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 113.802 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 17.5 p -116.47 -81.76 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.055 0.427 . . . . 0.0 111.07 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.28 73.47 10.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -76.57 -50.25 14.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.056 0.455 . . . . 0.0 109.896 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 14.9 t -131.96 75.71 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.338 0.59 . . . . 0.0 110.114 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 4.3 p -100.89 -48.12 4.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 20.6 mt 45.13 62.25 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.218 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.59 -81.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.082 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.0 p -102.4 60.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.596 -173.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -79.53 -23.3 42.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.36 0.6 . . . . 0.0 110.319 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 31.9 t -144.01 33.16 1.24 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.83 -176.6 45.37 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.494 -173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.14 -179.422 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.933 0.397 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.51 58.49 1.13 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.883 0.373 . . . . 0.0 110.617 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -81.16 157.05 71.41 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.204 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.35 -43.66 10.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.46 2.773 . . . . 0.0 114.461 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -59.26 -30.29 68.18 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.288 0.566 . . . . 0.0 111.104 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.64 58.06 2.65 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.417 ' HB ' ' HD3' ' C' ' 8' ' ' PRO . 34.5 m -53.2 -50.82 80.26 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.971 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' HB ' ' C' ' 7' ' ' THR . 66.9 Cg_endo -73.09 55.61 2.93 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.119 175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 40.9 t -71.24 -26.76 63.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.393 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' TRP . . . . . 0.408 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . 2.1 m-90 -66.47 116.48 34.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.471 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 10' ' ' TRP . 10.6 Cg_exo -70.38 119.5 6.4 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.385 2.057 . . . . 0.0 110.809 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 14.8 mt -115.05 138.25 51.08 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 58.1 m-85 -132.95 -169.76 2.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -168.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 9.8 mtmp? -141.25 135.31 30.54 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -170.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.735 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -77.94 -169.83 1.69 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.555 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -58.28 -45.72 87.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -102.23 -9.46 20.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.193 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.66 16.58 2.74 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.222 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.577 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 44.7 t -67.88 116.38 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.14 134.8 36.19 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.775 0.798 . . . . 0.0 110.185 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.75 136.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.57 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.3 m -86.48 144.09 27.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.265 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.68 117.34 33.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.566 0.698 . . . . 0.0 109.971 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.21 104.79 54.94 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.688 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.02 122.59 9.19 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.363 2.042 . . . . 0.0 112.275 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' ILE . . . . . 0.437 HG12 ' CZ ' ' C' ' 41' ' ' PHE . 38.1 mt -78.29 110.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -77.47 -46.94 20.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -157.18 160.55 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.984 0.421 . . . . 0.0 111.817 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.1 mt -146.56 143.47 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.659 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -130.48 111.99 12.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.413 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -82.61 104.56 12.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.27 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.44 165.12 25.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.745 0.783 . . . . 0.0 110.363 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.21 -19.33 65.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.193 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -84.8 -22.05 29.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.318 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.62 -25.96 6.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.559 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 60.0 p -66.47 148.66 51.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.423 . . . . 0.0 110.772 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.23 123.89 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 5.3 t30 -87.0 120.91 28.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.56 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.698 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -96.65 160.53 14.34 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.924 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -141.66 118.5 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.798 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' C' ' 26' ' ' ILE . 50.5 m-85 -117.31 171.85 7.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.75 -57.8 4.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.097 0.475 . . . . 0.0 111.474 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.7 -168.04 33.42 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.888 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.05 41.01 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.336 2.69 . . . . 0.0 112.493 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.33 -173.32 2.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.068 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -36.06 114.77 0.3 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 124.059 0.849 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.698 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 33.4 t70 -149.02 66.12 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.244 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.681 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 2.2 pp0? -168.81 163.26 11.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.036 -168.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' C' ' 38' ' ' ASN . 96.3 m-85 -80.07 111.76 16.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tpt -86.53 145.85 26.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.35 132.09 16.61 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.777 0.673 . . . . 0.0 111.722 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.55 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -62.13 -35.64 79.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.627 0.727 . . . . 0.0 109.63 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.6 m -74.83 -40.16 61.22 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.577 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 44.2 t -69.04 -25.71 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.88 91.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.837 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.7 -24.7 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.101 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -116.15 14.74 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -170.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 8.9 ptpp? -52.74 116.79 9.6 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.786 0.326 . . . . 0.0 111.447 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 5.5 Cg_endo -88.2 -149.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.179 2.586 . . . . 0.0 111.477 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.2 132.06 48.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.276 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.23 106.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.96 0.886 . . . . 0.0 109.967 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.86 33.42 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.067 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.17 -159.31 25.24 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.265 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.6 121.36 40.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 tp -96.43 157.66 15.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 46.9 p90 -148.84 153.95 38.8 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.745 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -149.38 142.88 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.276 0.36 . . . . 0.0 110.254 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 20.4 p -115.08 -175.81 2.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.269 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -69.37 -35.75 76.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.889 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.69 -4.7 28.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.156 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.95 19.53 57.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.85 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -86.05 109.09 18.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 109.895 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.3 pt? -130.32 139.62 50.69 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.838 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.656 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 67.8 mt -157.94 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.208 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -118.99 144.17 46.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.445 ' HA ' ' CE ' ' C' ' 77' ' ' MET . 1.8 mmt -147.11 145.94 29.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.738 0.304 . . . . 0.0 110.75 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 29.5 p -73.33 145.5 45.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.515 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 17.6 ptpt -51.12 -31.87 20.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -167.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -59.74 -57.32 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.25 -38.77 68.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.323 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 70.7 t80 -54.62 -44.37 73.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.49 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 27.8 tt0 -56.66 -51.25 69.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.901 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.44 41.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.893 0.378 . . . . 0.0 110.688 -167.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 87.1 m-20 -93.25 -33.42 13.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.026 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -148.82 66.64 1.05 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.566 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 31.1 p -169.03 -37.14 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' C' ' 89' ' ' ALA . 72.3 m -76.34 -161.2 0.17 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.466 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' C' ' 88' ' ' SER . . . 81.43 -6.45 1.53 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.055 0.942 . . . . 0.0 111.123 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t 69.3 165.62 0.26 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.185 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.15 -32.57 65.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.425 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -72.8 -22.81 60.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 110.527 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.05 -52.39 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.196 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.49 101.32 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -73.9 -8.73 57.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.5 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.25 -4.22 59.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.286 0.565 . . . . 0.0 110.82 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -112.9 -33.18 6.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.157 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.7 t -99.56 35.68 1.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.798 0.808 . . . . 0.0 108.878 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.99 139.11 58.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.31 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.77 10.14 36.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' LYS . . . . . 0.619 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 22.6 tptm -92.06 12.57 21.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.585 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.51 -57.77 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.357 -174.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 44.6 m -94.37 -14.24 25.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.332 . . . . 0.0 110.965 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 104' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' C' ' 101' ' ' LYS . 16.7 p -89.12 -2.25 58.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.991 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 105' ' ' ALA . . . . . 0.521 ' HB2' ' HG3' ' C' ' 101' ' ' LYS . . . -91.18 58.36 3.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.259 . . . . 0.0 110.457 175.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.19 40.2 6.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.972 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 49.1 p 49.74 75.37 0.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.041 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.97 -31.31 52.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.586 0.708 . . . . 0.0 109.823 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 109' ' ' THR . . . . . 0.471 HG22 HG22 ' C' ' 114' ' ' VAL . 14.1 p -83.39 -3.91 57.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.193 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mp 61.92 -90.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.652 -175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 22.1 p -120.44 -64.63 1.23 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.7 42.72 0.39 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.82 -36.34 2.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 111.498 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.471 HG22 HG22 ' C' ' 109' ' ' THR . 2.6 t 57.22 27.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.401 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 69.4 p 53.05 -74.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 112.798 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' C' ' 120' ' ' PHE . . . -73.5 -41.29 44.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.716 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -60.55 -33.88 73.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.988 0.423 . . . . 0.0 110.545 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 118' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' C' ' 119' ' ' SER . . . -64.96 -55.39 19.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.546 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' C' ' 118' ' ' ALA . 23.9 t 173.1 -9.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.665 0.603 . . . . 0.0 111.433 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 120' ' ' PHE . . . . . 0.421 ' C ' ' HA2' ' C' ' 116' ' ' GLY . 62.5 m-85 -107.7 72.45 0.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.924 0.393 . . . . 0.0 111.479 -172.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.07 -50.22 9.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.18 21.39 0.19 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.051 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -138.45 84.57 2.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.891 0.377 . . . . 0.0 110.256 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.96 -5.18 12.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 63.44 -88.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.864 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 6.0 t 47.71 49.1 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 110.273 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 50.1 p 56.32 -90.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 112.443 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' ILE . . . . . 0.54 ' HA ' ' OG1' ' C' ' 131' ' ' THR . 33.3 mm 57.94 47.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.938 0.875 . . . . 0.0 109.867 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -110.57 -75.67 0.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.659 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 2.3 p -92.44 7.25 43.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.629 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 131' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' C' ' 128' ' ' ILE . 23.3 p -64.2 -28.59 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.147 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -149.04 -31.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.164 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.27 41.65 7.36 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.785 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.339 -0.838 . . . . 0.0 109.769 -177.383 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.792 0.33 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.56 -24.46 60.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 110.307 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -115.91 98.48 51.18 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.759 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.4 53.37 4.73 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.783 2.322 . . . . 0.0 111.961 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -84.71 -55.02 4.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 52.52 46.92 25.79 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.245 0.545 . . . . 0.0 110.714 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.0 p -79.23 132.27 63.44 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.677 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 103.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.791 2.327 . . . . 0.0 111.666 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 8.1 m -65.58 -29.95 70.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -62.43 116.07 20.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.174 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.09 160.14 49.98 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.827 2.351 . . . . 0.0 111.237 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.79 165.17 25.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.261 0.553 . . . . 0.0 110.781 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.72 ' HB2' HG22 ' C' ' 21' ' ' VAL . 15.4 m-30 -93.25 160.13 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.873 -168.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' C' ' 86' ' ' TYR . 55.9 mttp -138.58 120.07 14.98 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -174.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.522 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -82.25 -165.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.659 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.467 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.81 -41.69 71.24 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.42 -8.71 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.56 9.02 5.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.398 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.522 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 78.7 t -77.6 100.04 2.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -84.15 163.12 19.97 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' C' ' 13' ' ' TYR . 3.7 m -147.98 139.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.388 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.42 153.22 24.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.872 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 127.73 55.16 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.379 0.609 . . . . 0.0 110.569 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.467 HD22 ' N ' ' C' ' 24' ' ' LEU . 2.4 mm? -112.2 98.0 41.22 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.993 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' C' ' 42' ' ' ASP . 20.8 Cg_exo -66.02 118.98 5.95 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.932 2.422 . . . . 0.0 112.94 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mt -85.4 96.0 4.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.069 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 60.3 tptt -66.72 -54.44 22.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.698 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -164.23 164.77 22.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.894 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.6 144.08 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.0 110.996 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -120.28 108.2 13.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.657 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.25 106.45 15.03 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.754 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 162.77 20.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.794 0.806 . . . . 0.0 110.789 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -77.14 -11.72 59.85 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.042 -171.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.23 -12.41 43.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.93 -37.1 3.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.22 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -67.02 131.75 46.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.325 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.69 121.31 41.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.625 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 2.3 m-20 -86.76 113.07 22.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.27 126.37 52.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.45 0.643 . . . . 0.0 112.359 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 39.9 mt-10 -86.26 108.25 18.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.318 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -107.66 160.81 15.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' ASP . . . . . 0.508 ' O ' ' HD2' ' C' ' 25' ' ' PRO . 1.9 m-20 -113.61 147.88 37.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.362 172.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.5 13.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.69 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 -31.12 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.808 2.339 . . . . 0.0 112.18 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -86.97 140.52 29.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.219 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.47 -162.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' HG2' ' C' ' 40' ' ' GLU . 2.1 m-20 -64.99 119.24 10.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -154.66 146.18 23.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.056 0.455 . . . . 0.0 111.627 -175.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.2 p90 -93.49 131.34 38.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.499 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.24 137.74 37.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.54 139.52 37.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.712 0.633 . . . . 0.0 111.298 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.56 75.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.473 -173.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -66.41 -34.92 79.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.53 0.681 . . . . 0.0 109.401 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m -71.98 -40.21 68.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.7 t -70.13 -26.66 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.447 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.17 79.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.87 -31.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.586 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.24 20.17 17.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' C' ' 59' ' ' LYS . 0.0 OUTLIER -49.27 110.12 1.44 Allowed Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.253 0.345 . . . . 0.0 110.413 172.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 9.7 Cg_endo -91.33 -155.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.86 2.373 . . . . 0.0 112.772 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.25 137.34 49.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.024 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' C' ' 28' ' ' ALA . 39.2 t -72.49 100.51 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.52 7.38 54.01 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.332 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.55 -166.38 40.0 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.563 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.61 130.41 56.72 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.93 0.395 . . . . 0.0 111.256 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 56.8 tp -119.07 139.53 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 29.5 p90 -146.03 156.29 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.956 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -147.44 139.27 24.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 89.7 p -110.57 179.7 4.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.89 -38.38 90.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.444 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -68.31 -18.8 64.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.093 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.29 12.78 32.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.1 119.78 25.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.0 pt? -130.91 130.62 43.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.2 mt -145.26 158.51 43.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -113.9 151.17 32.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' C' ' 81' ' ' ALA . 9.4 ttm -175.54 175.31 2.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.726 0.298 . . . . 0.0 110.455 170.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 23.6 p -81.89 -149.78 0.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.496 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.5 ptmt -66.78 -20.52 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -58.18 -64.82 0.78 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.131 0.491 . . . . 0.0 111.308 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' C' ' 77' ' ' MET . . . -62.53 -37.58 86.63 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.595 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 20.5 t80 -48.47 -55.87 9.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.532 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.832 ' HA ' ' CE2' ' C' ' 86' ' ' TYR . 35.2 tt0 -64.69 -22.21 66.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.373 0.606 . . . . 0.0 111.384 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' C' ' 88' ' ' SER . . . -89.23 -6.53 56.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.618 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 9.9 m-80 -107.32 -39.3 5.71 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.048 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.832 ' CE2' ' HA ' ' C' ' 83' ' ' GLU . 13.2 p90 -94.75 -7.34 40.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.356 -1.338 . . . . 0.0 112.318 -173.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.596 HG23 ' CD1' ' C' ' 86' ' ' TYR . 35.0 p -147.77 -53.67 0.2 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.388 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' C' ' 84' ' ' ALA . 9.8 t 71.13 154.83 0.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.706 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 175.51 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.62 -1.627 . . . . 0.0 107.762 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -145.77 -173.95 4.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.019 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 143.29 -115.22 0.89 Allowed Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 55.8 m -95.88 27.3 3.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.37 -71.62 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.666 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.74 14.06 0.35 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.594 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -162.75 152.93 16.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.256 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 75.61 -11.74 1.07 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.246 0.966 . . . . 0.0 112.883 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -139.19 -56.35 0.59 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.8 0.333 . . . . 0.0 111.013 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.4 m -53.53 -43.84 68.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.694 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.65 36.24 4.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.063 0.458 . . . . 0.0 110.322 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.75 -31.31 68.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.951 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -87.01 1.35 53.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.099 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.98 42.35 24.4 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.697 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -138.37 36.28 2.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.23 119.01 36.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.566 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 66.92 -77.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.802 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -124.99 -74.11 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 2.9 p 46.92 -101.76 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.542 0.737 . . . . 0.0 112.647 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.0 -58.67 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 111.286 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 15.6 p -65.98 -40.55 91.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 0.0 111.814 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' C' ' 110' ' ' LEU . 4.1 mm? -88.4 34.7 0.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.827 0.346 . . . . 0.0 111.596 -176.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 41.1 p -90.99 -36.17 14.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.31 0.576 . . . . 0.0 110.012 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -139.38 38.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.636 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' C' ' 114' ' ' VAL . . . 56.05 43.34 27.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.898 0.41 . . . . 0.0 111.262 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' C' ' 113' ' ' ALA . 53.5 t 68.33 143.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.227 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.2 p -75.87 51.63 0.65 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.077 0.465 . . . . 0.0 111.096 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.03 -105.6 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.731 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 5.0 m -104.63 -59.93 1.67 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 117.16 0.48 . . . . 0.0 110.863 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -179.27 63.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.408 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p 57.75 172.6 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.222 1.009 . . . . 0.0 111.671 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 61.38 28.12 17.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.776 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -97.32 55.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.674 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.03 48.36 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.673 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 40.0 m 61.34 44.5 9.56 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 72.68 -57.65 0.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.276 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' ASN . . . . . 0.402 ' OD1' HG23 ' C' ' 126' ' ' VAL . 22.6 t-20 -179.55 -71.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.402 HG23 ' OD1' ' C' ' 125' ' ' ASN . 69.8 t -138.62 117.94 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 110.51 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 3.2 p -77.59 -77.16 0.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.473 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 69.6 mt -141.71 -49.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -103.7 122.02 44.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.316 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 38.3 p -69.52 -34.6 74.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.979 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -81.98 69.78 8.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.226 0.536 . . . . 0.0 111.024 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -131.79 -8.13 3.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.399 0.618 . . . . 0.0 109.932 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.67 51.73 2.97 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.487 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.778 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.772 0.32 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.65 56.7 4.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 110.578 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 136.95 73.12 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.933 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.61 -30.42 60.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.066 2.511 . . . . 0.0 112.544 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 72.86 -19.7 0.3 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -86.83 108.7 18.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.484 0.659 . . . . 0.0 110.269 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 24.1 m -155.23 89.98 2.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.0 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.451 ' HB2' ' CE2' ' C' ' 10' ' ' TRP . 52.3 Cg_exo -55.56 138.47 80.74 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.953 2.435 . . . . 0.0 112.634 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 31.7 p -93.14 65.87 4.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.926 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' TRP . . . . . 0.611 ' O ' ' HG ' ' C' ' 12' ' ' LEU . 6.2 m-90 -60.27 155.87 43.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.37 102.86 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.346 2.031 . . . . 0.0 111.917 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.769 HD13 ' HA ' ' C' ' 22' ' ' SER . 52.5 mt -110.21 -178.2 3.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.523 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.582 ' HA ' HG21 ' C' ' 87' ' ' THR . 7.6 m-85 -92.31 166.03 12.8 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.92 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' C' ' 87' ' ' THR . 28.3 mmmt -115.38 154.46 29.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.55 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -93.55 -167.44 1.7 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.77 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -71.64 -42.07 68.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -170.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.75 -8.52 24.15 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.131 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.61 10.08 5.09 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.907 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.55 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.0 t -71.23 141.96 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.86 136.08 33.43 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.865 0.841 . . . . 0.0 109.447 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 20.0 m -134.26 135.31 54.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.356 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.769 ' HA ' HD13 ' C' ' 12' ' ' LEU . 14.3 m -73.94 147.27 43.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.631 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.77 115.15 29.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.102 0.477 . . . . 0.0 110.67 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.92 96.91 50.54 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.326 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.669 ' O ' ' HE3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -69.59 177.01 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.488 2.126 . . . . 0.0 111.655 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 26' ' ' ILE . . . . . 0.661 ' HB ' ' H ' ' C' ' 63' ' ' GLY . 0.1 OUTLIER -120.29 86.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.448 0.642 . . . . 0.0 109.753 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.695 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -87.36 -54.44 4.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.268 -163.024 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' C' ' 40' ' ' GLU . . . -158.89 151.4 21.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.994 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.81 143.8 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.2 0.524 . . . . 0.0 110.724 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.47 ' HB2' ' OD1' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -128.82 109.07 10.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.571 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -88.72 111.43 21.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.599 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.97 171.52 14.89 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.822 0.82 . . . . 0.0 110.49 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -78.52 -8.47 58.6 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.892 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -99.46 -7.52 25.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.915 0.388 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -19.69 29.3 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.599 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.53 155.02 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 110.442 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -141.35 143.57 34.08 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.989 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' C' ' 30' ' ' LYS . 1.8 p-10 -116.4 147.73 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.97 91.46 3.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.692 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' C' ' 28' ' ' ALA . 6.1 tp10 -64.16 101.34 0.4 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.859 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' PHE . . . . . 0.624 ' CD2' ' HE2' ' C' ' 27' ' ' LYS . 0.5 OUTLIER -62.36 161.9 10.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 113.396 169.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.84 -19.06 4.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.755 167.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' GLY . . . . . 0.449 ' H ' ' HD1' ' C' ' 41' ' ' PHE . . . -82.82 -150.67 9.35 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.872 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.39 35.87 0.56 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.323 2.682 . . . . 0.0 114.317 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.503 ' HB2' ' CD2' ' C' ' 41' ' ' PHE . 96.0 m-85 -140.96 -177.46 5.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' C' ' 41' ' ' PHE . . . -100.22 -164.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.634 -177.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.73 118.55 31.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -95.93 120.96 37.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 44.2 p90 -104.7 139.45 39.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.079 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.55 147.75 46.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.5 154.26 29.16 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.517 0.511 . . . . 0.0 111.704 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.01 -57.46 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -59.68 -27.72 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.415 0.626 . . . . 0.0 110.259 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.8 m -75.64 -37.26 59.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.055 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.08 -14.17 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.382 0.61 . . . . 0.0 110.061 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.44 68.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.41 -37.93 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.549 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.12 20.14 17.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.138 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 0.1 OUTLIER -49.16 114.77 4.12 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 123.515 0.509 . . . . 0.0 111.742 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' C' ' 65' ' ' TYR . 19.4 Cg_endo -98.14 -161.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 123.209 2.606 . . . . 0.0 112.289 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.585 ' O ' HG21 ' C' ' 26' ' ' ILE . 40.2 mt-10 -155.44 143.72 20.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.564 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -69.08 109.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.661 ' H ' ' HB ' ' C' ' 26' ' ' ILE . . . 93.24 15.21 52.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.011 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 64' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' C' ' 76' ' ' TYR . . . -136.79 63.79 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.947 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' TYR . . . . . 0.606 ' N ' HG12 ' C' ' 26' ' ' ILE . 0.1 OUTLIER -151.9 -171.44 3.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.341 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' C' ' 82' ' ' PHE . 0.5 OUTLIER -168.25 -79.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.24 -171.483 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -150.38 169.56 21.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.432 -165.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 55.8 ttt180 -151.81 131.09 12.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.153 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 97.0 p -97.02 175.38 6.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.845 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.93 -1.49 22.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.186 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -104.62 2.14 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.568 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.89 20.05 60.23 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.42 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 33.6 mt-10 -89.01 110.44 21.14 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.11 133.54 46.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.037 0.446 . . . . 0.0 110.297 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.77 167.96 18.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.676 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 76' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 64' ' ' GLY . 0.8 OUTLIER -118.71 150.6 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 19.4 ttm -179.58 -175.76 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -78.8 103.99 9.12 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 160.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.82 -26.9 62.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.612 -170.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 18.1 p -58.78 -33.91 70.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.119 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.85 -49.16 63.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 110.2 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.656 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 48.5 t80 -64.22 -53.53 47.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.819 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.07 -23.61 63.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.731 -174.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.05 -12.96 27.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.451 . . . . 0.0 110.849 -171.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -98.36 -32.1 11.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.217 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.656 ' HD1' ' O ' ' C' ' 82' ' ' PHE . 15.3 m-85 -97.84 -58.34 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.511 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.582 HG21 ' HA ' ' C' ' 13' ' ' TYR . 64.9 p -86.5 -65.39 1.02 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.204 174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 14.4 t 65.1 169.81 0.2 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.55 0.691 . . . . 0.0 110.841 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.46 28.73 3.65 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.483 ' HB2' HG22 ' C' ' 93' ' ' VAL . 7.7 m -96.55 -18.13 20.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.88 -67.94 3.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.767 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' SER . . . . . 0.44 ' HB2' ' HA ' ' C' ' 96' ' ' ALA . 12.4 p -97.65 80.86 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' C' ' 90' ' ' SER . 14.7 t -99.67 -78.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.24 -38.02 12.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.335 0.588 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -99.17 60.4 1.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' C' ' 92' ' ' SER . . . -80.13 55.7 2.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.128 -173.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 64.16 8.5 4.11 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.074 0.55 . . . . 0.0 111.638 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 10.3 t -96.74 -16.1 21.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.353 0.597 . . . . 0.0 110.06 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.93 28.56 8.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.685 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.44 -27.45 66.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.22 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 101' ' ' LYS . . . . . 0.665 ' H ' ' HD3' ' C' ' 101' ' ' LYS . 0.0 OUTLIER -95.79 -10.92 27.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 102' ' ' LEU . . . . . 0.487 ' O ' HG23 ' C' ' 104' ' ' THR . 95.2 mt 59.02 11.42 1.95 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.379 0.672 . . . . 0.0 112.461 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' SER . . . . . 0.532 ' H ' ' HG2' ' C' ' 101' ' ' LYS . 22.5 m 65.25 22.24 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.129 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 104' ' ' THR . . . . . 0.487 HG23 ' O ' ' C' ' 102' ' ' LEU . 53.1 p -117.99 -53.91 2.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.08 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.64 99.0 2.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.516 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 72.63 125.8 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.945 0.778 . . . . 0.0 110.565 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -78.6 70.0 4.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.9 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 53.6 mt -68.38 -21.24 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 15.7 p -61.81 -28.11 69.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.384 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' C' ' 114' ' ' VAL . 94.4 mt 55.54 -91.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.177 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 17.4 p -132.45 23.7 4.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 0.0 110.814 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.2 56.63 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -174.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.0 175.48 13.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.463 -0.869 . . . . 0.0 108.673 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 114' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' C' ' 110' ' ' LEU . 43.3 t -78.05 69.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.175 0.512 . . . . 0.0 110.507 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 69.0 p 51.61 24.35 2.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.118 0.967 . . . . 0.0 112.508 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.97 70.75 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.316 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -112.16 -12.2 13.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.078 0.466 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 58.94 27.51 16.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.52 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 170.64 14.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.896 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 63.2 23.74 14.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.15 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -159.95 -168.22 2.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.75 -2.21 41.92 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.378 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 19.6 m 65.31 90.39 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.702 0.401 . . . . 0.0 110.881 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.96 95.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.835 0.35 . . . . 0.0 110.682 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -165.99 79.88 0.28 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.873 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 60.5 t -115.33 -62.18 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.187 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 37.1 p 49.52 -96.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.402 0.681 . . . . 0.0 112.004 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.57 -57.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -147.72 94.46 2.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.702 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 26.9 p -79.71 -9.41 59.64 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 82.4 p -83.51 -3.64 57.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 110.591 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 70.8 m -158.42 50.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.34 166.77 12.17 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.322 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.754 -178.92 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.38 -15.66 20.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' C' ' 4' ' ' PRO . 7.5 t-20 -144.67 131.85 10.27 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.567 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 3' ' ' ASN . 2.2 Cg_endo -80.17 44.62 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.232 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 54.62 37.15 27.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 48.11 44.92 19.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.484 0.659 . . . . 0.0 111.419 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 m -121.26 120.2 29.18 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.894 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.4 45.15 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.283 2.655 . . . . 0.0 112.989 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -125.49 57.76 1.32 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -64.02 134.17 95.84 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.07 103.41 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.431 2.088 . . . . 0.0 111.58 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.36 169.96 17.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.356 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.622 ' HA ' HG22 ' C' ' 87' ' ' THR . 50.9 m-85 -92.25 123.92 35.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.601 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' C' ' 88' ' ' SER . 9.2 pttp -86.93 170.06 11.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.38 1.086 . . . . 0.0 111.157 -171.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -49.63 151.93 1.55 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.52 -2.127 . . . . 0.0 115.31 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.16 -54.7 2.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.113 -2.312 . . . . 0.0 108.614 163.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.43 -7.84 19.57 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.241 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.86 35.97 0.53 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.731 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.48 160.04 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.65 155.69 29.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.66 136.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.808 -170.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -74.33 154.41 38.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.57 130.88 52.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.464 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.62 98.48 49.54 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.598 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' C' ' 42' ' ' ASP . 7.4 Cg_exo -76.76 105.99 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.621 2.214 . . . . 0.0 111.202 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.59 117.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.229 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -93.71 -55.0 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.729 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.6 158.13 37.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.536 0.208 . . . . 0.0 111.062 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.56 145.23 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' C' ' 30' ' ' LYS . 27.2 mtpp -133.71 133.24 41.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.866 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -101.48 117.87 35.82 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.28 -172.62 3.88 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.144 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -74.71 -42.91 57.47 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.965 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.36 -20.23 62.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.74 -25.83 6.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.809 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 30.1 p -63.26 143.94 57.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -120.86 144.68 48.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 111.748 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 28.8 t-20 -106.54 127.65 53.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.749 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -111.66 116.58 31.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.35 121.58 25.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -110.95 147.08 35.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.959 0.409 . . . . 0.0 110.629 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' C' ' 25' ' ' PRO . 21.3 t70 -101.77 150.39 23.2 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.81 -139.66 15.29 Favored Glycine 0 C--N 1.313 -0.704 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.979 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.53 28.35 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.794 2.329 . . . . 0.0 112.467 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.93 165.68 25.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.29 -162.99 0.85 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.675 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.9 p-10 -93.91 150.41 20.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.67 153.36 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 46.9 p90 -109.34 143.17 39.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtt -127.69 148.18 50.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.901 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 152.92 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.71 98.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.49 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -56.61 -38.66 72.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.515 0.674 . . . . 0.0 110.165 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -69.04 -44.55 72.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.565 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 49.5 t -69.62 -27.37 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.821 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.86 76.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.357 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.57 -31.66 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.504 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.8 9.98 36.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 41.6 ttmt -55.58 114.19 6.91 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 98.9 Cg_endo -98.19 -145.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 123.525 2.817 . . . . 0.0 110.68 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' C' ' 76' ' ' TYR . 42.9 mm-40 -135.86 142.77 44.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.931 0.396 . . . . 0.0 110.701 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.1 127.19 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.781 0.8 . . . . 0.0 109.543 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.59 -8.74 56.79 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 -172.9 36.96 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.955 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 65' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' C' ' 79' ' ' LYS . 58.5 m-85 -146.51 149.33 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -173.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -175.24 -144.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.565 ' HE1' ' CE1' ' C' ' 82' ' ' PHE . 6.9 p90 -153.62 -179.3 7.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -140.09 126.37 20.0 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 42.0 p -98.59 177.21 5.39 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.863 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.56 16.12 1.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.86 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -107.99 3.07 23.7 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.24 89.57 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.222 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -78.21 114.52 17.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.118 0.485 . . . . 0.0 110.899 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.511 HD13 ' N ' ' C' ' 75' ' ' LEU . 3.4 tm? -100.08 137.8 38.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.511 ' N ' HD13 ' C' ' 74' ' ' LEU . 98.3 mt -142.24 158.62 43.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' C' ' 61' ' ' GLU . 17.8 t80 -126.73 147.81 49.94 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.765 0.665 . . . . 0.0 110.461 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.527 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -166.78 175.95 7.46 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 78' ' ' SER . . . . . 0.527 ' H ' ' HG3' ' C' ' 77' ' ' MET . 12.4 p -82.85 122.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 61.0 pttt -52.44 -46.68 66.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.424 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 30.9 p -51.9 -38.95 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.449 0.468 . . . . 0.0 112.164 -173.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.23 -57.08 4.27 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.294 0.569 . . . . 0.0 111.205 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.565 ' CE1' ' HE1' ' C' ' 67' ' ' PHE . 0.5 OUTLIER -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.344 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 83' ' ' GLU . . . . . 0.621 ' HG3' ' OG1' ' C' ' 87' ' ' THR . 12.9 tt0 -56.02 -39.89 72.62 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.851 0.46 . . . . 0.0 111.824 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.46 84.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.482 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.522 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 43.2 m-80 -98.22 -36.95 9.87 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.974 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.522 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.4 m-85 -120.99 59.77 0.93 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -171.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.622 HG22 ' HA ' ' C' ' 13' ' ' TYR . 71.9 p -160.62 -49.19 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 165.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.469 ' O ' ' HD3' ' C' ' 14' ' ' LYS . 5.4 t -61.32 162.51 7.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.613 -176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 75.5 -44.55 0.52 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.321 1.048 . . . . 0.0 110.171 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 22.5 m 50.63 17.74 0.41 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.572 -1.195 . . . . 0.0 114.034 171.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.96 27.7 69.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.149 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -146.26 -41.31 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.4 93.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.377 . . . . 0.0 111.373 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.64 18.89 10.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.458 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.15 152.78 32.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 65.03 -75.94 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.936 0.773 . . . . 0.0 112.521 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -71.9 -27.78 63.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.148 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 1.9 m -84.31 -8.42 59.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.49 144.37 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.719 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.39 -25.49 59.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -84.45 -29.36 26.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt 61.39 -98.72 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.058 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 74.5 m -155.85 90.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 104' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' C' ' 105' ' ' ALA . 6.9 p -86.24 -165.0 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.784 -175.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 105' ' ' ALA . . . . . 0.426 ' H ' ' HB ' ' C' ' 104' ' ' THR . . . 66.8 -84.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.888 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -154.5 30.93 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 40.2 p 48.85 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.066 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 4.1 mt -85.21 24.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.147 -170.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 44.7 p 50.02 37.46 14.16 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.993 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 59.75 80.29 0.2 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.074 0.464 . . . . 0.0 111.346 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 123.89 23.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.783 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.79 -86.77 0.82 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.451 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -165.68 -57.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.149 0.5 . . . . 0.0 110.871 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.55 133.7 54.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.411 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.7 p -77.52 54.76 1.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.261 0.553 . . . . 0.0 111.312 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -172.44 -105.81 0.19 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.673 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -153.48 102.75 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.053 0.427 . . . . 0.0 110.503 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 67.58 -75.01 0.06 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.437 0.695 . . . . 0.0 111.911 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 8.2 t -132.12 41.03 3.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 65.46 -86.18 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.981 -171.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -139.33 -57.35 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.636 0.732 . . . . 0.0 109.028 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.51 146.83 4.73 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 51.1 m -63.35 -29.38 70.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.598 0.699 . . . . 0.0 111.061 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.45 33.06 3.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.21 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.61 -24.32 62.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 110.073 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 t -86.0 123.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.475 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 127' ' ' THR . . . . . 0.436 ' C ' ' H ' ' C' ' 129' ' ' GLU . 7.8 p -73.96 -35.75 64.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.398 . . . . 0.0 111.299 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 21.3 mt 68.41 -8.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.633 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' C' ' 127' ' ' THR . 0.8 OUTLIER 58.25 33.36 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.429 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 2.2 p -77.08 86.07 3.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.101 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 31.2 p -81.26 9.06 7.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.723 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 15.5 t -145.69 23.68 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.55 -86.17 0.84 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.83 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.246 0.912 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.213 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.797 0.332 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.59 50.44 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.135 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -102.69 110.34 62.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.041 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.82 41.58 1.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 123.086 2.524 . . . . 0.0 112.935 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.21 43.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.436 0.636 . . . . 0.0 109.5 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -88.09 159.08 18.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.83 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' C' ' 8' ' ' PRO . 29.2 p -77.49 144.65 70.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.892 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 7' ' ' THR . 7.7 Cg_exo -71.76 65.97 3.13 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.758 2.305 . . . . 0.0 112.514 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -79.14 -43.74 23.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.947 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -78.03 165.02 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.484 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.24 101.06 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.085 1.856 . . . . 0.0 111.806 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.424 ' CD2' ' HA ' ' C' ' 22' ' ' SER . 10.9 mp -119.77 161.57 20.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -132.83 170.16 15.7 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.678 -172.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.45 125.23 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.537 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -75.36 -167.76 0.7 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.313 0.383 . . . . 0.0 111.771 -171.387 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.82 -47.45 75.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.6 -13.56 31.72 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.399 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.72 17.55 2.56 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.031 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.537 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 41.7 t -67.28 110.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 109.903 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -90.76 140.15 30.06 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.451 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -139.72 136.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.365 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.424 ' HA ' ' CD2' ' C' ' 12' ' ' LEU . 22.9 m -92.26 139.68 30.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.256 175.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.07 117.24 33.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.43 0.633 . . . . 0.0 110.899 -174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.405 HD22 ' N ' ' C' ' 24' ' ' LEU . 1.4 mm? -107.12 106.81 59.3 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.699 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.35 128.05 15.83 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.277 1.985 . . . . 0.0 112.644 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.51 107.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.108 0.48 . . . . 0.0 109.921 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 76.0 tttt -76.45 -59.93 2.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.925 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.08 166.14 17.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.0 mt -144.8 141.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 110.063 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.468 ' HB3' ' ND2' ' C' ' 38' ' ' ASN . 19.3 tptm -96.33 100.0 11.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.935 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -90.95 120.87 32.3 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.03 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.93 158.11 18.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.494 0.664 . . . . 0.0 109.56 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -71.24 -10.72 60.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.714 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.07 -26.22 20.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.016 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.22 -35.36 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -63.7 152.55 38.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 0.0 110.27 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -150.3 173.8 13.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.749 -177.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 1.3 p30 -145.71 140.08 26.98 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.43 157.58 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -167.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 42.4 mt-10 -126.42 107.28 10.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.51 171.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 41' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' C' ' 46' ' ' ALA . 84.2 m-85 -100.47 151.29 21.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.17 129.98 35.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 109.77 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.55 -179.67 26.75 Favored Glycine 0 C--N 1.31 -0.917 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.755 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.92 61.35 7.6 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.771 2.314 . . . . 0.0 111.852 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -124.76 -174.05 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.59 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.447 ' O ' ' HD1' ' C' ' 41' ' ' PHE . . . -43.49 121.68 2.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.612 0.72 . . . . 0.0 112.59 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.31 59.22 1.1 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.704 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 174.51 165.14 0.23 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.278 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.65 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER -155.49 -165.7 2.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.381 161.375 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -160.04 -129.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.455 0.57 . . . . 0.0 111.63 -167.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.29 136.58 3.95 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.655 0.782 . . . . 0.0 112.931 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.22 67.46 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.843 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -61.15 -39.65 90.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.401 0.619 . . . . 0.0 109.337 173.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.2 m -71.19 -40.55 71.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.675 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.715 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 67.5 t -78.46 -7.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.818 -176.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.56 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.41 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.25 -33.62 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.183 0.516 . . . . 0.0 109.655 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.85 21.56 16.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -174.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 20.6 ttmm -68.21 113.99 18.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.923 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 74.3 Cg_endo -100.98 -150.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.514 2.809 . . . . 0.0 111.356 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -146.06 128.61 16.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.31 123.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.166 0.984 . . . . 0.0 110.108 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.41 -28.14 5.85 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.139 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.9 37.72 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.371 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 43.6 m-85 -112.48 135.99 52.52 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.809 0.338 . . . . 0.0 110.685 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.37 125.46 37.99 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 47.7 p90 -124.3 147.19 48.31 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.453 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.407 ' CB ' ' HG ' ' C' ' 74' ' ' LEU . 7.3 ptm180 -124.31 148.41 47.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.665 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 58.8 p -121.31 173.94 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.604 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' GLN . . . . . 0.525 ' CD ' ' H ' ' C' ' 70' ' ' GLN . 20.2 mp0 -59.58 -42.13 91.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.465 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -72.47 0.97 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.649 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.42 28.44 55.53 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.964 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.37 104.61 17.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 5.7 mp -109.74 108.72 19.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.502 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.0 mm? -129.52 175.55 8.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.449 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' C' ' 60' ' ' PRO . 35.6 p90 -122.76 146.45 47.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 46.0 tpp -153.25 139.74 18.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.911 0.386 . . . . 0.0 110.413 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -60.75 138.91 58.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.427 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.483 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 61.5 pttt -64.07 -25.27 68.03 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.3 p -61.04 -52.22 65.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 110.283 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.53 63.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.7 t80 -57.27 -42.83 82.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.639 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.32 -34.83 79.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.362 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 84' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' C' ' 88' ' ' SER . . . -93.65 -30.43 14.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.985 -167.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -70.28 -30.07 67.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.475 ' CD2' ' N ' ' C' ' 86' ' ' TYR . 6.3 m-85 -100.19 -75.51 0.57 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.381 -175.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 33.7 p -86.23 -56.53 3.41 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.718 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' C' ' 84' ' ' ALA . 20.4 t 73.61 -48.74 0.68 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.328 1.051 . . . . 0.0 110.677 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.86 82.96 0.73 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.294 0.569 . . . . 0.0 109.912 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -63.93 -14.92 57.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.874 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.35 -57.5 4.74 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.493 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 32.3 t -80.85 18.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 0.0 111.328 -174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.42 ' O ' ' HB ' ' C' ' 98' ' ' THR . 47.5 t -82.48 -32.32 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.04 13.81 32.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.868 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -160.96 136.15 7.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.737 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 75.81 -45.06 0.52 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.83 0.852 . . . . 0.0 112.86 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -92.3 -21.97 19.99 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.27 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' C' ' 93' ' ' VAL . 14.7 t -89.39 2.98 53.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.43 0.633 . . . . 0.0 109.405 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.74 97.73 3.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.707 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.14 -12.14 20.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 101' ' ' LYS . . . . . 0.455 ' O ' HG22 ' C' ' 104' ' ' THR . 39.5 ttpt -109.53 -29.45 8.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.0 110.3 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.62 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.023 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -150.41 27.46 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.014 0.435 . . . . 0.0 110.244 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 104' ' ' THR . . . . . 0.455 HG22 ' O ' ' C' ' 101' ' ' LYS . 11.0 t -88.25 10.51 19.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.245 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.62 100.17 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.405 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 66.24 98.43 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.904 0.752 . . . . 0.0 110.273 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 12.4 p -73.39 83.52 1.44 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.629 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.93 90.08 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.93 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p 58.44 12.76 2.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.987 0.915 . . . . 0.0 112.323 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt 60.01 172.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.479 0.657 . . . . 0.0 111.592 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -92.54 58.68 3.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.864 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.01 73.46 0.55 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.097 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . 55.39 43.94 27.98 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.023 0.439 . . . . 0.0 110.805 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t 53.24 69.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.603 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.8 p 48.6 37.96 10.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 112.168 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.46 12.84 83.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.541 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 33.0 t -80.2 -25.98 39.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.534 0.667 . . . . 0.0 110.074 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 64.32 1.07 1.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.819 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.2 t 55.88 51.14 12.67 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.715 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -60.23 -40.37 89.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.46 52.7 5.62 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.806 0.813 . . . . 0.0 109.183 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.84 -175.83 14.24 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.731 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 27.6 p -78.21 -24.13 47.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.576 0.227 . . . . 0.0 111.231 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 71.58 -51.63 0.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.758 0.823 . . . . 0.0 111.347 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 59.48 86.96 0.09 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.871 0.468 . . . . 0.0 111.239 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 62.5 t 65.75 90.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.91 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 7.2 p -78.14 109.6 12.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.111 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 45.3 mm -80.22 85.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.69 153.8 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.445 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -82.48 11.76 5.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.285 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 44.1 p 58.21 135.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.364 1.466 . . . . 0.0 113.885 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 29.3 m -127.11 7.51 6.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.918 0.866 . . . . 0.0 108.82 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.9 35.52 1.08 Allowed Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.967 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.436 -177.188 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.21 53.52 2.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 110.39 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' ASN . . . . . 0.492 ' HB3' ' HA ' ' C' ' 6' ' ' PHE . 69.7 m-20 -117.76 101.54 52.06 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.775 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.05 -50.21 13.94 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.334 2.689 . . . . 0.0 113.136 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.87 26.86 4.63 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' C' ' 3' ' ' ASN . 89.5 m-85 65.09 159.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 -173.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m 60.13 76.95 0.4 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.45 73.94 2.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.909 2.406 . . . . 0.0 113.027 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -73.86 -47.07 40.89 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.65 89.85 29.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.14 175.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.48 102.31 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.231 1.954 . . . . 0.0 110.721 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.468 HD22 ' H ' ' C' ' 23' ' ' ALA . 59.9 mt -88.16 167.49 13.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.552 ' HB2' HG13 ' C' ' 21' ' ' VAL . 3.6 m-85 -93.04 143.25 26.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.171 0.51 . . . . 0.0 111.892 -166.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' LYS . . . . . 0.495 ' H ' HG23 ' C' ' 87' ' ' THR . 53.1 mtmt -129.45 112.47 13.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.626 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -70.18 -169.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.029 0.443 . . . . 0.0 111.873 -169.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -55.53 -53.98 49.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.438 -170.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.48 -14.26 26.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.174 0.512 . . . . 0.0 110.415 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.93 30.91 1.06 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.289 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.626 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.3 t -76.36 113.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -78.01 137.41 38.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.797 0.808 . . . . 0.0 110.528 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 21' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.44 125.82 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.355 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -88.74 162.02 16.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.468 ' H ' HD22 ' C' ' 12' ' ' LEU . . . -106.74 119.86 40.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.93 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.85 97.79 42.83 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.809 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.18 134.52 59.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.417 2.078 . . . . 0.0 111.569 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mt -76.2 93.67 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 21.9 tptm -70.57 -74.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.978 -172.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.85 143.75 24.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.865 0.364 . . . . 0.0 111.527 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.93 143.9 33.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.013 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.529 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 11.7 ptmm? -131.59 147.48 52.53 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -110.53 133.93 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.519 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.82 141.36 35.75 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.236 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -64.77 -15.09 61.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.167 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.44 -10.21 59.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.697 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.25 -34.03 4.75 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.417 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -64.45 164.38 11.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.784 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -142.12 146.15 35.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.529 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 6.3 t30 -106.42 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.485 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.58 ' HB3' ' OD1' ' C' ' 47' ' ' ASP . . . -119.35 175.91 5.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -173.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 10.3 pt-20 -160.28 144.55 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 165.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 41' ' ' PHE . . . . . 0.686 ' O ' ' HB2' ' C' ' 45' ' ' TYR . 88.4 m-85 -117.07 155.04 29.93 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.915 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' ASP . . . . . 0.47 ' OD1' ' HD2' ' C' ' 44' ' ' PRO . 19.9 t70 69.07 -64.06 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.121 0.968 . . . . 0.0 111.877 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.35 -73.15 0.2 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.532 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 71.6 Cg_endo -79.45 -3.96 13.33 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.798 2.332 . . . . 0.0 112.36 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' TYR . . . . . 0.686 ' HB2' ' O ' ' C' ' 41' ' ' PHE . 17.4 m-85 -85.34 155.29 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.131 0.491 . . . . 0.0 110.426 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.74 -174.18 2.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.023 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.58 ' OD1' ' HB3' ' C' ' 39' ' ' ALA . 14.9 t70 -174.45 -63.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.297 170.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.521 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 1.4 mp0 75.37 -159.3 0.05 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.027 0.931 . . . . 0.0 111.686 175.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 76.2 m-85 -75.02 140.67 43.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.377 0.608 . . . . 0.0 112.396 -172.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 44.8 ttp -129.79 148.49 51.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.401 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.67 137.26 25.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.522 0.677 . . . . 0.0 111.837 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.87 -41.27 91.16 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.956 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.79 -33.94 75.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 0.0 109.467 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -74.91 -40.65 60.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.471 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.38 -28.02 38.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.471 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.78 72.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.635 0.255 . . . . 0.0 111.041 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.374 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 58' ' ' PHE . . . . . 0.581 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 63.7 m-85 -95.41 14.84 21.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.596 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -81.65 99.91 0.65 Allowed Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 73.5 Cg_endo -101.07 -102.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.052 2.501 . . . . 0.0 112.917 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -143.61 123.45 13.45 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.8 t -72.18 101.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.15 -21.53 3.89 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.598 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.69 -159.6 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.163 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -124.04 120.26 31.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.059 0.456 . . . . 0.0 111.172 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.456 HD21 HD23 ' C' ' 74' ' ' LEU . 18.8 tp -93.96 154.95 17.4 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 50.9 p90 -139.47 146.99 40.71 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.563 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.99 123.76 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -172.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 25.8 p -91.81 167.29 12.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 109.957 175.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.12 11.18 0.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.38 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -109.72 -4.37 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 0.0 110.086 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.22 23.01 33.21 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.749 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 43.2 tt0 -99.22 120.44 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.456 HD23 HD21 ' C' ' 66' ' ' LEU . 6.4 mp -125.63 116.26 21.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.1 mm? -128.06 169.2 14.33 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -132.27 155.93 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.8 ptp -175.89 -175.77 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.316 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -70.58 121.05 17.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' C' ' 79' ' ' LYS . 11.7 ptmt -64.96 -24.65 67.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.75 -173.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 13.6 p -61.24 -32.13 71.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.963 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.52 -50.18 19.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.1 0.476 . . . . 0.0 111.011 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.525 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 8.0 t80 -72.89 -41.37 64.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.18 -31.71 71.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.422 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 84' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' C' ' 88' ' ' SER . . . -72.59 -35.06 67.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.772 -171.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.21 -25.8 60.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' TYR . . . . . 0.525 ' HD2' ' O ' ' C' ' 82' ' ' PHE . 14.7 m-85 -120.54 -85.94 0.65 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.374 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.495 HG23 ' H ' ' C' ' 14' ' ' LYS . 69.5 p -87.55 2.82 49.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -164.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' C' ' 84' ' ' ALA . 1.2 t -76.31 -46.66 26.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 50.74 52.38 15.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.213 0.53 . . . . 0.0 111.293 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 10.8 m -87.97 -6.94 57.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.071 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.31 -51.08 3.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.625 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 7.8 p -72.12 -50.17 30.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 122.898 -0.178 . . . . 0.0 111.445 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 t 42.57 44.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 123.744 0.652 . . . . 0.0 111.172 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . 68.44 -42.37 0.47 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.892 0.877 . . . . 0.0 113.094 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -65.05 -23.85 67.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.99 2.85 22.05 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -146.32 -57.69 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -83.7 48.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.572 0.701 . . . . 0.0 110.488 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.29 92.4 3.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.329 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.4 -3.87 19.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.361 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -66.26 -33.22 75.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.003 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt 48.31 64.9 1.48 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 171.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 70.6 m 57.69 38.43 27.57 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.349 0.595 . . . . 0.0 110.875 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 3.5 t -49.52 122.0 5.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.077 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.58 -95.75 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.431 173.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -127.74 19.09 6.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.58 0.229 . . . . 0.0 111.499 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' C' ' 110' ' ' LEU . 14.2 p -71.93 -56.45 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.192 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 23.1 mt 53.91 63.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.463 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 75.3 p 57.37 13.93 1.97 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.929 0.892 . . . . 0.0 113.116 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' C' ' 107' ' ' THR . 3.8 mm? -110.9 72.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.0 110.049 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 18.3 p -106.74 72.01 0.88 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.329 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.64 31.97 35.04 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.119 -175.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 113' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' C' ' 110' ' ' LEU . . . -106.93 -1.29 22.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.705 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 39.9 t 44.74 73.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 123.853 0.721 . . . . 0.0 111.998 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 58.5 p 53.32 13.47 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.45 -2.69 27.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.855 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 77.4 p -84.78 -9.89 57.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.902 0.851 . . . . 0.0 111.257 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 60.41 25.31 14.85 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.581 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.9 t 67.76 13.62 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.524 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -79.26 -9.81 59.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 110.185 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -86.27 -9.94 55.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.022 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.46 123.39 7.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.592 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 20.2 p -119.11 21.63 12.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.034 0.445 . . . . 0.0 110.409 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.54 94.66 0.19 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.424 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 62.08 26.78 16.15 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.556 0.343 . . . . 0.0 111.211 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.96 111.57 20.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 73.8 p 52.74 -85.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.43 1.081 . . . . 0.0 112.893 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 35.9 mt 60.97 61.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.884 0.85 . . . . 0.0 109.835 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -127.21 39.47 3.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.039 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 1.7 p -72.61 82.19 1.12 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.863 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 31.3 p -79.7 -8.64 59.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.495 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 20.0 m -141.33 44.9 1.75 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.12 127.38 27.21 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.982 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.274 -179.593 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.927 0.394 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.36 63.39 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.394 0.616 . . . . 0.0 109.919 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.91 108.68 19.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.203 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.16 0.82 7.95 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.479 2.119 . . . . 0.0 112.285 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.85 -29.83 63.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.299 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -148.45 146.17 28.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' C' ' 8' ' ' PRO . 10.5 t -151.73 135.98 9.95 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 7' ' ' THR . 17.3 Cg_exo -66.76 97.6 0.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.432 2.088 . . . . 0.0 112.134 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -69.65 -19.86 63.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.479 0.657 . . . . 0.0 109.719 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -90.55 109.14 32.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.49 ' C ' HD22 ' C' ' 12' ' ' LEU . 72.8 Cg_endo -79.72 101.42 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.674 1.583 . . . . 0.0 112.017 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.49 HD22 ' C ' ' C' ' 11' ' ' PRO . 3.4 mm? -133.39 111.4 10.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.627 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 30.0 m-85 -105.42 164.0 12.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.637 -170.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.44 -176.88 3.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.586 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -120.92 -164.35 1.1 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.271 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 16' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -61.54 -35.87 78.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.21 -11.87 12.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.3 20.04 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.935 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.586 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 55.4 t -70.05 131.35 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -82.31 141.5 32.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.779 0.799 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.81 140.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.368 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -98.59 143.35 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' C' ' 67' ' ' PHE . . . -106.5 132.75 52.16 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.712 0.768 . . . . 0.0 111.248 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.519 ' N ' HD12 ' C' ' 24' ' ' LEU . 3.3 mp -101.39 99.4 11.12 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.834 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.2 Cg_exo -64.99 105.64 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.699 2.266 . . . . 0.0 112.371 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 26' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' C' ' 66' ' ' LEU . 16.9 mt -73.25 110.88 7.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -98.1 -43.63 6.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.31 162.33 30.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -139.52 134.3 39.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 7.4 mmpt? -91.55 90.07 7.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.222 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -76.5 101.18 5.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.02 140.07 29.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.617 0.723 . . . . 0.0 110.329 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -63.63 -17.99 63.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.93 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -71.98 -18.48 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 110.805 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.5 -47.93 0.99 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.066 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 77.2 p -70.41 176.71 3.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.328 0.585 . . . . 0.0 110.969 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -155.14 -164.47 1.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.061 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.601 ' HB2' ' HA ' ' C' ' 48' ' ' GLN . 0.4 OUTLIER -166.83 145.33 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 168.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 39' ' ' ALA . . . . . 0.671 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -103.61 135.39 45.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.45 119.58 39.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.476 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -111.75 144.31 41.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 110.742 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.72 -25.91 44.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.706 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.07 -178.92 48.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.502 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.52 67.47 3.67 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.686 2.257 . . . . 0.0 111.524 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.25 -174.42 3.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.752 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.87 168.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.354 1.073 . . . . 0.0 113.83 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 16.2 p-10 -148.22 51.33 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.018 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 48' ' ' GLN . . . . . 0.601 ' HA ' ' HB2' ' C' ' 38' ' ' ASN . 28.0 mt-30 -163.99 144.35 8.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -157.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 49' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' C' ' 37' ' ' ALA . 9.2 m-85 -148.06 -166.76 2.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 160.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -179.02 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.439 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' SER . . . . . 0.407 ' O ' HG23 ' C' ' 55' ' ' VAL . 3.9 p -86.66 105.76 17.13 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.295 0.569 . . . . 0.0 111.477 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.78 82.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.732 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.14 -35.33 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.392 0.615 . . . . 0.0 110.183 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 41.8 m -77.48 -41.0 41.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.286 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 85.9 t -74.83 -14.75 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.936 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -36.52 58.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.7 -30.18 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.268 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -103.38 14.57 31.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.843 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 24.8 pttm -60.09 119.89 45.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 59.8 Cg_endo -97.54 -150.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.362 2.708 . . . . 0.0 110.579 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -135.42 157.57 46.55 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 95.0 t -87.67 105.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.197 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 -19.63 5.44 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.135 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.5 -171.76 47.35 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.315 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.49 107.78 15.18 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.991 0.424 . . . . 0.0 110.723 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.478 HD23 HD22 ' C' ' 24' ' ' LEU . 37.1 tp -78.67 152.28 31.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 67' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 50.1 p90 -146.0 151.3 37.56 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.538 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 38.3 ttm180 -143.69 140.09 29.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.303 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p -103.27 170.78 7.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.191 0.519 . . . . 0.0 110.576 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.9 -21.41 66.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.398 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -81.36 -6.87 59.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.549 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.2 56.49 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.646 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 34.5 tt0 -87.5 121.48 29.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.55 139.41 49.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 0.0 111.249 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 93.4 mt -153.1 169.27 23.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.31 145.57 46.96 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.399 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -157.85 144.94 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.403 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -64.05 129.58 40.57 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -62.51 -27.59 69.25 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.734 -167.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -56.11 -39.59 72.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.823 0.344 . . . . 0.0 111.876 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -44.07 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.989 0.423 . . . . 0.0 111.189 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -27.19 36.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -172.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.42 -32.32 62.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.982 0.42 . . . . 0.0 110.191 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 84' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' C' ' 88' ' ' SER . . . -74.61 -62.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.528 -171.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -75.12 -25.31 58.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -96.2 -57.69 2.27 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' THR . . . . . 0.627 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 20.4 p -84.18 -43.87 14.52 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.797 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 88' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' C' ' 84' ' ' ALA . 56.0 m -75.83 -19.78 58.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.69 32.94 6.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.656 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 12.4 t 62.55 -160.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.576 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.02 -75.42 0.77 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.824 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 51.9 m -137.6 88.34 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 80.0 t -89.5 -61.9 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.216 0.531 . . . . 0.0 109.576 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.54 24.21 0.46 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.867 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -117.05 -56.62 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.757 -170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.55 -36.7 51.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.076 0.465 . . . . 0.0 112.253 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.7 40.03 3.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.606 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 15.0 t 41.33 42.15 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.246 1.018 . . . . 0.0 113.671 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.78 84.49 0.14 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 112.264 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.86 -24.35 66.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.098 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.93 -17.83 63.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -177.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 96.8 mt 54.87 45.86 25.67 Favored 'General case' 0 C--N 1.335 -0.023 0 CA-C-O 121.088 0.471 . . . . 0.0 110.039 -175.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' SER . . . . . 0.662 ' HA ' ' OG1' ' C' ' 107' ' ' THR . 21.1 t -135.59 46.42 2.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.601 0.715 . . . . 0.0 109.594 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 4.5 p -69.63 -77.77 0.08 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.968 -1.014 . . . . 0.0 113.156 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.35 23.69 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -144.84 -48.27 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.297 0.57 . . . . 0.0 110.283 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.662 ' OG1' ' HA ' ' C' ' 103' ' ' SER . 2.8 p -82.98 169.2 16.25 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.396 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 34.1 mt -137.22 77.29 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p 49.15 76.76 0.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.168 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' LEU . . . . . 0.656 ' H ' HD22 ' C' ' 110' ' ' LEU . 2.7 mm? -54.65 -42.66 71.55 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.697 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 25.2 p 50.84 -93.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.898 . . . . 0.0 112.237 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -98.97 -64.98 0.84 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.925 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -154.55 147.74 24.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.03 124.53 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.036 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.5 p -79.09 52.21 1.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.968 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 -64.11 0.16 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 13.4 t -135.06 18.64 3.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 71.29 -35.26 0.32 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 112.249 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.8 m -62.06 153.42 29.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.67 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.97 171.69 8.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.104 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -163.27 153.43 15.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.03 -60.85 4.75 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.426 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 24.0 p 46.62 71.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.372 0.669 . . . . 0.0 111.402 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 124' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' C' ' 125' ' ' ASN . . . 70.39 -58.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.284 -176.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 125' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' C' ' 124' ' ' ALA . 3.5 p-10 170.43 -18.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.605 0.762 . . . . 0.0 109.224 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.85 87.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.361 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.13 79.67 6.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.211 0.529 . . . . 0.0 111.364 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.88 -31.36 45.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -93.08 133.21 36.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 42.5 p -89.04 19.18 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.207 0.527 . . . . 0.0 110.43 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 10.7 p -80.84 15.58 1.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.317 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 11.3 p -114.64 0.11 13.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -102.33 110.83 3.87 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.823 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.527 -178.816 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.538 HD22 ' HA ' ' C' ' 22' ' ' SER . 8.1 mt . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.708 ' CB ' ' HA ' ' C' ' 87' ' ' THR . 52.5 m-85 -117.71 -161.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -166.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -122.63 127.98 50.06 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 -157.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.554 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -74.84 -165.92 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.184 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.481 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.73 -44.69 96.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.93 -9.7 14.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.235 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.89 23.62 1.43 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.445 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.554 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 77.6 t -83.57 150.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' C' ' 70' ' ' GLN . 0.2 OUTLIER -83.54 148.02 27.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.131 0.967 . . . . 0.0 111.084 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.0 144.9 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.395 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.538 ' HA ' HD22 ' C' ' 12' ' ' LEU . 22.8 t -94.93 142.93 26.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.57 39.88 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.405 0.621 . . . . 0.0 110.313 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.427 ' N ' HD12 ' C' ' 24' ' ' LEU . 5.1 mp -108.09 97.95 24.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.764 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.7 101.64 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.431 2.087 . . . . 0.0 112.233 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.4 mt -66.36 110.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.426 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -81.01 -74.02 0.34 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.473 0.654 . . . . 0.0 109.496 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.94 169.97 16.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.212 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.423 0.63 . . . . 0.0 110.847 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.495 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.4 tmtp? -103.04 101.4 11.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.413 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -87.87 104.78 16.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.763 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 143.84 29.57 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.546 0.688 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -66.38 -13.13 60.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.174 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -76.22 -20.89 57.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.58 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.03 -37.63 2.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.496 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 69.7 p -74.85 157.77 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.893 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.12 139.77 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 2.5 p-10 -110.02 129.23 55.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.39 125.58 38.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.263 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -89.39 118.21 28.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.25 152.03 33.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.95 32.68 5.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' C' ' 45' ' ' TYR . . . -115.38 -137.49 6.28 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.846 172.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.85 30.07 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.553 2.169 . . . . 0.0 111.539 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' C' ' 43' ' ' GLY . 88.3 m-85 -142.45 139.81 31.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.778 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.36 -160.78 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.191 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.08 133.78 53.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 51.2 mm-40 -127.13 108.74 11.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -80.07 128.52 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.381 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.8 mmm -117.39 144.95 44.43 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . 0.569 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 0.0 OUTLIER -65.25 156.76 30.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -57.34 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.569 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 0.8 OUTLIER -61.72 -26.36 68.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.108 0.48 . . . . 0.0 110.395 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -75.76 -41.75 52.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.347 0.594 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.5 t -70.14 -17.2 20.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.382 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.2 -27.7 47.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.0 -32.2 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.364 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.96 16.19 26.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 49.4 pttt -59.53 107.09 0.86 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 111.399 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 87.7 Cg_endo -102.24 -150.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.649 2.899 . . . . 0.0 112.011 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.05 142.86 51.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.417 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.18 121.74 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 122.126 0.965 . . . . 0.0 109.683 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.63 28.8 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.472 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.27 -165.07 33.72 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.992 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -132.7 131.25 41.06 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' C' ' 75' ' ' LEU . 8.8 tt -114.13 154.52 27.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 53.4 p90 -134.14 159.57 40.46 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.173 -0.329 . . . . 0.0 110.272 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -133.36 116.0 15.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 71.7 p -100.01 162.69 12.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.833 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 13.8 mm100 -63.25 -15.73 58.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.775 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -81.08 -10.7 59.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.79 8.98 61.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.63 114.62 26.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.9 pt? -126.86 128.71 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 72.8 mt -150.48 159.9 44.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.894 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 139.95 34.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 1.7 mmt -137.43 163.16 31.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.381 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -81.04 143.33 32.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.9 pttp -52.36 -36.45 53.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -167.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.2 p -58.7 -49.35 77.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 111.356 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.79 -42.08 58.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.272 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 78.0 t80 -54.04 -52.31 61.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.93 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.65 -37.3 84.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.068 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.36 -19.6 31.19 Favored 'General case' 0 C--N 1.315 -0.929 0 O-C-N 121.869 -0.519 . . . . 0.0 111.291 -168.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.7 m-80 -113.74 -25.84 8.48 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.762 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.2 m-85 -128.66 25.57 5.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.708 ' HA ' ' CB ' ' C' ' 13' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.93 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.639 ' HB2' ' CZ ' ' C' ' 20' ' ' TYR . 2.2 mm? . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.494 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 29.7 m-85 -95.59 -179.54 4.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -166.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 93.3 mttt -140.03 131.64 27.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -170.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -77.33 -168.41 1.13 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.736 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.63 -38.29 86.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -105.85 -0.34 25.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.269 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.48 13.27 6.92 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.292 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 51.7 t -70.23 119.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . 0.639 ' CZ ' ' HB2' ' C' ' 12' ' ' LEU . 33.5 t80 -77.78 137.72 38.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 109.736 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.6 131.75 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.54 -171.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.423 ' HA ' ' HG ' ' C' ' 12' ' ' LEU . 12.1 m -89.21 141.48 28.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.61 117.48 34.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.625 0.726 . . . . 0.0 110.647 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.464 HD22 ' N ' ' C' ' 24' ' ' LEU . 2.3 mm? -113.51 101.32 53.52 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.518 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.683 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 23.0 Cg_exo -63.46 143.01 87.19 Favored 'Trans proline' 0 C--O 1.221 -0.368 0 C-N-CA 121.678 1.585 . . . . 0.0 110.775 -174.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' C' ' 60' ' ' PRO . 72.1 mt -78.55 106.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' C' ' 25' ' ' PRO . 0.0 OUTLIER -90.83 -73.69 0.52 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.67 -162.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HB3' ' HG3' ' C' ' 40' ' ' GLU . . . -156.11 144.27 19.83 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -142.83 153.94 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.567 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -146.67 144.06 29.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -93.27 126.11 38.22 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.61 176.92 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.41 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -60.7 -52.92 63.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.438 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.44 -28.79 68.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.665 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.84 -25.19 3.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.328 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 40.2 m -57.18 144.9 33.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.572 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.575 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -105.44 131.81 52.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -91.28 94.85 9.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.83 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.4 ' C ' ' HB3' ' C' ' 47' ' ' ASP . . . -83.55 156.89 22.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.118 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 7.3 pt-20 -162.34 115.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . 0.683 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 30.3 m-85 -60.4 154.18 21.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.539 0.685 . . . . 0.0 112.691 165.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.58 -27.83 17.11 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.219 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.34 170.15 52.06 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.416 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.27 67.22 2.69 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.795 2.33 . . . . 0.0 112.371 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.446 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 90.2 m-85 -133.28 -174.96 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.29 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' C' ' 47' ' ' ASP . . . -66.02 -160.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.255 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' C' ' 46' ' ' ALA . 3.6 m-20 99.95 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.594 1.158 . . . . 0.0 111.625 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.08 -152.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.193 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 121.39 18.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.125 0.488 . . . . 0.0 110.158 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.06 146.56 44.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.93 136.48 51.7 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.741 0.651 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.04 92.34 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.22 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -62.64 -32.75 73.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.518 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -73.41 -42.63 61.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.662 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' C' ' 37' ' ' ALA . 57.9 t -68.06 -26.22 33.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.747 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.39 74.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.089 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.8 -30.07 4.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.242 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.96 7.4 45.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.408 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 23.2 tptm -58.19 108.6 1.35 Allowed Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.581 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.612 ' HB2' HD13 ' C' ' 26' ' ' ILE . 54.9 Cg_endo -104.76 -148.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 124.072 3.181 . . . . 0.0 111.872 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.71 124.05 27.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.758 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.18 121.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 122.388 1.09 . . . . 0.0 110.476 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.98 30.78 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.247 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.53 -172.12 42.74 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.953 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 95.2 m-85 -124.67 112.1 16.38 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.961 0.41 . . . . 0.0 110.778 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 22.1 tp -85.76 147.45 26.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.518 ' HB2' ' CG2' ' C' ' 21' ' ' VAL . 39.3 p90 -147.09 153.18 39.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.52 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 3.9 ptp85 -146.8 145.0 29.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.24 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 88.6 p -115.07 -177.36 3.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.014 0.435 . . . . 0.0 111.513 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' C' ' 20' ' ' TYR . 53.7 mt-30 -56.83 -42.11 79.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.814 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.76 3.98 15.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.049 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.93 27.98 59.54 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.902 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 42.7 mt-10 -75.52 105.93 6.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' C' ' 75' ' ' LEU . 2.9 tm? -107.85 130.18 55.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.363 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' C' ' 74' ' ' LEU . 57.7 mt -168.06 162.73 13.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.638 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -129.3 148.16 51.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 33.2 ttm -152.79 149.51 28.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.653 0.263 . . . . 0.0 111.225 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 15.7 p -68.82 146.91 52.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.144 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 21.5 pttp -56.52 -29.54 61.98 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -166.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -60.4 -55.24 35.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.076 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.91 45.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 55.8 t80 -59.16 -49.31 78.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.069 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.528 ' HA ' HG23 ' C' ' 87' ' ' THR . 7.5 pt-20 -73.18 -32.56 64.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.658 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.64 -26.03 61.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.175 -172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 45.9 m-80 -99.87 -37.37 9.07 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.615 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.1 OUTLIER -135.21 72.23 1.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.528 HG23 ' HA ' ' C' ' 83' ' ' GLU . 51.0 p . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 166.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.701 ' CB ' ' HA ' ' C' ' 86' ' ' TYR . 76.0 m-85 -140.0 -161.61 1.22 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.635 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -129.09 132.82 47.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.355 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.665 ' HA ' ' O ' ' C' ' 84' ' ' ALA . 3.7 p-10 -86.65 -153.0 0.19 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.734 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.68 67.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -167.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.88 4.21 23.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.591 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.52 24.77 6.01 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.66 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.1 t -86.84 133.03 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 140.42 36.88 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.881 0.848 . . . . 0.0 109.91 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.3 145.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.242 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 6.3 m -105.82 131.53 53.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.0 117.06 33.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.614 0.721 . . . . 0.0 110.935 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.45 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.6 mp -96.33 111.77 57.77 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 24' ' ' LEU . 6.7 Cg_exo -73.31 114.34 4.01 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.543 2.162 . . . . 0.0 112.42 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' C' ' 66' ' ' LEU . 42.0 mt -79.0 107.2 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -75.57 -57.7 3.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.172 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.33 163.29 39.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.735 0.302 . . . . 0.0 111.078 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 62.7 mt -142.01 146.67 22.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.848 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.516 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 21.1 ptmt -133.25 144.53 49.81 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.29 123.89 50.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.822 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 167.91 12.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.441 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.19 -11.28 60.25 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.034 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -93.31 -5.87 48.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.953 0.406 . . . . 0.0 110.573 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.05 -16.83 42.2 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.793 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -71.46 140.99 50.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -112.85 120.24 40.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.134 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 5.7 t30 -83.3 119.26 24.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.008 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.706 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -114.22 124.94 53.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.98 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.55 131.49 54.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.021 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.84 154.68 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.612 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -87.12 74.13 9.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.128 0.966 . . . . 0.0 110.017 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.74 -171.6 43.84 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.246 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.69 50.9 3.58 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.079 2.52 . . . . 0.0 111.869 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.36 -176.55 3.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.31 166.41 18.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.854 0.835 . . . . 0.0 112.926 -174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.706 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 6.6 p-10 -149.63 85.66 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.105 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 77.7 mt-30 -149.12 154.68 39.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.791 -163.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 8.3 p90 -89.26 112.41 23.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.571 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.6 mtp -85.18 147.07 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.121 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' C' ' 53' ' ' GLN . 0.7 OUTLIER -52.06 141.09 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.996 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.87 -22.84 65.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.18 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' C' ' 51' ' ' SER . 12.1 pt20 -68.6 -38.51 80.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.9 m -77.78 -38.51 46.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.786 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.33 -18.58 19.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.288 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.53 80.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.022 0.439 . . . . 0.0 110.502 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.8 -33.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.307 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -109.54 22.65 15.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 19.5 ptmt -48.79 106.07 0.57 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.4 0.437 . . . . 0.0 111.433 174.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 1.6 Cg_endo -83.83 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.851 2.368 . . . . 0.0 112.112 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -136.0 138.85 42.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.9 105.02 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 11.17 60.11 Favored Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.089 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.2 -160.15 35.78 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.56 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.67 134.46 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.12 0.486 . . . . 0.0 111.163 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' C' ' 26' ' ' ILE . 48.1 tp -115.87 111.58 20.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.076 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -108.9 144.47 36.77 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.543 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.464 ' HB3' ' CD2' ' C' ' 74' ' ' LEU . 28.5 ptt180 -123.06 142.53 50.77 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.251 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 59.3 p -94.33 -174.87 3.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -54.46 -43.37 71.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.548 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -79.33 2.32 21.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.287 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.7 22.94 71.13 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.249 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.78 118.4 20.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' C' ' 68' ' ' ARG . 6.8 mt -99.97 126.92 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.259 0.552 . . . . 0.0 112.103 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.42 HD22 ' C ' ' C' ' 74' ' ' LEU . 3.2 mm? -132.41 140.84 48.62 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.636 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' C' ' 77' ' ' MET . 27.1 p90 -112.98 157.41 21.54 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.508 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -178.23 166.29 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.23 0.331 . . . . 0.0 110.524 172.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' C' ' 77' ' ' MET . 6.3 p -74.52 -156.76 0.05 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -67.93 -41.89 81.88 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -168.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 16.8 p -44.76 -63.58 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.75 0.656 . . . . 0.0 112.358 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . 0.402 ' HB3' ' HG2' ' C' ' 77' ' ' MET . . . -68.2 -37.18 80.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.758 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.701 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 28.9 t80 -59.72 -42.2 92.57 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.81 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 40.9 tt0 -62.97 -24.88 68.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.851 0.834 . . . . 0.0 110.669 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' C' ' 15' ' ' ASP . . . -89.63 2.14 55.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' C' ' 15' ' ' ASP . 16.7 m-80 -119.94 -19.69 7.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.978 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.81 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 5.9 p90 -115.11 7.24 15.35 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.21 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.224 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.321 0.581 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.629 ' HB3' ' O ' ' C' ' 86' ' ' TYR . 26.5 m-85 -106.83 162.85 13.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.373 -169.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.498 ' H ' ' HA ' ' C' ' 87' ' ' THR . 98.8 mttt -150.09 152.82 35.39 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -164.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.578 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -90.65 -156.99 0.46 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.735 175.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.91 -51.85 55.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.27 -8.36 23.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.564 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.77 16.63 2.7 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.763 -1.208 . . . . 0.0 113.206 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.578 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 76.3 t -76.9 101.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 173.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' C' ' 14' ' ' LYS . 2.8 p90 -81.19 168.58 18.37 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.627 0.727 . . . . 0.0 110.511 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -146.89 140.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.179 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -86.44 141.65 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -108.28 117.4 34.04 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.453 0.644 . . . . 0.0 110.598 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.427 HD22 ' N ' ' C' ' 24' ' ' LEU . 1.5 mm? -104.25 100.52 22.01 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.354 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.447 ' HB2' ' OD1' ' C' ' 42' ' ' ASP . 16.3 Cg_exo -68.42 121.1 8.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.316 2.011 . . . . 0.0 112.358 -172.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' C' ' 60' ' ' PRO . 40.0 mt -79.87 101.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.194 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 22.8 ttmm -67.92 -69.31 0.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.443 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.86 148.21 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 41.3 mt -132.16 151.81 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.131 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -135.68 116.45 14.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.268 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.98 119.3 31.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.084 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.4 161.84 13.91 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.994 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.59 -11.64 61.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.011 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.81 -13.86 38.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 -31.22 6.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.741 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -68.44 141.58 55.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.95 55.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 8.1 t30 -88.95 116.37 27.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.57 162.37 14.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.477 ' CA ' ' HB3' ' C' ' 47' ' ' ASP . 38.4 mt-10 -154.07 127.25 8.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.4 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.02 155.88 17.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' C' ' 25' ' ' PRO . 6.0 p-10 -110.41 171.45 7.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -155.9 23.54 Favored Glycine 0 C--N 1.307 -1.05 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -169.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.37 39.8 0.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.671 2.247 . . . . 0.0 112.021 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.96 159.53 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 111.724 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.48 179.93 3.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.077 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.477 ' HB3' ' CA ' ' C' ' 40' ' ' GLU . 3.8 t0 -167.62 169.5 11.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 165.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -149.49 179.75 7.72 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.475 -158.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.6 p90 -85.57 125.38 33.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 95.3 mmm -122.25 156.58 33.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.945 0.403 . . . . 0.0 111.487 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.75 151.9 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.355 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.13 77.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.36 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.09 -38.87 84.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.465 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.4 m -73.32 -41.23 63.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.965 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.55 -12.07 13.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.87 61.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.984 0.421 . . . . 0.0 110.253 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.38 -33.9 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.035 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -105.11 22.63 15.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.941 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 53.6 pttt -53.86 107.53 0.88 Allowed Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.518 0.512 . . . . 0.0 111.011 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.504 ' HB2' HD13 ' C' ' 26' ' ' ILE . 6.9 Cg_endo -93.61 -156.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.159 2.572 . . . . 0.0 112.367 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -143.4 130.44 20.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.992 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.42 100.66 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.133 0.492 . . . . 0.0 110.227 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.49 -25.39 5.1 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.312 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.27 -165.28 37.66 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.194 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.26 126.39 48.07 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.655 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.37 140.07 29.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 45.4 p90 -137.37 159.66 41.3 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.675 -173.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 48.0 ttt180 -139.19 135.65 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.784 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 87.0 p -107.33 -178.63 3.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.98 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.42 -28.63 69.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -75.62 -14.46 60.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.581 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 20.86 34.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 7.1 tp10 -69.44 101.03 1.48 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt -103.36 108.45 19.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.644 0.735 . . . . 0.0 110.972 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 98.6 mt -146.46 177.39 9.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.149 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -130.18 143.68 50.92 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -148.62 136.16 20.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.994 0.426 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -69.4 150.57 47.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.166 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.25 -38.87 59.36 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.31 -59.02 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 111.824 -176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.17 -33.3 61.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.504 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 56.4 t80 -58.99 -47.53 84.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.171 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.59 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 4.7 tp10 -62.64 -40.95 98.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.94 -18.43 40.08 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.819 -0.55 . . . . 0.0 111.613 -166.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.451 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.1 m-80 -121.09 -31.53 4.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.629 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 2.3 m-85 -117.91 13.84 14.09 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -171.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.6 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 13.7 p . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 118.647 0.658 . . . . 0.0 109.586 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.68 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 22.1 m-85 -92.92 156.05 17.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.834 -0.166 . . . . 0.0 110.762 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 23.8 ttpp -124.74 136.41 53.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.371 0.605 . . . . 0.0 110.38 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.552 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -81.5 -164.95 0.85 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.174 176.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.85 -56.43 10.41 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -98.94 -1.37 40.12 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.791 -168.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.66 13.92 2.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.289 -1.434 . . . . 0.0 114.037 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 61.2 t -80.6 125.34 39.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -96.73 174.38 6.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.331 -0.547 . . . . 0.0 109.828 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -148.66 139.81 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -175.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 46.1 m -77.8 142.08 38.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.6 117.7 34.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.352 0.596 . . . . 0.0 109.8 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 1.2 mm? -112.44 98.15 42.63 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.872 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.16 104.23 0.71 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.537 2.158 . . . . 0.0 111.806 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' C' ' 66' ' ' LEU . 8.4 mt -72.13 94.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -75.43 -59.23 2.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.154 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -155.61 148.18 24.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.943 0.401 . . . . 0.0 111.573 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 32.9 mt -137.68 131.63 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.969 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -124.52 110.45 14.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.89 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.18 115.42 6.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.167 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.4 -174.89 5.44 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.039 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.23 -26.27 52.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.182 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.73 -20.64 30.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.122 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.25 -32.55 4.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.916 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -65.09 157.99 27.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.98 131.37 49.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.939 0.399 . . . . 0.0 111.623 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 71.7 m-20 -77.42 126.95 31.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.766 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -105.19 153.9 20.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -136.25 122.1 19.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.871 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -122.32 -179.3 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.17 -39.9 73.06 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.83 -73.24 0.06 OUTLIER Glycine 0 C--N 1.316 -0.582 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.713 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.89 14.88 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.862 2.374 . . . . 0.0 113.913 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -128.8 -175.77 3.64 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.92 119.77 2.1 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 0.5 OUTLIER -133.8 61.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.261 168.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -167.64 175.04 7.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.299 -169.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 26.2 p90 -73.27 133.56 43.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 82.5 mtp -108.74 144.08 37.02 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.08 136.7 47.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.394 0.616 . . . . 0.0 111.312 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.88 76.4 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.316 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.504 0.668 . . . . 0.0 109.552 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -72.33 -40.99 67.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.719 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 72.4 t -74.67 -16.83 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.32 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.58 -35.5 67.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.82 -33.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.123 0.487 . . . . 0.0 110.092 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . 0.436 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 83.1 m-85 -102.83 18.0 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.445 -172.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' C' ' 59' ' ' LYS . 0.1 OUTLIER -71.0 110.12 6.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.088 170.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 56.7 Cg_endo -96.83 -100.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.708 2.272 . . . . 0.0 112.149 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -153.48 143.4 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' C' ' 28' ' ' ALA . 69.0 t -82.49 110.31 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.049 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.52 11.12 36.55 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.824 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.58 -163.41 29.25 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.164 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -132.16 123.73 27.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 15.2 tp -100.43 156.41 17.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.1 p90 -142.13 147.35 36.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.346 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -128.83 115.46 17.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 16.0 p -96.97 163.96 12.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.398 0.618 . . . . 0.0 110.125 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -73.5 -0.41 14.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.677 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.35 -4.55 58.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.04 24.11 46.1 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.527 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.431 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 7.0 tp10 -99.9 121.32 41.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.411 ' C ' HD22 ' C' ' 75' ' ' LEU . 6.5 mp -125.76 112.34 15.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.525 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 2.8 mm? -135.11 169.68 17.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.502 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -124.25 154.56 40.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 20.4 ptp -178.12 -178.79 0.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.36 0.413 . . . . 0.0 109.992 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 9.1 p -67.48 125.83 27.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -65.92 -23.54 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -59.54 -40.62 87.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.027 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.83 51.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.4 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 11.7 t80 -68.43 -42.05 79.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.74 -27.72 68.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.19 0.519 . . . . 0.0 111.085 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.39 -34.45 63.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.193 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.47 HD22 ' N ' ' C' ' 85' ' ' ASN . 0.9 OUTLIER -97.44 -33.47 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.318 -177.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 25.6 m-85 -90.79 -57.33 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -169.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.68 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 43.5 p . . . . . 0 C--N 1.317 -0.836 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.592 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.95 163.2 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -166.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 12.8 mptt -118.69 -173.7 2.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.51 0.672 . . . . 0.0 111.742 -167.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.533 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.6 OUTLIER -127.84 -148.57 0.38 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.515 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.91 -40.98 71.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.73 -12.69 13.33 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.491 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.79 26.16 1.3 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.522 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 68.5 t -83.88 124.44 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -91.15 175.27 7.0 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.447 0.641 . . . . 0.0 110.817 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.28 134.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 37.3 m -78.19 141.04 38.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.452 ' C ' HD23 ' C' ' 24' ' ' LEU . . . -127.9 137.46 52.31 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 0.4 OUTLIER -116.16 97.57 49.78 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.41 ' HD2' ' OD2' ' C' ' 42' ' ' ASP . 33.4 Cg_exo -61.95 122.34 10.82 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.34 2.027 . . . . 0.0 111.3 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.0 mt -83.58 107.69 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -69.95 -64.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.09 159.4 36.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -139.02 141.9 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.473 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -120.74 109.09 14.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.448 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.01 108.42 15.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.088 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.83 145.95 26.97 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -61.36 -18.88 60.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.887 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.83 -20.74 57.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.15 -38.17 2.07 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.204 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -73.64 152.94 40.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.407 . . . . 0.0 111.027 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.7 128.71 25.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.4 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 24.9 p30 -80.57 149.01 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.348 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -135.37 133.39 38.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.663 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.24 138.8 54.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.192 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' C' ' 45' ' ' TYR . 53.0 m-85 -112.38 -177.48 3.17 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' C' ' 25' ' ' PRO . 6.0 p-10 -52.68 -51.61 59.51 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -172.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.64 -144.0 7.59 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.239 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.78 62.38 5.65 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.54 2.827 . . . . 0.0 111.671 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' C' ' 41' ' ' PHE . 93.7 m-85 -115.43 -173.94 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.242 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 144.34 10.89 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.755 0.788 . . . . 0.0 112.523 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.588 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 28.1 t70 -148.02 80.84 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.656 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 9.2 pt20 -152.84 158.28 41.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -166.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 78.9 m-85 -79.33 114.25 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.883 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.7 mmt -84.01 145.01 28.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.08 171.0 4.96 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.92 -48.82 67.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.226 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.464 ' O ' HG23 ' C' ' 57' ' ' VAL . 29.0 mt-30 -63.44 -31.53 72.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.262 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -73.87 -51.82 14.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.604 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 24.1 t -64.53 -31.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.414 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.02 70.97 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.198 -0.314 . . . . 0.0 111.712 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . 0.464 HG23 ' O ' ' C' ' 53' ' ' GLN . 2.9 t -97.09 -30.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . 0.439 ' CD1' HD21 ' C' ' 75' ' ' LEU . 34.9 m-85 -109.26 14.54 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.091 -171.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 18.9 ptpt -53.88 117.73 13.38 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-O 121.177 0.513 . . . . 0.0 112.383 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -105.14 -152.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 124.153 3.235 . . . . 0.0 111.291 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.67 154.49 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.63 130.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.822 0.82 . . . . 0.0 109.86 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 -10.37 39.77 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.378 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' C' ' 76' ' ' TYR . . . -98.91 -158.55 29.42 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.098 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -129.29 138.34 51.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 57.9 mt -91.34 169.55 10.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' C' ' 22' ' ' SER . 13.9 p90 -170.28 167.06 8.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.991 0.359 . . . . 0.0 110.22 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 73.8 ttt180 -151.78 129.18 11.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.573 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -110.87 159.39 17.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -70.83 -10.51 59.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.405 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -86.63 -12.32 48.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.518 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.96 7.95 28.4 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.89 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 5.6 mp0 -75.04 121.11 21.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.599 0.699 . . . . 0.0 109.572 174.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' C' ' 75' ' ' LEU . 5.5 mt -131.94 167.51 19.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.363 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' C' ' 66' ' ' LEU . 91.2 mt 84.33 -139.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.304 1.003 . . . . 0.0 112.522 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' C' ' 64' ' ' GLY . 50.9 t80 -91.59 135.51 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.468 0.652 . . . . 0.0 111.355 -165.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.6 ptm -118.49 130.18 55.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.869 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -95.77 162.57 13.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.253 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 0.0 OUTLIER -56.97 -34.77 68.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.9 p -56.13 -48.17 76.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 0.0 111.176 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . 0.557 ' HA ' HD22 ' C' ' 85' ' ' ASN . . . -73.22 -50.08 24.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.498 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.0 t80 -37.75 -62.25 0.56 Allowed 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.964 1.415 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.18 -54.44 29.55 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.96 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.11 -34.86 14.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -161.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.557 HD22 ' HA ' ' C' ' 81' ' ' ALA . 33.7 m-80 -82.46 -28.55 31.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.177 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 34.6 m-85 -99.9 -71.12 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.415 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 51.3 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.683 -173.516 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.488 HD12 ' OH ' ' C' ' 20' ' ' TYR . 47.9 mt . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.017 0.437 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 66.6 m-85 -111.82 -169.97 1.56 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -157.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 19.9 pttm -156.09 159.95 39.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 120.956 0.408 . . . . 0.0 110.2 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.752 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 21.0 p-10 -84.52 -140.56 0.07 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.858 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.04 -44.65 19.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.784 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.78 -14.13 18.15 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.938 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.17 26.66 1.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.077 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.515 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 47.9 t -77.29 125.56 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . 0.488 ' OH ' HD12 ' C' ' 12' ' ' LEU . 76.9 t80 -73.69 142.67 46.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.93 0.871 . . . . 0.0 110.779 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.08 138.99 40.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.802 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.417 ' HA ' HD13 ' C' ' 12' ' ' LEU . 7.5 m -88.86 134.91 33.79 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.203 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.67 121.53 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.275 0.56 . . . . 0.0 110.324 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.8 mp -107.5 97.35 19.25 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.437 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 19.4 Cg_exo -68.98 118.77 5.88 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.57 2.18 . . . . 0.0 111.817 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mt -82.08 100.89 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 0.1 OUTLIER -68.86 -53.07 23.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.217 179.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.88 166.49 19.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.732 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.49 146.51 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.947 0.403 . . . . 0.0 110.178 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.7 tmtp? -130.28 115.67 17.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.292 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -85.24 117.44 24.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.49 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.38 146.76 26.84 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.215 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -60.53 -17.65 47.09 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.874 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.83 -13.55 55.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.525 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 -35.23 4.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.76 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 68.5 p -62.54 140.86 58.64 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.094 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.41 123.9 48.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -91.42 114.85 27.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -99.3 111.36 23.75 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 38.4 mt-10 -73.71 102.52 3.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.531 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.06 153.98 17.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 110.161 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -119.44 127.35 53.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.04 -128.2 7.12 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.161 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.37 9.35 3.45 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.748 2.299 . . . . 0.0 112.562 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.438 ' CE2' ' HG ' ' C' ' 24' ' ' LEU . 86.0 m-85 -135.06 145.35 47.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.381 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.82 -164.37 1.13 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.508 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 5.9 p-10 -84.86 144.6 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.154 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -149.03 141.16 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.527 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -88.35 139.24 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.6 tpt -122.62 146.66 47.25 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.0 135.36 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.684 0.615 . . . . 0.0 111.576 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.39 -38.25 90.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.363 -172.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -61.76 -34.97 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.545 0.688 . . . . 0.0 109.639 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 7.2 m -73.06 -42.04 63.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.4 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 54.1 t -68.25 -22.94 27.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.429 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.27 82.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.792 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.06 -33.2 4.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.451 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.94 20.09 18.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.799 -170.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 40.0 tttm -50.98 124.28 20.54 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.474 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 50.0 Cg_endo -99.89 -153.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.527 2.818 . . . . 0.0 111.429 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -149.85 164.63 34.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.664 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.16 128.53 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.96 0.886 . . . . 0.0 109.609 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.08 49.65 Favored Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.18 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -166.08 37.4 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.123 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -124.32 126.83 46.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.329 0.585 . . . . 0.0 111.476 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 34.7 tp -97.28 155.05 17.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.9 p90 -147.65 160.97 42.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.234 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -139.17 130.53 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.705 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 96.7 p -99.78 170.0 8.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.268 0.556 . . . . 0.0 110.241 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 11.2 mm100 -69.94 -9.1 53.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.069 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -90.38 -0.8 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.151 0.5 . . . . 0.0 109.985 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 17.62 64.5 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.765 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.431 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 21.0 mm-40 -92.09 122.16 34.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.947 0.403 . . . . 0.0 110.574 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.38 130.88 43.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.941 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 73.3 mt -151.43 157.85 42.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.994 -174.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -96.25 131.07 43.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.221 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.458 ' HA ' ' CE ' ' C' ' 77' ' ' MET . 0.9 OUTLIER -143.04 140.23 30.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 110.693 178.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -69.33 158.4 35.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.744 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' C' ' 80' ' ' THR . 1.5 ptmt -55.42 -32.43 62.68 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -168.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 5.7 p -55.33 -58.94 5.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.437 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.66 74.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.805 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.16 -44.07 92.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.54 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 24.3 tt0 -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.94 -27.85 63.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.848 -167.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 11.8 m120 -105.58 -30.7 9.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.466 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -142.79 70.66 1.33 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 80.5 p . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 123.825 0.85 . . . . 0.0 109.067 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.454 HD12 ' OH ' ' C' ' 20' ' ' TYR . 93.1 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' C' ' 86' ' ' TYR . 82.0 m-85 -111.13 -167.63 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -164.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 0.0 OUTLIER -158.7 164.37 35.98 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.998 0.428 . . . . 0.0 110.03 -167.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.588 ' OD2' ' HB ' ' C' ' 19' ' ' VAL . 2.4 p30 -103.07 -139.21 0.35 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.079 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -60.39 3.48 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -161.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.25 -4.98 50.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.283 0.563 . . . . 0.0 109.808 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.87 27.92 4.41 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.767 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.588 ' HB ' ' OD2' ' C' ' 15' ' ' ASP . 62.8 t -64.73 127.57 25.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . 0.454 ' OH ' HD12 ' C' ' 12' ' ' LEU . 50.8 t80 -81.93 134.99 35.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.032 0.92 . . . . 0.0 111.091 -172.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.75 131.87 4.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.65 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -90.71 152.05 20.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.654 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.406 ' HB2' ' HE2' ' C' ' 86' ' ' TYR . . . -106.04 116.28 31.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.356 0.598 . . . . 0.0 109.696 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.67 ' O ' ' HB3' ' C' ' 66' ' ' LEU . 16.8 mt -118.2 98.92 51.74 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.213 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.571 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -66.25 152.05 82.0 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 121.655 1.57 . . . . 0.0 111.267 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mt -82.7 98.04 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.672 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -86.12 -60.79 1.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.514 -163.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' C' ' 39' ' ' ALA . . . -154.56 154.53 33.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.366 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 73.7 mt -140.79 143.05 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.472 0.653 . . . . 0.0 110.558 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -135.84 124.76 24.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.263 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -85.37 118.72 25.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 110.009 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.402 ' HB2' HD21 ' C' ' 38' ' ' ASN . . . -86.81 -163.62 0.94 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.558 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.297 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -97.8 17.24 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.09 87.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.705 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 18.2 p -72.92 138.59 46.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.863 0.363 . . . . 0.0 110.371 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -100.28 113.97 27.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 15.5 m-80 -90.07 108.26 19.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.722 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 28' ' ' ALA . . . -87.73 89.11 7.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.149 0.499 . . . . 0.0 111.233 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 38.1 mt-10 -76.55 106.47 8.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.747 -174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . 0.598 ' CG ' ' HB2' ' C' ' 45' ' ' TYR . 1.6 m-85 -59.33 138.61 57.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.549 0.69 . . . . 0.0 112.164 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.22 -33.52 16.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.619 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.12 179.48 35.48 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.775 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 56.85 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.007 2.472 . . . . 0.0 113.103 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.598 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 89.9 m-85 -131.6 -177.95 4.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.046 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.7 -179.0 6.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.224 0.535 . . . . 0.0 111.533 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -111.48 127.38 55.68 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.84 124.77 40.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.584 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -87.21 112.11 21.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . 0.418 ' CG ' ' HB3' ' C' ' 37' ' ' ALA . 22.4 ptp -110.37 129.52 55.74 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.759 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . 0.461 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.6 OUTLIER -62.35 159.42 15.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.057 -176.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.46 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' C' ' 53' ' ' GLN . 0.2 OUTLIER -58.26 -40.14 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 109.144 173.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -72.96 -40.12 65.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 79.4 t -67.56 -22.45 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.283 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.7 74.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.08 -31.44 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.487 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -113.17 19.8 16.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 52.1 tttm -48.7 107.45 0.76 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.495 0.497 . . . . 0.0 111.526 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 85.9 Cg_endo -106.03 -154.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 123.809 3.006 . . . . 0.0 111.83 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.51 153.81 45.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.687 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.47 125.0 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.926 0.87 . . . . 0.0 109.753 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.31 -10.35 28.73 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.434 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.45 -158.24 27.95 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.042 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.35 156.95 34.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.915 0.388 . . . . 0.0 111.133 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.67 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 23.5 tp -147.08 154.03 40.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.12 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -151.5 163.6 38.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -143.33 132.9 23.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 31.2 p -102.55 178.28 4.62 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.442 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -55.28 -33.71 63.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.896 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' C' ' 73' ' ' GLU . 44.7 m-85 -72.52 -5.77 39.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.3 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.38 1.93 83.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.378 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' C' ' 71' ' ' TYR . 9.4 pt-20 -91.11 140.33 29.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.269 0.557 . . . . 0.0 110.478 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.471 HD23 ' N ' ' C' ' 74' ' ' LEU . 0.6 OUTLIER -131.13 155.34 47.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.895 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.553 ' O ' HD12 ' C' ' 66' ' ' LEU . 71.6 mt -148.44 157.27 43.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -91.7 138.06 31.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.019 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.531 ' HB2' ' HB3' ' C' ' 81' ' ' ALA . 0.4 OUTLIER -162.24 -179.81 7.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.196 0.522 . . . . 0.0 111.619 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.5 p -122.49 -174.91 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.068 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' C' ' 82' ' ' PHE . 18.5 ptpt -57.04 -28.5 62.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 8.6 p -54.27 -54.96 33.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' C' ' 77' ' ' MET . . . -74.21 -33.23 63.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.9 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.62 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 2.6 t80 -50.13 -49.59 51.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.309 0.576 . . . . 0.0 109.504 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.792 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 10.8 tp10 -60.85 -45.15 95.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.187 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.6 -26.02 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' C' ' 15' ' ' ASP . 0.9 OUTLIER -91.77 -27.39 18.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.63 ' O ' HG23 ' C' ' 87' ' ' THR . 0.2 OUTLIER -167.88 78.54 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.792 ' OG1' ' HA ' ' C' ' 83' ' ' GLU . 6.6 p . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 124.142 0.977 . . . . 0.0 109.52 162.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' C' ' 22' ' ' SER . 23.1 mt . . . . . 0 CA--C 1.523 -0.07 0 CA-C-O 120.653 0.264 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' C' ' 82' ' ' PHE . 2.8 m-85 -91.7 136.96 32.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.236 -174.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.501 ' H ' ' HB3' ' C' ' 86' ' ' TYR . 93.2 mttt -116.02 105.89 13.14 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.005 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -72.44 -166.26 0.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.505 -171.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.7 -50.64 72.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -170.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.36 -6.53 14.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.16 14.07 3.42 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.602 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 97.8 t -74.23 103.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . 0.448 ' OH ' ' HE2' ' C' ' 14' ' ' LYS . 1.2 m-85 -76.7 151.68 36.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.496 1.141 . . . . 0.0 112.261 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -148.8 120.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.81 -1.995 . . . . 0.0 108.952 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.454 ' HA ' HD22 ' C' ' 12' ' ' LEU . 23.0 t -78.04 148.86 34.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.114 -177.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.57 117.87 35.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.828 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.487 ' HB2' HD13 ' C' ' 66' ' ' LEU . 2.1 mm? -99.78 114.43 65.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.666 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.32 125.97 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 55.8 mt -80.35 96.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -67.22 -45.99 75.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.137 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' C' ' 62' ' ' VAL . . . -157.25 159.49 37.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 0.0 111.988 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.5 mt -145.71 145.58 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.982 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -131.42 132.03 44.04 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -94.3 136.0 35.09 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.916 -172.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.2 131.38 56.48 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.993 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -60.34 -19.85 57.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.329 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.81 -21.74 61.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.803 0.335 . . . . 0.0 110.78 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.98 -26.35 4.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.246 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 10.1 m -72.67 161.51 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.989 0.423 . . . . 0.0 110.883 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -141.07 122.53 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 9.0 t-20 -77.26 128.92 35.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -115.17 147.95 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.211 0.529 . . . . 0.0 112.179 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.03 110.35 11.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.859 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -102.3 156.47 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.33 132.49 33.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.72 -178.93 19.54 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.252 -174.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.77 58.31 6.91 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.883 2.389 . . . . 0.0 111.857 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -122.19 -176.51 3.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.6 50.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.734 0.778 . . . . 0.0 112.908 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.0 p-10 -132.78 79.91 1.87 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -152.62 169.16 23.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.205 -164.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 50.3 p90 -92.55 138.28 31.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.054 0.454 . . . . 0.0 110.747 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.3 mmt -103.64 140.75 37.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.234 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . 0.45 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 1.3 p -61.08 154.61 22.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.422 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -30.19 71.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . 0.45 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 23.4 mp0 -58.45 -44.77 89.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.756 0.789 . . . . 0.0 109.057 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -67.89 -43.6 78.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.949 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.2 t -65.63 -27.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.585 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -29.91 69.34 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.298 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.72 -34.11 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.51 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.14 24.53 11.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 0.0 OUTLIER -46.08 117.86 4.19 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 121.299 0.571 . . . . 0.0 111.36 175.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 83.6 Cg_endo -106.37 -156.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 123.403 2.735 . . . . 0.0 111.876 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.437 ' HB2' ' CZ ' ' C' ' 76' ' ' TYR . 48.1 mt-10 -149.18 142.65 25.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.05 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' C' ' 28' ' ' ALA . 5.2 p -78.27 111.63 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.834 0.826 . . . . 0.0 109.977 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.96 -18.68 7.47 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.74 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.8 -155.11 31.47 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.402 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -131.8 142.55 49.77 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' C' ' 24' ' ' LEU . 0.0 OUTLIER -118.84 134.88 54.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 44.0 p90 -109.56 158.04 18.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.758 -172.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -134.32 129.51 35.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . 0.476 ' HA ' ' HB ' ' C' ' 21' ' ' VAL . 40.5 p -95.35 178.0 5.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.002 0.43 . . . . 0.0 111.001 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.34 -9.49 58.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.991 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -85.04 -6.34 59.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.09 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.52 12.07 78.85 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.53 127.15 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.07 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.3 pt? -130.53 140.27 50.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.074 0.464 . . . . 0.0 110.843 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.511 HD22 ' C ' ' C' ' 74' ' ' LEU . 2.1 mm? -148.22 160.81 42.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.405 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 61' ' ' GLU . 71.7 t80 -92.52 141.57 28.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' C' ' 81' ' ' ALA . 40.6 tpp -155.86 147.38 22.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 111.134 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' C' ' 77' ' ' MET . 20.3 p -89.71 158.34 17.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 13.6 ptmm? -66.91 -13.01 61.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 11.3 p -60.38 -61.83 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.511 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . 0.482 ' HB3' ' SD ' ' C' ' 77' ' ' MET . . . -69.83 -38.01 76.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.694 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.523 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -50.8 -52.92 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.265 177.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.98 -36.52 64.54 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.16 25.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.786 -169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.09 -29.15 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.303 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.501 ' HB3' ' H ' ' C' ' 14' ' ' LYS . 23.0 m-85 -103.08 -73.01 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.748 -173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 C--N 1.317 -0.822 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -167.453 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 mt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' C' ' 86' ' ' TYR . 79.8 m-85 -145.63 -161.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.144 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -146.34 145.59 30.37 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.258 0.552 . . . . 0.0 109.916 -168.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.614 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -87.67 -165.08 1.21 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.536 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.455 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.36 -52.25 54.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.31 -6.96 22.5 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -170.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.37 26.18 1.22 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.385 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.614 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.3 t -83.54 117.56 29.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.038 0.446 . . . . 0.0 110.173 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -87.69 132.84 33.97 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 109.574 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.4 OUTLIER -150.74 139.36 14.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.876 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -105.23 163.89 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.596 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.433 ' HB1' ' CD2' ' C' ' 65' ' ' TYR . . . -108.66 117.29 33.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.125 0.488 . . . . 0.0 110.335 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.472 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.4 mp -107.37 115.26 59.89 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.922 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.427 ' HB2' ' HB3' ' C' ' 42' ' ' ASP . 3.0 Cg_exo -72.22 138.4 30.42 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.744 1.63 . . . . 0.0 112.206 -173.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.56 117.42 37.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.935 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -79.03 -60.79 2.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.996 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 151.27 9.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.816 0.341 . . . . 0.0 111.131 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 54.9 mt -132.11 140.87 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.912 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.3 114.48 16.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -65.56 104.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.584 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.84 170.99 15.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.606 0.717 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -69.75 -14.08 62.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.06 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.18 -18.4 21.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.475 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.93 -37.25 2.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.103 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -60.08 146.49 42.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.434 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -112.73 120.51 41.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 37.2 m-80 -71.77 117.43 13.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.836 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -106.47 107.86 19.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 0.0 112.104 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' C' ' 47' ' ' ASP . 43.6 mt-10 -89.45 114.37 25.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.054 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -99.43 148.1 24.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.871 0.367 . . . . 0.0 110.302 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 25' ' ' PRO . 21.3 t70 -83.22 125.85 32.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 0.0 109.929 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.63 17.65 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.201 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.95 59.37 6.89 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.551 2.168 . . . . 0.0 112.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.56 -175.76 3.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.432 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.606 ' HB1' HE21 ' C' ' 48' ' ' GLN . . . -66.01 152.9 43.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.562 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.703 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 8.3 p-10 -149.7 92.01 1.87 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 168.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.629 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 40.9 mt-30 -149.44 174.7 12.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 -164.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.93 112.65 9.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.9 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 51.6 tpp -91.2 129.78 37.15 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.03 135.35 31.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.337 0.589 . . . . 0.0 111.554 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.47 95.65 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.547 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -63.75 -31.49 72.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.405 0.622 . . . . 0.0 109.903 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 19.3 m -74.11 -40.93 62.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.679 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' C' ' 37' ' ' ALA . 77.7 t -70.53 -20.78 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.423 0.63 . . . . 0.0 110.308 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.46 73.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.87 -28.0 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.677 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -106.16 15.03 26.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.209 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 55.1 pttt -51.44 114.97 5.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.5 Cg_endo -102.99 -151.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.85 3.034 . . . . 0.0 111.123 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -138.23 143.03 39.93 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -80.1 119.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.279 1.038 . . . . 0.0 109.827 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.19 20.27 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.811 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 -155.09 30.06 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.577 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . 0.433 ' CD2' ' HB1' ' C' ' 23' ' ' ALA . 50.7 m-85 -122.23 146.82 46.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.291 0.567 . . . . 0.0 112.017 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.23 136.33 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 54.5 p90 -121.77 159.53 26.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.574 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -134.85 128.09 32.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.46 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 94.6 p -103.39 -170.19 1.75 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.221 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . 0.497 ' NE2' ' HA ' ' C' ' 19' ' ' VAL . 36.4 mt-30 -65.17 -45.99 82.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.434 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.09 18.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.22 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.97 34.05 70.63 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.322 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 32.3 mt-10 -89.7 123.88 34.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.4 pt? -130.71 132.38 45.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.046 0.451 . . . . 0.0 110.169 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.5 mt -153.44 -171.14 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.721 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.77 135.54 33.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.425 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 4.9 ttp -103.76 118.04 35.78 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 111.545 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 19.1 p -106.31 -169.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -76.87 -30.87 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.491 1.041 . . . . 0.0 111.026 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.0 p -60.73 -31.58 70.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.741 0.782 . . . . 0.0 109.885 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.67 33.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.129 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' C' ' 86' ' ' TYR . 62.8 t80 -56.56 -40.61 75.48 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.356 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.53 -49.51 66.24 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.895 -0.503 . . . . 0.0 111.655 174.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.28 77.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.861 0.362 . . . . 0.0 110.952 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.547 HD22 ' HB2' ' C' ' 15' ' ' ASP . 15.1 m120 -105.12 -24.68 12.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.833 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.528 ' HA ' ' HB2' ' C' ' 13' ' ' TYR . 6.7 m-85 -120.92 33.39 5.58 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 47.4 p . . . . . 0 C--N 1.314 -0.939 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.066 178.239 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' C' ' 12' ' ' LEU . 3.4 mm? . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.692 ' HB2' HG13 ' C' ' 21' ' ' VAL . 48.4 m-85 -93.19 141.65 28.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -133.85 123.34 24.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.583 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -90.64 -164.64 1.2 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.511 -177.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.472 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -63.07 -49.72 73.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -172.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.5 -4.2 17.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.589 -0.445 . . . . 0.0 112.107 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.01 18.25 2.38 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.771 -1.204 . . . . 0.0 113.575 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.583 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.7 t -73.74 133.88 30.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.09 160.86 30.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.684 0.754 . . . . 0.0 110.995 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.79 137.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.185 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 31.4 m -78.88 151.22 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.54 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.54 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . . . -119.42 128.44 54.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.758 0.314 . . . . 0.0 110.497 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.506 HD12 HD23 ' C' ' 66' ' ' LEU . 1.5 mt -105.35 105.68 53.11 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' C' ' 42' ' ' ASP . 13.9 Cg_exo -67.65 115.25 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.101 1.867 . . . . 0.0 111.395 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 27.9 mt -78.8 111.97 16.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.237 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.415 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 53.1 tttm -85.94 -63.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.04 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.32 158.39 32.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 70.0 mt -115.51 132.78 63.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.865 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.503 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 6.0 mmpt? -91.98 94.61 9.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.029 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -84.06 112.78 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.114 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.79 135.63 33.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -58.29 -19.89 38.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.491 -172.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.8 -20.25 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.714 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.11 -45.12 1.16 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.761 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' C' ' 50' ' ' MET . 2.3 m -60.71 158.48 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.034 0.445 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -145.47 179.09 7.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.618 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 0.2 OUTLIER -162.06 127.73 3.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 173.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -92.05 129.52 37.99 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.508 -172.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -90.9 130.2 36.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.44 146.7 35.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' C' ' 25' ' ' PRO . 44.6 m-20 -78.37 88.83 4.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.132 0.492 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.3 -148.42 17.65 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.063 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.75 26.09 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.41 2.74 . . . . 0.0 112.454 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -129.59 120.09 24.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.2 -161.02 0.6 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.668 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 7.6 p-10 -76.08 126.74 31.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.11 171.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.79 104.93 3.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.618 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 9.4 m-85 -154.91 -166.45 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' C' ' 36' ' ' SER . 44.3 tpp -159.21 -67.11 0.08 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.624 0.647 . . . . 0.0 112.427 -171.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . 0.414 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.3 OUTLIER -104.09 134.13 47.87 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.29 0.567 . . . . 0.0 111.455 -175.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.53 92.31 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.584 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -65.98 -31.05 71.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.562 0.696 . . . . 0.0 109.823 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.6 m -75.24 -38.01 60.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.577 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 74.8 t -70.21 -22.15 24.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.178 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.72 80.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.21 -29.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.861 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.53 9.63 31.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.96 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 87.1 tttt -70.95 113.43 18.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.764 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -101.06 -146.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.876 3.051 . . . . 0.0 111.828 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.0 131.61 45.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.068 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.13 121.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 122.232 1.015 . . . . 0.0 109.915 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.26 -23.02 9.35 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.484 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.34 36.37 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.227 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -125.51 130.76 52.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.764 0.316 . . . . 0.0 111.436 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.506 HD23 HD12 ' C' ' 24' ' ' LEU . 8.6 tp -87.42 172.54 9.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' C' ' 22' ' ' SER . 27.4 p90 -158.43 158.14 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.462 0.573 . . . . 0.0 110.902 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 60.9 ttt180 -148.9 114.83 5.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 77.3 p -95.37 175.88 6.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.459 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.19 -8.48 56.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.813 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -90.12 -7.11 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.076 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.84 14.31 56.69 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.848 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 31.5 mt-10 -78.09 121.58 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 33.3 tp -131.36 87.0 2.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 96.5 mt -134.5 -173.98 3.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.206 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.82 153.74 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.517 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.426 ' HE3' ' HA ' ' C' ' 81' ' ' ALA . 54.6 mtm -145.15 160.9 40.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 0.0 110.675 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 18.4 p -110.75 -87.32 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.242 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -77.94 -31.38 50.93 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.287 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 3.9 p -65.67 -18.3 65.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.219 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . 0.426 ' HA ' ' HE3' ' C' ' 77' ' ' MET . . . -70.4 -50.1 42.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.787 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.28 -47.93 80.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.315 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.565 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 34.3 tt0 -60.2 -20.2 57.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.702 0.286 . . . . 0.0 111.67 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' C' ' 13' ' ' TYR . . . -93.39 -19.66 21.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' C' ' 13' ' ' TYR . 1.1 m-80 -68.85 -17.41 63.99 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.774 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.565 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 4.3 p90 -132.01 -12.01 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.507 HG23 ' CD2' ' C' ' 86' ' ' TYR . 39.5 p . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 118.563 -1.255 . . . . 0.0 113.718 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.546 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 63.2 m-85 -92.98 143.26 26.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 67.0 mttm -117.06 139.71 50.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -170.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p-10 -46.98 136.18 8.68 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.14 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.88 -55.85 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.32 167.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.72 -7.04 47.81 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.65 26.81 1.24 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.767 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 54.3 t -116.24 119.86 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -97.87 138.66 34.88 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -148.15 124.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.646 -172.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -83.17 147.77 27.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.091 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.539 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.02 128.19 53.67 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.191 0.519 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 5.2 mp -98.74 98.7 6.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.242 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.8 Cg_exo -64.77 114.8 2.91 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.159 2.573 . . . . 0.0 113.116 -174.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . 0.583 HD11 ' HG ' ' C' ' 66' ' ' LEU . 12.0 mt -84.54 99.05 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' C' ' 27' ' ' LYS . 5.7 tmtm? -63.24 -69.57 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.65 162.15 41.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.374 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.82 132.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 0.0 109.932 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.456 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 11.5 mmpt? -105.87 100.29 9.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.427 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -73.98 112.4 10.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.161 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 153.26 28.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.709 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.28 -15.62 62.92 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.046 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.26 -21.63 31.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.348 . . . . 0.0 110.669 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.66 -26.19 5.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.109 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -70.09 165.73 21.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -140.58 122.31 15.33 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.955 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' C' ' 48' ' ' GLN . 5.1 t30 -83.83 114.86 21.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -94.69 155.78 16.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.452 -172.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -130.17 119.15 22.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.071 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 14.6 m-85 -126.13 179.49 5.22 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -175.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -36.27 -55.0 0.82 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.079 0.952 . . . . 0.0 113.405 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.8 -81.82 0.06 OUTLIER Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.185 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.63 45.17 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.094 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' C' ' 41' ' ' PHE . 97.4 m-85 -138.38 -173.48 3.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.082 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.33 116.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 0.0 112.078 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 9.8 p-10 -137.83 42.71 2.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.49 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.431 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 2.0 pp0? -165.32 173.92 10.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.841 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 29.3 p90 -97.11 132.51 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -109.43 166.8 10.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.05 144.41 12.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 112.368 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.38 90.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.057 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.539 0.685 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -74.13 -39.17 63.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.67 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.98 -32.31 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.8 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.7 68.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.787 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.68 -23.25 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.351 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.64 6.78 28.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.065 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -54.9 113.33 5.21 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -92.76 -99.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.231 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -156.95 140.6 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.633 0.373 . . . . 0.0 110.011 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.84 107.85 17.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.712 0.767 . . . . 0.0 109.806 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.04 -5.53 39.35 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.727 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.87 -158.85 34.56 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.147 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.27 123.64 28.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.918 0.389 . . . . 0.0 111.067 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 20.7 mt -79.28 163.53 24.86 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 43.8 p90 -148.21 147.9 29.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -134.92 120.55 19.39 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -94.67 164.44 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -79.72 19.11 0.69 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.624 -173.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.2 -6.41 18.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.444 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.29 -5.52 55.46 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.505 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.22 123.93 33.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.178 0.513 . . . . 0.0 111.111 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.456 HD23 ' N ' ' C' ' 74' ' ' LEU . 1.5 pt? -131.43 138.69 49.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.889 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 83.3 mt -150.1 179.62 7.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -107.72 141.38 39.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 34.4 mmm -150.12 144.07 25.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.855 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 33.0 p -65.38 126.55 28.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 167.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -61.01 -27.74 68.54 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.221 -171.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 17.3 p -52.91 -47.64 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.44 -38.46 55.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.157 0.503 . . . . 0.0 111.414 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.439 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 0.8 OUTLIER -74.16 -39.94 62.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.0 110.261 -175.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.13 -26.25 68.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.185 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.27 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.966 -172.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.22 -31.55 12.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 5.1 m-85 -97.1 -69.25 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 50.2 p . . . . . 0 C--N 1.319 -0.742 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -171.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' C' ' 86' ' ' TYR . 95.4 m-85 -125.84 155.86 40.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.401 -166.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -156.51 158.38 37.09 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -165.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.592 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 9.6 p-10 -96.17 -144.82 0.28 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.616 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.24 -40.85 36.01 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.29 -18.28 17.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.625 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.67 22.29 1.84 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.475 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.592 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.9 t -66.73 107.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -84.15 143.16 29.83 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.187 0.994 . . . . 0.0 111.803 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.49 137.27 18.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.482 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 25.9 t -81.79 144.26 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.523 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -105.96 122.72 46.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.591 0.71 . . . . 0.0 110.983 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.9 mm? -101.52 96.74 6.62 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.476 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 2.6 Cg_exo -76.37 104.26 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.778 2.319 . . . . 0.0 111.527 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 44.5 mt -71.29 90.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.718 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.786 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 27.9 tptp -66.65 -51.61 54.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.814 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.62 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -166.05 166.66 17.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.821 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . 0.47 ' CG2' ' HB1' ' C' ' 37' ' ' ALA . 73.1 mt -135.62 141.62 41.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' C' ' 30' ' ' LYS . 1.5 tpmt? -104.06 99.78 9.54 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.092 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -79.94 106.68 12.15 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.53 168.4 19.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.778 0.799 . . . . 0.0 110.316 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.15 -10.36 59.2 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.414 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.37 -15.47 37.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.182 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.06 -28.71 6.51 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.977 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -72.09 158.64 35.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.762 0.315 . . . . 0.0 110.411 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.47 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -134.12 162.21 32.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.697 0.284 . . . . 0.0 111.15 -177.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 23.8 m-80 -125.92 124.04 39.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.85 106.61 18.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.238 0.542 . . . . 0.0 111.198 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.786 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 23.6 mt-10 -77.77 89.73 4.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.382 -177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -91.18 141.64 28.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.28 -8.13 9.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.59 -124.63 0.72 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.409 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.09 11.25 2.87 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.822 2.348 . . . . 0.0 113.028 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.68 161.55 36.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.879 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.73 -165.0 1.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.31 133.21 36.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 46.8 mm-40 -132.92 139.19 47.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.949 -0.114 . . . . 0.0 110.867 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -75.66 154.47 36.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.876 0.369 . . . . 0.0 110.27 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.8 ptp -150.29 128.08 11.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.575 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 151.19 44.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.665 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.99 77.35 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.91 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.32 -35.2 80.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.401 0.62 . . . . 0.0 109.788 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -71.18 -36.62 72.02 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.282 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 55.5 t -70.18 -23.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.438 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.36 -31.48 67.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.779 0.323 . . . . 0.0 111.026 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.03 -29.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.639 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -116.1 21.96 13.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 20.2 ptmt -52.71 110.82 2.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.309 0.381 . . . . 0.0 111.034 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.2 Cg_endo -100.14 -151.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.411 2.741 . . . . 0.0 111.742 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.416 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 43.0 mt-10 -138.36 131.13 29.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.358 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.62 HG13 ' HA ' ' C' ' 28' ' ' ALA . 95.6 t -72.99 105.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 0.0 109.781 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.85 -23.12 4.47 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.457 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.0 -165.22 38.05 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.878 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -116.44 135.27 53.99 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.894 0.378 . . . . 0.0 110.991 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.525 HD12 ' O ' ' C' ' 75' ' ' LEU . 36.4 tp -106.32 149.93 26.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -148.29 154.92 40.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.221 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -121.9 121.96 38.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 5.2 p -106.56 -175.45 2.8 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.019 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.08 -46.91 88.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -69.9 -8.73 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.677 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.27 41.92 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.09 136.67 48.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 110.243 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.494 ' O ' HD22 ' C' ' 75' ' ' LEU . 1.6 pt? -130.7 128.43 40.85 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.525 ' O ' HD12 ' C' ' 66' ' ' LEU . 1.6 mm? -138.97 169.51 17.65 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.792 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' C' ' 77' ' ' MET . 24.2 p90 -122.35 156.87 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' C' ' 76' ' ' TYR . 35.7 tpp -177.21 166.12 2.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.411 0.444 . . . . 0.0 110.408 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 24.9 p -77.03 -147.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.703 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -75.09 -24.75 58.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.3 p -47.92 -45.6 30.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.654 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 77' ' ' MET . . . -82.16 -33.43 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.704 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.717 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 70.5 t80 -53.96 -40.44 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 110.947 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -74.12 -45.07 51.24 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.824 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.39 -30.85 27.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.79 -13.89 11.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.717 ' CD1' ' HA ' ' C' ' 82' ' ' PHE . 0.8 OUTLIER -104.75 -11.61 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.412 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 111.682 -175.182 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 58.1 m-85 -132.95 -169.76 2.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -168.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 9.8 mtmp? -141.25 135.31 30.54 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -170.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.735 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -77.94 -169.83 1.69 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.555 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -58.28 -45.72 87.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -102.23 -9.46 20.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.193 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.66 16.58 2.74 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.222 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.577 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 44.7 t -67.88 116.38 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.14 134.8 36.19 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.775 0.798 . . . . 0.0 110.185 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.75 136.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.57 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.3 m -86.48 144.09 27.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.265 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.68 117.34 33.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.566 0.698 . . . . 0.0 109.971 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.21 104.79 54.94 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.688 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.02 122.59 9.19 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.363 2.042 . . . . 0.0 112.275 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . 0.437 HG12 ' CZ ' ' C' ' 41' ' ' PHE . 38.1 mt -78.29 110.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -77.47 -46.94 20.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -157.18 160.55 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.984 0.421 . . . . 0.0 111.817 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.1 mt -146.56 143.47 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.659 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -130.48 111.99 12.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.413 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -82.61 104.56 12.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.27 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.44 165.12 25.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.745 0.783 . . . . 0.0 110.363 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.21 -19.33 65.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.193 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -84.8 -22.05 29.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.318 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.62 -25.96 6.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.559 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 60.0 p -66.47 148.66 51.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.423 . . . . 0.0 110.772 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.23 123.89 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 5.3 t30 -87.0 120.91 28.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.56 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.698 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -96.65 160.53 14.34 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.924 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -141.66 118.5 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.798 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' C' ' 26' ' ' ILE . 50.5 m-85 -117.31 171.85 7.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.75 -57.8 4.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.097 0.475 . . . . 0.0 111.474 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.7 -168.04 33.42 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.888 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.05 41.01 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.336 2.69 . . . . 0.0 112.493 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.33 -173.32 2.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.068 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -36.06 114.77 0.3 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 124.059 0.849 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.698 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 33.4 t70 -149.02 66.12 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.244 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.681 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 2.2 pp0? -168.81 163.26 11.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.036 -168.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' C' ' 38' ' ' ASN . 96.3 m-85 -80.07 111.76 16.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tpt -86.53 145.85 26.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.35 132.09 16.61 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.777 0.673 . . . . 0.0 111.722 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.55 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.13 -35.64 79.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.627 0.727 . . . . 0.0 109.63 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.6 m -74.83 -40.16 61.22 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.577 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 44.2 t -69.04 -25.71 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.88 91.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.837 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.7 -24.7 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.101 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -116.15 14.74 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -170.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 8.9 ptpp? -52.74 116.79 9.6 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.786 0.326 . . . . 0.0 111.447 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 5.5 Cg_endo -88.2 -149.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.179 2.586 . . . . 0.0 111.477 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.2 132.06 48.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.276 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.23 106.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.96 0.886 . . . . 0.0 109.967 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.86 33.42 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.067 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.17 -159.31 25.24 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.265 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.6 121.36 40.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 tp -96.43 157.66 15.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 46.9 p90 -148.84 153.95 38.8 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.745 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -149.38 142.88 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.276 0.36 . . . . 0.0 110.254 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 20.4 p -115.08 -175.81 2.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.269 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -69.37 -35.75 76.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.889 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.69 -4.7 28.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.156 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.95 19.53 57.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.85 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -86.05 109.09 18.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 109.895 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.3 pt? -130.32 139.62 50.69 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.838 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.656 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 67.8 mt -157.94 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.208 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -118.99 144.17 46.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.445 ' CE ' ' HA ' ' C' ' 77' ' ' MET . 1.8 mmt -147.11 145.94 29.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.738 0.304 . . . . 0.0 110.75 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 29.5 p -73.33 145.5 45.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.515 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 17.6 ptpt -51.12 -31.87 20.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -167.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -59.74 -57.32 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.25 -38.77 68.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.323 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 70.7 t80 -54.62 -44.37 73.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.49 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 27.8 tt0 -56.66 -51.25 69.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.901 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.44 41.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.893 0.378 . . . . 0.0 110.688 -167.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 13.6 m120 -93.25 -33.42 13.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.026 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -148.82 66.64 1.05 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.566 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 31.1 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.261 0.553 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.72 ' HB2' HG22 ' C' ' 21' ' ' VAL . 15.4 m-30 -93.25 160.13 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.873 -168.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' C' ' 86' ' ' TYR . 55.9 mttp -138.58 120.07 14.98 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -174.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.522 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -82.25 -165.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.659 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.467 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.81 -41.69 71.24 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.42 -8.71 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.56 9.02 5.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.398 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.522 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 78.7 t -77.6 100.04 2.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -84.15 163.12 19.97 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' C' ' 13' ' ' TYR . 3.7 m -147.98 139.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.388 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.42 153.22 24.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.872 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 127.73 55.16 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.379 0.609 . . . . 0.0 110.569 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.467 HD22 ' N ' ' C' ' 24' ' ' LEU . 2.4 mm? -112.2 98.0 41.22 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.993 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' C' ' 42' ' ' ASP . 20.8 Cg_exo -66.02 118.98 5.95 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.932 2.422 . . . . 0.0 112.94 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mt -85.4 96.0 4.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.069 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 60.3 tptt -66.72 -54.44 22.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.698 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -164.23 164.77 22.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.894 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.6 144.08 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.0 110.996 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -120.28 108.2 13.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.657 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.25 106.45 15.03 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.754 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 162.77 20.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.794 0.806 . . . . 0.0 110.789 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -77.14 -11.72 59.85 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.042 -171.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.23 -12.41 43.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.93 -37.1 3.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.22 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -67.02 131.75 46.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.325 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.69 121.31 41.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.625 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.558 HD22 ' N ' ' C' ' 38' ' ' ASN . 0.8 OUTLIER -86.76 113.07 22.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.27 126.37 52.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.45 0.643 . . . . 0.0 112.359 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 39.9 mt-10 -86.26 108.25 18.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.318 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -107.66 160.81 15.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . 0.508 ' O ' ' HD2' ' C' ' 25' ' ' PRO . 1.9 m-20 -113.61 147.88 37.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.362 172.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.5 13.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.69 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 -31.12 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.808 2.339 . . . . 0.0 112.18 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -86.97 140.52 29.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.219 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.47 -162.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' HG2' ' C' ' 40' ' ' GLU . 2.1 m-20 -64.99 119.24 10.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -154.66 146.18 23.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.056 0.455 . . . . 0.0 111.627 -175.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.2 p90 -93.49 131.34 38.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.499 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.24 137.74 37.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.54 139.52 37.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.712 0.633 . . . . 0.0 111.298 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.56 75.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.473 -173.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -66.41 -34.92 79.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.53 0.681 . . . . 0.0 109.401 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m -71.98 -40.21 68.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.7 t -70.13 -26.66 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.447 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.17 79.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.87 -31.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.586 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.24 20.17 17.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' C' ' 59' ' ' LYS . 0.0 OUTLIER -49.27 110.12 1.44 Allowed Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.253 0.345 . . . . 0.0 110.413 172.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 9.7 Cg_endo -91.33 -155.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.86 2.373 . . . . 0.0 112.772 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.25 137.34 49.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.024 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' C' ' 28' ' ' ALA . 39.2 t -72.49 100.51 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.52 7.38 54.01 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.332 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.55 -166.38 40.0 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.563 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.61 130.41 56.72 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.93 0.395 . . . . 0.0 111.256 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 56.8 tp -119.07 139.53 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 29.5 p90 -146.03 156.29 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.956 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -147.44 139.27 24.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 89.7 p -110.57 179.7 4.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.89 -38.38 90.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.444 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -68.31 -18.8 64.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.093 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.29 12.78 32.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.1 119.78 25.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.0 pt? -130.91 130.62 43.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.2 mt -145.26 158.51 43.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -113.9 151.17 32.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' C' ' 81' ' ' ALA . 9.4 ttm -175.54 175.31 2.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.726 0.298 . . . . 0.0 110.455 170.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 23.6 p -81.89 -149.78 0.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.496 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.5 ptmt -66.78 -20.52 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -58.18 -64.82 0.78 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.131 0.491 . . . . 0.0 111.308 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' C' ' 77' ' ' MET . . . -62.53 -37.58 86.63 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.595 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 20.5 t80 -48.47 -55.87 9.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.532 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.832 ' HA ' ' CE2' ' C' ' 86' ' ' TYR . 35.2 tt0 -64.69 -22.21 66.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.373 0.606 . . . . 0.0 111.384 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.23 -6.53 56.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.618 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 9.9 m-80 -107.32 -39.3 5.71 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.048 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.832 ' CE2' ' HA ' ' C' ' 83' ' ' GLU . 13.2 p90 -94.75 -7.34 40.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.356 -1.338 . . . . 0.0 112.318 -173.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.596 HG23 ' CD1' ' C' ' 86' ' ' TYR . 35.0 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.388 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.769 HD13 ' HA ' ' C' ' 22' ' ' SER . 52.5 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.582 ' HA ' HG21 ' C' ' 87' ' ' THR . 7.6 m-85 -92.31 166.03 12.8 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.92 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' C' ' 87' ' ' THR . 28.3 mmmt -115.38 154.46 29.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.55 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -93.55 -167.44 1.7 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.77 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -71.64 -42.07 68.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -170.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.75 -8.52 24.15 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.131 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.61 10.08 5.09 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.907 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.55 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.0 t -71.23 141.96 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . 0.442 ' HH ' ' N ' ' C' ' 12' ' ' LEU . 8.4 t80 -91.86 136.08 33.43 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.865 0.841 . . . . 0.0 109.447 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 20.0 m -134.26 135.31 54.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.356 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.769 ' HA ' HD13 ' C' ' 12' ' ' LEU . 14.3 m -73.94 147.27 43.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.631 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.77 115.15 29.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.102 0.477 . . . . 0.0 110.67 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.92 96.91 50.54 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.326 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.669 ' O ' ' HE3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -69.59 177.01 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.488 2.126 . . . . 0.0 111.655 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . 0.661 ' HB ' ' H ' ' C' ' 63' ' ' GLY . 0.1 OUTLIER -120.29 86.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.448 0.642 . . . . 0.0 109.753 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.695 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -87.36 -54.44 4.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.268 -163.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' C' ' 40' ' ' GLU . . . -158.89 151.4 21.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.994 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.81 143.8 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.2 0.524 . . . . 0.0 110.724 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.612 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -128.82 109.07 10.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.571 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -88.72 111.43 21.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.599 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.97 171.52 14.89 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.822 0.82 . . . . 0.0 110.49 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -78.52 -8.47 58.6 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.892 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -99.46 -7.52 25.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.915 0.388 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -19.69 29.3 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.599 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.53 155.02 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 110.442 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -141.35 143.57 34.08 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.989 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' C' ' 30' ' ' LYS . 11.5 p30 -116.4 147.73 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.97 91.46 3.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.692 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' C' ' 28' ' ' ALA . 6.1 tp10 -64.16 101.34 0.4 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.859 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . 0.624 ' CD2' ' HE2' ' C' ' 27' ' ' LYS . 0.5 OUTLIER -62.36 161.9 10.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 113.396 169.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.84 -19.06 4.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.755 167.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . 0.449 ' H ' ' HD1' ' C' ' 41' ' ' PHE . . . -82.82 -150.67 9.35 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.872 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.39 35.87 0.56 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.323 2.682 . . . . 0.0 114.317 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.503 ' HB2' ' CD2' ' C' ' 41' ' ' PHE . 96.0 m-85 -140.96 -177.46 5.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' C' ' 41' ' ' PHE . . . -100.22 -164.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.634 -177.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.73 118.55 31.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -95.93 120.96 37.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 44.2 p90 -104.7 139.45 39.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.079 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.55 147.75 46.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.5 154.26 29.16 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.517 0.511 . . . . 0.0 111.704 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.01 -57.46 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -59.68 -27.72 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.415 0.626 . . . . 0.0 110.259 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.8 m -75.64 -37.26 59.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.055 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.08 -14.17 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.382 0.61 . . . . 0.0 110.061 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.44 68.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.41 -37.93 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.549 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.12 20.14 17.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.138 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 0.1 OUTLIER -49.16 114.77 4.12 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 123.515 0.509 . . . . 0.0 111.742 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' C' ' 65' ' ' TYR . 19.4 Cg_endo -98.14 -161.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 123.209 2.606 . . . . 0.0 112.289 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.585 ' O ' HG21 ' C' ' 26' ' ' ILE . 40.2 mt-10 -155.44 143.72 20.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.564 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -69.08 109.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.661 ' H ' ' HB ' ' C' ' 26' ' ' ILE . . . 93.24 15.21 52.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.011 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' C' ' 76' ' ' TYR . . . -136.79 63.79 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.947 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . 0.606 ' N ' HG12 ' C' ' 26' ' ' ILE . 0.1 OUTLIER -151.9 -171.44 3.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' C' ' 82' ' ' PHE . 0.5 OUTLIER -168.25 -79.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.24 -171.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -150.38 169.56 21.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.432 -165.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 55.8 ttt180 -151.81 131.09 12.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.153 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 97.0 p -97.02 175.38 6.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.845 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.93 -1.49 22.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.186 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -104.62 2.14 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.568 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.89 20.05 60.23 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.42 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 33.6 mt-10 -89.01 110.44 21.14 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.11 133.54 46.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.037 0.446 . . . . 0.0 110.297 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.77 167.96 18.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.676 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 64' ' ' GLY . 0.8 OUTLIER -118.71 150.6 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 19.4 ttm -179.58 -175.76 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -78.8 103.99 9.12 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 160.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.82 -26.9 62.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.612 -170.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 18.1 p -58.78 -33.91 70.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.119 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.85 -49.16 63.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 110.2 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.656 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 48.5 t80 -64.22 -53.53 47.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.819 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.07 -23.61 63.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.731 -174.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.05 -12.96 27.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.451 . . . . 0.0 110.849 -171.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -98.36 -32.1 11.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.217 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.656 ' HD1' ' O ' ' C' ' 82' ' ' PHE . 15.3 m-85 -97.84 -58.34 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.511 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.582 HG21 ' HA ' ' C' ' 13' ' ' TYR . 64.9 p . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.204 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 74.2 mt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.622 ' HA ' HG22 ' C' ' 87' ' ' THR . 50.9 m-85 -92.25 123.92 35.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.601 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -86.93 170.06 11.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.38 1.086 . . . . 0.0 111.157 -171.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -49.63 151.93 1.55 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.52 -2.127 . . . . 0.0 115.31 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.16 -54.7 2.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.113 -2.312 . . . . 0.0 108.614 163.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.43 -7.84 19.57 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.241 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.86 35.97 0.53 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.731 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.48 160.04 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.65 155.69 29.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.66 136.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.808 -170.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -74.33 154.41 38.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.57 130.88 52.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.464 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.62 98.48 49.54 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.598 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' C' ' 42' ' ' ASP . 7.4 Cg_exo -76.76 105.99 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.621 2.214 . . . . 0.0 111.202 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.59 117.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.229 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -93.71 -55.0 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.729 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.6 158.13 37.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.536 0.208 . . . . 0.0 111.062 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.56 145.23 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' C' ' 30' ' ' LYS . 27.2 mtpp -133.71 133.24 41.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.866 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -101.48 117.87 35.82 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.28 -172.62 3.88 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.144 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -74.71 -42.91 57.47 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.965 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.36 -20.23 62.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.74 -25.83 6.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.809 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 30.1 p -63.26 143.94 57.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -120.86 144.68 48.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 111.748 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 8.2 t30 -106.54 127.65 53.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.749 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -111.66 116.58 31.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.35 121.58 25.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -110.95 147.08 35.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.959 0.409 . . . . 0.0 110.629 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' C' ' 25' ' ' PRO . 21.3 t70 -101.77 150.39 23.2 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.81 -139.66 15.29 Favored Glycine 0 C--N 1.313 -0.704 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.979 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.53 28.35 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.794 2.329 . . . . 0.0 112.467 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.93 165.68 25.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.29 -162.99 0.85 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.675 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.9 p-10 -93.91 150.41 20.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 153.36 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 46.9 p90 -109.34 143.17 39.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtt -127.69 148.18 50.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.901 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 152.92 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.71 98.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.49 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -56.61 -38.66 72.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.515 0.674 . . . . 0.0 110.165 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -69.04 -44.55 72.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.565 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 49.5 t -69.62 -27.37 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.821 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.86 76.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.357 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.57 -31.66 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.504 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.8 9.98 36.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 41.6 ttmt -55.58 114.19 6.91 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 98.9 Cg_endo -98.19 -145.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 123.525 2.817 . . . . 0.0 110.68 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' C' ' 76' ' ' TYR . 42.9 mm-40 -135.86 142.77 44.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.931 0.396 . . . . 0.0 110.701 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.1 127.19 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.781 0.8 . . . . 0.0 109.543 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.59 -8.74 56.79 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 -172.9 36.96 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.955 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' C' ' 79' ' ' LYS . 58.5 m-85 -146.51 149.33 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -173.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -175.24 -144.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.565 ' HE1' ' CE1' ' C' ' 82' ' ' PHE . 6.9 p90 -153.62 -179.3 7.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -140.09 126.37 20.0 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 42.0 p -98.59 177.21 5.39 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.863 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.56 16.12 1.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.86 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -107.99 3.07 23.7 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.24 89.57 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.222 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -78.21 114.52 17.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.118 0.485 . . . . 0.0 110.899 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.511 HD13 ' N ' ' C' ' 75' ' ' LEU . 3.4 tm? -100.08 137.8 38.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.511 ' N ' HD13 ' C' ' 74' ' ' LEU . 98.3 mt -142.24 158.62 43.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' C' ' 61' ' ' GLU . 17.8 t80 -126.73 147.81 49.94 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.765 0.665 . . . . 0.0 110.461 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.527 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -166.78 175.95 7.46 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . 0.527 ' H ' ' HG3' ' C' ' 77' ' ' MET . 12.4 p -82.85 122.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 61.0 pttt -52.44 -46.68 66.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.424 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 30.9 p -51.9 -38.95 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.449 0.468 . . . . 0.0 112.164 -173.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.23 -57.08 4.27 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.294 0.569 . . . . 0.0 111.205 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.565 ' CE1' ' HE1' ' C' ' 67' ' ' PHE . 0.5 OUTLIER -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.344 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . 0.621 ' HG3' ' OG1' ' C' ' 87' ' ' THR . 12.9 tt0 -56.02 -39.89 72.62 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.851 0.46 . . . . 0.0 111.824 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.46 84.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.482 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.522 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 43.2 m-80 -98.22 -36.95 9.87 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.974 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.522 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.4 m-85 -120.99 59.77 0.93 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -171.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.622 HG22 ' HA ' ' C' ' 13' ' ' TYR . 71.9 p . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 165.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.424 ' CD2' ' HA ' ' C' ' 22' ' ' SER . 10.9 mp . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -132.83 170.16 15.7 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.678 -172.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.45 125.23 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.537 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -75.36 -167.76 0.7 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.313 0.383 . . . . 0.0 111.771 -171.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.82 -47.45 75.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.6 -13.56 31.72 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.399 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.72 17.55 2.56 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.031 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.537 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 41.7 t -67.28 110.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 109.903 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -90.76 140.15 30.06 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.451 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -139.72 136.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.365 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.424 ' HA ' ' CD2' ' C' ' 12' ' ' LEU . 22.9 m -92.26 139.68 30.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.256 175.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.07 117.24 33.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.43 0.633 . . . . 0.0 110.899 -174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.405 HD22 ' N ' ' C' ' 24' ' ' LEU . 1.4 mm? -107.12 106.81 59.3 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.699 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.35 128.05 15.83 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.277 1.985 . . . . 0.0 112.644 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.51 107.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.108 0.48 . . . . 0.0 109.921 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 76.0 tttt -76.45 -59.93 2.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.925 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.08 166.14 17.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.0 mt -144.8 141.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 110.063 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.468 ' HB3' ' ND2' ' C' ' 38' ' ' ASN . 19.3 tptm -96.33 100.0 11.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.935 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -90.95 120.87 32.3 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.03 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.93 158.11 18.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.494 0.664 . . . . 0.0 109.56 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -71.24 -10.72 60.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.714 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.07 -26.22 20.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.016 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.22 -35.36 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -63.7 152.55 38.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 0.0 110.27 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -150.3 173.8 13.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.749 -177.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 1.3 p30 -145.71 140.08 26.98 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.43 157.58 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -167.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 42.4 mt-10 -126.42 107.28 10.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.51 171.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' C' ' 46' ' ' ALA . 84.2 m-85 -100.47 151.29 21.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.17 129.98 35.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 109.77 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.55 -179.67 26.75 Favored Glycine 0 C--N 1.31 -0.917 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.755 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.92 61.35 7.6 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.771 2.314 . . . . 0.0 111.852 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -124.76 -174.05 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.59 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.447 ' O ' ' HD1' ' C' ' 41' ' ' PHE . . . -43.49 121.68 2.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.612 0.72 . . . . 0.0 112.59 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.31 59.22 1.1 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.704 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 174.51 165.14 0.23 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.278 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.65 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER -155.49 -165.7 2.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.381 161.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -160.04 -129.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.455 0.57 . . . . 0.0 111.63 -167.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.29 136.58 3.95 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.655 0.782 . . . . 0.0 112.931 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.22 67.46 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.843 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -61.15 -39.65 90.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.401 0.619 . . . . 0.0 109.337 173.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.2 m -71.19 -40.55 71.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.675 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.715 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 67.5 t -78.46 -7.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.818 -176.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.56 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.41 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.25 -33.62 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.183 0.516 . . . . 0.0 109.655 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.85 21.56 16.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -174.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 20.6 ttmm -68.21 113.99 18.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.923 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 74.3 Cg_endo -100.98 -150.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.514 2.809 . . . . 0.0 111.356 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -146.06 128.61 16.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.31 123.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.166 0.984 . . . . 0.0 110.108 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.41 -28.14 5.85 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.139 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.9 37.72 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.371 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 43.6 m-85 -112.48 135.99 52.52 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.809 0.338 . . . . 0.0 110.685 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.37 125.46 37.99 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 47.7 p90 -124.3 147.19 48.31 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.453 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.407 ' CB ' ' HG ' ' C' ' 74' ' ' LEU . 7.3 ptm180 -124.31 148.41 47.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.665 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 58.8 p -121.31 173.94 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.604 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . 0.525 ' CD ' ' H ' ' C' ' 70' ' ' GLN . 20.2 mp0 -59.58 -42.13 91.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.465 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -72.47 0.97 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.649 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.42 28.44 55.53 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.964 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.37 104.61 17.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 5.7 mp -109.74 108.72 19.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.502 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.0 mm? -129.52 175.55 8.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.449 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' C' ' 60' ' ' PRO . 35.6 p90 -122.76 146.45 47.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 46.0 tpp -153.25 139.74 18.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.911 0.386 . . . . 0.0 110.413 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -60.75 138.91 58.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.427 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.483 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 61.5 pttt -64.07 -25.27 68.03 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.3 p -61.04 -52.22 65.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 110.283 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.53 63.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.7 t80 -57.27 -42.83 82.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.639 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.32 -34.83 79.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.362 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.65 -30.43 14.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.985 -167.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.28 -30.07 67.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.475 ' CD2' ' N ' ' C' ' 86' ' ' TYR . 6.3 m-85 -100.19 -75.51 0.57 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.381 -175.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--N 1.316 -0.856 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.718 -176.353 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.468 HD22 ' H ' ' C' ' 23' ' ' ALA . 59.9 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.552 ' HB2' HG13 ' C' ' 21' ' ' VAL . 3.6 m-85 -93.04 143.25 26.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.171 0.51 . . . . 0.0 111.892 -166.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . 0.495 ' H ' HG23 ' C' ' 87' ' ' THR . 53.1 mtmt -129.45 112.47 13.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.626 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -70.18 -169.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.029 0.443 . . . . 0.0 111.873 -169.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -55.53 -53.98 49.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.438 -170.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.48 -14.26 26.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.174 0.512 . . . . 0.0 110.415 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.93 30.91 1.06 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.289 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.626 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.3 t -76.36 113.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -78.01 137.41 38.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.797 0.808 . . . . 0.0 110.528 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.44 125.82 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.355 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -88.74 162.02 16.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.468 ' H ' HD22 ' C' ' 12' ' ' LEU . . . -106.74 119.86 40.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.93 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.85 97.79 42.83 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.809 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.18 134.52 59.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.417 2.078 . . . . 0.0 111.569 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mt -76.2 93.67 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 21.9 tptm -70.57 -74.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.978 -172.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.85 143.75 24.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.865 0.364 . . . . 0.0 111.527 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.93 143.9 33.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.013 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.529 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 11.7 ptmm? -131.59 147.48 52.53 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -110.53 133.93 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.519 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.82 141.36 35.75 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.236 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -64.77 -15.09 61.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.167 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.44 -10.21 59.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.697 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.25 -34.03 4.75 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.417 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -64.45 164.38 11.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.784 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -142.12 146.15 35.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.529 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 6.3 t30 -106.42 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.485 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.58 ' HB3' ' OD1' ' C' ' 47' ' ' ASP . . . -119.35 175.91 5.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -173.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 10.3 pt-20 -160.28 144.55 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 165.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . 0.686 ' O ' ' HB2' ' C' ' 45' ' ' TYR . 88.4 m-85 -117.07 155.04 29.93 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.915 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . 0.47 ' OD1' ' HD2' ' C' ' 44' ' ' PRO . 19.9 t70 69.07 -64.06 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.121 0.968 . . . . 0.0 111.877 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.35 -73.15 0.2 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.532 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 71.6 Cg_endo -79.45 -3.96 13.33 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.798 2.332 . . . . 0.0 112.36 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . 0.686 ' HB2' ' O ' ' C' ' 41' ' ' PHE . 17.4 m-85 -85.34 155.29 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.131 0.491 . . . . 0.0 110.426 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.557 ' HB1' HE22 ' C' ' 48' ' ' GLN . . . -99.74 -174.18 2.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.023 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.58 ' OD1' ' HB3' ' C' ' 39' ' ' ALA . 14.9 t70 -174.45 -63.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.297 170.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.557 HE22 ' HB1' ' C' ' 46' ' ' ALA . 2.9 mp0 75.37 -159.3 0.05 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.027 0.931 . . . . 0.0 111.686 175.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 76.2 m-85 -75.02 140.67 43.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.377 0.608 . . . . 0.0 112.396 -172.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 44.8 ttp -129.79 148.49 51.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.401 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.67 137.26 25.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.522 0.677 . . . . 0.0 111.837 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.87 -41.27 91.16 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.956 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.79 -33.94 75.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 0.0 109.467 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -74.91 -40.65 60.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.471 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.38 -28.02 38.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.471 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.78 72.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.635 0.255 . . . . 0.0 111.041 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.374 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . 0.581 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 63.7 m-85 -95.41 14.84 21.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.596 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -81.65 99.91 0.65 Allowed Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 73.5 Cg_endo -101.07 -102.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.052 2.501 . . . . 0.0 112.917 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -143.61 123.45 13.45 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.8 t -72.18 101.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.15 -21.53 3.89 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.598 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.69 -159.6 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.163 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -124.04 120.26 31.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.059 0.456 . . . . 0.0 111.172 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.456 HD21 HD23 ' C' ' 74' ' ' LEU . 18.8 tp -93.96 154.95 17.4 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 50.9 p90 -139.47 146.99 40.71 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.563 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.99 123.76 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -172.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 25.8 p -91.81 167.29 12.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 109.957 175.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.12 11.18 0.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.38 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -109.72 -4.37 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 0.0 110.086 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.22 23.01 33.21 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.749 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 43.2 tt0 -99.22 120.44 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.456 HD23 HD21 ' C' ' 66' ' ' LEU . 6.4 mp -125.63 116.26 21.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.1 mm? -128.06 169.2 14.33 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -132.27 155.93 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.8 ptp -175.89 -175.77 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.316 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -70.58 121.05 17.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' C' ' 79' ' ' LYS . 11.7 ptmt -64.96 -24.65 67.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.75 -173.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 13.6 p -61.24 -32.13 71.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.963 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.52 -50.18 19.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.1 0.476 . . . . 0.0 111.011 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.525 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 8.0 t80 -72.89 -41.37 64.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.18 -31.71 71.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.422 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.59 -35.06 67.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.772 -171.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.21 -25.8 60.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . 0.525 ' HD2' ' O ' ' C' ' 82' ' ' PHE . 14.7 m-85 -120.54 -85.94 0.65 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.374 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.495 HG23 ' H ' ' C' ' 14' ' ' LYS . 69.5 p . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -164.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' C' ' 12' ' ' LEU . 3.4 mm? . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.627 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 30.0 m-85 -105.42 164.0 12.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.637 -170.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.44 -176.88 3.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ASP . . . . . 0.586 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -120.92 -164.35 1.1 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -61.54 -35.87 78.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.21 -11.87 12.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.3 20.04 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.935 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.586 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 55.4 t -70.05 131.35 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -82.31 141.5 32.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.779 0.799 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.81 140.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.368 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -98.59 143.35 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' C' ' 67' ' ' PHE . . . -106.5 132.75 52.16 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.712 0.768 . . . . 0.0 111.248 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.519 ' N ' HD12 ' C' ' 24' ' ' LEU . 3.3 mp -101.39 99.4 11.12 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.834 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.2 Cg_exo -64.99 105.64 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.699 2.266 . . . . 0.0 112.371 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' C' ' 66' ' ' LEU . 16.9 mt -73.25 110.88 7.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -98.1 -43.63 6.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.31 162.33 30.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -139.52 134.3 39.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 7.4 mmpt? -91.55 90.07 7.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.222 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -76.5 101.18 5.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.02 140.07 29.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.617 0.723 . . . . 0.0 110.329 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -63.63 -17.99 63.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.93 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -71.98 -18.48 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 110.805 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.5 -47.93 0.99 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.066 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 77.2 p -70.41 176.71 3.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.328 0.585 . . . . 0.0 110.969 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -155.14 -164.47 1.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.061 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.601 ' HB2' ' HA ' ' C' ' 48' ' ' GLN . 2.6 p30 -166.83 145.33 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 168.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' ALA . . . . . 0.671 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -103.61 135.39 45.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.45 119.58 39.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.476 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -111.75 144.31 41.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 110.742 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.72 -25.91 44.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.706 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.07 -178.92 48.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.502 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.52 67.47 3.67 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.686 2.257 . . . . 0.0 111.524 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.25 -174.42 3.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.752 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.87 168.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.354 1.073 . . . . 0.0 113.83 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 16.2 p-10 -148.22 51.33 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.018 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' GLN . . . . . 0.601 ' HA ' ' HB2' ' C' ' 38' ' ' ASN . 28.0 mt-30 -163.99 144.35 8.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -157.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' C' ' 37' ' ' ALA . 9.2 m-85 -148.06 -166.76 2.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 160.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -179.02 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.439 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' SER . . . . . 0.407 ' O ' HG23 ' C' ' 55' ' ' VAL . 3.9 p -86.66 105.76 17.13 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.295 0.569 . . . . 0.0 111.477 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.78 82.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.732 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.14 -35.33 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.392 0.615 . . . . 0.0 110.183 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 41.8 m -77.48 -41.0 41.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.286 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 85.9 t -74.83 -14.75 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.936 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -36.52 58.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.7 -30.18 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.268 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -103.38 14.57 31.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.843 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 24.8 pttm -60.09 119.89 45.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 59.8 Cg_endo -97.54 -150.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.362 2.708 . . . . 0.0 110.579 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -135.42 157.57 46.55 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 95.0 t -87.67 105.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.197 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 -19.63 5.44 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.135 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.5 -171.76 47.35 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.315 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.49 107.78 15.18 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.991 0.424 . . . . 0.0 110.723 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.478 HD23 HD22 ' C' ' 24' ' ' LEU . 37.1 tp -78.67 152.28 31.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 50.1 p90 -146.0 151.3 37.56 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.538 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 38.3 ttm180 -143.69 140.09 29.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.303 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p -103.27 170.78 7.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.191 0.519 . . . . 0.0 110.576 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.9 -21.41 66.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.398 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -81.36 -6.87 59.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.549 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.2 56.49 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.646 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 34.5 tt0 -87.5 121.48 29.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.55 139.41 49.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 0.0 111.249 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 93.4 mt -153.1 169.27 23.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.31 145.57 46.96 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.399 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -157.85 144.94 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.403 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -64.05 129.58 40.57 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -62.51 -27.59 69.25 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.734 -167.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -56.11 -39.59 72.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.823 0.344 . . . . 0.0 111.876 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -44.07 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.989 0.423 . . . . 0.0 111.189 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -27.19 36.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -172.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.42 -32.32 62.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.982 0.42 . . . . 0.0 110.191 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.61 -62.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.528 -171.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -75.12 -25.31 58.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -96.2 -57.69 2.27 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' THR . . . . . 0.627 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 20.4 p . . . . . 0 C--N 1.324 -0.505 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.648 0.261 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.13 71.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.735 0.778 . . . . 0.0 109.767 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -101.08 130.97 23.88 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.532 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.08 13.84 1.44 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.428 2.085 . . . . 0.0 113.15 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.5 m120 52.48 43.31 31.14 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.169 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' C' ' 7' ' ' THR . 38.7 p90 -70.05 -33.92 72.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.401 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.433 HG23 ' CE1' ' C' ' 6' ' ' PHE . 1.2 p -78.27 123.19 85.92 Favored Pre-proline 0 N--CA 1.446 -0.656 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.296 176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.42 45.31 1.56 Allowed 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.761 2.308 . . . . 0.0 112.639 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 8.7 m -77.23 -56.48 4.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.294 0.569 . . . . 0.0 109.633 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -80.56 127.53 75.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.335 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.91 102.17 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.92 1.747 . . . . 0.0 112.333 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.538 HD22 ' HA ' ' C' ' 22' ' ' SER . 8.1 mt -97.41 148.39 23.23 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.708 ' CB ' ' HA ' ' C' ' 87' ' ' THR . 52.5 m-85 -117.71 -161.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -166.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -122.63 127.98 50.06 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 -157.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.554 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -74.84 -165.92 0.42 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.184 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.481 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.73 -44.69 96.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -110.93 -9.7 14.43 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.235 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.89 23.62 1.43 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.931 -1.128 . . . . 0.0 113.445 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.554 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 77.6 t -83.57 150.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . 0.444 ' O ' ' HG2' ' C' ' 70' ' ' GLN . 0.2 OUTLIER -83.54 148.02 27.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.131 0.967 . . . . 0.0 111.084 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.0 144.9 21.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.395 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.538 ' HA ' HD22 ' C' ' 12' ' ' LEU . 22.8 t -94.93 142.93 26.9 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -109.37 119.57 39.88 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.405 0.621 . . . . 0.0 110.313 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.427 ' N ' HD12 ' C' ' 24' ' ' LEU . 5.1 mp -108.09 97.95 24.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.764 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.7 101.64 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.431 2.087 . . . . 0.0 112.233 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.4 mt -66.36 110.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.426 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' C' ' 27' ' ' LYS . 0.1 OUTLIER -81.01 -74.02 0.34 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.473 0.654 . . . . 0.0 109.496 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.94 169.97 16.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.212 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.4 mt -135.16 139.82 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.423 0.63 . . . . 0.0 110.847 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.495 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.4 tmtp? -103.04 101.4 11.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.413 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -87.87 104.78 16.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.763 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 143.84 29.57 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.546 0.688 . . . . 0.0 110.058 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -66.38 -13.13 60.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.174 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -76.22 -20.89 57.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.58 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.03 -37.63 2.26 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.496 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 69.7 p -74.85 157.77 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.96 0.41 . . . . 0.0 110.893 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.12 139.77 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 2.5 p-10 -110.02 129.23 55.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.687 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.39 125.58 38.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.263 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -89.39 118.21 28.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.25 152.03 33.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.95 32.68 5.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.641 0.734 . . . . 0.0 110.86 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' C' ' 45' ' ' TYR . . . -115.38 -137.49 6.28 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.846 172.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.85 30.07 0.44 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.553 2.169 . . . . 0.0 111.539 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' C' ' 43' ' ' GLY . 88.3 m-85 -142.45 139.81 31.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.778 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.36 -160.78 0.8 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.191 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.08 133.78 53.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 51.2 mm-40 -127.13 108.74 11.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -80.07 128.52 33.59 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.381 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.8 mmm -117.39 144.95 44.43 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . 0.569 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 0.0 OUTLIER -65.25 156.76 30.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -57.34 11.08 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -173.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.569 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 0.8 OUTLIER -61.72 -26.36 68.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.108 0.48 . . . . 0.0 110.395 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.4 m -75.76 -41.75 52.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.347 0.594 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.5 t -70.14 -17.2 20.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.382 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.2 -27.7 47.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.0 -32.2 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.364 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.96 16.19 26.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 49.4 pttt -59.53 107.09 0.86 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 111.399 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 87.7 Cg_endo -102.24 -150.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.649 2.899 . . . . 0.0 112.011 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.05 142.86 51.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.417 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.18 121.74 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 122.126 0.965 . . . . 0.0 109.683 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.63 28.8 Favored Glycine 0 C--N 1.302 -1.337 0 CA-C-N 114.591 -1.186 . . . . 0.0 112.472 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -81.27 -165.07 33.72 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.992 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -132.7 131.25 41.06 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.839 0.352 . . . . 0.0 110.713 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' C' ' 75' ' ' LEU . 8.8 tt -114.13 154.52 27.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 53.4 p90 -134.14 159.57 40.46 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.173 -0.329 . . . . 0.0 110.272 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -133.36 116.0 15.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 71.7 p -100.01 162.69 12.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.833 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 13.8 mm100 -63.25 -15.73 58.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.775 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -81.08 -10.7 59.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.79 8.98 61.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -89.63 114.62 26.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.9 pt? -126.86 128.71 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' C' ' 66' ' ' LEU . 72.8 mt -150.48 159.9 44.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.894 -173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 139.95 34.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 1.7 mmt -137.43 163.16 31.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.381 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -81.04 143.33 32.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.42 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.9 pttp -52.36 -36.45 53.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -167.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.2 p -58.7 -49.35 77.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.147 0.499 . . . . 0.0 111.356 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.79 -42.08 58.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.272 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 78.0 t80 -54.04 -52.31 61.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.93 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.65 -37.3 84.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.068 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.36 -19.6 31.19 Favored 'General case' 0 C--N 1.315 -0.929 0 O-C-N 121.869 -0.519 . . . . 0.0 111.291 -168.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.7 m-80 -113.74 -25.84 8.48 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.762 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.2 m-85 -128.66 25.57 5.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.708 ' HA ' ' CB ' ' C' ' 13' ' ' TYR . 16.7 p -150.84 -34.17 0.15 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.93 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 58.5 m -95.61 -70.35 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -170.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' C' ' 90' ' ' SER . . . 59.46 66.92 0.95 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -170.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' C' ' 89' ' ' ALA . 49.7 m 76.38 148.86 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.245 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.0 57.94 2.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.648 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 16.4 m -150.6 -43.61 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 60.9 t 69.15 -78.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.5 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.23 -7.6 24.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.24 0.543 . . . . 0.0 110.799 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 60.45 39.49 18.32 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.41 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.25 3.58 12.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.403 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -78.78 -36.41 42.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . 0.449 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 0.0 OUTLIER -79.0 -18.99 52.7 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.166 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.53 -150.2 0.43 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.187 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -85.2 -23.23 28.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.314 . . . . 0.0 110.98 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -72.45 -27.16 62.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.671 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt 57.93 22.23 8.51 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.289 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' C' ' 106' ' ' ARG . 3.0 p -142.23 44.52 1.66 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.421 0.629 . . . . 0.0 111.054 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' C' ' 98' ' ' THR . 21.0 p -83.39 -80.45 0.18 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.418 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -119.61 6.05 11.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.86 0.838 . . . . 0.0 109.181 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' C' ' 103' ' ' SER . 66.6 mtt180 -132.01 151.09 51.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.241 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p -121.23 98.78 6.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.122 0.487 . . . . 0.0 110.06 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.31 74.52 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.071 -174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 23.9 p 49.01 50.83 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.496 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.28 130.24 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 173.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 13.0 p -92.0 33.05 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.953 0.406 . . . . 0.0 111.521 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.36 -93.44 0.53 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.168 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.39 63.51 7.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.126 0.489 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.35 129.25 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.326 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.3 p -58.43 -32.76 68.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.426 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.3 9.4 58.07 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.861 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -134.45 -43.63 0.77 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.48 87.55 2.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.817 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 19.4 m -68.28 135.22 51.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 68.59 -75.92 0.06 Allowed 'General case' 0 C--N 1.346 0.413 0 C-N-CA 123.337 0.655 . . . . 0.0 111.658 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -164.24 172.78 13.14 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.46 72.47 1.26 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.755 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -68.39 149.3 49.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.959 0.409 . . . . 0.0 111.154 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.56 157.41 24.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.718 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 74.68 145.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.275 0.985 . . . . 0.0 110.24 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 39.9 t 59.52 74.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.54 . . . . 0.0 109.701 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 24.2 p 51.16 -100.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.893 -175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 75.2 mt -136.02 -40.68 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.526 0.679 . . . . 0.0 109.996 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -146.51 136.97 23.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.146 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 39.9 p -66.23 -28.88 69.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.894 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -107.6 97.66 7.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.071 174.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 46.6 m -141.24 33.35 1.7 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 0.0 109.961 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.18 44.07 0.46 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.054 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.248 1.012 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.81 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.91 -25.69 32.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 111.314 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' C' ' 6' ' ' PHE . 7.8 t-20 -126.94 78.43 73.97 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.189 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.93 -32.58 0.76 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.383 2.056 . . . . 0.0 113.672 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -123.78 25.82 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -172.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . 0.41 ' HA ' ' OD1' ' C' ' 3' ' ' ASN . 96.6 m-85 69.08 -72.07 0.11 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.949 0.5 . . . . 0.0 111.467 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' C' ' 8' ' ' PRO . 92.0 m 65.26 117.69 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.784 0.433 . . . . 0.0 111.469 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' C' ' 7' ' ' THR . 11.6 Cg_endo -54.48 103.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.92 2.414 . . . . 0.0 112.417 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -132.94 44.05 2.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.434 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.41 171.18 11.68 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.691 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.38 179.99 2.65 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.906 1.737 . . . . 0.0 110.594 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.639 ' HB2' ' CZ ' ' C' ' 20' ' ' TYR . 2.2 mm? -83.49 177.36 8.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.203 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.494 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 29.7 m-85 -95.59 -179.54 4.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -166.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 93.3 mttt -140.03 131.64 27.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -170.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -77.33 -168.41 1.13 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.736 -178.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.63 -38.29 86.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -171.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -105.85 -0.34 25.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.269 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.48 13.27 6.92 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.292 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 51.7 t -70.23 119.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 0.0 110.304 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . 0.639 ' CZ ' ' HB2' ' C' ' 12' ' ' LEU . 33.5 t80 -77.78 137.72 38.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.511 0.672 . . . . 0.0 109.736 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.6 131.75 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.54 -171.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.423 ' HA ' ' HG ' ' C' ' 12' ' ' LEU . 12.1 m -89.21 141.48 28.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.61 117.48 34.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.625 0.726 . . . . 0.0 110.647 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.464 HD22 ' N ' ' C' ' 24' ' ' LEU . 2.3 mm? -113.51 101.32 53.52 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.518 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.683 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 23.0 Cg_exo -63.46 143.01 87.19 Favored 'Trans proline' 0 C--O 1.221 -0.368 0 C-N-CA 121.678 1.585 . . . . 0.0 110.775 -174.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' C' ' 60' ' ' PRO . 72.1 mt -78.55 106.44 9.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' C' ' 25' ' ' PRO . 0.0 OUTLIER -90.83 -73.69 0.52 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.67 -162.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HB3' ' HG3' ' C' ' 40' ' ' GLU . . . -156.11 144.27 19.83 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.184 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -142.83 153.94 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.567 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -146.67 144.06 29.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -93.27 126.11 38.22 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.126 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.61 176.92 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.41 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -60.7 -52.92 63.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.438 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.44 -28.79 68.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.665 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.84 -25.19 3.76 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.328 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 40.2 m -57.18 144.9 33.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.392 . . . . 0.0 110.572 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.575 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -105.44 131.81 52.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -91.28 94.85 9.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.83 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.4 ' C ' ' HB3' ' C' ' 47' ' ' ASP . . . -83.55 156.89 22.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.118 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 7.3 pt-20 -162.34 115.91 1.77 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . 0.683 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 30.3 m-85 -60.4 154.18 21.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.539 0.685 . . . . 0.0 112.691 165.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.58 -27.83 17.11 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.219 170.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.34 170.15 52.06 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.416 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.27 67.22 2.69 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.795 2.33 . . . . 0.0 112.371 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.446 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 90.2 m-85 -133.28 -174.96 3.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.29 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' C' ' 47' ' ' ASP . . . -66.02 -160.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.255 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' C' ' 46' ' ' ALA . 3.6 m-20 99.95 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.594 1.158 . . . . 0.0 111.625 177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.08 -152.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.193 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 121.39 18.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.125 0.488 . . . . 0.0 110.158 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.06 146.56 44.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.316 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.93 136.48 51.7 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.741 0.651 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.04 92.34 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.22 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -62.64 -32.75 73.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.53 0.681 . . . . 0.0 109.518 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -73.41 -42.63 61.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.662 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' C' ' 37' ' ' ALA . 57.9 t -68.06 -26.22 33.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.747 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.39 74.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.089 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.8 -30.07 4.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.242 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.96 7.4 45.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.408 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 23.2 tptm -58.19 108.6 1.35 Allowed Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.581 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.612 ' HB2' HD13 ' C' ' 26' ' ' ILE . 54.9 Cg_endo -104.76 -148.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 124.072 3.181 . . . . 0.0 111.872 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.71 124.05 27.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.758 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.18 121.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 122.388 1.09 . . . . 0.0 110.476 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.97 -15.98 30.78 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.247 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.53 -172.12 42.74 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.953 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 95.2 m-85 -124.67 112.1 16.38 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.961 0.41 . . . . 0.0 110.778 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 22.1 tp -85.76 147.45 26.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.518 ' HB2' ' CG2' ' C' ' 21' ' ' VAL . 39.3 p90 -147.09 153.18 39.65 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.52 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 3.9 ptp85 -146.8 145.0 29.76 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.24 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 88.6 p -115.07 -177.36 3.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.014 0.435 . . . . 0.0 111.513 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' C' ' 20' ' ' TYR . 53.7 mt-30 -56.83 -42.11 79.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.814 178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -78.76 3.98 15.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.049 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.93 27.98 59.54 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.902 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 42.7 mt-10 -75.52 105.93 6.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.536 ' O ' ' HG ' ' C' ' 75' ' ' LEU . 2.9 tm? -107.85 130.18 55.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.363 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' C' ' 74' ' ' LEU . 57.7 mt -168.06 162.73 13.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.638 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -129.3 148.16 51.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 33.2 ttm -152.79 149.51 28.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.653 0.263 . . . . 0.0 111.225 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 15.7 p -68.82 146.91 52.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.144 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 21.5 pttp -56.52 -29.54 61.98 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -166.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -60.4 -55.24 35.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.306 0.574 . . . . 0.0 111.076 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.91 45.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.424 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 55.8 t80 -59.16 -49.31 78.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.069 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.528 ' HA ' HG23 ' C' ' 87' ' ' THR . 7.5 pt-20 -73.18 -32.56 64.91 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.658 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.64 -26.03 61.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.175 -172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 45.9 m-80 -99.87 -37.37 9.07 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.615 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.1 OUTLIER -135.21 72.23 1.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.528 HG23 ' HA ' ' C' ' 83' ' ' GLU . 51.0 p -165.11 -54.4 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 166.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -60.67 -77.5 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.702 -173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 45.18 55.5 6.27 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.0 110.993 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 50.7 m -147.48 175.42 10.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.255 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.55 94.0 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.384 -0.436 . . . . 0.0 113.676 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 15.7 m -66.52 -27.5 67.82 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.6 -0.353 . . . . 0.0 111.641 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 61.8 t 65.23 -81.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 123.578 0.549 . . . . 0.0 111.122 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.21 6.59 28.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.24 0.543 . . . . 0.0 109.688 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' C' ' 99' ' ' ALA . 8.1 m120 66.6 45.98 1.92 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.823 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.83 25.78 2.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.081 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -136.97 -63.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.6 t -88.29 63.69 7.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.279 1.037 . . . . 0.0 108.316 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' C' ' 95' ' ' ASN . . . -64.17 92.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.947 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.84 -36.64 56.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.963 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -91.01 -31.53 16.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.05 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 6.6 mp 64.9 163.78 0.14 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.259 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . 0.426 ' HB3' ' HB ' ' C' ' 108' ' ' ILE . 49.8 m 63.63 22.55 13.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.066 174.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 8.4 t -99.2 -2.49 36.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -173.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.73 29.33 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -136.55 14.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.557 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 4.0 p 41.87 39.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' C' ' 103' ' ' SER . 79.6 mt -77.43 97.35 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 77.1 p 58.62 28.82 17.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.693 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -89.63 140.62 29.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.8 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 3.0 p -74.74 76.01 2.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.195 0.521 . . . . 0.0 110.987 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.96 -75.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.321 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.536 ' H ' ' HB2' ' C' ' 118' ' ' ALA . . . -156.71 122.6 4.85 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.513 HG12 ' H ' ' C' ' 115' ' ' THR . 16.0 t 65.92 171.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 123.444 0.465 . . . . 0.0 109.768 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.513 ' H ' HG12 ' C' ' 114' ' ' VAL . 12.8 p -66.52 -23.1 66.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 111.581 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.81 63.64 0.15 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.378 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 16.2 t -150.23 18.23 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.083 0.468 . . . . 0.0 110.464 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . 0.536 ' HB2' ' H ' ' C' ' 113' ' ' ALA . . . -74.46 -56.19 5.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.3 p 43.02 65.15 1.0 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.25 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -73.21 154.47 40.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.401 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -157.23 169.26 25.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.57 -65.7 3.91 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.997 -1.096 . . . . 0.0 112.182 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 46.7 m 59.54 40.41 20.44 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.999 0.428 . . . . 0.0 111.22 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' C' ' 128' ' ' ILE . . . -92.45 121.04 33.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.8 -26.67 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.033 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -71.84 -74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.722 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 14.0 p -92.52 3.16 56.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.949 0.404 . . . . 0.0 110.804 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' C' ' 124' ' ' ALA . 65.3 mt 72.98 -49.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.904 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -119.67 152.03 37.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 41.1 p 50.36 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.843 0.857 . . . . 0.0 113.279 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 7.3 p -64.25 -40.72 96.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.44 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 27.4 t 179.28 -45.42 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.716 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -171.51 -138.2 2.49 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.361 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.282 179.092 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.454 ' O ' ' HD3' ' C' ' 4' ' ' PRO . . . -91.53 -6.56 52.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.919 0.39 . . . . 0.0 110.803 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -102.49 100.06 14.88 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.585 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' C' ' 2' ' ' ALA . 98.3 Cg_endo -82.09 57.35 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.8 2.333 . . . . 0.0 112.072 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -91.83 -2.96 56.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.893 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.65 22.53 0.9 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.969 0.414 . . . . 0.0 110.85 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.536 ' H ' ' HD2' ' C' ' 8' ' ' PRO . 19.8 m -118.55 -54.21 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' H ' ' C' ' 7' ' ' THR . 72.9 Cg_endo -75.41 90.96 1.08 Allowed 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 121.793 1.662 . . . . 0.0 113.49 -171.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 9.6 t -84.25 -60.91 1.94 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.97 88.9 35.68 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 172.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.03 105.37 2.06 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.226 2.617 . . . . 0.0 112.75 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.09 108.33 18.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.299 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.701 ' CB ' ' HA ' ' C' ' 86' ' ' TYR . 76.0 m-85 -140.0 -161.61 1.22 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.635 -174.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -129.09 132.82 47.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.355 -163.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.665 ' HA ' ' O ' ' C' ' 84' ' ' ALA . 3.7 p-10 -86.65 -153.0 0.19 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.734 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.68 67.69 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -167.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.88 4.21 23.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.591 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.52 24.77 6.01 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.66 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.557 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.1 t -86.84 133.03 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 140.42 36.88 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 121.881 0.848 . . . . 0.0 109.91 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.3 145.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.242 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 6.3 m -105.82 131.53 53.05 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.0 117.06 33.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.614 0.721 . . . . 0.0 110.935 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.45 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.6 mp -96.33 111.77 57.77 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 24' ' ' LEU . 6.7 Cg_exo -73.31 114.34 4.01 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.543 2.162 . . . . 0.0 112.42 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' C' ' 66' ' ' LEU . 42.0 mt -79.0 107.2 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -75.57 -57.7 3.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.172 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.33 163.29 39.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.735 0.302 . . . . 0.0 111.078 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 62.7 mt -142.01 146.67 22.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.848 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.516 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 21.1 ptmt -133.25 144.53 49.81 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.29 123.89 50.02 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.822 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.97 167.91 12.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.441 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -74.19 -11.28 60.25 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.034 -170.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -93.31 -5.87 48.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.953 0.406 . . . . 0.0 110.573 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.05 -16.83 42.2 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.793 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 55.1 m -71.46 140.99 50.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -112.85 120.24 40.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.134 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 5.7 t30 -83.3 119.26 24.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.008 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.706 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -114.22 124.94 53.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.98 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.55 131.49 54.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.021 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.84 154.68 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.835 0.35 . . . . 0.0 110.612 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -87.12 74.13 9.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.128 0.966 . . . . 0.0 110.017 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.74 -171.6 43.84 Favored Glycine 0 C--N 1.303 -1.302 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.246 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.69 50.9 3.58 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.079 2.52 . . . . 0.0 111.869 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.36 -176.55 3.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.85 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.31 166.41 18.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.854 0.835 . . . . 0.0 112.926 -174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.706 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 6.6 p-10 -149.63 85.66 1.44 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.105 172.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 77.7 mt-30 -149.12 154.68 39.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.791 -163.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 8.3 p90 -89.26 112.41 23.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.571 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 89.6 mtp -85.18 147.07 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.121 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' C' ' 53' ' ' GLN . 0.7 OUTLIER -52.06 141.09 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.996 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.87 -22.84 65.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.18 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' C' ' 51' ' ' SER . 12.1 pt20 -68.6 -38.51 80.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.9 m -77.78 -38.51 46.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.786 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -72.33 -18.58 19.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.288 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.04 -36.53 80.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.022 0.439 . . . . 0.0 110.502 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.8 -33.63 5.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.307 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -109.54 22.65 15.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -172.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 19.5 ptmt -48.79 106.07 0.57 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.4 0.437 . . . . 0.0 111.433 174.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 1.6 Cg_endo -83.83 -155.31 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.851 2.368 . . . . 0.0 112.112 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -136.0 138.85 42.66 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.598 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.9 105.02 6.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.25 11.17 60.11 Favored Glycine 0 C--N 1.315 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.089 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.2 -160.15 35.78 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.56 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.67 134.46 44.86 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.12 0.486 . . . . 0.0 111.163 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' C' ' 26' ' ' ILE . 48.1 tp -115.87 111.58 20.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.076 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -108.9 144.47 36.77 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.543 -174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.464 ' HB3' ' CD2' ' C' ' 74' ' ' LEU . 28.5 ptt180 -123.06 142.53 50.77 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.251 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 59.3 p -94.33 -174.87 3.48 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.846 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -54.46 -43.37 71.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.548 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -79.33 2.32 21.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.287 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.7 22.94 71.13 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.249 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.78 118.4 20.09 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' C' ' 68' ' ' ARG . 6.8 mt -99.97 126.92 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.259 0.552 . . . . 0.0 112.103 -174.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.42 HD22 ' C ' ' C' ' 74' ' ' LEU . 3.2 mm? -132.41 140.84 48.62 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.636 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' C' ' 77' ' ' MET . 27.1 p90 -112.98 157.41 21.54 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.508 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -178.23 166.29 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.23 0.331 . . . . 0.0 110.524 172.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' C' ' 77' ' ' MET . 6.3 p -74.52 -156.76 0.05 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.424 172.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -67.93 -41.89 81.88 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -168.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 16.8 p -44.76 -63.58 0.88 Allowed 'General case' 0 C--N 1.321 -0.633 0 O-C-N 123.75 0.656 . . . . 0.0 112.358 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . 0.402 ' HB3' ' HG2' ' C' ' 77' ' ' MET . . . -68.2 -37.18 80.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.758 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.701 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 28.9 t80 -59.72 -42.2 92.57 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.661 -178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.81 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 40.9 tt0 -62.97 -24.88 68.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.851 0.834 . . . . 0.0 110.669 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' C' ' 15' ' ' ASP . . . -89.63 2.14 55.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' HA ' ' C' ' 15' ' ' ASP . 16.7 m-80 -119.94 -19.69 7.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.978 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.81 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 5.9 p90 -115.11 7.24 15.35 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 117.802 -1.559 . . . . 0.0 113.21 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -155.34 -63.14 0.12 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.524 ' C ' ' H ' ' C' ' 90' ' ' SER . 20.0 t 68.72 -60.78 0.43 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.858 172.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' C' ' 90' ' ' SER . . . 72.95 -27.43 0.19 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.777 0.831 . . . . 0.0 110.91 -172.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.524 ' H ' ' C ' ' C' ' 88' ' ' SER . 9.2 t 163.15 -41.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.138 0.975 . . . . 0.0 108.488 -174.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.98 -118.51 0.94 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 12.9 m -89.54 80.5 6.68 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.45 -43.81 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.424 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.64 47.86 1.56 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.748 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.593 ' O ' HG22 ' C' ' 98' ' ' THR . 23.5 p30 -164.63 143.82 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.512 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.44 1.93 20.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.488 ' HA ' ' HB3' ' C' ' 101' ' ' LYS . 32.4 mt-10 -72.38 -29.32 63.65 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.593 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . 0.593 HG22 ' O ' ' C' ' 95' ' ' ASN . 5.1 t -76.14 -15.56 60.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.254 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.76 -94.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -108.12 2.61 23.1 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -170.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . 0.488 ' HB3' ' HA ' ' C' ' 97' ' ' GLU . 59.9 tttp -73.25 -52.42 14.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.719 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 mt 72.95 -45.54 0.63 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.476 0.71 . . . . 0.0 111.541 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -88.39 54.23 2.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.385 0.612 . . . . 0.0 111.127 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 97' ' ' GLU . 0.9 OUTLIER -101.17 -2.58 31.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.98 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -133.09 26.66 4.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.648 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' C' ' 106' ' ' ARG . 11.4 mmp_? 61.71 21.82 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.729 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 5.2 p -91.64 -21.74 20.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.896 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 54.1 mt 66.82 -81.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.998 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 23.3 p -92.27 2.01 56.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -173.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -124.86 148.85 48.04 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.636 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 6.8 p -82.51 70.8 9.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.192 177.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.37 46.99 92.72 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.191 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -131.68 152.17 51.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.91 0.386 . . . . 0.0 110.854 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.02 158.45 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.778 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 11.3 p -50.3 -42.35 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.27 8.79 79.21 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.404 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t 56.9 25.25 10.27 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.32 0.648 . . . . 0.0 111.333 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 60.81 20.21 10.38 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.284 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 78.2 p -110.64 163.56 13.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.312 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -98.54 41.32 1.14 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.45 0.643 . . . . 0.0 109.818 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -145.83 151.6 38.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.677 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.63 0.92 88.3 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.158 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 14.1 m -64.12 -53.68 45.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.09 0.156 . . . . 0.0 110.603 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 53.11 65.08 1.62 Allowed 'General case' 0 C--O 1.234 0.244 0 O-C-N 123.561 0.538 . . . . 0.0 111.742 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -112.99 148.15 35.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 29.8 t -113.39 82.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.88 -57.53 2.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.148 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 21.2 mt 52.39 62.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.398 0.618 . . . . 0.0 110.269 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -84.95 78.92 9.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 22.5 p 46.94 64.04 1.7 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.646 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 16.0 p -72.68 -55.96 6.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.482 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 24.2 p -135.05 -40.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.878 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.2 16.38 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.722 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.46 178.526 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.51 33.57 20.51 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.63 0.581 . . . . 0.0 112.114 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -124.31 138.69 31.35 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.86 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.62 -63.23 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.155 1.903 . . . . 0.0 112.111 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 47.49 53.55 10.9 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.309 0.644 . . . . 0.0 111.221 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -75.06 153.4 38.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.074 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.434 ' HB ' ' HD3' ' C' ' 8' ' ' PRO . 3.6 m -53.86 -52.91 63.53 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' C' ' 7' ' ' THR . 96.6 Cg_endo -76.22 50.13 2.79 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.305 2.003 . . . . 0.0 113.207 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 56.47 0.82 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 110.144 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -63.07 154.8 76.02 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.06 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.29 102.49 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.17 1.914 . . . . 0.0 110.657 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.61 -178.94 5.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.321 0.581 . . . . 0.0 111.264 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.629 ' HB3' ' O ' ' C' ' 86' ' ' TYR . 26.5 m-85 -106.83 162.85 13.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.373 -169.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.498 ' H ' ' HA ' ' C' ' 87' ' ' THR . 98.8 mttt -150.09 152.82 35.39 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.837 0.827 . . . . 0.0 111.734 -164.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.578 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.2 OUTLIER -90.65 -156.99 0.46 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.735 175.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.91 -51.85 55.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -171.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.27 -8.36 23.55 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.564 -170.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.77 16.63 2.7 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.763 -1.208 . . . . 0.0 113.206 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.578 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 76.3 t -76.9 101.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 173.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' C' ' 14' ' ' LYS . 2.8 p90 -81.19 168.58 18.37 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.627 0.727 . . . . 0.0 110.511 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 m -146.89 140.37 19.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.179 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.9 t -86.44 141.65 28.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -108.28 117.4 34.04 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.453 0.644 . . . . 0.0 110.598 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.427 HD22 ' N ' ' C' ' 24' ' ' LEU . 1.5 mm? -104.25 100.52 22.01 Favored Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.354 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.447 ' HB2' ' OD1' ' C' ' 42' ' ' ASP . 16.3 Cg_exo -68.42 121.1 8.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.316 2.011 . . . . 0.0 112.358 -172.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' C' ' 60' ' ' PRO . 40.0 mt -79.87 101.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.194 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 22.8 ttmm -67.92 -69.31 0.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.443 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.86 148.21 23.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.778 0.323 . . . . 0.0 111.143 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 41.3 mt -132.16 151.81 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.131 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -135.68 116.45 14.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.268 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -91.98 119.3 31.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.084 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.4 161.84 13.91 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.994 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -69.59 -11.64 61.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.011 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -88.81 -13.86 38.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 -31.22 6.72 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.741 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -68.44 141.58 55.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.95 55.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 8.1 t30 -88.95 116.37 27.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.061 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.57 162.37 14.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.477 ' CA ' ' HB3' ' C' ' 47' ' ' ASP . 38.4 mt-10 -154.07 127.25 8.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.4 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.02 155.88 17.24 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' C' ' 25' ' ' PRO . 6.0 p-10 -110.41 171.45 7.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 168.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.68 -155.9 23.54 Favored Glycine 0 C--N 1.307 -1.05 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -169.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.37 39.8 0.87 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.671 2.247 . . . . 0.0 112.021 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.96 159.53 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 111.724 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.48 179.93 3.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.077 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.477 ' HB3' ' CA ' ' C' ' 40' ' ' GLU . 3.8 t0 -167.62 169.5 11.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 165.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -149.49 179.75 7.72 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.475 -158.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.6 p90 -85.57 125.38 33.05 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 95.3 mmm -122.25 156.58 33.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.945 0.403 . . . . 0.0 111.487 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.75 151.9 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.355 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.13 77.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.36 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -60.09 -38.87 84.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.465 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.4 m -73.32 -41.23 63.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.965 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -77.55 -12.07 13.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.87 61.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.984 0.421 . . . . 0.0 110.253 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.38 -33.9 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.035 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -105.11 22.63 15.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.941 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 53.6 pttt -53.86 107.53 0.88 Allowed Pre-proline 0 N--CA 1.467 0.402 0 O-C-N 123.518 0.512 . . . . 0.0 111.011 173.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.504 ' HB2' HD13 ' C' ' 26' ' ' ILE . 6.9 Cg_endo -93.61 -156.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.159 2.572 . . . . 0.0 112.367 -177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -143.4 130.44 20.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.992 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.42 100.66 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.133 0.492 . . . . 0.0 110.227 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.49 -25.39 5.1 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.312 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.27 -165.28 37.66 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.194 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.26 126.39 48.07 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.655 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tt -93.37 140.07 29.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 45.4 p90 -137.37 159.66 41.3 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.675 -173.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 48.0 ttt180 -139.19 135.65 34.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.784 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 87.0 p -107.33 -178.63 3.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.98 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.42 -28.63 69.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -75.62 -14.46 60.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.581 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 20.86 34.79 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.827 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 7.1 tp10 -69.44 101.03 1.48 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt -103.36 108.45 19.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.644 0.735 . . . . 0.0 110.972 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 98.6 mt -146.46 177.39 9.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.149 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -130.18 143.68 50.92 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -148.62 136.16 20.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.994 0.426 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -69.4 150.57 47.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.166 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.25 -38.87 59.36 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -166.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.31 -59.02 4.9 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.888 0.375 . . . . 0.0 111.824 -176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.17 -33.3 61.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.773 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.504 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 56.4 t80 -58.99 -47.53 84.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.171 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.59 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 4.7 tp10 -62.64 -40.95 98.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.421 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.94 -18.43 40.08 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.819 -0.55 . . . . 0.0 111.613 -166.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.451 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 35.1 m-80 -121.09 -31.53 4.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.629 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 2.3 m-85 -117.91 13.84 14.09 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -171.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.6 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 13.7 p -143.13 -53.11 0.38 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.647 0.658 . . . . 0.0 109.586 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 4.5 t -86.57 159.4 19.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 174.71 -50.88 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 46.9 t 73.2 -52.91 0.7 Allowed 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.873 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.74 -38.76 3.17 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . 0.483 ' HB3' ' OE1' ' C' ' 97' ' ' GLU . 16.0 m -77.22 8.07 4.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 111.4 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.79 -55.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -114.83 16.02 17.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -166.01 -53.32 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' C' ' 92' ' ' SER . . . -74.2 5.3 4.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' C' ' 92' ' ' SER . 32.2 mt-10 -144.81 58.71 1.31 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 30.7 p 69.75 -35.6 0.32 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.177 1.391 . . . . 0.0 113.974 172.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.02 27.62 14.26 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 122.796 0.439 . . . . 0.0 110.879 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.58 -69.09 0.22 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.787 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' C' ' 103' ' ' SER . 0.1 OUTLIER -111.45 -17.83 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.259 -0.276 . . . . 0.0 110.956 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.79 -11.49 0.33 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.597 0.759 . . . . 0.0 111.849 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . 0.528 ' H ' ' HG3' ' C' ' 101' ' ' LYS . 53.9 p 53.4 37.87 26.56 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.283 1.033 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 25.8 p -69.29 -13.31 62.32 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.97 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -49.57 75.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.001 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -118.35 0.42 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.662 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 37.9 p 47.72 53.01 11.91 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.168 -172.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.61 67.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . 0.419 ' HA ' ' OG ' ' C' ' 103' ' ' SER . 5.0 p -16.05 74.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 O-C-N 125.316 1.635 . . . . 0.0 115.317 -172.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.42 HD11 HG23 ' C' ' 115' ' ' THR . 1.8 mm? -126.47 122.47 35.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.505 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 11.4 p -110.15 -35.15 6.18 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.094 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.8 147.18 18.48 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . 70.64 -37.42 0.39 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.59 0.756 . . . . 0.0 112.399 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.432 ' O ' HG12 ' C' ' 114' ' ' VAL . 23.5 t 72.84 2.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.333 0.587 . . . . 0.0 110.876 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.42 HG23 HD11 ' C' ' 110' ' ' LEU . 19.2 p 48.99 33.54 4.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.204 -178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.73 -100.7 0.2 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.514 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 16.5 t -118.38 21.69 12.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.059 0.456 . . . . 0.0 109.903 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 55.9 41.2 30.26 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.564 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 8.9 m -78.31 73.63 4.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.732 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -74.39 -41.01 61.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 110.177 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -150.7 -68.37 0.19 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.111 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.62 -175.7 17.99 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.581 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 23.5 p -119.35 129.95 55.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.48 15.35 8.72 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -102.76 -7.08 21.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 0.0 110.614 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 55.2 t 66.3 -80.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.775 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 2.7 p -139.82 -72.64 0.37 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.284 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 18.3 mm 57.1 35.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 122.007 0.908 . . . . 0.0 109.298 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -98.11 -31.3 12.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.344 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.7 p -88.65 58.31 4.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.552 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' C' ' 132' ' ' SER . 22.2 p -81.73 -64.72 1.12 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' C' ' 131' ' ' THR . 15.3 t 174.68 -34.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.032 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.12 -151.56 22.69 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.623 178.196 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.38 -61.22 1.9 Allowed 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.874 0.845 . . . . 0.0 110.398 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -128.06 88.85 51.88 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.869 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.8 -61.45 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.839 2.36 . . . . 0.0 112.876 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' C' ' 7' ' ' THR . 40.2 m-80 -148.92 -59.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.525 0.202 . . . . 0.0 111.297 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' C' ' 5' ' ' ASN . 59.4 m-85 71.92 -36.27 0.35 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.746 0.818 . . . . 0.0 111.7 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.419 ' H ' ' C ' ' C' ' 5' ' ' ASN . 8.0 t -148.56 134.69 9.88 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.803 0.335 . . . . 0.0 110.17 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.47 -10.81 25.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.541 2.161 . . . . 0.0 111.931 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -96.99 74.62 2.61 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.661 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -64.8 123.65 84.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.56 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.49 142.09 10.32 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.611 2.207 . . . . 0.0 112.613 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.7 mp -104.34 166.85 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.68 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 22.1 m-85 -92.92 156.05 17.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.834 -0.166 . . . . 0.0 110.762 -172.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 23.8 ttpp -124.74 136.41 53.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.371 0.605 . . . . 0.0 110.38 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.552 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -81.5 -164.95 0.85 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.174 176.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.476 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -66.85 -56.43 10.41 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -172.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' C' ' 96' ' ' ALA . 1.6 p-10 -98.94 -1.37 40.12 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.791 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.66 13.92 2.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.289 -1.434 . . . . 0.0 114.037 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 61.2 t -80.6 125.34 39.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -96.73 174.38 6.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.331 -0.547 . . . . 0.0 109.828 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -148.66 139.81 17.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -175.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 46.1 m -77.8 142.08 38.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.454 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.6 117.7 34.74 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.352 0.596 . . . . 0.0 109.8 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 1.2 mm? -112.44 98.15 42.63 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.872 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.16 104.23 0.71 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.537 2.158 . . . . 0.0 111.806 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' C' ' 66' ' ' LEU . 8.4 mt -72.13 94.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -75.43 -59.23 2.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.154 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -155.61 148.18 24.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.943 0.401 . . . . 0.0 111.573 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 32.9 mt -137.68 131.63 43.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.969 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -124.52 110.45 14.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.89 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.18 115.42 6.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.167 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.4 -174.89 5.44 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.039 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.23 -26.27 52.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.182 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.73 -20.64 30.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.843 0.354 . . . . 0.0 111.122 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.25 -32.55 4.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.916 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -65.09 157.99 27.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.98 131.37 49.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.939 0.399 . . . . 0.0 111.623 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 71.7 m-20 -77.42 126.95 31.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.766 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -105.19 153.9 20.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.398 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -136.25 122.1 19.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.871 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -122.32 -179.3 4.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.17 -39.9 73.06 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.83 -73.24 0.06 OUTLIER Glycine 0 C--N 1.316 -0.582 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.713 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.89 14.88 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.862 2.374 . . . . 0.0 113.913 -173.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -128.8 -175.77 3.64 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.92 119.77 2.1 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 0.5 OUTLIER -133.8 61.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.261 168.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -167.64 175.04 7.27 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.299 -169.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 26.2 p90 -73.27 133.56 43.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 82.5 mtp -108.74 144.08 37.02 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.08 136.7 47.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.394 0.616 . . . . 0.0 111.312 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.88 76.4 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.316 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.504 0.668 . . . . 0.0 109.552 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 11.5 m -72.33 -40.99 67.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.719 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 72.4 t -74.67 -16.83 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.32 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.58 -35.5 67.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 t -93.82 -33.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.123 0.487 . . . . 0.0 110.092 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . 0.436 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 83.1 m-85 -102.83 18.0 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.445 -172.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' C' ' 59' ' ' LYS . 0.1 OUTLIER -71.0 110.12 6.59 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.088 170.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 56.7 Cg_endo -96.83 -100.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.708 2.272 . . . . 0.0 112.149 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -153.48 143.4 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.019 0.438 . . . . 0.0 110.586 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' C' ' 28' ' ' ALA . 69.0 t -82.49 110.31 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.049 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.52 11.12 36.55 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 113.824 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.58 -163.41 29.25 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.164 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -132.16 123.73 27.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 15.2 tp -100.43 156.41 17.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.1 p90 -142.13 147.35 36.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.346 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -128.83 115.46 17.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 16.0 p -96.97 163.96 12.74 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.398 0.618 . . . . 0.0 110.125 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -73.5 -0.41 14.97 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.677 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.35 -4.55 58.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.04 24.11 46.1 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.527 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.431 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 7.0 tp10 -99.9 121.32 41.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.411 ' C ' HD22 ' C' ' 75' ' ' LEU . 6.5 mp -125.76 112.34 15.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.525 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 2.8 mm? -135.11 169.68 17.06 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.502 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -124.25 154.56 40.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 20.4 ptp -178.12 -178.79 0.68 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.36 0.413 . . . . 0.0 109.992 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 9.1 p -67.48 125.83 27.39 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -65.92 -23.54 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 7.7 p -59.54 -40.62 87.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.027 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.7 -46.83 51.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.4 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 11.7 t80 -68.43 -42.05 79.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.63 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.74 -27.72 68.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.19 0.519 . . . . 0.0 111.085 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.39 -34.45 63.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.193 -169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.47 HD22 ' N ' ' C' ' 85' ' ' ASN . 0.9 OUTLIER -97.44 -33.47 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.318 -177.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 25.6 m-85 -90.79 -57.33 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -169.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.68 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 43.5 p -84.29 -38.0 20.99 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.592 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 4.9 t -82.11 170.21 15.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.023 0.439 . . . . 0.0 110.894 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 58.4 29.66 18.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.012 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -113.25 0.22 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.803 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.32 96.88 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.588 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . 0.52 ' H ' ' HG3' ' C' ' 97' ' ' GLU . 37.9 m 70.69 -6.05 1.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.419 0.688 . . . . 0.0 112.147 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -79.74 -18.3 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.51 0.671 . . . . 0.0 109.706 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.84 -12.32 59.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.781 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.468 HD22 ' N ' ' C' ' 95' ' ' ASN . 0.9 OUTLIER 72.93 -41.85 0.52 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.485 174.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' C' ' 17' ' ' ASP . . . -72.1 10.25 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.05 0.453 . . . . 0.0 111.18 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' C' ' 92' ' ' SER . 77.4 mm-40 -79.51 -11.86 59.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 2.1 m 65.49 26.6 11.79 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.346 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.7 -164.57 0.25 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.423 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -85.66 -37.52 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.955 0.407 . . . . 0.0 110.848 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -76.19 -15.34 60.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.99 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 84.8 mt 60.81 -97.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.003 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 7.5 p -151.78 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.256 0.55 . . . . 0.0 112.08 -177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -88.9 -81.74 0.26 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.724 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.69 12.53 1.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.586 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -99.0 -63.29 1.14 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.498 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' C' ' 110' ' ' LEU . 34.5 p -72.31 -78.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.372 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm 72.54 -47.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.181 0.592 . . . . 0.0 111.659 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 21.6 p -81.24 -6.12 58.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.991 0.424 . . . . 0.0 111.767 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' C' ' 107' ' ' THR . 4.6 mm? -94.24 34.59 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.433 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 22.9 p -88.82 123.55 33.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.325 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.63 -92.39 1.1 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.222 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.31 51.73 1.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.553 0.216 . . . . 0.0 110.674 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 60.2 t 66.03 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.454 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 p -80.56 48.83 1.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.73 -86.68 0.11 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.223 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 8.6 t -149.35 77.59 1.35 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 70.72 -64.64 0.37 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.595 0.758 . . . . 0.0 112.125 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 62.9 p -120.51 -170.7 2.03 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -56.83 -54.37 47.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.519 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -129.54 -70.09 0.66 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.998 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.23 -166.76 31.33 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.4 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 6.0 t 60.08 41.15 17.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.671 . . . . 0.0 110.474 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.37 0.38 55.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.197 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -86.44 36.73 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.793 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.24 95.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.285 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 15.5 p -87.08 -50.89 6.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.208 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 55.1 mt 59.71 75.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.528 0.68 . . . . 0.0 109.868 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -73.78 -22.71 59.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.562 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 24.9 p -77.33 111.51 13.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 5.2 p -73.88 -26.56 60.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.16 0.505 . . . . 0.0 110.373 177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -155.98 -42.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.877 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.72 -100.41 0.49 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.066 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.805 -178.462 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.772 0.32 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 -57.88 2.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.027 0.441 . . . . 0.0 111.387 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.453 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 57.9 m-80 -63.0 -52.55 62.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.267 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' C' ' 3' ' ' ASN . 38.1 Cg_endo -66.42 -20.65 54.51 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.882 1.722 . . . . 0.0 112.788 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -111.59 47.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.158 0.504 . . . . 0.0 110.174 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -66.62 148.01 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.75 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -114.35 89.41 17.71 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -85.62 3.07 7.35 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.946 2.431 . . . . 0.0 113.833 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -57.27 -46.0 83.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 0.0 110.769 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -103.19 128.79 26.84 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.449 ' C ' HD12 ' C' ' 12' ' ' LEU . 72.1 Cg_endo -82.43 99.27 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.795 1.664 . . . . 0.0 112.58 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.449 HD12 ' C ' ' C' ' 11' ' ' PRO . 8.4 mp -133.17 153.93 51.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -102.95 163.2 12.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -166.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 12.8 mptt -118.69 -173.7 2.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.51 0.672 . . . . 0.0 111.742 -167.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.533 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.6 OUTLIER -127.84 -148.57 0.38 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.515 178.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.91 -40.98 71.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -112.73 -12.69 13.33 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.491 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.79 26.16 1.3 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.522 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.533 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 68.5 t -83.88 124.44 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -91.15 175.27 7.0 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.447 0.641 . . . . 0.0 110.817 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.28 134.35 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 37.3 m -78.19 141.04 38.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.452 ' C ' HD23 ' C' ' 24' ' ' LEU . . . -127.9 137.46 52.31 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -173.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 0.4 OUTLIER -116.16 97.57 49.78 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.41 ' HD2' ' OD2' ' C' ' 42' ' ' ASP . 33.4 Cg_exo -61.95 122.34 10.82 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.34 2.027 . . . . 0.0 111.3 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 52.0 mt -83.58 107.69 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -69.95 -64.28 0.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.09 159.4 36.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -139.02 141.9 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.473 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -120.74 109.09 14.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.448 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.01 108.42 15.49 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.088 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.83 145.95 26.97 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -61.36 -18.88 60.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.887 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.83 -20.74 57.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.759 0.314 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.15 -38.17 2.07 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.204 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -73.64 152.94 40.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.956 0.407 . . . . 0.0 111.027 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.7 128.71 25.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.4 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 24.9 p30 -80.57 149.01 30.09 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.348 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -135.37 133.39 38.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.663 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -125.24 138.8 54.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.192 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' C' ' 45' ' ' TYR . 53.0 m-85 -112.38 -177.48 3.17 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . 0.41 ' OD2' ' HD2' ' C' ' 25' ' ' PRO . 6.0 p-10 -52.68 -51.61 59.51 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -172.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.64 -144.0 7.59 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.239 -172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.78 62.38 5.65 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.54 2.827 . . . . 0.0 111.671 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' C' ' 41' ' ' PHE . 93.7 m-85 -115.43 -173.94 2.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.242 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.62 144.34 10.89 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.755 0.788 . . . . 0.0 112.523 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.588 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 28.1 t70 -148.02 80.84 1.48 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.656 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 9.2 pt20 -152.84 158.28 41.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -166.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 78.9 m-85 -79.33 114.25 18.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.883 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.7 mmt -84.01 145.01 28.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.08 171.0 4.96 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.92 -48.82 67.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.226 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.464 ' O ' HG23 ' C' ' 57' ' ' VAL . 29.0 mt-30 -63.44 -31.53 72.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.262 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -73.87 -51.82 14.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.604 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 24.1 t -64.53 -31.58 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.414 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.02 70.97 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.198 -0.314 . . . . 0.0 111.712 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . 0.464 HG23 ' O ' ' C' ' 53' ' ' GLN . 2.9 t -97.09 -30.2 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . 0.439 ' CD1' HD21 ' C' ' 75' ' ' LEU . 34.9 m-85 -109.26 14.54 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.091 -171.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 18.9 ptpt -53.88 117.73 13.38 Favored Pre-proline 0 N--CA 1.468 0.471 0 CA-C-O 121.177 0.513 . . . . 0.0 112.383 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -105.14 -152.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 124.153 3.235 . . . . 0.0 111.291 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.67 154.49 45.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.63 130.45 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.822 0.82 . . . . 0.0 109.86 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 -10.37 39.77 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.378 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' C' ' 76' ' ' TYR . . . -98.91 -158.55 29.42 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.098 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -129.29 138.34 51.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 57.9 mt -91.34 169.55 10.71 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' C' ' 22' ' ' SER . 13.9 p90 -170.28 167.06 8.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.991 0.359 . . . . 0.0 110.22 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 73.8 ttt180 -151.78 129.18 11.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.573 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 91.6 p -110.87 159.39 17.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -70.83 -10.51 59.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.405 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -86.63 -12.32 48.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.518 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.96 7.95 28.4 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.89 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 5.6 mp0 -75.04 121.11 21.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.599 0.699 . . . . 0.0 109.572 174.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' C' ' 75' ' ' LEU . 5.5 mt -131.94 167.51 19.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.363 -175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' C' ' 66' ' ' LEU . 91.2 mt 84.33 -139.83 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.304 1.003 . . . . 0.0 112.522 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' C' ' 64' ' ' GLY . 50.9 t80 -91.59 135.51 33.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.468 0.652 . . . . 0.0 111.355 -165.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.6 ptm -118.49 130.18 55.79 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.869 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -95.77 162.57 13.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.253 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 0.0 OUTLIER -56.97 -34.77 68.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.9 p -56.13 -48.17 76.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.202 0.525 . . . . 0.0 111.176 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . 0.557 ' HA ' HD22 ' C' ' 85' ' ' ASN . . . -73.22 -50.08 24.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.498 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.0 t80 -37.75 -62.25 0.56 Allowed 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.964 1.415 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.18 -54.44 29.55 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.96 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.11 -34.86 14.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -161.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.557 HD22 ' HA ' ' C' ' 81' ' ' ALA . 33.7 m-80 -82.46 -28.55 31.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.177 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 34.6 m-85 -99.9 -71.12 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.415 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 51.3 p -83.89 -46.7 11.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.683 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 9.6 t 60.81 -165.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.239 0.542 . . . . 0.0 111.426 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 177.0 -48.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.113 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -141.96 43.6 1.69 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.862 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.39 -79.67 0.54 Allowed Glycine 0 C--N 1.32 -0.347 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.433 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . 0.44 ' HB2' ' ND2' ' C' ' 95' ' ' ASN . 4.4 m -79.63 -17.02 54.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.148 0.499 . . . . 0.0 109.722 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' C' ' 92' ' ' SER . 90.1 t 78.53 -62.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.542 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.09 -25.6 13.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.493 0.663 . . . . 0.0 110.31 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' C' ' 92' ' ' SER . 9.1 m120 59.16 30.42 20.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.529 171.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -110.68 9.84 22.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -117.68 7.77 12.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.324 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.0 m 57.41 55.04 6.05 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.276 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.98 44.66 2.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.855 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . 0.426 ' HA ' ' OG ' ' C' ' 92' ' ' SER . 4.7 p-10 -75.45 -11.33 60.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.946 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -88.03 -25.67 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.804 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 7.8 mp 61.64 -80.75 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.703 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 47.7 m -128.84 -3.0 5.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.723 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 20.3 p -86.29 123.5 31.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.722 0.296 . . . . 0.0 110.785 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 73.41 -37.01 0.37 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.735 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -138.35 124.01 19.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 37.5 p -84.14 66.81 9.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.321 0.582 . . . . 0.0 110.589 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mt -64.74 -28.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.181 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 31.3 p -83.99 -0.03 49.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' C' ' 110' ' ' LEU . 4.1 mm? 59.12 39.12 23.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.7 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 7.6 p -79.28 34.89 0.26 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.543 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.36 -83.49 0.96 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -136.94 -92.79 0.23 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.526 0.203 . . . . 0.0 110.56 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' C' ' 117' ' ' SER . 6.7 t -140.6 155.48 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -48.76 77.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 111.495 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.95 71.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.485 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . 0.516 ' HB3' HG11 ' C' ' 114' ' ' VAL . 33.1 t -148.76 -66.96 0.23 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.837 -0.214 . . . . 0.0 110.988 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.25 -57.01 14.05 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.837 0.351 . . . . 0.0 111.587 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 14.4 m -115.95 30.52 7.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.258 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 59.0 -152.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.933 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.15 -34.14 24.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.75 -71.98 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.905 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 7.9 p -128.12 139.93 52.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.01 -45.61 11.28 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -100.88 -17.8 16.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.788 0.327 . . . . 0.0 111.238 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.7 76.08 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.054 0.454 . . . . 0.0 110.768 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 31.8 p -105.37 112.04 24.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.142 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.2 -45.11 16.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.763 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -105.21 -40.18 5.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' C' ' 133' ' ' GLY . 21.0 p -83.08 43.79 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.417 -172.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 1.9 p -78.72 68.63 4.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.195 0.522 . . . . 0.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 29.6 t 174.0 -33.58 0.0 OUTLIER 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' C' ' 130' ' ' THR . . . 176.21 -113.56 0.44 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.429 174.762 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.79 38.54 27.35 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.567 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -138.24 97.19 9.71 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.006 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.6 -29.58 43.72 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.057 2.505 . . . . 0.0 112.579 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.17 -36.48 13.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -103.61 60.59 0.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.356 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.532 ' N ' ' HD2' ' C' ' 8' ' ' PRO . 15.8 m -62.01 -47.04 91.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.737 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 7' ' ' THR . 31.2 Cg_endo -64.6 89.01 0.17 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.036 1.824 . . . . 0.0 112.487 175.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -64.28 -33.08 75.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.186 0.517 . . . . 0.0 110.65 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -75.17 125.07 89.51 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.432 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.72 115.02 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.286 1.99 . . . . 0.0 110.11 171.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.488 HD12 ' OH ' ' C' ' 20' ' ' TYR . 47.9 mt -65.11 157.32 28.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.017 0.437 . . . . 0.0 110.519 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 66.6 m-85 -111.82 -169.97 1.56 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -157.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 19.9 pttm -156.09 159.95 39.52 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 120.956 0.408 . . . . 0.0 110.2 -171.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.752 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 21.0 p-10 -84.52 -140.56 0.07 Allowed 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.858 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.04 -44.65 19.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.784 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -100.78 -14.13 18.15 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.938 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.17 26.66 1.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.077 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.515 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 47.9 t -77.29 125.56 37.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . 0.488 ' OH ' HD12 ' C' ' 12' ' ' LEU . 76.9 t80 -73.69 142.67 46.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.93 0.871 . . . . 0.0 110.779 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -139.08 138.99 40.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.802 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.417 ' HA ' HD13 ' C' ' 12' ' ' LEU . 7.5 m -88.86 134.91 33.79 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.203 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -106.67 121.53 44.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.275 0.56 . . . . 0.0 110.324 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.8 mp -107.5 97.35 19.25 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.437 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 19.4 Cg_exo -68.98 118.77 5.88 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.57 2.18 . . . . 0.0 111.817 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mt -82.08 100.89 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 0.1 OUTLIER -68.86 -53.07 23.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.217 179.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.88 166.49 19.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.732 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -129.49 146.51 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.947 0.403 . . . . 0.0 110.178 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' C' ' 30' ' ' LYS . 1.7 tmtp? -130.28 115.67 17.27 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.292 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -85.24 117.44 24.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.49 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.38 146.76 26.84 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.215 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -60.53 -17.65 47.09 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.874 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -82.83 -13.55 55.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.916 0.389 . . . . 0.0 110.525 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 -35.23 4.02 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.76 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 68.5 p -62.54 140.86 58.64 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.094 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.41 123.9 48.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -91.42 114.85 27.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -99.3 111.36 23.75 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 38.4 mt-10 -73.71 102.52 3.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.531 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.06 153.98 17.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 110.161 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -119.44 127.35 53.0 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.04 -128.2 7.12 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.161 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.37 9.35 3.45 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.748 2.299 . . . . 0.0 112.562 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.438 ' CE2' ' HG ' ' C' ' 24' ' ' LEU . 86.0 m-85 -135.06 145.35 47.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.381 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.82 -164.37 1.13 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.508 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 5.9 p-10 -84.86 144.6 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.154 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -149.03 141.16 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.527 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -88.35 139.24 30.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.384 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.6 tpt -122.62 146.66 47.25 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.0 135.36 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.684 0.615 . . . . 0.0 111.576 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.39 -38.25 90.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.363 -172.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -61.76 -34.97 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.545 0.688 . . . . 0.0 109.639 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 7.2 m -73.06 -42.04 63.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.4 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 54.1 t -68.25 -22.94 27.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.429 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.27 82.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.792 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.06 -33.2 4.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.451 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.94 20.09 18.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.799 -170.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 40.0 tttm -50.98 124.28 20.54 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.474 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 50.0 Cg_endo -99.89 -153.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 123.527 2.818 . . . . 0.0 111.429 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -149.85 164.63 34.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.664 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -91.16 128.53 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.96 0.886 . . . . 0.0 109.609 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.08 49.65 Favored Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.18 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -166.08 37.4 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.123 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -124.32 126.83 46.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.329 0.585 . . . . 0.0 111.476 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' C' ' 24' ' ' LEU . 34.7 tp -97.28 155.05 17.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 170.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 38.9 p90 -147.65 160.97 42.08 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.234 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -139.17 130.53 26.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.705 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 96.7 p -99.78 170.0 8.85 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.268 0.556 . . . . 0.0 110.241 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' C' ' 20' ' ' TYR . 11.2 mm100 -69.94 -9.1 53.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.069 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -90.38 -0.8 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.151 0.5 . . . . 0.0 109.985 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.16 17.62 64.5 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.765 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.431 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 21.0 mm-40 -92.09 122.16 34.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.947 0.403 . . . . 0.0 110.574 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.38 130.88 43.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.941 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 73.3 mt -151.43 157.85 42.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.994 -174.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -96.25 131.07 43.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.221 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.458 ' HA ' ' CE ' ' C' ' 77' ' ' MET . 0.9 OUTLIER -143.04 140.23 30.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.926 0.394 . . . . 0.0 110.693 178.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -69.33 158.4 35.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.744 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' C' ' 80' ' ' THR . 1.5 ptmt -55.42 -32.43 62.68 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -168.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 5.7 p -55.33 -58.94 5.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.437 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.66 74.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.805 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -59.16 -44.07 92.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.54 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 24.3 tt0 -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.94 -27.85 63.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.848 -167.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 11.8 m120 -105.58 -30.7 9.34 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.466 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' C' ' 14' ' ' LYS . 0.0 OUTLIER -142.79 70.66 1.33 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 80.5 p -166.54 -35.43 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.825 0.85 . . . . 0.0 109.067 169.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -64.33 171.07 3.32 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.678 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.34 42.62 5.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.232 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.0 p -69.78 -18.13 63.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.113 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.54 -22.33 26.64 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.731 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 11.9 t -114.37 -9.35 12.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.075 0.464 . . . . 0.0 110.541 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.763 ' HB ' ' ND2' ' C' ' 95' ' ' ASN . 18.4 t 63.99 3.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.52 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' C' ' 97' ' ' GLU . . . 62.06 31.41 17.89 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.763 ' ND2' ' HB ' ' C' ' 93' ' ' VAL . 41.9 m-80 -62.19 -58.11 8.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.412 -177.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.52 9.59 40.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.375 0.607 . . . . 0.0 109.963 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' C' ' 94' ' ' ALA . 8.9 mp0 -97.4 -56.55 2.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.541 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . 0.441 HG22 HG22 ' C' ' 107' ' ' THR . 48.1 p -97.86 -15.98 19.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.268 -177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.31 -168.83 0.21 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.414 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -83.02 -28.9 29.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 110.962 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . 0.476 ' HG3' ' H ' ' C' ' 103' ' ' SER . 1.1 ptpm? -80.88 -11.88 59.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.213 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 72.3 mt 58.01 25.89 12.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.926 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . 0.476 ' H ' ' HG3' ' C' ' 101' ' ' LYS . 49.1 m -151.77 79.53 1.27 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.784 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -160.19 140.95 12.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.771 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 58.83 -99.31 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.887 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' C' ' 106' ' ' ARG . 14.3 mmt85 -104.34 21.63 16.29 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -172.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.441 HG22 HG22 ' C' ' 98' ' ' THR . 7.4 p -69.78 -68.4 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.35 0.595 . . . . 0.0 111.009 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' C' ' 110' ' ' LEU . 5.5 mt -107.34 5.93 9.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 65.2 p 61.52 -28.05 0.06 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.295 1.438 . . . . 0.0 113.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' C' ' 108' ' ' ILE . 4.2 mm? -121.41 77.76 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.986 0.422 . . . . 0.0 110.332 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.03 125.06 34.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.233 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.72 19.61 67.71 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.42 165.03 37.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.021 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.438 HG12 ' H ' ' C' ' 116' ' ' GLY . 67.3 t -93.59 127.6 45.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.3 p -64.32 -26.7 68.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.438 ' H ' HG12 ' C' ' 114' ' ' VAL . . . -68.19 -81.66 0.18 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.983 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 15.6 p -84.2 2.89 37.68 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 67.85 4.79 4.14 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.214 0.605 . . . . 0.0 111.107 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.8 p 47.42 38.33 7.42 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.081 0.952 . . . . 0.0 112.968 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -97.86 -4.64 36.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.335 0.588 . . . . 0.0 110.215 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -98.69 54.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.668 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.32 126.79 43.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.179 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 18.6 t 72.74 -32.88 0.25 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.732 0.813 . . . . 0.0 112.039 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.67 -28.01 60.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 111.059 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -132.68 133.95 44.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.815 0.341 . . . . 0.0 110.813 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.27 119.54 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.666 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 24.7 p -86.49 -94.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.363 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 46.6 mt -136.06 -56.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 110.481 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' C' ' 129' ' ' GLU . 0.3 OUTLIER -100.03 40.83 1.21 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.795 -172.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 3.0 p -68.07 -73.77 0.14 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 110.47 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -122.28 16.81 10.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.399 0.618 . . . . 0.0 110.451 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 28.8 m -128.62 23.3 5.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -154.19 43.86 0.59 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.567 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.708 -179.032 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.571 0.224 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.12 -51.59 2.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.468 177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -136.11 76.35 51.65 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.546 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.26 -24.97 26.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 113.312 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.91 -51.26 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 0.0 110.543 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.55 143.24 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.194 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -91.57 112.59 55.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.804 175.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.96 110.28 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.4 m -68.82 -35.63 77.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.317 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -81.68 130.47 61.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.839 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.87 105.38 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.192 1.928 . . . . 0.0 111.479 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.454 HD12 ' OH ' ' C' ' 20' ' ' TYR . 93.1 mt -70.13 147.11 50.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' C' ' 86' ' ' TYR . 82.0 m-85 -111.13 -167.63 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -164.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 0.0 OUTLIER -158.7 164.37 35.98 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.998 0.428 . . . . 0.0 110.03 -167.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.588 ' OD2' ' HB ' ' C' ' 19' ' ' VAL . 2.4 p30 -103.07 -139.21 0.35 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.079 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -60.39 3.48 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -161.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -93.25 -4.98 50.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.283 0.563 . . . . 0.0 109.808 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.87 27.92 4.41 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.767 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.588 ' HB ' ' OD2' ' C' ' 15' ' ' ASP . 62.8 t -64.73 127.57 25.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . 0.454 ' OH ' HD12 ' C' ' 12' ' ' LEU . 50.8 t80 -81.93 134.99 35.43 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 122.032 0.92 . . . . 0.0 111.091 -172.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.75 131.87 4.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.65 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -90.71 152.05 20.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.654 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.406 ' HB2' ' HE2' ' C' ' 86' ' ' TYR . . . -106.04 116.28 31.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.356 0.598 . . . . 0.0 109.696 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.67 ' O ' ' HB3' ' C' ' 66' ' ' LEU . 16.8 mt -118.2 98.92 51.74 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.213 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.571 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -66.25 152.05 82.0 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 121.655 1.57 . . . . 0.0 111.267 -173.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mt -82.7 98.04 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.672 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -86.12 -60.79 1.91 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.514 -163.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' C' ' 39' ' ' ALA . . . -154.56 154.53 33.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.366 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 73.7 mt -140.79 143.05 29.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.472 0.653 . . . . 0.0 110.558 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -135.84 124.76 24.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.263 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -85.37 118.72 25.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.108 0.48 . . . . 0.0 110.009 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.402 ' HB2' HD21 ' C' ' 38' ' ' ASN . . . -86.81 -163.62 0.94 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.558 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -64.88 -38.24 90.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.297 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -97.8 17.24 18.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.976 0.417 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.09 87.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.705 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 18.2 p -72.92 138.59 46.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.863 0.363 . . . . 0.0 110.371 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -100.28 113.97 27.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.087 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' C' ' 29' ' ' ILE . 15.5 m-80 -90.07 108.26 19.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.722 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 28' ' ' ALA . . . -87.73 89.11 7.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.149 0.499 . . . . 0.0 111.233 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' C' ' 27' ' ' LYS . 38.1 mt-10 -76.55 106.47 8.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.747 -174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . 0.598 ' CG ' ' HB2' ' C' ' 45' ' ' TYR . 1.6 m-85 -59.33 138.61 57.57 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.549 0.69 . . . . 0.0 112.164 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -89.22 -33.52 16.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.619 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.12 179.48 35.48 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.775 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 56.85 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.007 2.472 . . . . 0.0 113.103 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.598 ' HB2' ' CG ' ' C' ' 41' ' ' PHE . 89.9 m-85 -131.6 -177.95 4.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.046 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.7 -179.0 6.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.224 0.535 . . . . 0.0 111.533 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -111.48 127.38 55.68 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -96.84 124.77 40.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.584 -171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -87.21 112.11 21.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . 0.418 ' CG ' ' HB3' ' C' ' 37' ' ' ALA . 22.4 ptp -110.37 129.52 55.74 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.759 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . 0.461 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.6 OUTLIER -62.35 159.42 15.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.057 -176.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.57 -34.46 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' C' ' 53' ' ' GLN . 0.2 OUTLIER -58.26 -40.14 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 109.144 173.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 60.3 m -72.96 -40.12 65.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 79.4 t -67.56 -22.45 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.283 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.7 74.78 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.08 -31.44 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.487 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -113.17 19.8 16.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 52.1 tttm -48.7 107.45 0.76 Allowed Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 123.495 0.497 . . . . 0.0 111.526 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 85.9 Cg_endo -106.03 -154.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 123.809 3.006 . . . . 0.0 111.83 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.51 153.81 45.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.687 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.47 125.0 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 121.926 0.87 . . . . 0.0 109.753 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.31 -10.35 28.73 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.434 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.45 -158.24 27.95 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.042 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.35 156.95 34.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.915 0.388 . . . . 0.0 111.133 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.67 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 23.5 tp -147.08 154.03 40.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.12 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -151.5 163.6 38.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -143.33 132.9 23.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 31.2 p -102.55 178.28 4.62 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.442 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -55.28 -33.71 63.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.896 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' C' ' 73' ' ' GLU . 44.7 m-85 -72.52 -5.77 39.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.3 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.38 1.93 83.26 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.378 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' C' ' 71' ' ' TYR . 9.4 pt-20 -91.11 140.33 29.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.269 0.557 . . . . 0.0 110.478 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.471 HD23 ' N ' ' C' ' 74' ' ' LEU . 0.6 OUTLIER -131.13 155.34 47.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.895 -179.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.553 ' O ' HD12 ' C' ' 66' ' ' LEU . 71.6 mt -148.44 157.27 43.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.836 0.351 . . . . 0.0 111.147 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -91.7 138.06 31.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.019 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.531 ' HB2' ' HB3' ' C' ' 81' ' ' ALA . 0.4 OUTLIER -162.24 -179.81 7.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.196 0.522 . . . . 0.0 111.619 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 5.5 p -122.49 -174.91 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.068 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' C' ' 82' ' ' PHE . 18.5 ptpt -57.04 -28.5 62.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 8.6 p -54.27 -54.96 33.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' C' ' 77' ' ' MET . . . -74.21 -33.23 63.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.9 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.62 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 2.6 t80 -50.13 -49.59 51.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.309 0.576 . . . . 0.0 109.504 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.792 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 10.8 tp10 -60.85 -45.15 95.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.187 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.6 -26.02 23.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.07 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' C' ' 15' ' ' ASP . 0.9 OUTLIER -91.77 -27.39 18.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -178.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.63 ' O ' HG23 ' C' ' 87' ' ' THR . 0.2 OUTLIER -167.88 78.54 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.792 ' OG1' ' HA ' ' C' ' 83' ' ' GLU . 6.6 p -164.85 -28.55 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.142 0.977 . . . . 0.0 109.52 162.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 8.6 t -67.19 -179.32 0.96 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.867 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.12 1.76 3.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.788 0.835 . . . . 0.0 112.454 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.505 ' HB2' HG23 ' C' ' 93' ' ' VAL . 15.1 m 65.07 167.78 0.18 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.873 0.844 . . . . 0.0 113.154 172.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.3 -65.21 1.89 Allowed Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.251 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -104.86 87.66 2.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.552 0.692 . . . . 0.0 112.084 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.505 HG23 ' HB2' ' C' ' 90' ' ' SER . 87.3 t -126.65 -54.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.131 171.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.99 -43.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.039 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.413 ' OD1' ' HG3' ' C' ' 14' ' ' LYS . 8.7 p30 -61.09 -12.95 13.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.05 9.39 7.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.692 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -131.43 -35.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.138 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 79.3 p -88.76 -64.59 1.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 46.91 45.94 15.43 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.964 0.79 . . . . 0.0 112.431 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -107.54 -67.13 0.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.933 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -113.28 -69.45 0.86 Allowed 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.835 -0.54 . . . . 0.0 109.914 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' C' ' 110' ' ' LEU . 7.0 mp 54.59 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.198 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 1.6 p -136.9 16.61 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 60.3 p -79.6 39.13 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.82 -89.24 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.61 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -140.98 -2.78 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.529 0.681 . . . . 0.0 109.412 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 12.5 p -86.62 159.21 19.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.507 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 35.8 mm -132.16 -51.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.637 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 19.1 p -82.37 26.42 0.55 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' C' ' 102' ' ' LEU . 60.9 mt -102.76 18.21 21.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.185 0.517 . . . . 0.0 110.433 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 11.6 p -85.12 36.8 0.64 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.377 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.62 -56.45 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.334 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -147.64 155.32 41.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.608 0.242 . . . . 0.0 110.477 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.74 94.83 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.868 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.9 p -56.96 -40.67 76.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.149 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.69 -17.13 62.2 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.891 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 41.2 t -103.84 -42.62 5.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.957 0.408 . . . . 0.0 110.131 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.28 -23.14 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.614 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -57.39 -33.22 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.701 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -90.09 -55.49 3.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.178 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -152.97 -51.65 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 98.04 -172.63 27.03 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.445 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 22.3 t -157.02 138.91 14.33 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.3 77.85 9.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.149 0.499 . . . . 0.0 110.26 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.92 137.78 36.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.679 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 25.4 t -94.03 94.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.81 49.88 1.7 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.091 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 59.5 mt 64.76 -78.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.586 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 38.04 52.25 1.53 Allowed 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.654 0.597 . . . . 0.0 112.058 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 48.6 p 50.16 27.48 2.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -126.99 133.54 50.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.824 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 48.4 m -149.75 31.37 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.286 0.565 . . . . 0.0 109.776 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.8 -63.67 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.458 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.486 179.374 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.59 -48.03 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.42 ' HB2' ' HD3' ' C' ' 4' ' ' PRO . 53.2 m-80 -62.2 -54.13 52.41 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.37 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' C' ' 3' ' ' ASN . 96.8 Cg_endo -77.48 26.74 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.749 1.633 . . . . 0.0 112.439 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -134.87 -60.0 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.127 0.489 . . . . 0.0 110.042 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -97.64 178.85 5.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.132 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.514 ' OG1' ' HD3' ' C' ' 8' ' ' PRO . 0.0 OUTLIER -81.24 -54.02 0.73 Allowed Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.646 177.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.514 ' HD3' ' OG1' ' C' ' 7' ' ' THR . 6.0 Cg_exo -75.29 156.22 41.68 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 111.635 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -65.74 -35.4 80.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.486 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -96.22 121.06 61.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.528 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.608 ' HB2' ' CZ ' ' C' ' 82' ' ' PHE . 68.6 Cg_endo -76.87 101.89 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.152 1.902 . . . . 0.0 111.406 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' C' ' 22' ' ' SER . 23.1 mt -86.81 155.15 20.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -172.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' C' ' 82' ' ' PHE . 2.8 m-85 -91.7 136.96 32.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.236 -174.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.501 ' H ' ' HB3' ' C' ' 86' ' ' TYR . 93.2 mttt -116.02 105.89 13.14 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.005 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.547 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -72.44 -166.26 0.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.505 -171.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.44 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -60.7 -50.64 72.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -170.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -112.36 -6.53 14.03 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.16 14.07 3.42 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.602 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.547 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 97.8 t -74.23 103.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . 0.448 ' OH ' ' HE2' ' C' ' 14' ' ' LYS . 1.2 m-85 -76.7 151.68 36.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.496 1.141 . . . . 0.0 112.261 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -148.8 120.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 112.81 -1.995 . . . . 0.0 108.952 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.454 ' HA ' HD22 ' C' ' 12' ' ' LEU . 23.0 t -78.04 148.86 34.12 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.114 -177.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.57 117.87 35.18 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.828 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.487 ' HB2' HD13 ' C' ' 66' ' ' LEU . 2.1 mm? -99.78 114.43 65.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.666 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.32 125.97 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 55.8 mt -80.35 96.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -67.22 -45.99 75.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.137 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' C' ' 62' ' ' VAL . . . -157.25 159.49 37.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 0.0 111.988 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.5 mt -145.71 145.58 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.982 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -131.42 132.03 44.04 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -94.3 136.0 35.09 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.916 -172.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.2 131.38 56.48 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.993 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -60.34 -19.85 57.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.329 -172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.81 -21.74 61.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.803 0.335 . . . . 0.0 110.78 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.98 -26.35 4.78 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.246 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 10.1 m -72.67 161.51 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.989 0.423 . . . . 0.0 110.883 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -141.07 122.53 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 9.0 t-20 -77.26 128.92 35.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -115.17 147.95 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.211 0.529 . . . . 0.0 112.179 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.03 110.35 11.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.859 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -102.3 156.47 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.33 132.49 33.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.72 -178.93 19.54 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.252 -174.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.77 58.31 6.91 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.883 2.389 . . . . 0.0 111.857 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -122.19 -176.51 3.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.6 50.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.734 0.778 . . . . 0.0 112.908 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.0 p-10 -132.78 79.91 1.87 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -152.62 169.16 23.37 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.205 -164.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 50.3 p90 -92.55 138.28 31.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.054 0.454 . . . . 0.0 110.747 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.3 mmt -103.64 140.75 37.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.234 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . 0.45 ' HB2' ' OE1' ' C' ' 53' ' ' GLN . 1.3 p -61.08 154.61 22.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.422 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -30.19 71.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . 0.45 ' OE1' ' HB2' ' C' ' 51' ' ' SER . 23.4 mp0 -58.45 -44.77 89.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.756 0.789 . . . . 0.0 109.057 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -67.89 -43.6 78.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.949 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 53.2 t -65.63 -27.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.585 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.64 -29.91 69.34 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.298 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.72 -34.11 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.51 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -117.14 24.53 11.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 0.0 OUTLIER -46.08 117.86 4.19 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 121.299 0.571 . . . . 0.0 111.36 175.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 83.6 Cg_endo -106.37 -156.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 123.403 2.735 . . . . 0.0 111.876 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.437 ' HB2' ' CZ ' ' C' ' 76' ' ' TYR . 48.1 mt-10 -149.18 142.65 25.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.05 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' C' ' 28' ' ' ALA . 5.2 p -78.27 111.63 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.834 0.826 . . . . 0.0 109.977 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.96 -18.68 7.47 Favored Glycine 0 C--N 1.314 -0.665 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.74 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.8 -155.11 31.47 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.402 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -131.8 142.55 49.77 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' C' ' 24' ' ' LEU . 0.0 OUTLIER -118.84 134.88 54.86 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 167.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.556 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 44.0 p90 -109.56 158.04 18.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.758 -172.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -134.32 129.51 35.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . 0.476 ' HA ' ' HB ' ' C' ' 21' ' ' VAL . 40.5 p -95.35 178.0 5.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.002 0.43 . . . . 0.0 111.001 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.34 -9.49 58.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.991 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -85.04 -6.34 59.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.09 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.52 12.07 78.85 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.457 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.53 127.15 36.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.07 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.3 pt? -130.53 140.27 50.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.074 0.464 . . . . 0.0 110.843 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.511 HD22 ' C ' ' C' ' 74' ' ' LEU . 2.1 mm? -148.22 160.81 42.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.405 -174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' C' ' 61' ' ' GLU . 71.7 t80 -92.52 141.57 28.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' C' ' 81' ' ' ALA . 40.6 tpp -155.86 147.38 22.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 111.134 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' C' ' 77' ' ' MET . 20.3 p -89.71 158.34 17.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 13.6 ptmm? -66.91 -13.01 61.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 11.3 p -60.38 -61.83 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.511 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . 0.482 ' HB3' ' SD ' ' C' ' 77' ' ' MET . . . -69.83 -38.01 76.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.694 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' C' ' 11' ' ' PRO . 0.2 OUTLIER -50.8 -52.92 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.265 177.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.98 -36.52 64.54 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.46 -42.16 25.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.786 -169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -86.09 -29.15 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.303 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.501 ' HB3' ' H ' ' C' ' 14' ' ' LYS . 23.0 m-85 -103.08 -73.01 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.748 -173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 68.8 p -84.22 -9.36 58.59 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -167.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -63.91 -48.53 76.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.643 0.259 . . . . 0.0 110.714 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.26 -76.65 0.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.454 -176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.4 t 57.28 35.43 26.1 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.905 0.859 . . . . 0.0 109.508 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.84 -81.12 0.43 Allowed Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.428 -177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . 0.441 ' HB2' ' HA ' ' C' ' 95' ' ' ASN . 58.6 m -148.69 6.66 0.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.354 0.262 . . . . 0.0 110.562 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 50.4 t 63.21 -79.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 123.734 0.646 . . . . 0.0 111.376 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.36 -14.05 27.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.21 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' C' ' 92' ' ' SER . 48.8 m-80 74.95 -43.57 0.52 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.948 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.02 33.87 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.835 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' C' ' 95' ' ' ASN . 29.7 mm-40 -100.28 -49.55 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 10.9 t -74.65 -17.64 60.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.678 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.72 48.67 2.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.674 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.84 -24.18 48.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.121 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . 0.632 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 83.2 tttt -73.04 -13.52 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.149 0.5 . . . . 0.0 110.851 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.95 -31.04 72.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 18.3 m -92.33 -28.35 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.545 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . 0.632 ' OG1' ' HA ' ' C' ' 101' ' ' LYS . 42.2 p -85.32 -28.26 25.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.14 -31.75 11.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -98.94 -63.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.644 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 33.9 p -84.61 -54.79 4.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 70.0 mt 75.79 -31.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 12.8 p -76.94 2.0 16.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.63 -57.24 0.78 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.676 0.274 . . . . 0.0 110.522 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 23.7 p 50.46 -101.0 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.891 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.9 34.39 1.23 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.8 -73.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.901 0.381 . . . . 0.0 111.248 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 40.1 t -136.72 133.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -78.28 56.15 1.65 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 111.97 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.59 -62.05 0.33 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.772 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -81.27 4.4 20.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.637 0.256 . . . . 0.0 111.502 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -78.92 -8.37 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.086 0.469 . . . . 0.0 110.08 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.9 t -67.83 103.69 1.51 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.628 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 67.94 -74.89 0.07 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-O 121.098 0.475 . . . . 0.0 110.609 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -163.66 -25.34 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.664 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 148.51 -165.84 29.12 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 10.7 t -164.65 -29.27 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.102 0.477 . . . . 0.0 110.211 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.44 -6.46 46.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.298 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -85.64 -17.64 35.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.575 HG12 ' H ' ' C' ' 128' ' ' ILE . 16.2 t -80.96 138.61 19.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 2.2 p -75.18 -2.13 26.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . 0.575 ' H ' HG12 ' C' ' 126' ' ' VAL . 10.3 mt 55.45 33.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.703 0.763 . . . . 0.0 110.95 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -97.31 159.2 15.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.825 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 7.3 p -71.41 108.09 4.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.635 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 11.7 p -78.26 56.46 1.7 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.435 0.636 . . . . 0.0 111.301 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 18.0 p -146.17 -56.62 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.459 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 152.23 -19.29 0.83 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.519 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.381 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.806 0.336 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.91 43.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.333 0.587 . . . . 0.0 110.164 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -143.86 115.37 5.59 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.749 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.89 4.07 2.46 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.913 2.409 . . . . 0.0 113.029 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 56.7 32.9 21.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.401 0.68 . . . . 0.0 111.549 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -70.28 -25.34 63.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.472 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -155.1 78.96 4.67 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.596 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.43 -16.12 38.77 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.59 2.194 . . . . 0.0 112.448 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -105.99 68.81 0.79 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -62.46 130.02 93.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.441 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.41 101.47 1.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.073 1.849 . . . . 0.0 111.296 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 30.7 mt -121.96 143.06 49.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.83 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' C' ' 86' ' ' TYR . 79.8 m-85 -145.63 -161.29 1.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.144 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' C' ' 89' ' ' ALA . 2.0 mptp? -146.34 145.59 30.37 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 121.258 0.552 . . . . 0.0 109.916 -168.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.614 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -87.67 -165.08 1.21 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.536 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' C' ' 90' ' ' SER . . . -65.36 -52.25 54.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -102.31 -6.96 22.5 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -170.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.432 ' HA2' ' OG ' ' C' ' 90' ' ' SER . . . 126.37 26.18 1.22 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.385 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.614 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.3 t -83.54 117.56 29.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.038 0.446 . . . . 0.0 110.173 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -87.69 132.84 33.97 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.724 0.773 . . . . 0.0 109.574 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 0.4 OUTLIER -150.74 139.36 14.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.053 -1.431 . . . . 0.0 110.876 -174.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.6 p -105.23 163.89 12.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.596 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.433 ' HB1' ' CD2' ' C' ' 65' ' ' TYR . . . -108.66 117.29 33.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.125 0.488 . . . . 0.0 110.335 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.472 ' N ' HD12 ' C' ' 24' ' ' LEU . 4.4 mp -107.37 115.26 59.89 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.922 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.427 ' HB2' ' HB3' ' C' ' 42' ' ' ASP . 3.0 Cg_exo -72.22 138.4 30.42 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.744 1.63 . . . . 0.0 112.206 -173.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -93.56 117.42 37.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.935 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -79.03 -60.79 2.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.996 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 151.27 9.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.816 0.341 . . . . 0.0 111.131 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 54.9 mt -132.11 140.87 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.912 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.3 114.48 16.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.376 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -65.56 104.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.584 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.84 170.99 15.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.606 0.717 . . . . 0.0 110.254 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -69.75 -14.08 62.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.06 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.18 -18.4 21.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.815 0.34 . . . . 0.0 110.475 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.93 -37.25 2.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.103 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -60.08 146.49 42.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.86 0.362 . . . . 0.0 110.434 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -112.73 120.51 41.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 37.2 m-80 -71.77 117.43 13.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.836 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -106.47 107.86 19.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 0.0 112.104 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' C' ' 47' ' ' ASP . 43.6 mt-10 -89.45 114.37 25.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.054 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -99.43 148.1 24.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.871 0.367 . . . . 0.0 110.302 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 25' ' ' PRO . 21.3 t70 -83.22 125.85 32.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 0.0 109.929 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.63 17.65 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.201 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.95 59.37 6.89 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.551 2.168 . . . . 0.0 112.015 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.56 -175.76 3.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.432 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.606 ' HB1' HE21 ' C' ' 48' ' ' GLN . . . -66.01 152.9 43.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.562 -176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.703 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 8.3 p-10 -149.7 92.01 1.87 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 168.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.629 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 40.9 mt-30 -149.44 174.7 12.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 -164.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.93 112.65 9.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.9 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 51.6 tpp -91.2 129.78 37.15 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.03 135.35 31.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.337 0.589 . . . . 0.0 111.554 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.47 95.65 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.547 -171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -63.75 -31.49 72.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.405 0.622 . . . . 0.0 109.903 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 19.3 m -74.11 -40.93 62.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.679 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' C' ' 37' ' ' ALA . 77.7 t -70.53 -20.78 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.423 0.63 . . . . 0.0 110.308 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.46 73.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.87 -28.0 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.677 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -106.16 15.03 26.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.209 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 55.1 pttt -51.44 114.97 5.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.986 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.5 Cg_endo -102.99 -151.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.85 3.034 . . . . 0.0 111.123 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -138.23 143.03 39.93 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -80.1 119.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 122.279 1.038 . . . . 0.0 109.827 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.19 20.27 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.811 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 -155.09 30.06 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.577 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . 0.433 ' CD2' ' HB1' ' C' ' 23' ' ' ALA . 50.7 m-85 -122.23 146.82 46.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.291 0.567 . . . . 0.0 112.017 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.23 136.33 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 54.5 p90 -121.77 159.53 26.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.574 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -134.85 128.09 32.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.46 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' C' ' 73' ' ' GLU . 94.6 p -103.39 -170.19 1.75 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.221 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . 0.497 ' NE2' ' HA ' ' C' ' 19' ' ' VAL . 36.4 mt-30 -65.17 -45.99 82.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.434 -174.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.09 18.52 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.22 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.97 34.05 70.63 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.322 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' C' ' 69' ' ' SER . 32.3 mt-10 -89.7 123.88 34.11 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.4 pt? -130.71 132.38 45.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.046 0.451 . . . . 0.0 110.169 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.5 mt -153.44 -171.14 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.721 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.77 135.54 33.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.216 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.425 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 4.9 ttp -103.76 118.04 35.78 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 111.545 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 19.1 p -106.31 -169.99 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -76.87 -30.87 56.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.491 1.041 . . . . 0.0 111.026 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 6.0 p -60.73 -31.58 70.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.741 0.782 . . . . 0.0 109.885 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.67 33.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.129 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' C' ' 86' ' ' TYR . 62.8 t80 -56.56 -40.61 75.48 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.356 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.53 -49.51 66.24 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 121.895 -0.503 . . . . 0.0 111.655 174.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.01 -36.28 77.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.861 0.362 . . . . 0.0 110.952 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.547 HD22 ' HB2' ' C' ' 15' ' ' ASP . 15.1 m120 -105.12 -24.68 12.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.833 -176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.528 ' HA ' ' HB2' ' C' ' 13' ' ' TYR . 6.7 m-85 -120.92 33.39 5.58 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 47.4 p -154.87 -40.5 0.09 Allowed 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.066 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' C' ' 16' ' ' ALA . 7.9 t -46.62 -38.51 9.73 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.901 0.751 . . . . 0.0 112.32 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . 0.515 ' HA ' ' HB2' ' C' ' 14' ' ' LYS . . . 63.63 22.09 12.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.062 172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' C' ' 16' ' ' ALA . 44.5 m 70.32 122.16 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 O-C-N 124.023 0.827 . . . . 0.0 112.07 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.87 -9.33 74.52 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' C' ' 95' ' ' ASN . 12.6 m -92.67 51.39 1.72 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.401 0.62 . . . . 0.0 110.701 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.88 -63.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.926 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.94 2.4 16.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.935 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' C' ' 92' ' ' SER . 9.2 p30 -154.22 160.28 41.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.993 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 67.02 17.02 10.45 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.021 0.825 . . . . 0.0 111.186 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.98 -25.39 27.79 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -68.05 -22.81 64.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.016 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' C' ' 102' ' ' LEU . . . 69.6 124.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.931 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.96 -12.44 60.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.268 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -79.8 0.61 30.12 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.376 0.608 . . . . 0.0 110.721 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' C' ' 127' ' ' THR . 3.7 mm? -72.25 114.53 10.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' C' ' 124' ' ' ALA . 22.1 m 78.94 23.91 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.294 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 82.6 p -88.09 -15.3 36.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.318 0.58 . . . . 0.0 110.247 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.56 -157.44 0.27 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.295 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' C' ' 110' ' ' LEU . 99.7 mtt180 -71.28 75.44 0.72 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.535 0.683 . . . . 0.0 110.143 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -106.41 -58.96 1.85 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.726 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 60.7 mt -148.81 -58.94 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.189 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 7.0 p -64.89 -60.39 3.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.004 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' C' ' 106' ' ' ARG . 82.3 mt -85.26 118.89 25.08 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 19.0 p -101.24 -31.29 11.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.75 -79.19 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.292 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.54 144.8 26.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' C' ' 117' ' ' SER . 41.0 t -65.49 144.75 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -70.35 62.27 0.23 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 168.72 -56.41 0.21 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . 0.645 ' O ' ' HB ' ' C' ' 114' ' ' VAL . 27.6 t -144.97 137.73 26.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -85.29 43.89 1.05 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 110.168 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 24.3 t -92.11 -27.43 17.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.181 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 59.76 52.16 5.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.494 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -79.91 -14.03 58.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.711 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.03 -46.52 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.191 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 32.1 t 66.41 13.8 9.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.071 0.548 . . . . 0.0 111.451 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' C' ' 103' ' ' SER . . . -113.67 87.78 2.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.887 0.375 . . . . 0.0 110.435 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -101.97 129.63 48.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.803 0.335 . . . . 0.0 110.596 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' C' ' 130' ' ' THR . 98.0 t 70.61 -64.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.824 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' C' ' 102' ' ' LEU . 40.9 p 48.36 -105.13 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.097 0.559 . . . . 0.0 111.284 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 46.8 mt -139.15 -52.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -90.87 11.83 21.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.569 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' C' ' 126' ' ' VAL . 33.6 p 53.37 -89.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.134 0.974 . . . . 0.0 112.004 -174.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 19.5 p -85.66 -73.44 0.45 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.998 0.428 . . . . 0.0 110.319 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 60.7 m -161.82 -45.69 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.96 34.31 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.112 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.457 -179.501 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.64 0.257 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.01 38.38 17.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.946 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.405 ' HA ' ' HD3' ' C' ' 4' ' ' PRO . 8.4 m120 -126.37 118.8 23.23 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 3' ' ' ASN . 35.1 Cg_exo -61.28 -19.07 62.34 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.102 2.534 . . . . 0.0 112.713 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.421 ' ND2' ' HE2' ' C' ' 14' ' ' LYS . 5.8 m-20 -77.67 -26.59 50.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.992 0.425 . . . . 0.0 110.706 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' C' ' 8' ' ' PRO . 60.9 m-85 -94.97 -15.81 23.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.146 0.498 . . . . 0.0 110.041 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -122.22 71.55 34.54 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.845 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' C' ' 6' ' ' PHE . 11.8 Cg_endo -90.23 107.99 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.134 2.556 . . . . 0.0 112.57 -176.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -64.34 -41.15 96.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.2 0.524 . . . . 0.0 109.899 176.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -85.69 133.27 42.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.536 ' O ' HD22 ' C' ' 12' ' ' LEU . 74.0 Cg_endo -76.76 99.75 1.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.511 1.474 . . . . 0.0 111.885 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.536 HD22 ' O ' ' C' ' 11' ' ' PRO . 3.4 mm? -137.23 132.85 34.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.271 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.692 ' HB2' HG13 ' C' ' 21' ' ' VAL . 48.4 m-85 -93.19 141.65 28.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.421 ' HE2' ' ND2' ' C' ' 5' ' ' ASN . 28.3 mtpp -133.85 123.34 24.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.583 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -90.64 -164.64 1.2 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.511 -177.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.472 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -63.07 -49.72 73.41 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -172.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.5 -4.2 17.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.589 -0.445 . . . . 0.0 112.107 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.01 18.25 2.38 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.771 -1.204 . . . . 0.0 113.575 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.583 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 53.7 t -73.74 133.88 30.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 172.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.09 160.86 30.67 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.684 0.754 . . . . 0.0 110.995 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.79 137.0 12.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.185 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 67' ' ' PHE . 31.4 m -78.88 151.22 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.54 -175.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.54 ' HB2' ' CE2' ' C' ' 13' ' ' TYR . . . -119.42 128.44 54.03 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.758 0.314 . . . . 0.0 110.497 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.506 HD12 HD23 ' C' ' 66' ' ' LEU . 1.5 mt -105.35 105.68 53.11 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' C' ' 42' ' ' ASP . 13.9 Cg_exo -67.65 115.25 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.101 1.867 . . . . 0.0 111.395 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 27.9 mt -78.8 111.97 16.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.237 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.415 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 53.1 tttm -85.94 -63.38 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.04 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -159.32 158.39 32.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 70.0 mt -115.51 132.78 63.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.865 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.503 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 6.0 mmpt? -91.98 94.61 9.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.029 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -84.06 112.78 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.114 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.79 135.63 33.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -58.29 -19.89 38.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.491 -172.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.8 -20.25 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.714 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.11 -45.12 1.16 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.761 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' C' ' 50' ' ' MET . 2.3 m -60.71 158.48 12.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.034 0.445 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -145.47 179.09 7.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.618 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 0.2 OUTLIER -162.06 127.73 3.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.978 0.418 . . . . 0.0 110.398 173.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -92.05 129.52 37.99 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.508 -172.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -90.9 130.2 36.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.44 146.7 35.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' C' ' 25' ' ' PRO . 44.6 m-20 -78.37 88.83 4.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.132 0.492 . . . . 0.0 110.562 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.3 -148.42 17.65 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.063 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.75 26.09 0.57 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.41 2.74 . . . . 0.0 112.454 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -129.59 120.09 24.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.866 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.2 -161.02 0.6 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.668 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 7.6 p-10 -76.08 126.74 31.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.11 171.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.79 104.93 3.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.618 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 9.4 m-85 -154.91 -166.45 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 161.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' C' ' 36' ' ' SER . 44.3 tpp -159.21 -67.11 0.08 Allowed 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 118.624 0.647 . . . . 0.0 112.427 -171.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . 0.414 ' O ' HG23 ' C' ' 55' ' ' VAL . 0.3 OUTLIER -104.09 134.13 47.87 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.29 0.567 . . . . 0.0 111.455 -175.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.53 92.31 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.584 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -65.98 -31.05 71.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.562 0.696 . . . . 0.0 109.823 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 26.6 m -75.24 -38.01 60.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.577 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 74.8 t -70.21 -22.15 24.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.178 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.72 80.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.21 -29.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.861 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -91.53 9.63 31.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.96 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 87.1 tttt -70.95 113.43 18.85 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.764 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -101.06 -146.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.876 3.051 . . . . 0.0 111.828 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.0 131.61 45.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.068 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.5 m -79.13 121.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 122.232 1.015 . . . . 0.0 109.915 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.26 -23.02 9.35 Favored Glycine 0 C--N 1.301 -1.381 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.484 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.34 36.37 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.227 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -125.51 130.76 52.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.764 0.316 . . . . 0.0 111.436 -175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.506 HD23 HD12 ' C' ' 24' ' ' LEU . 8.6 tp -87.42 172.54 9.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' C' ' 22' ' ' SER . 27.4 p90 -158.43 158.14 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 118.462 0.573 . . . . 0.0 110.902 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 60.9 ttt180 -148.9 114.83 5.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 77.3 p -95.37 175.88 6.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.459 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.19 -8.48 56.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.813 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -90.12 -7.11 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.076 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.84 14.31 56.69 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.848 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 31.5 mt-10 -78.09 121.58 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 33.3 tp -131.36 87.0 2.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 96.5 mt -134.5 -173.98 3.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.206 -177.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.82 153.74 37.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.517 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.426 ' HE3' ' HA ' ' C' ' 81' ' ' ALA . 54.6 mtm -145.15 160.9 40.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 0.0 110.675 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 18.4 p -110.75 -87.32 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.242 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -77.94 -31.38 50.93 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.287 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 3.9 p -65.67 -18.3 65.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.219 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . 0.426 ' HA ' ' HE3' ' C' ' 77' ' ' MET . . . -70.4 -50.1 42.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.787 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.28 -47.93 80.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.315 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.565 ' HA ' ' CE1' ' C' ' 86' ' ' TYR . 34.3 tt0 -60.2 -20.2 57.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.702 0.286 . . . . 0.0 111.67 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . 0.448 ' HA ' ' CA ' ' C' ' 88' ' ' SER . . . -93.39 -19.66 21.09 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' C' ' 13' ' ' TYR . 1.1 m-80 -68.85 -17.41 63.99 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.774 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.565 ' CE1' ' HA ' ' C' ' 83' ' ' GLU . 4.3 p90 -132.01 -12.01 3.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 175.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.507 HG23 ' CD2' ' C' ' 86' ' ' TYR . 39.5 p -147.08 -51.7 0.2 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 118.563 -1.255 . . . . 0.0 113.718 -172.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.448 ' CA ' ' HA ' ' C' ' 84' ' ' ALA . 28.2 m 72.78 -35.51 0.33 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.213 1.005 . . . . 0.0 111.581 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' C' ' 87' ' ' THR . . . -126.07 -67.12 0.89 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.407 ' HB2' HG22 ' C' ' 93' ' ' VAL . 66.5 m -164.16 -179.98 6.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -77.59 1.23 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.763 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . 0.55 ' HB3' ' ND2' ' C' ' 95' ' ' ASN . 49.2 m -71.28 -37.43 71.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 0.0 110.621 177.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.572 ' H ' ' HG3' ' C' ' 97' ' ' GLU . 46.4 t 78.15 -77.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.495 172.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.35 5.15 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.844 -173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.55 ' ND2' ' HB3' ' C' ' 92' ' ' SER . 7.4 p30 -150.37 135.45 17.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 69.25 -26.27 0.15 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.686 0.794 . . . . 0.0 113.141 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.572 ' HG3' ' H ' ' C' ' 93' ' ' VAL . 6.2 mm-40 -94.84 -47.06 6.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -76.67 -29.91 56.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.28 73.11 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.254 0.55 . . . . 0.0 110.499 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.24 -4.11 30.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.661 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -77.01 -17.29 58.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 85.6 mt 63.34 14.43 7.87 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.45 169.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 16.0 m 56.54 73.13 0.46 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.432 0.634 . . . . 0.0 109.69 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 4.7 t -93.51 -171.88 2.75 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.867 -170.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.4 -41.81 63.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -171.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.503 ' HA ' HD23 ' C' ' 110' ' ' LEU . 96.7 mtt180 -126.11 77.47 1.68 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.76 -81.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.38 175.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 59.0 mt -86.79 -28.71 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.529 0.681 . . . . 0.0 109.8 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -63.6 -27.93 69.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.664 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' C' ' 106' ' ' ARG . 4.1 mm? -111.89 86.67 2.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.396 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 13.8 p -80.58 -55.46 4.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.344 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.98 35.4 1.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.44 155.67 24.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -176.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 80.2 t -90.94 127.77 43.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.001 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' C' ' 120' ' ' PHE . 25.5 p -60.39 -40.58 91.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.376 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.37 38.49 2.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.211 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 11.4 t -154.9 -45.48 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.74 27.25 1.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.576 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.2 m 61.1 61.29 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.097 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' C' ' 115' ' ' THR . 72.6 m-85 -132.82 102.6 5.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -121.52 133.88 55.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.75 -107.6 3.19 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.189 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 36.2 m 54.97 46.63 23.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.339 0.59 . . . . 0.0 110.264 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.46 31.64 4.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.69 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 71.41 150.46 0.1 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.021 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 46.8 t -80.79 93.96 2.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 5.9 p -82.53 83.66 7.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.311 0.577 . . . . 0.0 111.453 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.32 -36.31 77.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.144 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -115.15 147.95 39.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.267 175.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.5 p -132.01 117.71 18.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.687 0.279 . . . . 0.0 110.809 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 23.0 p -66.26 100.86 0.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.064 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 5.3 p -149.3 13.06 0.84 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.367 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -122.57 -1.0 10.09 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.889 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.421 -179.926 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.959 0.409 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.57 56.59 0.64 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -97.98 123.92 49.57 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.258 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.96 32.1 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.933 2.422 . . . . 0.0 111.864 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -129.24 28.66 5.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -80.55 149.01 30.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.336 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 1.1 t -144.05 101.62 4.88 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.511 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.55 39.52 0.56 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.132 2.554 . . . . 0.0 112.661 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 33.7 t -70.79 -53.92 13.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -83.73 122.32 76.46 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.554 ' O ' ' HB3' ' C' ' 23' ' ' ALA . 72.7 Cg_endo -77.21 103.84 1.8 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.243 1.962 . . . . 0.0 112.293 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.4 HD22 ' C ' ' C' ' 11' ' ' PRO . 3.6 mm? -125.2 128.26 48.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.546 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 63.2 m-85 -92.98 143.26 26.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' C' ' 86' ' ' TYR . 67.0 mttm -117.06 139.71 50.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.771 0.796 . . . . 0.0 111.113 -170.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' C' ' 19' ' ' VAL . 6.2 p-10 -46.98 136.18 8.68 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.022 -1.445 . . . . 0.0 114.14 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.88 -55.85 2.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.668 -1.605 . . . . 0.0 109.32 167.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -92.72 -7.04 47.81 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.65 26.81 1.24 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.767 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 54.3 t -116.24 119.86 63.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -97.87 138.66 34.88 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -148.15 124.79 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.646 -172.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 2.9 p -83.17 147.77 27.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.091 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' C' ' 11' ' ' PRO . . . -106.02 128.19 53.67 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.191 0.519 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 66' ' ' LEU . 5.2 mp -98.74 98.7 6.46 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.242 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.8 Cg_exo -64.77 114.8 2.91 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.159 2.573 . . . . 0.0 113.116 -174.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . 0.583 HD11 ' HG ' ' C' ' 66' ' ' LEU . 12.0 mt -84.54 99.05 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' C' ' 27' ' ' LYS . 5.7 tmtm? -63.24 -69.57 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.65 162.15 41.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.374 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.82 132.04 64.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 0.0 109.932 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.456 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 11.5 mmpt? -105.87 100.29 9.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.427 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -73.98 112.4 10.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.161 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 153.26 28.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.709 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.28 -15.62 62.92 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.046 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -84.26 -21.63 31.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.348 . . . . 0.0 110.669 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.66 -26.19 5.46 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.109 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 15.1 m -70.09 165.73 21.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -140.58 122.31 15.33 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.955 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' C' ' 48' ' ' GLN . 5.1 t30 -83.83 114.86 21.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -94.69 155.78 16.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.452 -172.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -130.17 119.15 22.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.071 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' C' ' 45' ' ' TYR . 14.6 m-85 -126.13 179.49 5.22 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -175.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -36.27 -55.0 0.82 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.079 0.952 . . . . 0.0 113.405 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.8 -81.82 0.06 OUTLIER Glycine 0 C--N 1.311 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.185 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.63 45.17 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.094 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' C' ' 41' ' ' PHE . 97.4 m-85 -138.38 -173.48 3.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.082 -177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.33 116.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 0.0 112.078 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 9.8 p-10 -137.83 42.71 2.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.49 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.431 ' HA ' ' OD1' ' C' ' 38' ' ' ASN . 2.0 pp0? -165.32 173.92 10.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.841 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 29.3 p90 -97.11 132.51 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -109.43 166.8 10.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.659 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.05 144.41 12.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.624 0.726 . . . . 0.0 112.368 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.38 90.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.057 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.539 0.685 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -74.13 -39.17 63.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.67 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.98 -32.31 51.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.8 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.7 68.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.787 -175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.68 -23.25 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.351 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.64 6.78 28.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.065 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -54.9 113.33 5.21 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-O 120.827 0.346 . . . . 0.0 110.833 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -92.76 -99.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.231 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -156.95 140.6 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.633 0.373 . . . . 0.0 110.011 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.84 107.85 17.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.712 0.767 . . . . 0.0 109.806 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.04 -5.53 39.35 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.727 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.87 -158.85 34.56 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.147 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.27 123.64 28.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.918 0.389 . . . . 0.0 111.067 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' C' ' 24' ' ' LEU . 20.7 mt -79.28 163.53 24.86 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 43.8 p90 -148.21 147.9 29.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -134.92 120.55 19.39 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -94.67 164.44 12.95 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -79.72 19.11 0.69 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.624 -173.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.2 -6.41 18.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.444 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.29 -5.52 55.46 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.505 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.22 123.93 33.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.178 0.513 . . . . 0.0 111.111 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.456 HD23 ' N ' ' C' ' 74' ' ' LEU . 1.5 pt? -131.43 138.69 49.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.889 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 83.3 mt -150.1 179.62 7.93 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -107.72 141.38 39.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 34.4 mmm -150.12 144.07 25.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.855 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 33.0 p -65.38 126.55 28.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 167.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -61.01 -27.74 68.54 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.221 -171.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 17.3 p -52.91 -47.64 67.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.44 -38.46 55.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.157 0.503 . . . . 0.0 111.414 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.439 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 0.8 OUTLIER -74.16 -39.94 62.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.45 0.643 . . . . 0.0 110.261 -175.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.13 -26.25 68.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.185 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.27 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.966 -172.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.22 -31.55 12.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' C' ' 14' ' ' LYS . 5.1 m-85 -97.1 -69.25 0.76 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 50.2 p -84.85 -20.98 30.01 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -171.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 13.1 t -58.6 -50.92 72.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 50.94 63.05 2.4 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.295 0.569 . . . . 0.0 110.861 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 20.3 m -133.14 147.76 52.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.123 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 -17.53 68.92 Favored Glycine 0 CA--C 1.517 0.173 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.508 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 73.5 p -97.02 -9.38 28.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.474 0.654 . . . . 0.0 109.894 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t 69.96 -79.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.318 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.77 -13.93 43.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 61.67 31.51 18.62 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.143 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.95 5.35 3.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.146 0.498 . . . . 0.0 111.691 -176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.21 -28.13 32.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.572 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -111.48 11.59 21.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.956 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 59.04 -156.44 0.34 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.785 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.48 10.99 3.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 0.0 111.385 -177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -67.46 -12.98 61.6 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.938 -0.477 . . . . 0.0 111.044 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 32.0 mt -81.34 9.1 7.67 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.952 -0.468 . . . . 0.0 110.603 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -107.46 -30.71 8.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.172 172.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 52.5 p -64.43 109.02 1.8 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.72 0.295 . . . . 0.0 110.629 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 69.64 6.39 5.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.648 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -103.82 -44.88 4.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.033 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' C' ' 108' ' ' ILE . 34.2 p -91.69 -36.93 13.33 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' C' ' 107' ' ' THR . 50.1 mm 79.96 -37.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.041 175.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 2.4 p -75.87 43.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.468 0.652 . . . . 0.0 111.527 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 72.1 mt -81.64 161.46 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.341 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -101.9 18.11 21.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.18 0.514 . . . . 0.0 110.733 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -154.86 169.06 32.98 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.29 112.43 24.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 0.0 110.941 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.87 137.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -69.49 61.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.062 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -162.9 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.665 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t -106.05 14.53 27.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 0.0 110.184 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 57.79 31.68 20.83 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.779 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 m 64.92 13.4 8.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.672 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 67.64 164.96 0.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.644 0.59 . . . . 0.0 111.314 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -166.28 157.5 13.18 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.42 23.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.218 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 15.3 m -82.65 104.11 12.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.65 73.49 6.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.145 0.498 . . . . 0.0 110.836 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.66 133.34 32.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.643 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.89 95.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.499 0.666 . . . . 0.0 111.525 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -126.45 6.81 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.329 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mm 62.12 36.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 122.225 1.012 . . . . 0.0 109.644 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -109.13 162.54 14.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.421 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.9 p -79.77 29.3 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.748 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 2.9 p -79.76 137.04 36.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -155.23 -45.48 0.08 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.239 0.542 . . . . 0.0 109.739 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 156.26 173.4 24.77 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.404 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.872 179.715 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 91.5 mtp . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.97 -33.83 0.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 111.449 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -105.79 106.17 55.65 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.554 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.23 -21.07 48.66 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.555 2.17 . . . . 0.0 112.612 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -102.78 -75.23 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.668 0.27 . . . . 0.0 110.597 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -165.41 158.3 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.867 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' C' ' 8' ' ' PRO . 20.4 p -80.37 110.8 18.11 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 7' ' ' THR . 7.7 Cg_exo -72.87 54.93 2.68 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.048 2.499 . . . . 0.0 113.064 -177.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.2 m -74.07 -48.9 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . 0.404 ' CE3' ' HB3' ' C' ' 44' ' ' PRO . 0.8 OUTLIER -90.05 124.79 62.5 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.61 178.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.02 160.53 26.93 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.507 2.138 . . . . 0.0 112.008 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -96.17 161.24 14.04 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' C' ' 86' ' ' TYR . 95.4 m-85 -125.84 155.86 40.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.401 -166.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' C' ' 89' ' ' ALA . 4.1 ptmm? -156.51 158.38 37.09 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -165.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.592 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 9.6 p-10 -96.17 -144.82 0.28 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.616 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.24 -40.85 36.01 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.29 -18.28 17.65 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.625 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.67 22.29 1.84 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.475 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.592 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.9 t -66.73 107.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -84.15 143.16 29.83 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.187 0.994 . . . . 0.0 111.803 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.49 137.27 18.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.482 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 25.9 t -81.79 144.26 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.523 ' O ' ' HD3' ' C' ' 25' ' ' PRO . . . -105.96 122.72 46.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.591 0.71 . . . . 0.0 110.983 -175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' C' ' 66' ' ' LEU . 2.9 mm? -101.52 96.74 6.62 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.476 175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 2.6 Cg_exo -76.37 104.26 1.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.778 2.319 . . . . 0.0 111.527 -177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 44.5 mt -71.29 90.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.718 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.786 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 27.9 tptp -66.65 -51.61 54.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.814 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.62 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -166.05 166.66 17.08 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.821 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.47 ' CG2' ' HB1' ' C' ' 37' ' ' ALA . 73.1 mt -135.62 141.62 41.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' C' ' 30' ' ' LYS . 1.5 tpmt? -104.06 99.78 9.54 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.092 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -79.94 106.68 12.15 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.53 168.4 19.85 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.778 0.799 . . . . 0.0 110.316 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -82.15 -10.36 59.2 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.414 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.37 -15.47 37.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.182 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.06 -28.71 6.51 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.977 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -72.09 158.64 35.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.762 0.315 . . . . 0.0 110.411 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.47 ' HB1' ' CG2' ' C' ' 29' ' ' ILE . . . -134.12 162.21 32.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.697 0.284 . . . . 0.0 111.15 -177.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 23.8 m-80 -125.92 124.04 39.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.85 106.61 18.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.238 0.542 . . . . 0.0 111.198 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.786 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 23.6 mt-10 -77.77 89.73 4.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.382 -177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -91.18 141.64 28.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.28 -8.13 9.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.59 -124.63 0.72 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.409 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.404 ' HB3' ' CE3' ' C' ' 10' ' ' TRP . 74.3 Cg_endo -80.09 11.25 2.87 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.822 2.348 . . . . 0.0 113.028 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -138.68 161.55 36.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.879 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.73 -165.0 1.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.296 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.31 133.21 36.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 46.8 mm-40 -132.92 139.19 47.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.949 -0.114 . . . . 0.0 110.867 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -75.66 154.47 36.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.876 0.369 . . . . 0.0 110.27 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 21.8 ptp -150.29 128.08 11.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.575 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 151.19 44.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.665 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.96 -33.99 77.35 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.91 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.32 -35.2 80.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.401 0.62 . . . . 0.0 109.788 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -71.18 -36.62 72.02 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.282 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 55.5 t -70.18 -23.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.438 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.36 -31.48 67.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.779 0.323 . . . . 0.0 111.026 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.03 -29.69 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.639 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -116.1 21.96 13.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 20.2 ptmt -52.71 110.82 2.15 Favored Pre-proline 0 C--N 1.327 -0.377 0 O-C-N 123.309 0.381 . . . . 0.0 111.034 172.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 79.2 Cg_endo -100.14 -151.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 123.411 2.741 . . . . 0.0 111.742 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.416 ' H ' ' HB2' ' C' ' 60' ' ' PRO . 43.0 mt-10 -138.36 131.13 29.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.358 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.62 HG13 ' HA ' ' C' ' 28' ' ' ALA . 95.6 t -72.99 105.49 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.207 0.527 . . . . 0.0 109.781 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.85 -23.12 4.47 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.457 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.0 -165.22 38.05 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.878 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -116.44 135.27 53.99 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.894 0.378 . . . . 0.0 110.991 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.525 HD12 ' O ' ' C' ' 75' ' ' LEU . 36.4 tp -106.32 149.93 26.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -148.29 154.92 40.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.221 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -121.9 121.96 38.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 5.2 p -106.56 -175.45 2.8 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.019 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.08 -46.91 88.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -166.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -69.9 -8.73 51.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.677 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.27 41.92 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.09 136.67 48.35 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.228 0.537 . . . . 0.0 110.243 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.494 ' O ' HD22 ' C' ' 75' ' ' LEU . 1.6 pt? -130.7 128.43 40.85 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.186 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.525 ' O ' HD12 ' C' ' 66' ' ' LEU . 1.6 mm? -138.97 169.51 17.65 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.792 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' C' ' 77' ' ' MET . 24.2 p90 -122.35 156.87 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' C' ' 76' ' ' TYR . 35.7 tpp -177.21 166.12 2.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.411 0.444 . . . . 0.0 110.408 172.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 24.9 p -77.03 -147.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.703 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -75.09 -24.75 58.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.3 p -47.92 -45.6 30.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.654 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' C' ' 77' ' ' MET . . . -82.16 -33.43 29.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.704 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.717 ' HA ' ' CD1' ' C' ' 86' ' ' TYR . 70.5 t80 -53.96 -40.44 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 110.947 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -74.12 -45.07 51.24 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.824 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.39 -30.85 27.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.79 -13.89 11.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.717 ' CD1' ' HA ' ' C' ' 82' ' ' PHE . 0.8 OUTLIER -104.75 -11.61 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.42 -0.912 . . . . 0.0 113.412 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 40.9 p -140.25 -102.73 0.16 Allowed 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 111.682 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t 49.65 -161.15 0.05 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.572 0.749 . . . . 0.0 111.391 175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . 0.471 ' HB3' ' NZ ' ' C' ' 14' ' ' LYS . . . 52.67 55.59 8.83 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.319 170.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 39.6 m -70.98 105.96 3.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.703 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.08 -50.81 21.14 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.329 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 14.1 m -91.62 -26.76 18.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.587 0.232 . . . . 0.0 110.807 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 60.1 t 65.03 -82.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.319 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.25 -6.02 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.762 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 63.94 23.09 13.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.49 0.18 55.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.297 0.57 . . . . 0.0 110.85 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.96 -58.29 2.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.421 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -81.61 -16.94 49.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.14 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' C' ' 102' ' ' LEU . . . -136.94 73.99 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.567 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.43 -4.65 47.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.306 0.574 . . . . 0.0 110.174 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -96.55 13.4 28.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.438 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' C' ' 99' ' ' ALA . 89.1 mt -54.76 107.32 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.281 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 35.0 m 71.77 28.29 2.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.564 175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 43.9 p -100.33 121.71 41.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.027 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.79 -91.5 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.191 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -139.18 44.92 1.99 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 1.3 p -79.83 -105.28 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.9 -58.95 2.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 6.4 p -63.64 -43.33 97.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.066 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -118.65 126.48 52.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 48.1 p -87.83 -23.96 23.86 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.91 0.862 . . . . 0.0 108.893 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -129.52 131.13 6.58 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.058 173.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.58 32.44 0.51 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.127 0.463 . . . . 0.0 111.904 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' C' ' 117' ' ' SER . 61.3 t 65.96 110.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.471 0.653 . . . . 0.0 111.111 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.9 p -59.29 -31.69 69.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.926 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.4 24.0 19.05 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.475 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . 0.403 ' HB3' ' HB ' ' C' ' 114' ' ' VAL . 33.3 t -139.39 -49.39 0.49 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.75 70.88 10.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.707 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.2 m -62.87 -44.74 95.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.248 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -100.13 -58.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -152.57 -25.06 0.17 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.109 0.481 . . . . 0.0 110.424 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.44 45.15 6.26 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.758 -0.655 . . . . 0.0 113.802 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 17.5 p -116.47 -81.76 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 117.055 0.427 . . . . 0.0 111.07 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.28 73.47 10.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -76.57 -50.25 14.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.056 0.455 . . . . 0.0 109.896 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 14.9 t -131.96 75.71 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.338 0.59 . . . . 0.0 110.114 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 4.3 p -100.89 -48.12 4.56 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.12 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 20.6 mt 45.13 62.25 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.218 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.59 -81.74 0.63 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.082 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 16.0 p -102.4 60.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.596 -173.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 12.9 p -79.53 -23.3 42.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.36 0.6 . . . . 0.0 110.319 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 31.9 t -144.01 33.16 1.24 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.83 -176.6 45.37 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.494 -173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.14 -179.422 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.933 0.397 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.51 58.49 1.13 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.883 0.373 . . . . 0.0 110.617 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -81.16 157.05 71.41 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.204 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -43.35 -43.66 10.48 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.46 2.773 . . . . 0.0 114.461 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -59.26 -30.29 68.18 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.288 0.566 . . . . 0.0 111.104 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.64 58.06 2.65 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.417 ' HB ' ' HD3' ' C' ' 8' ' ' PRO . 34.5 m -53.2 -50.82 80.26 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.971 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' HB ' ' C' ' 7' ' ' THR . 66.9 Cg_endo -73.09 55.61 2.93 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.119 175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 40.9 t -71.24 -26.76 63.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.393 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . 0.408 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . 2.1 m-90 -66.47 116.48 34.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.471 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 10' ' ' TRP . 10.6 Cg_exo -70.38 119.5 6.4 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.385 2.057 . . . . 0.0 110.809 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 14.8 mt -115.05 138.25 51.08 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' C' ' 87' ' ' THR . 58.1 m-85 -132.95 -169.76 2.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -168.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' C' ' 86' ' ' TYR . 9.8 mtmp? -141.25 135.31 30.54 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -170.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.735 ' HA ' ' O ' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -77.94 -169.83 1.69 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.555 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -58.28 -45.72 87.38 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -102.23 -9.46 20.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.193 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.66 16.58 2.74 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.222 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.577 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 44.7 t -67.88 116.38 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -80.14 134.8 36.19 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.775 0.798 . . . . 0.0 110.185 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' C' ' 67' ' ' PHE . 1.5 p -148.75 136.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.176 -1.374 . . . . 0.0 111.57 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.3 m -86.48 144.09 27.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.265 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.68 117.34 33.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.566 0.698 . . . . 0.0 109.971 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.21 104.79 54.94 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.688 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.02 122.59 9.19 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.363 2.042 . . . . 0.0 112.275 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . 0.437 HG12 ' CZ ' ' C' ' 41' ' ' PHE . 38.1 mt -78.29 110.3 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -77.47 -46.94 20.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -157.18 160.55 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.984 0.421 . . . . 0.0 111.817 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.1 mt -146.56 143.47 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.659 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -130.48 111.99 12.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.413 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -82.61 104.56 12.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.27 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.44 165.12 25.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.745 0.783 . . . . 0.0 110.363 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.21 -19.33 65.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.193 -171.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -84.8 -22.05 29.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.318 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.62 -25.96 6.09 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.559 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 60.0 p -66.47 148.66 51.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.989 0.423 . . . . 0.0 110.772 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.23 123.89 44.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' C' ' 48' ' ' GLN . 5.3 t30 -87.0 120.91 28.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.56 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.698 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -96.65 160.53 14.34 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.924 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -141.66 118.5 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.798 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' C' ' 26' ' ' ILE . 50.5 m-85 -117.31 171.85 7.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.75 -57.8 4.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.097 0.475 . . . . 0.0 111.474 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.7 -168.04 33.42 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.888 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.05 41.01 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.336 2.69 . . . . 0.0 112.493 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.33 -173.32 2.39 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.068 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -36.06 114.77 0.3 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 124.059 0.849 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.698 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 33.4 t70 -149.02 66.12 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.244 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.681 ' O ' ' HA ' ' C' ' 38' ' ' ASN . 2.2 pp0? -168.81 163.26 11.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.036 -168.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' C' ' 38' ' ' ASN . 96.3 m-85 -80.07 111.76 16.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 13.3 tpt -86.53 145.85 26.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.35 132.09 16.61 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.777 0.673 . . . . 0.0 111.722 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.95 76.55 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.13 -35.64 79.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.627 0.727 . . . . 0.0 109.63 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.6 m -74.83 -40.16 61.22 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.577 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 44.2 t -69.04 -25.71 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.399 0.618 . . . . 0.0 110.338 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.88 91.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.837 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.7 -24.7 4.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.101 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -116.15 14.74 15.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -170.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 8.9 ptpp? -52.74 116.79 9.6 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-O 120.786 0.326 . . . . 0.0 111.447 175.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 5.5 Cg_endo -88.2 -149.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.179 2.586 . . . . 0.0 111.477 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.2 132.06 48.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.276 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.23 106.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.96 0.886 . . . . 0.0 109.967 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.31 16.86 33.42 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.067 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.17 -159.31 25.24 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.265 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.6 121.36 40.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 tp -96.43 157.66 15.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.656 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 46.9 p90 -148.84 153.95 38.8 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.745 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -149.38 142.88 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.276 0.36 . . . . 0.0 110.254 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 20.4 p -115.08 -175.81 2.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.269 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -69.37 -35.75 76.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 109.889 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.69 -4.7 28.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.156 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.95 19.53 57.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.85 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -86.05 109.09 18.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 109.895 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.3 pt? -130.32 139.62 50.69 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.838 -178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.656 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 67.8 mt -157.94 177.22 11.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.208 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -118.99 144.17 46.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.445 ' HA ' ' CE ' ' C' ' 77' ' ' MET . 1.8 mmt -147.11 145.94 29.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.738 0.304 . . . . 0.0 110.75 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 29.5 p -73.33 145.5 45.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.515 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 17.6 ptpt -51.12 -31.87 20.82 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -167.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -59.74 -57.32 13.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.25 -38.77 68.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.323 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.515 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 70.7 t80 -54.62 -44.37 73.06 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.49 ' HA ' ' OG1' ' C' ' 87' ' ' THR . 27.8 tt0 -56.66 -51.25 69.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.901 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.44 41.07 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.893 0.378 . . . . 0.0 110.688 -167.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' C' ' 15' ' ' ASP . 13.6 m120 -93.25 -33.42 13.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.026 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' C' ' 85' ' ' ASN . 0.0 OUTLIER -148.82 66.64 1.05 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.566 ' HA ' ' HB3' ' C' ' 13' ' ' TYR . 31.1 p -169.03 -37.14 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 169.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' C' ' 89' ' ' ALA . 72.3 m -76.34 -161.2 0.17 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.466 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' C' ' 88' ' ' SER . . . 81.43 -6.45 1.53 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.055 0.942 . . . . 0.0 111.123 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 37.9 t 69.3 165.62 0.26 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.185 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.15 -32.57 65.54 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.425 175.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -72.8 -22.81 60.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 110.527 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 83.2 t 74.05 -52.39 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.196 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.49 101.32 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.144 0.497 . . . . 0.0 110.939 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.9 -8.73 57.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.5 -177.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.25 -4.22 59.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.286 0.565 . . . . 0.0 110.82 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -112.9 -33.18 6.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.157 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.7 t -99.56 35.68 1.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.798 0.808 . . . . 0.0 108.878 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.99 139.11 58.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.31 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -94.77 10.14 36.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 172.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . 0.619 ' HA ' ' OG1' ' C' ' 104' ' ' THR . 22.6 tptm -92.06 12.57 21.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.585 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 93.7 mt -55.51 -57.77 10.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.357 -174.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 44.6 m -94.37 -14.24 25.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.332 . . . . 0.0 110.965 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' C' ' 101' ' ' LYS . 16.7 p -89.12 -2.25 58.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.991 -176.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . 0.521 ' HB2' ' HG3' ' C' ' 101' ' ' LYS . . . -91.18 58.36 3.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.643 0.259 . . . . 0.0 110.457 175.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.19 40.2 6.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.972 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 49.1 p 49.74 75.37 0.16 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.041 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.97 -31.31 52.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.586 0.708 . . . . 0.0 109.823 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . 0.471 HG22 HG22 ' C' ' 114' ' ' VAL . 14.1 p -83.39 -3.91 57.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.193 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mp 61.92 -90.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.652 -175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 22.1 p -120.44 -64.63 1.23 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.7 42.72 0.39 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -126.82 -36.34 2.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 111.498 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.471 HG22 HG22 ' C' ' 109' ' ' THR . 2.6 t 57.22 27.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.401 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 69.4 p 53.05 -74.58 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.435 1.094 . . . . 0.0 112.798 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' C' ' 120' ' ' PHE . . . -73.5 -41.29 44.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.716 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 17.5 t -60.55 -33.88 73.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.988 0.423 . . . . 0.0 110.545 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' C' ' 119' ' ' SER . . . -64.96 -55.39 19.43 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.546 175.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' C' ' 118' ' ' ALA . 23.9 t 173.1 -9.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.665 0.603 . . . . 0.0 111.433 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . 0.421 ' C ' ' HA2' ' C' ' 116' ' ' GLY . 62.5 m-85 -107.7 72.45 0.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.924 0.393 . . . . 0.0 111.479 -172.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.07 -50.22 9.92 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -162.18 21.39 0.19 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.051 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -138.45 84.57 2.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.891 0.377 . . . . 0.0 110.256 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.96 -5.18 12.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 63.44 -88.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.864 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 6.0 t 47.71 49.1 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 110.273 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 50.1 p 56.32 -90.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.949 0.9 . . . . 0.0 112.443 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . 0.54 ' HA ' ' OG1' ' C' ' 131' ' ' THR . 33.3 mm 57.94 47.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.938 0.875 . . . . 0.0 109.867 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -110.57 -75.67 0.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.659 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 2.3 p -92.44 7.25 43.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.629 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' C' ' 128' ' ' ILE . 23.3 p -64.2 -28.59 69.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.147 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -149.04 -31.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.164 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.27 41.65 7.36 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.785 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.339 -0.838 . . . . 0.0 109.769 -177.383 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.792 0.33 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.56 -24.46 60.1 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.443 0.64 . . . . 0.0 110.307 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -115.91 98.48 51.18 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.759 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.4 53.37 4.73 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.783 2.322 . . . . 0.0 111.961 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -84.71 -55.02 4.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.107 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 52.52 46.92 25.79 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.245 0.545 . . . . 0.0 110.714 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.0 p -79.23 132.27 63.44 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.677 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 103.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.791 2.327 . . . . 0.0 111.666 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 8.1 m -65.58 -29.95 70.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -62.43 116.07 20.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.174 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.09 160.14 49.98 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.827 2.351 . . . . 0.0 111.237 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.79 165.17 25.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.261 0.553 . . . . 0.0 110.781 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.72 ' HB2' HG22 ' C' ' 21' ' ' VAL . 15.4 m-30 -93.25 160.13 14.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.873 -168.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.512 ' H ' ' HA ' ' C' ' 86' ' ' TYR . 55.9 mttp -138.58 120.07 14.98 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -174.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.522 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -82.25 -165.02 0.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.659 -176.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.467 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -70.81 -41.69 71.24 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -105.42 -8.71 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.56 9.02 5.09 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.398 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.522 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 78.7 t -77.6 100.04 2.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -84.15 163.12 19.97 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' C' ' 13' ' ' TYR . 3.7 m -147.98 139.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.388 -174.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 15.1 t -83.42 153.22 24.62 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.872 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.29 127.73 55.16 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.379 0.609 . . . . 0.0 110.569 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.467 HD22 ' N ' ' C' ' 24' ' ' LEU . 2.4 mm? -112.2 98.0 41.22 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.993 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' C' ' 42' ' ' ASP . 20.8 Cg_exo -66.02 118.98 5.95 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.932 2.422 . . . . 0.0 112.94 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mt -85.4 96.0 4.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.069 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 60.3 tptt -66.72 -54.44 22.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.698 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HA ' HG13 ' C' ' 62' ' ' VAL . . . -164.23 164.77 22.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.894 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.7 mt -138.6 144.08 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.31 0.576 . . . . 0.0 110.996 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -120.28 108.2 13.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.657 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.25 106.45 15.03 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.754 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.12 162.77 20.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.794 0.806 . . . . 0.0 110.789 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -77.14 -11.72 59.85 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.042 -171.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -88.23 -12.41 43.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.93 -37.1 3.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.22 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -67.02 131.75 46.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.325 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.69 121.31 41.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.625 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.558 HD22 ' N ' ' C' ' 38' ' ' ASN . 0.8 OUTLIER -86.76 113.07 22.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.27 126.37 52.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.45 0.643 . . . . 0.0 112.359 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 39.9 mt-10 -86.26 108.25 18.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.318 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -107.66 160.81 15.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . 0.508 ' O ' ' HD2' ' C' ' 25' ' ' PRO . 1.9 m-20 -113.61 147.88 37.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.362 172.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.5 13.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.69 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 -31.12 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.808 2.339 . . . . 0.0 112.18 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -86.97 140.52 29.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.219 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.47 -162.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' HG2' ' C' ' 40' ' ' GLU . 2.1 m-20 -64.99 119.24 10.38 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -154.66 146.18 23.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.056 0.455 . . . . 0.0 111.627 -175.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 24.2 p90 -93.49 131.34 38.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.499 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 25.8 mmt -99.24 137.74 37.33 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.54 139.52 37.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.712 0.633 . . . . 0.0 111.298 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.51 -34.56 75.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.473 -173.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -66.41 -34.92 79.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.53 0.681 . . . . 0.0 109.401 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m -71.98 -40.21 68.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.7 t -70.13 -26.66 30.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.447 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.17 79.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.87 -31.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.586 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.24 20.17 17.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' C' ' 59' ' ' LYS . 0.0 OUTLIER -49.27 110.12 1.44 Allowed Pre-proline 0 CA--C 1.537 0.444 0 O-C-N 123.253 0.345 . . . . 0.0 110.413 172.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 9.7 Cg_endo -91.33 -155.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.86 2.373 . . . . 0.0 112.772 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -130.25 137.34 49.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.024 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' C' ' 28' ' ' ALA . 39.2 t -72.49 100.51 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.52 7.38 54.01 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.332 -175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.55 -166.38 40.0 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.563 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.61 130.41 56.72 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.93 0.395 . . . . 0.0 111.256 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' C' ' 24' ' ' LEU . 56.8 tp -119.07 139.53 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 29.5 p90 -146.03 156.29 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.956 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -147.44 139.27 24.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 89.7 p -110.57 179.7 4.0 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -64.89 -38.38 90.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.444 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -68.31 -18.8 64.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.093 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.29 12.78 32.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.658 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.1 119.78 25.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 2.0 pt? -130.91 130.62 43.72 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 92.2 mt -145.26 158.51 43.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.302 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -113.9 151.17 32.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' C' ' 81' ' ' ALA . 9.4 ttm -175.54 175.31 2.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.726 0.298 . . . . 0.0 110.455 170.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 23.6 p -81.89 -149.78 0.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.496 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 20.5 ptmt -66.78 -20.52 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 19.8 p -58.18 -64.82 0.78 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.131 0.491 . . . . 0.0 111.308 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' C' ' 77' ' ' MET . . . -62.53 -37.58 86.63 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.322 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.595 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 20.5 t80 -48.47 -55.87 9.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.532 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.832 ' HA ' ' CE2' ' C' ' 86' ' ' TYR . 35.2 tt0 -64.69 -22.21 66.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.373 0.606 . . . . 0.0 111.384 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' C' ' 88' ' ' SER . . . -89.23 -6.53 56.78 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.618 ' O ' ' HB3' ' C' ' 13' ' ' TYR . 9.9 m-80 -107.32 -39.3 5.71 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.048 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.832 ' CE2' ' HA ' ' C' ' 83' ' ' GLU . 13.2 p90 -94.75 -7.34 40.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.356 -1.338 . . . . 0.0 112.318 -173.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.596 HG23 ' CD1' ' C' ' 86' ' ' TYR . 35.0 p -147.77 -53.67 0.2 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.388 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' C' ' 84' ' ' ALA . 9.8 t 71.13 154.83 0.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.706 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 175.51 -50.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.62 -1.627 . . . . 0.0 107.762 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -145.77 -173.95 4.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.019 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 143.29 -115.22 0.89 Allowed Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 55.8 m -95.88 27.3 3.61 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.37 -71.62 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.666 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.74 14.06 0.35 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.594 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.409 HD22 ' C ' ' C' ' 95' ' ' ASN . 0.3 OUTLIER -162.75 152.93 16.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.256 -177.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 75.61 -11.74 1.07 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.246 0.966 . . . . 0.0 112.883 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -139.19 -56.35 0.59 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.8 0.333 . . . . 0.0 111.013 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 6.4 m -53.53 -43.84 68.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.694 -176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.65 36.24 4.49 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.063 0.458 . . . . 0.0 110.322 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.75 -31.31 68.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.951 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -87.01 1.35 53.13 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.099 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.98 42.35 24.4 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.697 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -138.37 36.28 2.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.834 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 6.5 t -112.23 119.01 36.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.566 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 66.92 -77.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.802 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -124.99 -74.11 0.62 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 2.9 p 46.92 -101.76 0.07 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.542 0.737 . . . . 0.0 112.647 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.0 -58.67 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.688 0.28 . . . . 0.0 111.286 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 15.6 p -65.98 -40.55 91.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.88 0.371 . . . . 0.0 111.814 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' C' ' 110' ' ' LEU . 4.1 mm? -88.4 34.7 0.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.827 0.346 . . . . 0.0 111.596 -176.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 41.1 p -90.99 -36.17 14.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.31 0.576 . . . . 0.0 110.012 172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -139.38 38.43 1.64 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.636 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' C' ' 114' ' ' VAL . . . 56.05 43.34 27.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.898 0.41 . . . . 0.0 111.262 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' C' ' 113' ' ' ALA . 53.5 t 68.33 143.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.227 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.2 p -75.87 51.63 0.65 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.077 0.465 . . . . 0.0 111.096 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.03 -105.6 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.731 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 5.0 m -104.63 -59.93 1.67 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 117.16 0.48 . . . . 0.0 110.863 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -179.27 63.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.408 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p 57.75 172.6 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.222 1.009 . . . . 0.0 111.671 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 61.38 28.12 17.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.776 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -97.32 55.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.674 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 148.03 48.36 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.673 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 40.0 m 61.34 44.5 9.56 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 72.68 -57.65 0.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.276 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . 0.402 ' OD1' HG23 ' C' ' 126' ' ' VAL . 22.6 t-20 -179.55 -71.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.402 HG23 ' OD1' ' C' ' 125' ' ' ASN . 69.8 t -138.62 117.94 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.163 0.506 . . . . 0.0 110.51 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 3.2 p -77.59 -77.16 0.16 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.473 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 69.6 mt -141.71 -49.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -103.7 122.02 44.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.316 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 38.3 p -69.52 -34.6 74.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.979 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 15.6 p -81.98 69.78 8.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.226 0.536 . . . . 0.0 111.024 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -131.79 -8.13 3.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.399 0.618 . . . . 0.0 109.932 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.67 51.73 2.97 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.487 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.778 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.772 0.32 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.65 56.7 4.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.369 0.604 . . . . 0.0 110.578 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.96 136.95 73.12 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.933 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.61 -30.42 60.55 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.066 2.511 . . . . 0.0 112.544 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 m120 72.86 -19.7 0.3 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -86.83 108.7 18.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.484 0.659 . . . . 0.0 110.269 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 24.1 m -155.23 89.98 2.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.0 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.451 ' HB2' ' CE2' ' C' ' 10' ' ' TRP . 52.3 Cg_exo -55.56 138.47 80.74 Favored 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.953 2.435 . . . . 0.0 112.634 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 31.7 p -93.14 65.87 4.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.926 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . 0.611 ' O ' ' HG ' ' C' ' 12' ' ' LEU . 6.2 m-90 -60.27 155.87 43.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.37 102.86 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.346 2.031 . . . . 0.0 111.917 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.769 HD13 ' HA ' ' C' ' 22' ' ' SER . 52.5 mt -110.21 -178.2 3.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.523 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.582 ' HA ' HG21 ' C' ' 87' ' ' THR . 7.6 m-85 -92.31 166.03 12.8 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.92 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' C' ' 87' ' ' THR . 28.3 mmmt -115.38 154.46 29.17 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.55 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -93.55 -167.44 1.7 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.77 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -71.64 -42.07 68.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -170.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.75 -8.52 24.15 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.131 -173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.61 10.08 5.09 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.907 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.55 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 59.0 t -71.23 141.96 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.86 136.08 33.43 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.865 0.841 . . . . 0.0 109.447 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 20.0 m -134.26 135.31 54.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.356 -172.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.769 ' HA ' HD13 ' C' ' 12' ' ' LEU . 14.3 m -73.94 147.27 43.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.631 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.77 115.15 29.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.102 0.477 . . . . 0.0 110.67 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.92 96.91 50.54 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.326 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.669 ' O ' ' HE3' ' C' ' 27' ' ' LYS . 18.0 Cg_exo -69.59 177.01 5.89 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.488 2.126 . . . . 0.0 111.655 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . 0.661 ' HB ' ' H ' ' C' ' 63' ' ' GLY . 0.1 OUTLIER -120.29 86.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.448 0.642 . . . . 0.0 109.753 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.695 ' H ' ' HD2' ' C' ' 27' ' ' LYS . 0.0 OUTLIER -87.36 -54.44 4.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.371 -1.741 . . . . 0.0 110.268 -163.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.658 ' HB3' ' HB3' ' C' ' 40' ' ' GLU . . . -158.89 151.4 21.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.994 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.81 143.8 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.2 0.524 . . . . 0.0 110.724 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.612 ' HB2' ' ND2' ' C' ' 38' ' ' ASN . 0.0 OUTLIER -128.82 109.07 10.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.571 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -88.72 111.43 21.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.599 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.97 171.52 14.89 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.822 0.82 . . . . 0.0 110.49 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -78.52 -8.47 58.6 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.892 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -99.46 -7.52 25.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.915 0.388 . . . . 0.0 110.206 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.21 -19.69 29.3 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.599 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.53 155.02 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 110.442 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -141.35 143.57 34.08 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.989 -178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' C' ' 30' ' ' LYS . 11.5 p30 -116.4 147.73 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.931 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.97 91.46 3.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.692 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' C' ' 28' ' ' ALA . 6.1 tp10 -64.16 101.34 0.4 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.859 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . 0.624 ' CD2' ' HE2' ' C' ' 27' ' ' LYS . 0.5 OUTLIER -62.36 161.9 10.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.108 0.963 . . . . 0.0 113.396 169.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.84 -19.06 4.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.755 167.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . 0.449 ' H ' ' HD1' ' C' ' 41' ' ' PHE . . . -82.82 -150.67 9.35 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.872 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.39 35.87 0.56 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.323 2.682 . . . . 0.0 114.317 -172.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.503 ' HB2' ' CD2' ' C' ' 41' ' ' PHE . 96.0 m-85 -140.96 -177.46 5.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' C' ' 41' ' ' PHE . . . -100.22 -164.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 0.0 111.634 -177.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -94.73 118.55 31.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -95.93 120.96 37.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.574 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 44.2 p90 -104.7 139.45 39.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.079 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 26.2 mmt -123.55 147.75 46.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.5 154.26 29.16 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.517 0.511 . . . . 0.0 111.704 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.01 -57.46 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -59.68 -27.72 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.415 0.626 . . . . 0.0 110.259 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 28.8 m -75.64 -37.26 59.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.055 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.08 -14.17 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.382 0.61 . . . . 0.0 110.061 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.44 68.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.019 0.438 . . . . 0.0 110.058 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.41 -37.93 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.549 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.12 20.14 17.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.138 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' C' ' 60' ' ' PRO . 0.1 OUTLIER -49.16 114.77 4.12 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 123.515 0.509 . . . . 0.0 111.742 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' C' ' 65' ' ' TYR . 19.4 Cg_endo -98.14 -161.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.473 0 C-N-CA 123.209 2.606 . . . . 0.0 112.289 -176.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.585 ' O ' HG21 ' C' ' 26' ' ' ILE . 40.2 mt-10 -155.44 143.72 20.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.564 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -69.08 109.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.661 ' H ' ' HB ' ' C' ' 26' ' ' ILE . . . 93.24 15.21 52.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.075 -0.966 . . . . 0.0 113.011 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' C' ' 76' ' ' TYR . . . -136.79 63.79 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.947 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . 0.606 ' N ' HG12 ' C' ' 26' ' ' ILE . 0.1 OUTLIER -151.9 -171.44 3.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' C' ' 82' ' ' PHE . 0.5 OUTLIER -168.25 -79.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.24 -171.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -150.38 169.56 21.13 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.432 -165.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 55.8 ttt180 -151.81 131.09 12.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.153 177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 97.0 p -97.02 175.38 6.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.591 0.71 . . . . 0.0 110.845 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.93 -1.49 22.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.186 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -104.62 2.14 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.568 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.89 20.05 60.23 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.42 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 33.6 mt-10 -89.01 110.44 21.14 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -130.11 133.54 46.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.037 0.446 . . . . 0.0 110.297 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -130.77 167.96 18.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.676 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' C' ' 64' ' ' GLY . 0.8 OUTLIER -118.71 150.6 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 19.4 ttm -179.58 -175.76 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -78.8 103.99 9.12 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 160.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.82 -26.9 62.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.612 -170.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 18.1 p -58.78 -33.91 70.86 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 0.0 111.119 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.85 -49.16 63.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.488 0.661 . . . . 0.0 110.2 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.656 ' O ' ' HD1' ' C' ' 86' ' ' TYR . 48.5 t80 -64.22 -53.53 47.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.819 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.07 -23.61 63.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.731 -174.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.05 -12.96 27.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.046 0.451 . . . . 0.0 110.849 -171.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -98.36 -32.1 11.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.217 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.656 ' HD1' ' O ' ' C' ' 82' ' ' PHE . 15.3 m-85 -97.84 -58.34 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.511 -173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.582 HG21 ' HA ' ' C' ' 13' ' ' TYR . 64.9 p -86.5 -65.39 1.02 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.204 174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 14.4 t 65.1 169.81 0.2 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.55 0.691 . . . . 0.0 110.841 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.46 28.73 3.65 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.483 ' HB2' HG22 ' C' ' 93' ' ' VAL . 7.7 m -96.55 -18.13 20.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.88 -67.94 3.32 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.767 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . 0.44 ' HB2' ' HA ' ' C' ' 96' ' ' ALA . 12.4 p -97.65 80.86 2.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.287 0.565 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' C' ' 90' ' ' SER . 14.7 t -99.67 -78.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.38 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.24 -38.02 12.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.335 0.588 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -99.17 60.4 1.19 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' C' ' 92' ' ' SER . . . -80.13 55.7 2.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.128 -173.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 64.16 8.5 4.11 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.074 0.55 . . . . 0.0 111.638 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 10.3 t -96.74 -16.1 21.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.353 0.597 . . . . 0.0 110.06 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.93 28.56 8.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.685 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -68.44 -27.45 66.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.22 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . 0.665 ' H ' ' HD3' ' C' ' 101' ' ' LYS . 0.0 OUTLIER -95.79 -10.92 27.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . 0.487 ' O ' HG23 ' C' ' 104' ' ' THR . 95.2 mt 59.02 11.42 1.95 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.379 0.672 . . . . 0.0 112.461 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . 0.532 ' H ' ' HG2' ' C' ' 101' ' ' LYS . 22.5 m 65.25 22.24 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.363 0.665 . . . . 0.0 110.129 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . 0.487 HG23 ' O ' ' C' ' 102' ' ' LEU . 53.1 p -117.99 -53.91 2.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.08 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.64 99.0 2.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.516 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 72.63 125.8 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.945 0.778 . . . . 0.0 110.565 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -78.6 70.0 4.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.9 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 53.6 mt -68.38 -21.24 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 15.7 p -61.81 -28.11 69.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.384 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' C' ' 114' ' ' VAL . 94.4 mt 55.54 -91.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.177 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 17.4 p -132.45 23.7 4.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.123 0.487 . . . . 0.0 110.814 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.2 56.63 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -174.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.0 175.48 13.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.463 -0.869 . . . . 0.0 108.673 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' C' ' 110' ' ' LEU . 43.3 t -78.05 69.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.175 0.512 . . . . 0.0 110.507 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 69.0 p 51.61 24.35 2.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.118 0.967 . . . . 0.0 112.508 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.97 70.75 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.316 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -112.16 -12.2 13.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.078 0.466 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 58.94 27.51 16.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.52 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 14.9 m -83.64 170.64 14.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.896 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 63.2 23.74 14.02 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.15 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -159.95 -168.22 2.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.75 -2.21 41.92 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.378 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 19.6 m 65.31 90.39 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.702 0.401 . . . . 0.0 110.881 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.96 95.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.835 0.35 . . . . 0.0 110.682 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -165.99 79.88 0.28 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.873 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 60.5 t -115.33 -62.18 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.187 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 37.1 p 49.52 -96.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.402 0.681 . . . . 0.0 112.004 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.57 -57.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -147.72 94.46 2.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.702 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 26.9 p -79.71 -9.41 59.64 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 82.4 p -83.51 -3.64 57.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.067 0.461 . . . . 0.0 110.591 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 70.8 m -158.42 50.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -113.34 166.77 12.17 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.322 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.754 -178.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.38 -15.66 20.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' C' ' 4' ' ' PRO . 7.5 t-20 -144.67 131.85 10.27 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.567 -175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 3' ' ' ASN . 2.2 Cg_endo -80.17 44.62 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.232 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 54.62 37.15 27.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 48.11 44.92 19.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.484 0.659 . . . . 0.0 111.419 -176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 69.6 m -121.26 120.2 29.18 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.894 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -70.4 45.15 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.283 2.655 . . . . 0.0 112.989 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -125.49 57.76 1.32 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -64.02 134.17 95.84 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.11 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.07 103.41 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.431 2.088 . . . . 0.0 111.58 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.36 169.96 17.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.356 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.622 ' HA ' HG22 ' C' ' 87' ' ' THR . 50.9 m-85 -92.25 123.92 35.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.601 -176.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' C' ' 88' ' ' SER . 9.2 pttp -86.93 170.06 11.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.38 1.086 . . . . 0.0 111.157 -171.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -49.63 151.93 1.55 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 112.52 -2.127 . . . . 0.0 115.31 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.16 -54.7 2.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 112.113 -2.312 . . . . 0.0 108.614 163.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -104.43 -7.84 19.57 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.241 176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.86 35.97 0.53 Allowed Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.731 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.48 160.04 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.65 155.69 29.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 171.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 5.7 m -149.66 136.2 12.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.808 -170.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -74.33 154.41 38.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.444 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.57 130.88 52.49 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 110.464 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.62 98.48 49.54 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.598 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' C' ' 42' ' ' ASP . 7.4 Cg_exo -76.76 105.99 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.621 2.214 . . . . 0.0 111.202 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 24.6 mt -81.59 117.38 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.229 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -93.71 -55.0 3.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.729 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.6 158.13 37.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.536 0.208 . . . . 0.0 111.062 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.56 145.23 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' C' ' 30' ' ' LYS . 27.2 mtpp -133.71 133.24 41.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.866 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -101.48 117.87 35.82 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.773 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.28 -172.62 3.88 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.144 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -74.71 -42.91 57.47 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.965 -173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.36 -20.23 62.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.74 -25.83 6.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.809 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 30.1 p -63.26 143.94 57.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' C' ' 55' ' ' VAL . . . -120.86 144.68 48.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 111.748 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' C' ' 49' ' ' TYR . 8.2 t30 -106.54 127.65 53.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.749 178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -111.66 116.58 31.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -79.35 121.58 25.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -110.95 147.08 35.45 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 120.959 0.409 . . . . 0.0 110.629 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' C' ' 25' ' ' PRO . 21.3 t70 -101.77 150.39 23.2 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.81 -139.66 15.29 Favored Glycine 0 C--N 1.313 -0.704 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.979 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.53 28.35 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.794 2.329 . . . . 0.0 112.467 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -135.93 165.68 25.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.252 0.549 . . . . 0.0 111.455 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.29 -162.99 0.85 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.675 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 10.9 p-10 -93.91 150.41 20.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.67 153.36 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' C' ' 38' ' ' ASN . 46.9 p90 -109.34 143.17 39.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtt -127.69 148.18 50.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.901 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.14 152.92 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.01 -41.71 98.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.49 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -56.61 -38.66 72.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.515 0.674 . . . . 0.0 110.165 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 25.4 m -69.04 -44.55 72.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.565 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 49.5 t -69.62 -27.37 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.821 -176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.46 -33.86 76.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.357 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.57 -31.66 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.504 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.8 9.98 36.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 41.6 ttmt -55.58 114.19 6.91 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.871 177.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 98.9 Cg_endo -98.19 -145.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 123.525 2.817 . . . . 0.0 110.68 176.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' C' ' 76' ' ' TYR . 42.9 mm-40 -135.86 142.77 44.8 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.931 0.396 . . . . 0.0 110.701 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.1 127.19 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.781 0.8 . . . . 0.0 109.543 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.59 -8.74 56.79 Favored Glycine 0 C--N 1.302 -1.314 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.32 -172.9 36.96 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.955 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' C' ' 79' ' ' LYS . 58.5 m-85 -146.51 149.33 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -173.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' C' ' 67' ' ' PHE . 0.2 OUTLIER -175.24 -144.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.565 ' HE1' ' CE1' ' C' ' 82' ' ' PHE . 6.9 p90 -153.62 -179.3 7.67 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -167.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -140.09 126.37 20.0 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 42.0 p -98.59 177.21 5.39 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.863 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.56 16.12 1.47 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.86 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -107.99 3.07 23.7 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.07 6.24 89.57 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.222 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -78.21 114.52 17.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.118 0.485 . . . . 0.0 110.899 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.511 HD13 ' N ' ' C' ' 75' ' ' LEU . 3.4 tm? -100.08 137.8 38.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.511 ' N ' HD13 ' C' ' 74' ' ' LEU . 98.3 mt -142.24 158.62 43.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' C' ' 61' ' ' GLU . 17.8 t80 -126.73 147.81 49.94 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.765 0.665 . . . . 0.0 110.461 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.527 ' HG3' ' H ' ' C' ' 78' ' ' SER . 0.0 OUTLIER -166.78 175.95 7.46 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . 0.527 ' H ' ' HG3' ' C' ' 77' ' ' MET . 12.4 p -82.85 122.49 28.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' C' ' 65' ' ' TYR . 61.0 pttt -52.44 -46.68 66.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.424 ' N ' ' HG3' ' C' ' 79' ' ' LYS . 30.9 p -51.9 -38.95 58.18 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.449 0.468 . . . . 0.0 112.164 -173.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.23 -57.08 4.27 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.294 0.569 . . . . 0.0 111.205 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.565 ' CE1' ' HE1' ' C' ' 67' ' ' PHE . 0.5 OUTLIER -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.344 -173.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . 0.621 ' HG3' ' OG1' ' C' ' 87' ' ' THR . 12.9 tt0 -56.02 -39.89 72.62 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.851 0.46 . . . . 0.0 111.824 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.46 84.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.482 -169.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.522 ' HB2' ' CE1' ' C' ' 86' ' ' TYR . 43.2 m-80 -98.22 -36.95 9.87 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.974 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.522 ' CE1' ' HB2' ' C' ' 85' ' ' ASN . 3.4 m-85 -120.99 59.77 0.93 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -171.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.622 HG22 ' HA ' ' C' ' 13' ' ' TYR . 71.9 p -160.62 -49.19 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 165.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.469 ' O ' ' HD3' ' C' ' 14' ' ' LYS . 5.4 t -61.32 162.51 7.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.613 -176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 75.5 -44.55 0.52 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.321 1.048 . . . . 0.0 110.171 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 22.5 m 50.63 17.74 0.41 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.572 -1.195 . . . . 0.0 114.034 171.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.96 27.7 69.13 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.149 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -146.26 -41.31 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 56.4 t -71.4 93.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.377 . . . . 0.0 111.373 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.64 18.89 10.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.458 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.15 152.78 32.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 65.03 -75.94 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.936 0.773 . . . . 0.0 112.521 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -71.9 -27.78 63.06 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.148 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 1.9 m -84.31 -8.42 59.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.49 144.37 29.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.719 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.39 -25.49 59.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -84.45 -29.36 26.15 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.342 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt 61.39 -98.72 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.058 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 74.5 m -155.85 90.86 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' C' ' 105' ' ' ALA . 6.9 p -86.24 -165.0 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.784 -175.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . 0.426 ' H ' ' HB ' ' C' ' 104' ' ' THR . . . 66.8 -84.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.888 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -154.5 30.93 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 40.2 p 48.85 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.066 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 4.1 mt -85.21 24.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.147 -170.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 44.7 p 50.02 37.46 14.16 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.993 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 mm? 59.75 80.29 0.2 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.074 0.464 . . . . 0.0 111.346 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.07 123.89 23.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.783 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.79 -86.77 0.82 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.451 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -165.68 -57.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.149 0.5 . . . . 0.0 110.871 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.55 133.7 54.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.411 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 1.7 p -77.52 54.76 1.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.261 0.553 . . . . 0.0 111.312 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -172.44 -105.81 0.19 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.673 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -153.48 102.75 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.053 0.427 . . . . 0.0 110.503 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 67.58 -75.01 0.06 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.437 0.695 . . . . 0.0 111.911 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 8.2 t -132.12 41.03 3.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 65.46 -86.18 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.981 -171.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -139.33 -57.35 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.636 0.732 . . . . 0.0 109.028 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.51 146.83 4.73 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 51.1 m -63.35 -29.38 70.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.598 0.699 . . . . 0.0 111.061 -176.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.45 33.06 3.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.21 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.61 -24.32 62.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 110.073 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 t -86.0 123.33 39.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.475 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . 0.436 ' C ' ' H ' ' C' ' 129' ' ' GLU . 7.8 p -73.96 -35.75 64.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.937 0.398 . . . . 0.0 111.299 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 21.3 mt 68.41 -8.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.633 175.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' C' ' 127' ' ' THR . 0.8 OUTLIER 58.25 33.36 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.429 -178.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 2.2 p -77.08 86.07 3.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.101 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 31.2 p -81.26 9.06 7.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.723 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 15.5 t -145.69 23.68 1.4 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.55 -86.17 0.84 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.83 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.246 0.912 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.213 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.797 0.332 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.59 50.44 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 111.135 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.69 110.34 62.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.041 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.82 41.58 1.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 123.086 2.524 . . . . 0.0 112.935 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.21 43.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.436 0.636 . . . . 0.0 109.5 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -88.09 159.08 18.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.83 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' C' ' 8' ' ' PRO . 29.2 p -77.49 144.65 70.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.892 176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 7' ' ' THR . 7.7 Cg_exo -71.76 65.97 3.13 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.758 2.305 . . . . 0.0 112.514 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -79.14 -43.74 23.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.947 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -78.03 165.02 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.484 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.24 101.06 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.085 1.856 . . . . 0.0 111.806 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.424 ' CD2' ' HA ' ' C' ' 22' ' ' SER . 10.9 mp -119.77 161.57 20.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -132.83 170.16 15.7 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.678 -172.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.45 125.23 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.537 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -75.36 -167.76 0.7 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.313 0.383 . . . . 0.0 111.771 -171.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -65.82 -47.45 75.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -170.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -91.6 -13.56 31.72 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.399 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.72 17.55 2.56 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.031 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.537 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 41.7 t -67.28 110.91 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 109.903 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -90.76 140.15 30.06 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.451 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -139.72 136.22 39.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.365 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.424 ' HA ' ' CD2' ' C' ' 12' ' ' LEU . 22.9 m -92.26 139.68 30.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.256 175.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.07 117.24 33.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.43 0.633 . . . . 0.0 110.899 -174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.405 HD22 ' N ' ' C' ' 24' ' ' LEU . 1.4 mm? -107.12 106.81 59.3 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.699 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.35 128.05 15.83 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.277 1.985 . . . . 0.0 112.644 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.51 107.83 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.108 0.48 . . . . 0.0 109.921 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 76.0 tttt -76.45 -59.93 2.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.925 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -166.08 166.14 17.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.321 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 73.0 mt -144.8 141.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.154 0.502 . . . . 0.0 110.063 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.468 ' HB3' ' ND2' ' C' ' 38' ' ' ASN . 19.3 tptm -96.33 100.0 11.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.935 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -90.95 120.87 32.3 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.03 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.93 158.11 18.18 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.494 0.664 . . . . 0.0 109.56 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -71.24 -10.72 60.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.714 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -90.07 -26.22 20.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.016 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.22 -35.36 2.44 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.688 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -63.7 152.55 38.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.088 0.47 . . . . 0.0 110.27 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' C' ' 30' ' ' LYS . . . -150.3 173.8 13.57 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.749 -177.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' C' ' 49' ' ' TYR . 1.3 p30 -145.71 140.08 26.98 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.43 157.58 16.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -167.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 42.4 mt-10 -126.42 107.28 10.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.51 171.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . 0.447 ' HD1' ' O ' ' C' ' 46' ' ' ALA . 84.2 m-85 -100.47 151.29 21.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.17 129.98 35.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 109.77 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.55 -179.67 26.75 Favored Glycine 0 C--N 1.31 -0.917 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.755 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.92 61.35 7.6 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.771 2.314 . . . . 0.0 111.852 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -124.76 -174.05 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.59 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.447 ' O ' ' HD1' ' C' ' 41' ' ' PHE . . . -43.49 121.68 2.36 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.612 0.72 . . . . 0.0 112.59 -176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -123.31 59.22 1.1 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.704 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 174.51 165.14 0.23 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.278 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.65 ' HB2' ' HA ' ' C' ' 38' ' ' ASN . 0.3 OUTLIER -155.49 -165.7 2.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.381 161.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 18.0 ptt? -160.04 -129.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.455 0.57 . . . . 0.0 111.63 -167.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.29 136.58 3.95 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.655 0.782 . . . . 0.0 112.931 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.71 -27.22 67.46 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.843 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -61.15 -39.65 90.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.401 0.619 . . . . 0.0 109.337 173.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 12.2 m -71.19 -40.55 71.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.675 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.715 ' O ' ' HB2' ' C' ' 59' ' ' LYS . 67.5 t -78.46 -7.61 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.818 -176.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.59 -34.56 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.41 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -90.25 -33.62 6.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.183 0.516 . . . . 0.0 109.655 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.85 21.56 16.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -174.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' C' ' 55' ' ' VAL . 20.6 ttmm -68.21 113.99 18.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.923 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 74.3 Cg_endo -100.98 -150.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.514 2.809 . . . . 0.0 111.356 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -146.06 128.61 16.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.408 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 29.1 m -71.31 123.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 122.166 0.984 . . . . 0.0 110.108 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.41 -28.14 5.85 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.139 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.3 -169.9 37.72 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.371 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' C' ' 79' ' ' LYS . 43.6 m-85 -112.48 135.99 52.52 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.809 0.338 . . . . 0.0 110.685 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -93.37 125.46 37.99 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 47.7 p90 -124.3 147.19 48.31 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.453 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.407 ' CB ' ' HG ' ' C' ' 74' ' ' LEU . 7.3 ptm180 -124.31 148.41 47.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.665 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 58.8 p -121.31 173.94 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.604 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . 0.525 ' CD ' ' H ' ' C' ' 70' ' ' GLN . 20.2 mp0 -59.58 -42.13 91.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.465 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -72.47 0.97 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.649 -175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.42 28.44 55.53 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.964 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -91.37 104.61 17.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 5.7 mp -109.74 108.72 19.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.502 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.0 mm? -129.52 175.55 8.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.449 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . 0.408 ' CD2' ' HA ' ' C' ' 60' ' ' PRO . 35.6 p90 -122.76 146.45 47.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 46.0 tpp -153.25 139.74 18.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.911 0.386 . . . . 0.0 110.413 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -60.75 138.91 58.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.427 172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.483 ' HA ' ' HB3' ' C' ' 82' ' ' PHE . 61.5 pttt -64.07 -25.27 68.03 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.3 p -61.04 -52.22 65.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 110.283 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.53 63.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' C' ' 79' ' ' LYS . 7.7 t80 -57.27 -42.83 82.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.639 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.32 -34.83 79.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.362 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' C' ' 88' ' ' SER . . . -93.65 -30.43 14.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.985 -167.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.28 -30.07 67.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.475 ' CD2' ' N ' ' C' ' 86' ' ' TYR . 6.3 m-85 -100.19 -75.51 0.57 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.381 -175.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . . . . . . . . . 33.7 p -86.23 -56.53 3.41 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.718 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' C' ' 84' ' ' ALA . 20.4 t 73.61 -48.74 0.68 Allowed 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 124.328 1.051 . . . . 0.0 110.677 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.86 82.96 0.73 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.294 0.569 . . . . 0.0 109.912 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 5.1 m -63.93 -14.92 57.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.874 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.35 -57.5 4.74 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.493 174.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . 0.496 ' HA ' ' ND2' ' C' ' 95' ' ' ASN . 32.3 t -80.85 18.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 0.0 111.328 -174.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.42 ' O ' ' HB ' ' C' ' 98' ' ' THR . 47.5 t -82.48 -32.32 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -100.04 13.81 32.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.868 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' C' ' 92' ' ' SER . 1.1 p-10 -160.96 136.15 7.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.737 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . 75.81 -45.06 0.52 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.83 0.852 . . . . 0.0 112.86 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -92.3 -21.97 19.99 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.27 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' C' ' 93' ' ' VAL . 14.7 t -89.39 2.98 53.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.43 0.633 . . . . 0.0 109.405 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.74 97.73 3.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.707 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.14 -12.14 20.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . 0.455 ' O ' HG22 ' C' ' 104' ' ' THR . 39.5 ttpt -109.53 -29.45 8.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.979 0.418 . . . . 0.0 110.3 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 5.6 mp 54.62 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.023 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -150.41 27.46 0.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.014 0.435 . . . . 0.0 110.244 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . 0.455 HG22 ' O ' ' C' ' 101' ' ' LYS . 11.0 t -88.25 10.51 19.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.245 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.62 100.17 1.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.405 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 66.24 98.43 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.904 0.752 . . . . 0.0 110.273 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 12.4 p -73.39 83.52 1.44 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.629 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 47.0 mm -79.93 90.08 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.93 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 80.5 p 58.44 12.76 2.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.987 0.915 . . . . 0.0 112.323 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt 60.01 172.91 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.479 0.657 . . . . 0.0 111.592 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -92.54 58.68 3.2 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.864 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 64.01 73.46 0.55 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.097 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . 55.39 43.94 27.98 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.023 0.439 . . . . 0.0 110.805 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 38.9 t 53.24 69.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.603 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.8 p 48.6 37.96 10.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.223 0.535 . . . . 0.0 112.168 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.46 12.84 83.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.541 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 33.0 t -80.2 -25.98 39.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.534 0.667 . . . . 0.0 110.074 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 64.32 1.07 1.17 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.819 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.2 t 55.88 51.14 12.67 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.715 -178.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -60.23 -40.37 89.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.46 52.7 5.62 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.806 0.813 . . . . 0.0 109.183 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.84 -175.83 14.24 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.731 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 27.6 p -78.21 -24.13 47.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.576 0.227 . . . . 0.0 111.231 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . 71.58 -51.63 0.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.758 0.823 . . . . 0.0 111.347 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 59.48 86.96 0.09 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.871 0.468 . . . . 0.0 111.239 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 62.5 t 65.75 90.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.91 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 7.2 p -78.14 109.6 12.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.111 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 45.3 mm -80.22 85.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 175.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.69 153.8 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.445 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 31.8 p -82.48 11.76 5.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.285 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 44.1 p 58.21 135.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.364 1.466 . . . . 0.0 113.885 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 29.3 m -127.11 7.51 6.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.918 0.866 . . . . 0.0 108.82 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.9 35.52 1.08 Allowed Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.967 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.436 -177.188 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.21 53.52 2.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 110.39 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . 0.492 ' HB3' ' HA ' ' C' ' 6' ' ' PHE . 11.8 m120 -117.76 101.54 52.06 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.775 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.05 -50.21 13.94 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.334 2.689 . . . . 0.0 113.136 -176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.87 26.86 4.63 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' C' ' 3' ' ' ASN . 89.5 m-85 65.09 159.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 -173.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m 60.13 76.95 0.4 Allowed Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.45 73.94 2.15 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.909 2.406 . . . . 0.0 113.027 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t -73.86 -47.07 40.89 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -116.65 89.85 29.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.14 175.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.48 102.31 1.54 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.231 1.954 . . . . 0.0 110.721 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.468 HD22 ' H ' ' C' ' 23' ' ' ALA . 59.9 mt -88.16 167.49 13.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.552 ' HB2' HG13 ' C' ' 21' ' ' VAL . 3.6 m-85 -93.04 143.25 26.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.171 0.51 . . . . 0.0 111.892 -166.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . 0.495 ' H ' HG23 ' C' ' 87' ' ' THR . 53.1 mtmt -129.45 112.47 13.83 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.626 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -70.18 -169.11 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.029 0.443 . . . . 0.0 111.873 -169.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -55.53 -53.98 49.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.438 -170.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.48 -14.26 26.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.174 0.512 . . . . 0.0 110.415 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.93 30.91 1.06 Allowed Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.289 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.626 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 42.3 t -76.36 113.82 15.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 173.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -78.01 137.41 38.26 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.797 0.808 . . . . 0.0 110.528 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' C' ' 13' ' ' TYR . 0.2 OUTLIER -150.44 125.82 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.704 -1.589 . . . . 0.0 110.355 -178.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -88.74 162.02 16.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.803 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.468 ' H ' HD22 ' C' ' 12' ' ' LEU . . . -106.74 119.86 40.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.93 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.85 97.79 42.83 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.809 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.18 134.52 59.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.417 2.078 . . . . 0.0 111.569 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . . . . . . . . . 32.2 mt -76.2 93.67 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' C' ' 40' ' ' GLU . 21.9 tptm -70.57 -74.01 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.978 -172.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.85 143.75 24.59 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.865 0.364 . . . . 0.0 111.527 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.93 143.9 33.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.013 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.529 ' CG ' ' HB3' ' C' ' 38' ' ' ASN . 11.7 ptmm? -131.59 147.48 52.53 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -110.53 133.93 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.519 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.82 141.36 35.75 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.236 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -64.77 -15.09 61.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.167 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -81.44 -10.21 59.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.697 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.25 -34.03 4.75 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.417 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -64.45 164.38 11.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.784 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' C' ' 49' ' ' TYR . . . -142.12 146.15 35.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.529 ' HB3' ' CG ' ' C' ' 30' ' ' LYS . 6.3 t30 -106.42 123.88 48.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.485 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.58 ' HB3' ' OD1' ' C' ' 47' ' ' ASP . . . -119.35 175.91 5.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -173.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' C' ' 27' ' ' LYS . 10.3 pt-20 -160.28 144.55 14.31 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 165.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . 0.686 ' O ' ' HB2' ' C' ' 45' ' ' TYR . 88.4 m-85 -117.07 155.04 29.93 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.915 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . 0.47 ' OD1' ' HD2' ' C' ' 44' ' ' PRO . 19.9 t70 69.07 -64.06 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.121 0.968 . . . . 0.0 111.877 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.35 -73.15 0.2 Allowed Glycine 0 C--N 1.308 -0.991 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.532 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' C' ' 42' ' ' ASP . 71.6 Cg_endo -79.45 -3.96 13.33 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.798 2.332 . . . . 0.0 112.36 176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . 0.686 ' HB2' ' O ' ' C' ' 41' ' ' PHE . 17.4 m-85 -85.34 155.29 21.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.131 0.491 . . . . 0.0 110.426 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.557 ' HB1' HE22 ' C' ' 48' ' ' GLN . . . -99.74 -174.18 2.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.023 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.58 ' OD1' ' HB3' ' C' ' 39' ' ' ALA . 14.9 t70 -174.45 -63.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.297 170.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.557 HE22 ' HB1' ' C' ' 46' ' ' ALA . 2.9 mp0 75.37 -159.3 0.05 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 124.027 0.931 . . . . 0.0 111.686 175.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' C' ' 37' ' ' ALA . 76.2 m-85 -75.02 140.67 43.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.377 0.608 . . . . 0.0 112.396 -172.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 44.8 ttp -129.79 148.49 51.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.401 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.67 137.26 25.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.522 0.677 . . . . 0.0 111.837 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.87 -41.27 91.16 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.956 -174.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -61.79 -33.94 75.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 0.0 109.467 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -74.91 -40.65 60.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.471 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.38 -28.02 38.96 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.471 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.78 72.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.635 0.255 . . . . 0.0 111.041 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.46 -30.99 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.374 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . 0.581 ' O ' ' HD3' ' C' ' 60' ' ' PRO . 63.7 m-85 -95.41 14.84 21.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.596 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -81.65 99.91 0.65 Allowed Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' C' ' 58' ' ' PHE . 73.5 Cg_endo -101.07 -102.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.052 2.501 . . . . 0.0 112.917 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -143.61 123.45 13.45 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.8 t -72.18 101.8 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.15 -21.53 3.89 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.598 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.69 -159.6 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.163 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -124.04 120.26 31.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.059 0.456 . . . . 0.0 111.172 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.456 HD21 HD23 ' C' ' 74' ' ' LEU . 18.8 tp -93.96 154.95 17.4 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' C' ' 75' ' ' LEU . 50.9 p90 -139.47 146.99 40.71 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.563 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -132.99 123.76 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.875 -172.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' C' ' 73' ' ' GLU . 25.8 p -91.81 167.29 12.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.106 0.479 . . . . 0.0 109.957 175.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.12 11.18 0.6 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.38 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -109.72 -4.37 16.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 0.0 110.086 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.22 23.01 33.21 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.749 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.494 ' HB3' ' OG ' ' C' ' 69' ' ' SER . 43.2 tt0 -99.22 120.44 39.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.456 HD23 HD21 ' C' ' 66' ' ' LEU . 6.4 mp -125.63 116.26 21.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 3.1 mm? -128.06 169.2 14.33 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -132.27 155.93 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.949 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 21.8 ptp -175.89 -175.77 0.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.316 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 7.6 p -70.58 121.05 17.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' C' ' 79' ' ' LYS . 11.7 ptmt -64.96 -24.65 67.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.75 -173.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 13.6 p -61.24 -32.13 71.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.963 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.52 -50.18 19.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.1 0.476 . . . . 0.0 111.011 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.525 ' O ' ' HD2' ' C' ' 86' ' ' TYR . 8.0 t80 -72.89 -41.37 64.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -174.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -61.18 -31.71 71.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 0.0 110.422 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' C' ' 88' ' ' SER . . . -72.59 -35.06 67.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.772 -171.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.21 -25.8 60.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . 0.525 ' HD2' ' O ' ' C' ' 82' ' ' PHE . 14.7 m-85 -120.54 -85.94 0.65 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.365 -0.934 . . . . 0.0 113.374 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.495 HG23 ' H ' ' C' ' 14' ' ' LYS . 69.5 p -87.55 2.82 49.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -164.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' C' ' 84' ' ' ALA . 1.2 t -76.31 -46.66 26.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 50.74 52.38 15.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.213 0.53 . . . . 0.0 111.293 177.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 10.8 m -87.97 -6.94 57.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.071 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.31 -51.08 3.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.625 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 7.8 p -72.12 -50.17 30.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 122.898 -0.178 . . . . 0.0 111.445 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.54 ' HB ' ' ND2' ' C' ' 95' ' ' ASN . 5.2 t 42.57 44.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 123.744 0.652 . . . . 0.0 111.172 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . 68.44 -42.37 0.47 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.892 0.877 . . . . 0.0 113.094 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . 0.54 ' ND2' ' HB ' ' C' ' 93' ' ' VAL . 8.9 p30 -65.05 -23.85 67.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -172.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.99 2.85 22.05 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -146.32 -57.69 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -83.7 48.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.572 0.701 . . . . 0.0 110.488 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.29 92.4 3.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.329 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.4 -3.87 19.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.361 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -66.26 -33.22 75.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.003 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt 48.31 64.9 1.48 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 171.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . . . . . . . . . 70.6 m 57.69 38.43 27.57 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.349 0.595 . . . . 0.0 110.875 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 3.5 t -49.52 122.0 5.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.077 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.58 -95.75 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.431 173.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -127.74 19.09 6.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.58 0.229 . . . . 0.0 111.499 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' C' ' 110' ' ' LEU . 14.2 p -71.93 -56.45 5.66 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.192 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 23.1 mt 53.91 63.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.463 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 75.3 p 57.37 13.93 1.97 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.929 0.892 . . . . 0.0 113.116 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' C' ' 107' ' ' THR . 3.8 mm? -110.9 72.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.335 0.588 . . . . 0.0 110.049 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 18.3 p -106.74 72.01 0.88 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.329 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.64 31.97 35.04 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.119 -175.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' C' ' 110' ' ' LEU . . . -106.93 -1.29 22.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.705 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 39.9 t 44.74 73.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 123.853 0.721 . . . . 0.0 111.998 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 58.5 p 53.32 13.47 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.45 -2.69 27.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.855 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 77.4 p -84.78 -9.89 57.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.902 0.851 . . . . 0.0 111.257 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 60.41 25.31 14.85 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.581 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.9 t 67.76 13.62 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.524 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -79.26 -9.81 59.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 110.185 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -86.27 -9.94 55.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.022 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.46 123.39 7.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.592 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 20.2 p -119.11 21.63 12.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.034 0.445 . . . . 0.0 110.409 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.54 94.66 0.19 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.424 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 62.08 26.78 16.15 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.556 0.343 . . . . 0.0 111.211 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.96 111.57 20.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 73.8 p 52.74 -85.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.43 1.081 . . . . 0.0 112.893 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 35.9 mt 60.97 61.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.884 0.85 . . . . 0.0 109.835 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -127.21 39.47 3.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.039 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 1.7 p -72.61 82.19 1.12 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.863 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 31.3 p -79.7 -8.64 59.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.495 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 20.0 m -141.33 44.9 1.75 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.12 127.38 27.21 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.982 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 12.7 t . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.274 -179.593 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.927 0.394 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.36 63.39 4.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.394 0.616 . . . . 0.0 109.919 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.91 108.68 19.57 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.203 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.16 0.82 7.95 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.479 2.119 . . . . 0.0 112.285 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.85 -29.83 63.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.299 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -148.45 146.17 28.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.535 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' C' ' 8' ' ' PRO . 10.5 t -151.73 135.98 9.95 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 175.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 7' ' ' THR . 17.3 Cg_exo -66.76 97.6 0.39 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.432 2.088 . . . . 0.0 112.134 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 14.0 m -69.65 -19.86 63.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.479 0.657 . . . . 0.0 109.719 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -90.55 109.14 32.05 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.49 ' C ' HD22 ' C' ' 12' ' ' LEU . 72.8 Cg_endo -79.72 101.42 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.674 1.583 . . . . 0.0 112.017 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.49 HD22 ' C ' ' C' ' 11' ' ' PRO . 3.4 mm? -133.39 111.4 10.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.627 ' HA ' ' CG2' ' C' ' 87' ' ' THR . 30.0 m-85 -105.42 164.0 12.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.637 -170.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -107.44 -176.88 3.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.586 ' CG ' ' HB ' ' C' ' 19' ' ' VAL . 0.0 OUTLIER -120.92 -164.35 1.1 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' C' ' 15' ' ' ASP . . . -61.54 -35.87 78.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -174.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.21 -11.87 12.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.3 20.04 2.05 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.935 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.586 ' HB ' ' CG ' ' C' ' 15' ' ' ASP . 55.4 t -70.05 131.35 34.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -82.31 141.5 32.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.779 0.799 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.81 140.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 113.984 -1.462 . . . . 0.0 109.368 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 19.1 m -98.59 143.35 29.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' C' ' 67' ' ' PHE . . . -106.5 132.75 52.16 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.712 0.768 . . . . 0.0 111.248 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.519 ' N ' HD12 ' C' ' 24' ' ' LEU . 3.3 mp -101.39 99.4 11.12 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.834 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 23' ' ' ALA . 22.2 Cg_exo -64.99 105.64 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.699 2.266 . . . . 0.0 112.371 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' C' ' 66' ' ' LEU . 16.9 mt -73.25 110.88 7.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -98.1 -43.63 6.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.938 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.31 162.33 30.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -139.52 134.3 39.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' C' ' 30' ' ' LYS . 7.4 mmpt? -91.55 90.07 7.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.222 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -76.5 101.18 5.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.048 0.452 . . . . 0.0 110.276 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.02 140.07 29.99 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.617 0.723 . . . . 0.0 110.329 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -63.63 -17.99 63.47 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.93 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -71.98 -18.48 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 110.805 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.5 -47.93 0.99 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.066 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 77.2 p -70.41 176.71 3.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.328 0.585 . . . . 0.0 110.969 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' C' ' 49' ' ' TYR . . . -155.14 -164.47 1.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.061 -178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.601 ' HB2' ' HA ' ' C' ' 48' ' ' GLN . 2.6 p30 -166.83 145.33 5.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 168.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' ALA . . . . . 0.671 ' O ' ' HA ' ' C' ' 47' ' ' ASP . . . -103.61 135.39 45.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -102.45 119.58 39.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.476 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -111.75 144.31 41.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 0.0 110.742 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.72 -25.91 44.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.706 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.07 -178.92 48.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.502 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.52 67.47 3.67 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.686 2.257 . . . . 0.0 111.524 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -136.25 -174.42 3.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.752 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.87 168.45 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.354 1.073 . . . . 0.0 113.83 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' C' ' 39' ' ' ALA . 16.2 p-10 -148.22 51.33 1.02 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 108.018 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' GLN . . . . . 0.601 ' HA ' ' HB2' ' C' ' 38' ' ' ASN . 28.0 mt-30 -163.99 144.35 8.33 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -157.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' TYR . . . . . 0.604 ' HB2' ' O ' ' C' ' 37' ' ' ALA . 9.2 m-85 -148.06 -166.76 2.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 160.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -179.02 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.439 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' SER . . . . . 0.407 ' O ' HG23 ' C' ' 55' ' ' VAL . 3.9 p -86.66 105.76 17.13 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.295 0.569 . . . . 0.0 111.477 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.78 82.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.732 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -59.14 -35.33 73.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.392 0.615 . . . . 0.0 110.183 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 41.8 m -77.48 -41.0 41.13 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.286 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' C' ' 59' ' ' LYS . 85.9 t -74.83 -14.75 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.936 -177.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.12 -36.52 58.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.7 -30.18 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.268 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -103.38 14.57 31.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.843 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' C' ' 55' ' ' VAL . 24.8 pttm -60.09 119.89 45.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.034 0.445 . . . . 0.0 111.148 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' C' ' 59' ' ' LYS . 59.8 Cg_endo -97.54 -150.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.362 2.708 . . . . 0.0 110.579 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -135.42 157.57 46.55 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 95.0 t -87.67 105.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.197 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.08 -19.63 5.44 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.135 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.5 -171.76 47.35 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.315 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.49 107.78 15.18 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.991 0.424 . . . . 0.0 110.723 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.478 HD23 HD22 ' C' ' 24' ' ' LEU . 37.1 tp -78.67 152.28 31.75 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' C' ' 74' ' ' LEU . 50.1 p90 -146.0 151.3 37.56 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.538 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' C' ' 73' ' ' GLU . 38.3 ttm180 -143.69 140.09 29.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.303 -174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p -103.27 170.78 7.75 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.191 0.519 . . . . 0.0 110.576 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -65.9 -21.41 66.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.398 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -81.36 -6.87 59.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.549 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.24 12.2 56.49 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.646 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' C' ' 68' ' ' ARG . 34.5 tt0 -87.5 121.48 29.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' C' ' 67' ' ' PHE . 1.6 pt? -131.55 139.41 49.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.074 0.464 . . . . 0.0 111.249 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' C' ' 67' ' ' PHE . 93.4 mt -153.1 169.27 23.35 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -120.31 145.57 46.96 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.399 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 44.9 tpp -157.85 144.94 18.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.403 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -64.05 129.58 40.57 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -62.51 -27.59 69.25 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.734 -167.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -56.11 -39.59 72.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.823 0.344 . . . . 0.0 111.876 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.42 -44.07 22.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.989 0.423 . . . . 0.0 111.189 -178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.8 -27.19 36.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.411 -172.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.42 -32.32 62.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.982 0.42 . . . . 0.0 110.191 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' C' ' 88' ' ' SER . . . -74.61 -62.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.528 -171.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -75.12 -25.31 58.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -96.2 -57.69 2.27 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' THR . . . . . 0.627 ' CG2' ' HA ' ' C' ' 13' ' ' TYR . 20.4 p -84.18 -43.87 14.52 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.797 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' C' ' 84' ' ' ALA . 56.0 m -75.83 -19.78 58.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.69 32.94 6.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.656 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 12.4 t 62.55 -160.72 0.3 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.576 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.02 -75.42 0.77 Allowed Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.824 176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 51.9 m -137.6 88.34 2.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.012 0.434 . . . . 0.0 111.375 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 80.0 t -89.5 -61.9 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.216 0.531 . . . . 0.0 109.576 175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.54 24.21 0.46 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.867 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -117.05 -56.62 2.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.757 -170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.55 -36.7 51.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.076 0.465 . . . . 0.0 112.253 -173.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.7 40.03 3.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.606 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' THR . . . . . . . . . . . . . 15.0 t 41.33 42.15 1.71 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.246 1.018 . . . . 0.0 113.671 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' ALA . . . . . . . . . . . . . . . 62.78 84.49 0.14 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 112.264 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.86 -24.35 66.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.098 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.93 -17.83 63.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -177.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' LEU . . . . . . . . . . . . . 96.8 mt 54.87 45.86 25.67 Favored 'General case' 0 C--N 1.335 -0.023 0 CA-C-O 121.088 0.471 . . . . 0.0 110.039 -175.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' SER . . . . . 0.662 ' HA ' ' OG1' ' C' ' 107' ' ' THR . 21.1 t -135.59 46.42 2.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.601 0.715 . . . . 0.0 109.594 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' THR . . . . . . . . . . . . . 4.5 p -69.63 -77.77 0.08 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.968 -1.014 . . . . 0.0 113.156 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.35 23.69 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -144.84 -48.27 0.25 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.297 0.57 . . . . 0.0 110.283 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.662 ' OG1' ' HA ' ' C' ' 103' ' ' SER . 2.8 p -82.98 169.2 16.25 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.396 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' ILE . . . . . . . . . . . . . 34.1 mt -137.22 77.29 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' THR . . . . . . . . . . . . . 38.4 p 49.15 76.76 0.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.168 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' LEU . . . . . 0.656 ' H ' HD22 ' C' ' 110' ' ' LEU . 2.7 mm? -54.65 -42.66 71.55 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.697 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' THR . . . . . . . . . . . . . 25.2 p 50.84 -93.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.944 0.898 . . . . 0.0 112.237 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -98.97 -64.98 0.84 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.925 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -154.55 147.74 24.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.03 124.53 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.036 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.5 p -79.09 52.21 1.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.103 0.478 . . . . 0.0 111.968 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 -64.11 0.16 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' SER . . . . . . . . . . . . . 13.4 t -135.06 18.64 3.44 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . 71.29 -35.26 0.32 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.872 0.869 . . . . 0.0 112.249 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.8 m -62.06 153.42 29.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.67 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.97 171.69 8.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.104 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -163.27 153.43 15.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.03 -60.85 4.75 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.426 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' SER . . . . . . . . . . . . . 24.0 p 46.62 71.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.372 0.669 . . . . 0.0 111.402 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' C' ' 125' ' ' ASN . . . 70.39 -58.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.284 -176.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' C' ' 124' ' ' ALA . 3.5 p-10 170.43 -18.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.605 0.762 . . . . 0.0 109.224 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.85 87.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.361 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.13 79.67 6.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.211 0.529 . . . . 0.0 111.364 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 47.9 mt -70.88 -31.36 45.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -93.08 133.21 36.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.423 -177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 42.5 p -89.04 19.18 4.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.207 0.527 . . . . 0.0 110.43 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' THR . . . . . . . . . . . . . 10.7 p -80.84 15.58 1.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.317 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' SER . . . . . . . . . . . . . 11.3 p -114.64 0.11 13.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -102.33 110.83 3.87 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.823 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.337 -0.84 . . . . 0.0 109.527 -178.816 . . . . . . . . 0 0 . 1 stop_ save_